<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:dcterms="http://purl.org/dc/terms/"
 xmlns:cc="http://web.resource.org/cc/"
 xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/"
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns:admin="http://webns.net/mvcb/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/">
    <channel rdf:about="https://www.mdpi.com/rss/journal/cosmetics">
		<title>Cosmetics</title>
		<description>Latest open access articles published in Cosmetics at https://www.mdpi.com/journal/cosmetics</description>
		<link>https://www.mdpi.com/journal/cosmetics</link>
		<admin:generatorAgent rdf:resource="https://www.mdpi.com/journal/cosmetics"/>
		<admin:errorReportsTo rdf:resource="mailto:support@mdpi.com"/>
		<dc:publisher>MDPI</dc:publisher>
		<dc:language>en</dc:language>
		<dc:rights>Creative Commons Attribution (CC-BY)</dc:rights>
						<prism:copyright>MDPI</prism:copyright>
		<prism:rightsAgent>support@mdpi.com</prism:rightsAgent>
        						<items>
			<rdf:Seq>
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/315" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/314" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/313" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/312" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/311" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/310" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/309" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/308" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/307" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/306" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/305" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/304" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/303" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/302" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/301" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/300" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/299" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/298" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/297" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/296" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/295" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/294" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/293" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/292" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/291" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/290" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/289" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/288" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/287" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/286" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/285" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/6/284" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/282" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/283" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/281" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/280" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/279" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/278" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/277" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/276" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/275" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/274" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/273" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/272" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/271" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/270" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/269" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/268" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/267" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/266" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/265" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/264" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/263" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/262" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/261" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/260" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/259" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/258" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/257" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/256" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/255" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/254" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/253" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/252" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/251" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/250" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/249" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/248" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/247" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/246" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/245" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/244" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/243" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/242" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/241" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/240" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/239" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/238" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/237" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/236" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/235" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/234" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/233" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/232" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/231" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/230" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/229" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/228" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/227" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/226" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/225" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/224" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/223" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/222" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/221" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/220" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/219" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/218" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/217" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2079-9284/13/5/216" />
                    	</rdf:Seq>
		</items>
				<cc:license rdf:resource="https://creativecommons.org/licenses/by/4.0/" />
	</channel>

        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/315">

	<title>Cosmetics, Vol. 13, Pages 315: Evaluation of the Effect of PRP Injections on Changes in Facial Skin Structures Assessed by Ultrasound Imaging</title>
	<link>https://www.mdpi.com/2079-9284/13/6/315</link>
	<description>The aim of this study was to evaluate the efficacy of platelet-rich plasma (PRP) injections into the facial skin in women based on facial skin ultrasound findings. The study included 50 women who underwent intradermal PRP injections into the facial skin for the first time. All patients underwent an ultrasound scan of the facial soft tissues and a skin assessment using a 3D skin analyzer both before the procedure and one month afterwards. Positive changes in the ultrasound parameters of the facial soft tissues were observed. The median thickness of the dermis increased by 30.8% in the forehead region, by 29.6% in the mid-cheek region and by 17.4% in the parotid region (p &amp;amp;lt; 0.05). The thickness of the subcutaneous fat layer increased by 37.1%, 14.0% and 25.0% respectively (p &amp;amp;lt; 0.05). The thickness of the subepidermal low-echogenic band decreased by 16.7% in the forehead region, by 8.3% in the mid-cheek region and by 16.7% in the parotid region; statistically significant changes were observed in the mid-cheek (p = 0.0299) and parotid regions (p = 0.036). High-frequency ultrasound enabled the quantitative assessment of short-term changes in facial soft tissue parameters following PRP administration. However, these findings represent ultrasound-derived morphometric changes and do not independently establish the presence of tissue regeneration or a treatment-specific biological effect.</description>
	<pubDate>2026-11-13</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 315: Evaluation of the Effect of PRP Injections on Changes in Facial Skin Structures Assessed by Ultrasound Imaging</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/315">doi: 10.3390/cosmetics13060315</a></p>
	<p>Authors:
		Alina Koshkinbayeva
		Alina Ogizbayeva
		Olga Ponamareva
		Bauyrzhan Omarkulov
		</p>
	<p>The aim of this study was to evaluate the efficacy of platelet-rich plasma (PRP) injections into the facial skin in women based on facial skin ultrasound findings. The study included 50 women who underwent intradermal PRP injections into the facial skin for the first time. All patients underwent an ultrasound scan of the facial soft tissues and a skin assessment using a 3D skin analyzer both before the procedure and one month afterwards. Positive changes in the ultrasound parameters of the facial soft tissues were observed. The median thickness of the dermis increased by 30.8% in the forehead region, by 29.6% in the mid-cheek region and by 17.4% in the parotid region (p &amp;amp;lt; 0.05). The thickness of the subcutaneous fat layer increased by 37.1%, 14.0% and 25.0% respectively (p &amp;amp;lt; 0.05). The thickness of the subepidermal low-echogenic band decreased by 16.7% in the forehead region, by 8.3% in the mid-cheek region and by 16.7% in the parotid region; statistically significant changes were observed in the mid-cheek (p = 0.0299) and parotid regions (p = 0.036). High-frequency ultrasound enabled the quantitative assessment of short-term changes in facial soft tissue parameters following PRP administration. However, these findings represent ultrasound-derived morphometric changes and do not independently establish the presence of tissue regeneration or a treatment-specific biological effect.</p>
	]]></content:encoded>

	<dc:title>Evaluation of the Effect of PRP Injections on Changes in Facial Skin Structures Assessed by Ultrasound Imaging</dc:title>
			<dc:creator>Alina Koshkinbayeva</dc:creator>
			<dc:creator>Alina Ogizbayeva</dc:creator>
			<dc:creator>Olga Ponamareva</dc:creator>
			<dc:creator>Bauyrzhan Omarkulov</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060315</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-11-13</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-11-13</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>315</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060315</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/315</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/314">

	<title>Cosmetics, Vol. 13, Pages 314: Plant-Derived Bioactives in Skin Microbiology: A Narrative Review of Current Evidence on Bakuchiol, Berberine and EGCG</title>
	<link>https://www.mdpi.com/2079-9284/13/6/314</link>
	<description>The skin microbiome contributes to cutaneous barrier function and immune homeostasis, while microbial dysbiosis is associated with inflammatory skin disorders. This narrative review examines preclinical and clinical evidence concerning bakuchiol, berberine, and epigallocatechin-3-gallate, distinguishing direct antimicrobial activity, modulation of host inflammatory responses, and changes in resident microbial communities. Preclinical investigations report activity against selected skin-associated pathogens, attenuation of inflammatory pathways, and improvements in experimental skin inflammation or wound healing. Clinical studies suggest benefits for acne, photoaging-related outcomes, and radiation-induced dermatitis, although differences in study design, administration route, and multicomponent formulations limit compound-specific conclusions. These observations do not establish restoration of skin microbial homeostasis by the unmodified compounds. Overall, antimicrobial and anti-inflammatory effects should not be equated with selective microbiome modulation. Standardized longitudinal studies combining microbial profiling, skin-barrier assessment, and validated dermatological outcomes are needed to establish clinical relevance.</description>
	<pubDate>2026-11-12</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 314: Plant-Derived Bioactives in Skin Microbiology: A Narrative Review of Current Evidence on Bakuchiol, Berberine and EGCG</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/314">doi: 10.3390/cosmetics13060314</a></p>
	<p>Authors:
		Diana Uțu
		Sergio Liga
		Ion-Dragoş Uțu
		</p>
	<p>The skin microbiome contributes to cutaneous barrier function and immune homeostasis, while microbial dysbiosis is associated with inflammatory skin disorders. This narrative review examines preclinical and clinical evidence concerning bakuchiol, berberine, and epigallocatechin-3-gallate, distinguishing direct antimicrobial activity, modulation of host inflammatory responses, and changes in resident microbial communities. Preclinical investigations report activity against selected skin-associated pathogens, attenuation of inflammatory pathways, and improvements in experimental skin inflammation or wound healing. Clinical studies suggest benefits for acne, photoaging-related outcomes, and radiation-induced dermatitis, although differences in study design, administration route, and multicomponent formulations limit compound-specific conclusions. These observations do not establish restoration of skin microbial homeostasis by the unmodified compounds. Overall, antimicrobial and anti-inflammatory effects should not be equated with selective microbiome modulation. Standardized longitudinal studies combining microbial profiling, skin-barrier assessment, and validated dermatological outcomes are needed to establish clinical relevance.</p>
	]]></content:encoded>

	<dc:title>Plant-Derived Bioactives in Skin Microbiology: A Narrative Review of Current Evidence on Bakuchiol, Berberine and EGCG</dc:title>
			<dc:creator>Diana Uțu</dc:creator>
			<dc:creator>Sergio Liga</dc:creator>
			<dc:creator>Ion-Dragoş Uțu</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060314</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-11-12</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-11-12</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>314</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060314</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/314</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/313">

	<title>Cosmetics, Vol. 13, Pages 313: Multidimensional Evaluation of a Dual-Compartment Sheet Mask for Skin Whitening and Repair of UV-Induced Erythema and Pigmentation: Human Efficacy Assessment and In Vitro Evidence</title>
	<link>https://www.mdpi.com/2079-9284/13/6/313</link>
	<description>Skin hyperpigmentation and ultraviolet (UV)-induced photodamage represent prevalent cosmetic concerns that demand safe and effective topical intervention strategies. This study evaluated the skin-whitening, pigmentation-improving, and post-UV repair efficacy of a novel dual-compartment sheet mask (DCSM) formulated with eight complementary depigmenting ingredients, namely niacinamide, &amp;amp;alpha;-arbutin, glabridin, hexylresorcinol, ascorbyl tetraisopalmitate (VC-IP), paeonol, Camellia japonica flower extract and Ormosia henryi bark extract, through two independent human efficacy studies and in vitro cell experiments. In a 28-day, self-controlled human efficacy study (Cohort 1; n = 32), regular DCSM use was associated with significant increases in the individual typology angle (ITA), significant decreases in the b* value, significant reductions in H-channel standard deviation (H-SD), significant decreases in the melanin index (MI), and significant diminishment of pigment spot area and optical density, suggesting progressive and sustained improvements in skin tone, uniformity, and pigmentation. In a separate UV-induced skin erythema model (Cohort 2; n = 30), seven days of daily DCSM application significantly attenuated UV-induced increases in MI, erythema index (EI), and a* value while promoting recovery of skin lightness (ITA) relative to untreated control sites, indicating effective post-sun erythema alleviation and pigmentation suppression. In vitro, treatment of &amp;amp;alpha;-MSH-stimulated A-875 human melanoma cells with 5% (v/v) DCSM emulsion significantly suppressed intracellular melanin synthesis at a non-cytotoxic concentration, providing supportive evidence consistent with the human efficacy findings observed in vivo. Collectively, these multidimensional findings indicate that DCSM use was associated with improvements in skin hyperpigmentation, an even skin tone, and facilitated recovery from UV-induced photodamage, supporting its potential as a cosmetic intervention for pigmentation regulation and post-sun skin repair.</description>
	<pubDate>2026-11-12</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 313: Multidimensional Evaluation of a Dual-Compartment Sheet Mask for Skin Whitening and Repair of UV-Induced Erythema and Pigmentation: Human Efficacy Assessment and In Vitro Evidence</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/313">doi: 10.3390/cosmetics13060313</a></p>
	<p>Authors:
		Ruomei Han
		Dandan Chen
		Xuelian Lu
		Guo Yu
		Xiangzhen Kong
		Xijun Bao
		</p>
	<p>Skin hyperpigmentation and ultraviolet (UV)-induced photodamage represent prevalent cosmetic concerns that demand safe and effective topical intervention strategies. This study evaluated the skin-whitening, pigmentation-improving, and post-UV repair efficacy of a novel dual-compartment sheet mask (DCSM) formulated with eight complementary depigmenting ingredients, namely niacinamide, &amp;amp;alpha;-arbutin, glabridin, hexylresorcinol, ascorbyl tetraisopalmitate (VC-IP), paeonol, Camellia japonica flower extract and Ormosia henryi bark extract, through two independent human efficacy studies and in vitro cell experiments. In a 28-day, self-controlled human efficacy study (Cohort 1; n = 32), regular DCSM use was associated with significant increases in the individual typology angle (ITA), significant decreases in the b* value, significant reductions in H-channel standard deviation (H-SD), significant decreases in the melanin index (MI), and significant diminishment of pigment spot area and optical density, suggesting progressive and sustained improvements in skin tone, uniformity, and pigmentation. In a separate UV-induced skin erythema model (Cohort 2; n = 30), seven days of daily DCSM application significantly attenuated UV-induced increases in MI, erythema index (EI), and a* value while promoting recovery of skin lightness (ITA) relative to untreated control sites, indicating effective post-sun erythema alleviation and pigmentation suppression. In vitro, treatment of &amp;amp;alpha;-MSH-stimulated A-875 human melanoma cells with 5% (v/v) DCSM emulsion significantly suppressed intracellular melanin synthesis at a non-cytotoxic concentration, providing supportive evidence consistent with the human efficacy findings observed in vivo. Collectively, these multidimensional findings indicate that DCSM use was associated with improvements in skin hyperpigmentation, an even skin tone, and facilitated recovery from UV-induced photodamage, supporting its potential as a cosmetic intervention for pigmentation regulation and post-sun skin repair.</p>
	]]></content:encoded>

	<dc:title>Multidimensional Evaluation of a Dual-Compartment Sheet Mask for Skin Whitening and Repair of UV-Induced Erythema and Pigmentation: Human Efficacy Assessment and In Vitro Evidence</dc:title>
			<dc:creator>Ruomei Han</dc:creator>
			<dc:creator>Dandan Chen</dc:creator>
			<dc:creator>Xuelian Lu</dc:creator>
			<dc:creator>Guo Yu</dc:creator>
			<dc:creator>Xiangzhen Kong</dc:creator>
			<dc:creator>Xijun Bao</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060313</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-11-12</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-11-12</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>313</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060313</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/313</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/312">

	<title>Cosmetics, Vol. 13, Pages 312: Efficacy of Non-Invasive Technological Regenerative Aesthetic Medicine for the Face and Neck: A Cohort Study</title>
	<link>https://www.mdpi.com/2079-9284/13/6/312</link>
	<description>Background: Combined high-intensity focused ultrasound (HIFU) and dynamic quadripolar radiofrequency (DQRF) represent non-invasive energy-based technologies increasingly used in facial and neck rejuvenation. These approaches aim to improve skin laxity, wrinkles, and overall skin quality by stimulating dermal remodeling and neocollagenesis, while minimizing downtime and adverse effects. Given the multifactorial nature of facial aging, the need for standardized clinical evaluation of combined regenerative approaches remains relevant. Materials and Methods: This cohort study included 20 of the 28 patients initially enrolled, who successfully completed the combined HIFU and DQRF treatments according to a predefined protocol with multiple sessions and follow-up assessments over one year. Participants were stratified into three age groups (25&amp;amp;ndash;40, 41&amp;amp;ndash;55, 56&amp;amp;ndash;70 years). Outcomes were evaluated using validated patient-reported measures (FACE-Q, FLO-11, FLSQ, SGA, FTS) and standardized photographic analysis. Objective wrinkle and photoaging assessment was performed using validated scales including FWS, Fitzpatrick Wrinkle Classification, WAS, and Griffiths Photonumeric Scale. Safety and tolerability were also monitored throughout the study. Results: Overall, both subjective and objective outcomes showed consistent improvement across all age groups. The most pronounced clinical and patient-reported benefits were observed in the 41&amp;amp;ndash;55-year group, which showed the highest response across FACE-Q improvements and photographic score reductions. The 25&amp;amp;ndash;40-year group showed mild but consistent improvements, while the 56&amp;amp;ndash;70-year group exhibited moderate but less marked changes, despite higher baseline severity. Photographic analysis confirmed reductions in wrinkle depth and photoaging indices across all cohorts. Patient-reported outcomes indicated increased satisfaction, improved perceived facial freshness, and reduced wrinkle-related concerns. No clinically relevant adverse events were reported. Conclusions: The combined use of HIFU and DQRF appears to be a safe and potentially effective non-invasive approach for facial and neck rejuvenation, with an age-dependent response pattern favoring mid-age patients. Results support the role of energy-based regenerative technologies in aesthetic medicine, although further controlled studies with larger samples are required to confirm efficacy, optimize protocols, and refine patient selection.</description>
	<pubDate>2026-11-11</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 312: Efficacy of Non-Invasive Technological Regenerative Aesthetic Medicine for the Face and Neck: A Cohort Study</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/312">doi: 10.3390/cosmetics13060312</a></p>
	<p>Authors:
		Ornella Rossi
		Giovanna Perrotti
		Massimo Del Fabbro
		Tiziano Testori
		</p>
	<p>Background: Combined high-intensity focused ultrasound (HIFU) and dynamic quadripolar radiofrequency (DQRF) represent non-invasive energy-based technologies increasingly used in facial and neck rejuvenation. These approaches aim to improve skin laxity, wrinkles, and overall skin quality by stimulating dermal remodeling and neocollagenesis, while minimizing downtime and adverse effects. Given the multifactorial nature of facial aging, the need for standardized clinical evaluation of combined regenerative approaches remains relevant. Materials and Methods: This cohort study included 20 of the 28 patients initially enrolled, who successfully completed the combined HIFU and DQRF treatments according to a predefined protocol with multiple sessions and follow-up assessments over one year. Participants were stratified into three age groups (25&amp;amp;ndash;40, 41&amp;amp;ndash;55, 56&amp;amp;ndash;70 years). Outcomes were evaluated using validated patient-reported measures (FACE-Q, FLO-11, FLSQ, SGA, FTS) and standardized photographic analysis. Objective wrinkle and photoaging assessment was performed using validated scales including FWS, Fitzpatrick Wrinkle Classification, WAS, and Griffiths Photonumeric Scale. Safety and tolerability were also monitored throughout the study. Results: Overall, both subjective and objective outcomes showed consistent improvement across all age groups. The most pronounced clinical and patient-reported benefits were observed in the 41&amp;amp;ndash;55-year group, which showed the highest response across FACE-Q improvements and photographic score reductions. The 25&amp;amp;ndash;40-year group showed mild but consistent improvements, while the 56&amp;amp;ndash;70-year group exhibited moderate but less marked changes, despite higher baseline severity. Photographic analysis confirmed reductions in wrinkle depth and photoaging indices across all cohorts. Patient-reported outcomes indicated increased satisfaction, improved perceived facial freshness, and reduced wrinkle-related concerns. No clinically relevant adverse events were reported. Conclusions: The combined use of HIFU and DQRF appears to be a safe and potentially effective non-invasive approach for facial and neck rejuvenation, with an age-dependent response pattern favoring mid-age patients. Results support the role of energy-based regenerative technologies in aesthetic medicine, although further controlled studies with larger samples are required to confirm efficacy, optimize protocols, and refine patient selection.</p>
	]]></content:encoded>

	<dc:title>Efficacy of Non-Invasive Technological Regenerative Aesthetic Medicine for the Face and Neck: A Cohort Study</dc:title>
			<dc:creator>Ornella Rossi</dc:creator>
			<dc:creator>Giovanna Perrotti</dc:creator>
			<dc:creator>Massimo Del Fabbro</dc:creator>
			<dc:creator>Tiziano Testori</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060312</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-11-11</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-11-11</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>312</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060312</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/312</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/311">

	<title>Cosmetics, Vol. 13, Pages 311: Microbiome-Related Cosmetic Products in Selected Latin American Countries: Market Analysis, Claim&amp;ndash;Ingredient Alignment, Terminological Inconsistencies and Regulatory Challenges</title>
	<link>https://www.mdpi.com/2079-9284/13/6/311</link>
	<description>Rapid growth in microbiome-oriented cosmetics has resulted in the increased use of bioactive compounds with prebiotic, probiotic, postbiotic and microbiome-friendly marketing claims. However, inconsistencies in terminology, formulation practices and regulatory requirements result in some products being launched with claims that are not adequately aligned with the scientific and performance characteristics of the ingredients. Analysis was conducted on 264 products that were launched between December 2024 and December 2025 across selected Latin American countries which stated prebiotic, probiotic, postbiotic and skin microbiome claims on the label. A surprising finding was the substantial terminology mismatch between label claims and ingredients used; only 163 products were found to be consistent, i.e., a prebiotic claim and prebiotic ingredient. The remaining 101 products showed various inconsistencies, including 43 products making prebiotic or probiotic claims that contain no relevant ingredients. We also identified potentially microbiome-disruptive preservatives and surfactants in products that are marketed as microbiome-friendly. This study has shown that there is a growing market for cosmetic products with &amp;amp;lsquo;microbiome&amp;amp;rsquo; claims but also highlights that there are discrepancies between marketing claims and the ingredients used. Future development of products in this area should focus on accurate marketing terminology and ingredient choice (e.g., if you are claiming a &amp;amp;lsquo;prebiotic&amp;amp;rsquo;, then you should use a prebiotic ingredient in the product). Establishing harmonised definitions and validated methodologies and applying clear regulatory guidance across Brazil and the rest of Latin America would help with scientific credibility and consumer protection.</description>
	<pubDate>2026-11-11</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 311: Microbiome-Related Cosmetic Products in Selected Latin American Countries: Market Analysis, Claim&amp;ndash;Ingredient Alignment, Terminological Inconsistencies and Regulatory Challenges</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/311">doi: 10.3390/cosmetics13060311</a></p>
	<p>Authors:
		Vanessa Alves Arruda
		Laiara Torres
		Rafael Chelala Moreira
		Juliano Lemos Bicas
		Gislaine Ricci Leonardi
		</p>
	<p>Rapid growth in microbiome-oriented cosmetics has resulted in the increased use of bioactive compounds with prebiotic, probiotic, postbiotic and microbiome-friendly marketing claims. However, inconsistencies in terminology, formulation practices and regulatory requirements result in some products being launched with claims that are not adequately aligned with the scientific and performance characteristics of the ingredients. Analysis was conducted on 264 products that were launched between December 2024 and December 2025 across selected Latin American countries which stated prebiotic, probiotic, postbiotic and skin microbiome claims on the label. A surprising finding was the substantial terminology mismatch between label claims and ingredients used; only 163 products were found to be consistent, i.e., a prebiotic claim and prebiotic ingredient. The remaining 101 products showed various inconsistencies, including 43 products making prebiotic or probiotic claims that contain no relevant ingredients. We also identified potentially microbiome-disruptive preservatives and surfactants in products that are marketed as microbiome-friendly. This study has shown that there is a growing market for cosmetic products with &amp;amp;lsquo;microbiome&amp;amp;rsquo; claims but also highlights that there are discrepancies between marketing claims and the ingredients used. Future development of products in this area should focus on accurate marketing terminology and ingredient choice (e.g., if you are claiming a &amp;amp;lsquo;prebiotic&amp;amp;rsquo;, then you should use a prebiotic ingredient in the product). Establishing harmonised definitions and validated methodologies and applying clear regulatory guidance across Brazil and the rest of Latin America would help with scientific credibility and consumer protection.</p>
	]]></content:encoded>

	<dc:title>Microbiome-Related Cosmetic Products in Selected Latin American Countries: Market Analysis, Claim&amp;amp;ndash;Ingredient Alignment, Terminological Inconsistencies and Regulatory Challenges</dc:title>
			<dc:creator>Vanessa Alves Arruda</dc:creator>
			<dc:creator>Laiara Torres</dc:creator>
			<dc:creator>Rafael Chelala Moreira</dc:creator>
			<dc:creator>Juliano Lemos Bicas</dc:creator>
			<dc:creator>Gislaine Ricci Leonardi</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060311</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-11-11</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-11-11</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>311</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060311</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/311</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/310">

	<title>Cosmetics, Vol. 13, Pages 310: Reduction of Hair Damage by Biomimetic Amino Acids and Wool Keratin Pretreatments</title>
	<link>https://www.mdpi.com/2079-9284/13/6/310</link>
	<description>Hair care pretreatments may limit the structural changes caused by chemical, thermal, and ultraviolet (UV) damage. We examined whether biomimetic amino acid (AA) and wool keratin (WK) pretreatments reduced these forms of hair damage. Virgin black human hair fibers were treated with 1% (w/w) AA or WK, washed with sodium laureth sulfate, and then subjected to oxidative bleaching, flat-iron treatment, or UV irradiation. Cuticular morphology was examined by scanning electron microscopy (SEM) and graded using a damage score. Cortical ultrastructure was assessed by transmission electron microscopy (TEM), and the cortical void-like area fraction was measured by quantitative image analysis. Across the three exposure protocols, fibers pretreated with AA or WK showed more continuous cuticular coverage and lower SEM damage scores than non-pretreated fibers exposed to the same conditions. Their cortical matrices were also more continuous, and their cortical void-like area fractions were lower (adjusted p &amp;amp;lt; 0.05). Together, these findings indicate a reduced severity of cuticular and cortical changes relative to the corresponding damage-only group.</description>
	<pubDate>2026-11-11</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 310: Reduction of Hair Damage by Biomimetic Amino Acids and Wool Keratin Pretreatments</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/310">doi: 10.3390/cosmetics13060310</a></p>
	<p>Authors:
		Yifei Song
		Yue Wang
		Xinru Wang
		Ling Ge
		Xian Cui
		Shuang Chen
		Mei Chen
		Xi Li
		Yaoyao Wu
		Xiaowei Chang
		Jingbi Meng
		Longquan Pi
		</p>
	<p>Hair care pretreatments may limit the structural changes caused by chemical, thermal, and ultraviolet (UV) damage. We examined whether biomimetic amino acid (AA) and wool keratin (WK) pretreatments reduced these forms of hair damage. Virgin black human hair fibers were treated with 1% (w/w) AA or WK, washed with sodium laureth sulfate, and then subjected to oxidative bleaching, flat-iron treatment, or UV irradiation. Cuticular morphology was examined by scanning electron microscopy (SEM) and graded using a damage score. Cortical ultrastructure was assessed by transmission electron microscopy (TEM), and the cortical void-like area fraction was measured by quantitative image analysis. Across the three exposure protocols, fibers pretreated with AA or WK showed more continuous cuticular coverage and lower SEM damage scores than non-pretreated fibers exposed to the same conditions. Their cortical matrices were also more continuous, and their cortical void-like area fractions were lower (adjusted p &amp;amp;lt; 0.05). Together, these findings indicate a reduced severity of cuticular and cortical changes relative to the corresponding damage-only group.</p>
	]]></content:encoded>

	<dc:title>Reduction of Hair Damage by Biomimetic Amino Acids and Wool Keratin Pretreatments</dc:title>
			<dc:creator>Yifei Song</dc:creator>
			<dc:creator>Yue Wang</dc:creator>
			<dc:creator>Xinru Wang</dc:creator>
			<dc:creator>Ling Ge</dc:creator>
			<dc:creator>Xian Cui</dc:creator>
			<dc:creator>Shuang Chen</dc:creator>
			<dc:creator>Mei Chen</dc:creator>
			<dc:creator>Xi Li</dc:creator>
			<dc:creator>Yaoyao Wu</dc:creator>
			<dc:creator>Xiaowei Chang</dc:creator>
			<dc:creator>Jingbi Meng</dc:creator>
			<dc:creator>Longquan Pi</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060310</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-11-11</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-11-11</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>310</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060310</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/310</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/309">

	<title>Cosmetics, Vol. 13, Pages 309: FTIR- and LC-MS/MS-Identified Phytochemicals and In Vitro Cytotoxic, Antioxidant and Anti-Inflammatory Activities of Oroxylum indicum Extracts Obtained by Microwave-Assisted Extraction</title>
	<link>https://www.mdpi.com/2079-9284/13/6/309</link>
	<description>Acne vulgaris is a chronic inflammatory disorder of the pilosebaceous units. Although the overcolonization of Cutibacterium acnes is a primary contributor to acne development, acne-related inflammation is typically driven by a combination of pro-inflammatory cytokines and oxidative stress mediated by reactive oxygen species (ROS). This study aimed to screen extracts of Oroxylum indicum to assess its potential as an anti-acne candidate for cosmetic formulations. Bark (OB), leaf (OL), pod (OP), and seed (OS) extracts of O. indicum were obtained by microwave-assisted extraction (MAE) with 50% (v/v) and 70% (v/v) aqueous ethanol. The extracts were subjected to UV&amp;amp;ndash;Vis and Fourier transform infrared (FTIR) spectroscopic analyses and skin-related cytotoxicity, antioxidant, and anti-inflammatory activity assays. UV&amp;amp;ndash;Vis and FTIR spectral analyses suggested the presence of phenolic compounds in O. indicum extracts. The antioxidant (free-radical-scavenging) activity of most extracts against DPPH radicals was evident from their IC50 values ranging between 0.35 &amp;amp;plusmn; 0.06 mg/mL and 0.54 &amp;amp;plusmn; 0.04 mg/mL, while that of MAE-OB50 and MAE-OP50 was 1.04 &amp;amp;plusmn; 0.08 mg/mL and 1.06 &amp;amp;plusmn; 0.15 mg/mL, respectively. Most extracts, with the exception of the pod extracts, exhibited a low level of cytotoxicity at 200 &amp;amp;mu;g/mL in HaCaT and MRC-5 cells. Anti-inflammatory activities affecting nitric oxide (NO) production were observed in the O. indicum extracts MAE-OL50 (IC50: 128.00 &amp;amp;plusmn; 2.80 &amp;amp;mu;g/mL), MAE-OB70 (IC50: 178.72 &amp;amp;plusmn; 3.52 &amp;amp;mu;g/mL), MAE-OL70 (IC50: 126.26 &amp;amp;plusmn; 0.71 &amp;amp;mu;g/mL), and MAE-OS70 (IC50: 147.03 &amp;amp;plusmn; 0.59 &amp;amp;mu;g/mL). The predominant phytochemicals in MAE-OL50, MAE-OB70, MAE-OL70, and MAE-OS70, tentatively identified by liquid chromatography&amp;amp;ndash;tandem mass spectrometry (LC-MS/MS), belong to flavonoids and their glycosides, methoxylated flavones, isoflavones, phenolic glycosides, and sugar-related metabolites. The results suggest that O. indicum extracts could be promising candidate ingredients for cosmetic formulations targeting inflammation-associated and oxidative stress-related skin concerns, such as acne-prone skin.</description>
	<pubDate>2026-11-11</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 309: FTIR- and LC-MS/MS-Identified Phytochemicals and In Vitro Cytotoxic, Antioxidant and Anti-Inflammatory Activities of Oroxylum indicum Extracts Obtained by Microwave-Assisted Extraction</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/309">doi: 10.3390/cosmetics13060309</a></p>
	<p>Authors:
		Panisara Rachprasit
		Santi Phosri
		Sukanya Tastub
		Sarita Sangthong
		Phanuphong Chaiwut
		Lutfun Nahar
		Satyajit D. Sarker
		Tinnakorn Theansungnoen
		</p>
	<p>Acne vulgaris is a chronic inflammatory disorder of the pilosebaceous units. Although the overcolonization of Cutibacterium acnes is a primary contributor to acne development, acne-related inflammation is typically driven by a combination of pro-inflammatory cytokines and oxidative stress mediated by reactive oxygen species (ROS). This study aimed to screen extracts of Oroxylum indicum to assess its potential as an anti-acne candidate for cosmetic formulations. Bark (OB), leaf (OL), pod (OP), and seed (OS) extracts of O. indicum were obtained by microwave-assisted extraction (MAE) with 50% (v/v) and 70% (v/v) aqueous ethanol. The extracts were subjected to UV&amp;amp;ndash;Vis and Fourier transform infrared (FTIR) spectroscopic analyses and skin-related cytotoxicity, antioxidant, and anti-inflammatory activity assays. UV&amp;amp;ndash;Vis and FTIR spectral analyses suggested the presence of phenolic compounds in O. indicum extracts. The antioxidant (free-radical-scavenging) activity of most extracts against DPPH radicals was evident from their IC50 values ranging between 0.35 &amp;amp;plusmn; 0.06 mg/mL and 0.54 &amp;amp;plusmn; 0.04 mg/mL, while that of MAE-OB50 and MAE-OP50 was 1.04 &amp;amp;plusmn; 0.08 mg/mL and 1.06 &amp;amp;plusmn; 0.15 mg/mL, respectively. Most extracts, with the exception of the pod extracts, exhibited a low level of cytotoxicity at 200 &amp;amp;mu;g/mL in HaCaT and MRC-5 cells. Anti-inflammatory activities affecting nitric oxide (NO) production were observed in the O. indicum extracts MAE-OL50 (IC50: 128.00 &amp;amp;plusmn; 2.80 &amp;amp;mu;g/mL), MAE-OB70 (IC50: 178.72 &amp;amp;plusmn; 3.52 &amp;amp;mu;g/mL), MAE-OL70 (IC50: 126.26 &amp;amp;plusmn; 0.71 &amp;amp;mu;g/mL), and MAE-OS70 (IC50: 147.03 &amp;amp;plusmn; 0.59 &amp;amp;mu;g/mL). The predominant phytochemicals in MAE-OL50, MAE-OB70, MAE-OL70, and MAE-OS70, tentatively identified by liquid chromatography&amp;amp;ndash;tandem mass spectrometry (LC-MS/MS), belong to flavonoids and their glycosides, methoxylated flavones, isoflavones, phenolic glycosides, and sugar-related metabolites. The results suggest that O. indicum extracts could be promising candidate ingredients for cosmetic formulations targeting inflammation-associated and oxidative stress-related skin concerns, such as acne-prone skin.</p>
	]]></content:encoded>

	<dc:title>FTIR- and LC-MS/MS-Identified Phytochemicals and In Vitro Cytotoxic, Antioxidant and Anti-Inflammatory Activities of Oroxylum indicum Extracts Obtained by Microwave-Assisted Extraction</dc:title>
			<dc:creator>Panisara Rachprasit</dc:creator>
			<dc:creator>Santi Phosri</dc:creator>
			<dc:creator>Sukanya Tastub</dc:creator>
			<dc:creator>Sarita Sangthong</dc:creator>
			<dc:creator>Phanuphong Chaiwut</dc:creator>
			<dc:creator>Lutfun Nahar</dc:creator>
			<dc:creator>Satyajit D. Sarker</dc:creator>
			<dc:creator>Tinnakorn Theansungnoen</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060309</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-11-11</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-11-11</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>309</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060309</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/309</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/308">

	<title>Cosmetics, Vol. 13, Pages 308: Influence of Mothers&amp;rsquo; Experiences with Atopic Dermatitis on Their Children&amp;rsquo;s Skin Care Practices in the Japanese Cultural Context: Habit Formation and Intergenerational Transmission</title>
	<link>https://www.mdpi.com/2079-9284/13/6/308</link>
	<description>The study aimed to compare mothers&amp;amp;rsquo; and children&amp;amp;rsquo;s cleansing, moisturisation, and photoprotection practices between mothers with and without atopic dermatitis (AD) and explore how maternal AD experiences may be reflected in children&amp;amp;rsquo;s skin care habit formation. Semi-structured interviews were conducted with six mothers with AD and seven healthy controls (HC). Verbatim transcripts were analysed using a structured descriptive qualitative approach, supplemented by text mining. Childhood moisturisation was more frequently reported by mothers in the AD group than by HC mothers. Mothers in both groups moisturised their children from infancy; however, sustained whole-body moisturisation beyond school age was more evident in the AD group. Mothers with AD regarded moisturisation as necessary for symptom prevention and management, whereas HC mothers initiated it based primarily on parenting information. The AD group emphasised gentle, low-irritation cleansing; similar practices were reported for their children. Year-round photoprotection was not established among children in either group. Accessible product placement and parental encouragement facilitated habit formation, whereas stickiness, inconvenience, reapplication burden, and school restrictions inhibited continuation. These findings suggest that maternal AD experiences may be reflected in the development and maintenance of children&amp;amp;rsquo;s skin care practices. Larger quantitative and prospective studies are needed to test these hypotheses.</description>
	<pubDate>2026-11-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 308: Influence of Mothers&amp;rsquo; Experiences with Atopic Dermatitis on Their Children&amp;rsquo;s Skin Care Practices in the Japanese Cultural Context: Habit Formation and Intergenerational Transmission</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/308">doi: 10.3390/cosmetics13060308</a></p>
	<p>Authors:
		Yumi Murakami
		</p>
	<p>The study aimed to compare mothers&amp;amp;rsquo; and children&amp;amp;rsquo;s cleansing, moisturisation, and photoprotection practices between mothers with and without atopic dermatitis (AD) and explore how maternal AD experiences may be reflected in children&amp;amp;rsquo;s skin care habit formation. Semi-structured interviews were conducted with six mothers with AD and seven healthy controls (HC). Verbatim transcripts were analysed using a structured descriptive qualitative approach, supplemented by text mining. Childhood moisturisation was more frequently reported by mothers in the AD group than by HC mothers. Mothers in both groups moisturised their children from infancy; however, sustained whole-body moisturisation beyond school age was more evident in the AD group. Mothers with AD regarded moisturisation as necessary for symptom prevention and management, whereas HC mothers initiated it based primarily on parenting information. The AD group emphasised gentle, low-irritation cleansing; similar practices were reported for their children. Year-round photoprotection was not established among children in either group. Accessible product placement and parental encouragement facilitated habit formation, whereas stickiness, inconvenience, reapplication burden, and school restrictions inhibited continuation. These findings suggest that maternal AD experiences may be reflected in the development and maintenance of children&amp;amp;rsquo;s skin care practices. Larger quantitative and prospective studies are needed to test these hypotheses.</p>
	]]></content:encoded>

	<dc:title>Influence of Mothers&amp;amp;rsquo; Experiences with Atopic Dermatitis on Their Children&amp;amp;rsquo;s Skin Care Practices in the Japanese Cultural Context: Habit Formation and Intergenerational Transmission</dc:title>
			<dc:creator>Yumi Murakami</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060308</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-11-10</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-11-10</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>308</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060308</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/308</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/307">

	<title>Cosmetics, Vol. 13, Pages 307: Candlenut Oil (Aleurites moluccana Seed Oil): An Indonesian Bioresource for Scalp Care&amp;mdash;Scientific Evidence, Cosmetic Formulation, and Comparative Analysis with Brazilian Biodiversity</title>
	<link>https://www.mdpi.com/2079-9284/13/6/307</link>
	<description>Candlenut or kukui oil, extracted from the seeds of Aleurites moluccanus (L.) Willd. (INCI name: Aleurites moluccana), is a lipid-rich Southeast Asian bioresource with a long history of use in hair and scalp care. This narrative review examines its botanical origin, lipid chemistry, safety profile, biological evidence, and formulation potential, with particular emphasis on follicular vigor and scalp homeostasis. The oil contains a high proportion of linoleic and &amp;amp;alpha;-linolenic acids, which provide emollient properties but also enhance susceptibility to oxidative instability. Previous animal studies have indicated hair-growth-promoting activity. More recent evidence has strengthened these findings by demonstrating increased hair shaft length in ex vivo human scalp follicles. To contextualize this Indonesian bioresource within broader tropical cosmetic innovation, the review draws a comparative analysis with three Brazilian oils: andiroba (Carapa guianensis seed oil), pracaxi (Pentaclethra macroloba seed oil), and buriti (Mauritia flexuosa fruit oil) oils, revealing complementary rather than equivalent profiles across anti-inflammatory, hair-conditioning, and photoprotective properties. Formulation considerations, existing evidence gaps, and the importance of traceability, community engagement, and access-and-benefit-sharing mechanisms in biodiversity-derived ingredient supply chains are also discussed.</description>
	<pubDate>2026-11-07</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 307: Candlenut Oil (Aleurites moluccana Seed Oil): An Indonesian Bioresource for Scalp Care&amp;mdash;Scientific Evidence, Cosmetic Formulation, and Comparative Analysis with Brazilian Biodiversity</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/307">doi: 10.3390/cosmetics13060307</a></p>
	<p>Authors:
		M Alif Al Farizi
		Lorella Giovannelli
		Lara Camillo
		Paola Savoia
		Elisa Zavattaro
		</p>
	<p>Candlenut or kukui oil, extracted from the seeds of Aleurites moluccanus (L.) Willd. (INCI name: Aleurites moluccana), is a lipid-rich Southeast Asian bioresource with a long history of use in hair and scalp care. This narrative review examines its botanical origin, lipid chemistry, safety profile, biological evidence, and formulation potential, with particular emphasis on follicular vigor and scalp homeostasis. The oil contains a high proportion of linoleic and &amp;amp;alpha;-linolenic acids, which provide emollient properties but also enhance susceptibility to oxidative instability. Previous animal studies have indicated hair-growth-promoting activity. More recent evidence has strengthened these findings by demonstrating increased hair shaft length in ex vivo human scalp follicles. To contextualize this Indonesian bioresource within broader tropical cosmetic innovation, the review draws a comparative analysis with three Brazilian oils: andiroba (Carapa guianensis seed oil), pracaxi (Pentaclethra macroloba seed oil), and buriti (Mauritia flexuosa fruit oil) oils, revealing complementary rather than equivalent profiles across anti-inflammatory, hair-conditioning, and photoprotective properties. Formulation considerations, existing evidence gaps, and the importance of traceability, community engagement, and access-and-benefit-sharing mechanisms in biodiversity-derived ingredient supply chains are also discussed.</p>
	]]></content:encoded>

	<dc:title>Candlenut Oil (Aleurites moluccana Seed Oil): An Indonesian Bioresource for Scalp Care&amp;amp;mdash;Scientific Evidence, Cosmetic Formulation, and Comparative Analysis with Brazilian Biodiversity</dc:title>
			<dc:creator>M Alif Al Farizi</dc:creator>
			<dc:creator>Lorella Giovannelli</dc:creator>
			<dc:creator>Lara Camillo</dc:creator>
			<dc:creator>Paola Savoia</dc:creator>
			<dc:creator>Elisa Zavattaro</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060307</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-11-07</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-11-07</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>307</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060307</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/307</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/306">

	<title>Cosmetics, Vol. 13, Pages 306: Longitudinal Changes in Facial Bacterial Communities, Co-Occurrence Networks and Skin Barrier Function During Matrinium Salicylate-Based Skincare Intervention in Acne</title>
	<link>https://www.mdpi.com/2079-9284/13/6/306</link>
	<description>Acne vulgaris frequently co-occurs with compromised epidermal barrier integrity and microbial dysbiosis, posing therapeutic challenges, particularly in individuals with sensitive skin. In an 8-week, two-center, open-label, randomized, parallel-group study, 131 adults with mild-to-moderate acne were evaluated across four arms: negative control (NC), matrinium salicylate ([Mat][Sal])-containing sheet mask (G1), essence (G2), and their combination (G3). Longitudinal clinical lesions and standardized physiological barrier parameters were recorded. Cutaneous bacterial community dynamics and genus-level co-occurrence networks were profiled via 16S rRNA gene sequencing at the baseline, week 4, and week 8. All [Mat][Sal] regimens induced sustained reductions in inflammatory and noninflammatory lesions. Compared with single-product regimens, the combination regimen (G3) produced greater improvements in stratum corneum hydration, transepidermal water loss, and the erythema index. Alpha diversity remained stable across visits, indicating preserved ecological richness. Community shifts were modest but significant (PERMANOVA R2 = 0.013&amp;amp;ndash;0.042). Crucially, G3 showed key taxonomic shifts, manifesting as a significant reduction in the relative abundance of the dominant Cutibacterium, accompanied by an increase in the relative abundance of Staphylococcus. Overall, [Mat][Sal]-containing regimens provide simultaneous reductions in acne lesions and improvements in epidermal barrier function, with no significant changes in microbial alpha diversity, offering a well-tolerated, barrier-protective skincare approach.</description>
	<pubDate>2026-11-06</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 306: Longitudinal Changes in Facial Bacterial Communities, Co-Occurrence Networks and Skin Barrier Function During Matrinium Salicylate-Based Skincare Intervention in Acne</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/306">doi: 10.3390/cosmetics13060306</a></p>
	<p>Authors:
		Pengyao An
		Yexiang Zhang
		Qitian Fu
		Tianjing Liu
		Lei Wei
		Sisi Chang
		Jinhao Wu
		Yao Pan
		</p>
	<p>Acne vulgaris frequently co-occurs with compromised epidermal barrier integrity and microbial dysbiosis, posing therapeutic challenges, particularly in individuals with sensitive skin. In an 8-week, two-center, open-label, randomized, parallel-group study, 131 adults with mild-to-moderate acne were evaluated across four arms: negative control (NC), matrinium salicylate ([Mat][Sal])-containing sheet mask (G1), essence (G2), and their combination (G3). Longitudinal clinical lesions and standardized physiological barrier parameters were recorded. Cutaneous bacterial community dynamics and genus-level co-occurrence networks were profiled via 16S rRNA gene sequencing at the baseline, week 4, and week 8. All [Mat][Sal] regimens induced sustained reductions in inflammatory and noninflammatory lesions. Compared with single-product regimens, the combination regimen (G3) produced greater improvements in stratum corneum hydration, transepidermal water loss, and the erythema index. Alpha diversity remained stable across visits, indicating preserved ecological richness. Community shifts were modest but significant (PERMANOVA R2 = 0.013&amp;amp;ndash;0.042). Crucially, G3 showed key taxonomic shifts, manifesting as a significant reduction in the relative abundance of the dominant Cutibacterium, accompanied by an increase in the relative abundance of Staphylococcus. Overall, [Mat][Sal]-containing regimens provide simultaneous reductions in acne lesions and improvements in epidermal barrier function, with no significant changes in microbial alpha diversity, offering a well-tolerated, barrier-protective skincare approach.</p>
	]]></content:encoded>

	<dc:title>Longitudinal Changes in Facial Bacterial Communities, Co-Occurrence Networks and Skin Barrier Function During Matrinium Salicylate-Based Skincare Intervention in Acne</dc:title>
			<dc:creator>Pengyao An</dc:creator>
			<dc:creator>Yexiang Zhang</dc:creator>
			<dc:creator>Qitian Fu</dc:creator>
			<dc:creator>Tianjing Liu</dc:creator>
			<dc:creator>Lei Wei</dc:creator>
			<dc:creator>Sisi Chang</dc:creator>
			<dc:creator>Jinhao Wu</dc:creator>
			<dc:creator>Yao Pan</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060306</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-11-06</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-11-06</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>306</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060306</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/306</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/305">

	<title>Cosmetics, Vol. 13, Pages 305: AI-Assisted Conceptual Design for Cosmetic Product Innovation: A Knowledge-Based Framework</title>
	<link>https://www.mdpi.com/2079-9284/13/6/305</link>
	<description>The cosmetic industry is a highly innovative and competitive sector in which new product development (NPD) requires integrating multidisciplinary knowledge from different scientific and technological domains. However, the increasing complexity of cosmetic product development requires the coordination and transformation of information into useful knowledge to support innovation activities. In this context, artificial intelligence (AI) could facilitate the collection, organization, connection, and transformation of information into knowledge. This paper proposes an AI-Assisted Knowledge Process for cosmetic product innovation to systematize the integration of AI, knowledge management, and innovation methods during the conceptual design phase of NPD. The process includes four main activities in which AI supports different tasks. First, AI assists with problem formulation and opportunity identification, including creating the Network of Problems. Second, AI supports knowledge acquisition and solution exploration. Third, AI assists in concept generation and development. Finally, AI supports the structuring and capitalization of knowledge acquired and generated during the conceptual design phase to facilitate future reuse. A retrospective illustrative example from a previous experimental project involving a hydrating sheet mask shows how the proposed process can be applied. In this example, AI supports interdisciplinary knowledge management, the exploration and generation of alternative solutions, and concept development, while human experts retain responsibility for evaluation and decision-making.</description>
	<pubDate>2026-11-06</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 305: AI-Assisted Conceptual Design for Cosmetic Product Innovation: A Knowledge-Based Framework</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/305">doi: 10.3390/cosmetics13060305</a></p>
	<p>Authors:
		Diana Barragan Ferrer
		Jesus Manuel Barragan Ferrer
		Guillermo Cortés-Robles
		</p>
	<p>The cosmetic industry is a highly innovative and competitive sector in which new product development (NPD) requires integrating multidisciplinary knowledge from different scientific and technological domains. However, the increasing complexity of cosmetic product development requires the coordination and transformation of information into useful knowledge to support innovation activities. In this context, artificial intelligence (AI) could facilitate the collection, organization, connection, and transformation of information into knowledge. This paper proposes an AI-Assisted Knowledge Process for cosmetic product innovation to systematize the integration of AI, knowledge management, and innovation methods during the conceptual design phase of NPD. The process includes four main activities in which AI supports different tasks. First, AI assists with problem formulation and opportunity identification, including creating the Network of Problems. Second, AI supports knowledge acquisition and solution exploration. Third, AI assists in concept generation and development. Finally, AI supports the structuring and capitalization of knowledge acquired and generated during the conceptual design phase to facilitate future reuse. A retrospective illustrative example from a previous experimental project involving a hydrating sheet mask shows how the proposed process can be applied. In this example, AI supports interdisciplinary knowledge management, the exploration and generation of alternative solutions, and concept development, while human experts retain responsibility for evaluation and decision-making.</p>
	]]></content:encoded>

	<dc:title>AI-Assisted Conceptual Design for Cosmetic Product Innovation: A Knowledge-Based Framework</dc:title>
			<dc:creator>Diana Barragan Ferrer</dc:creator>
			<dc:creator>Jesus Manuel Barragan Ferrer</dc:creator>
			<dc:creator>Guillermo Cortés-Robles</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060305</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-11-06</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-11-06</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>305</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060305</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/305</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/304">

	<title>Cosmetics, Vol. 13, Pages 304: Enzymatic Low-Molecular-Weight Modification of Mung Bean Protein Isolate: Effects on Physicochemical Characteristics and Cosmetic Bioactivities</title>
	<link>https://www.mdpi.com/2079-9284/13/6/304</link>
	<description>In this study, we investigated the effects of enzymatic low-molecular-weight modification on the physicochemical characteristics and cosmetic-related bioactivities of mung bean protein isolate. Mung bean protein isolate (MBPI) was prepared by alkaline extraction and isoelectric precipitation, followed by sequential treatment with Viscozyme L and Protana Prime, and centrifugal filtration was then performed to obtain a low-molecular-weight fraction (LMBPI). Among the tested enzymatic treatment conditions, the selected condition produced the lowest mean particle size (160.09 &amp;amp;plusmn; 2.24 nm). The resulting hydrolysate showed a solubility of 93.98 &amp;amp;plusmn; 0.43%, compared with 89.08 &amp;amp;plusmn; 1.49% for untreated MBPI. SDS-PAGE and molecular weight distribution analyses showed that enzymatic treatment decreased the proportion of high-molecular-weight proteins and increased the low-molecular-weight fractions, with the 1&amp;amp;ndash;5 kDa fraction reaching 60% after centrifugal filtration. Compared with MBPI, LMBPI exhibited greater DPPH and ABTS radical scavenging activities and more effectively reduced nitric oxide and prostaglandin E2 production in lipopolysaccharide-stimulated RAW264.7 cells. LMBPI also showed higher tyrosinase and elastase inhibitory activities and reduced &amp;amp;alpha;-MSH-induced melanin production in B16F10 cells and UVA-induced matrix metalloproteinase-1 production in human dermal fibroblasts. These results indicate that enzymatic low-molecular-weight modification generated a smaller, lower-molecular-weight mung bean protein fraction with greater antioxidant, anti-inflammatory, anti-melanogenic, and anti-wrinkle-related activities than untreated MBPI, suggesting the potential of LMBPI as a multifunctional plant-derived cosmetic ingredient.</description>
	<pubDate>2026-11-05</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 304: Enzymatic Low-Molecular-Weight Modification of Mung Bean Protein Isolate: Effects on Physicochemical Characteristics and Cosmetic Bioactivities</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/304">doi: 10.3390/cosmetics13060304</a></p>
	<p>Authors:
		Jiseon Lee
		Seonghyeon Lee
		Daewoo Lee
		Kilteak Hwang
		Hyejin Hong
		Soyoung Shin
		Hyo Tae Kim
		</p>
	<p>In this study, we investigated the effects of enzymatic low-molecular-weight modification on the physicochemical characteristics and cosmetic-related bioactivities of mung bean protein isolate. Mung bean protein isolate (MBPI) was prepared by alkaline extraction and isoelectric precipitation, followed by sequential treatment with Viscozyme L and Protana Prime, and centrifugal filtration was then performed to obtain a low-molecular-weight fraction (LMBPI). Among the tested enzymatic treatment conditions, the selected condition produced the lowest mean particle size (160.09 &amp;amp;plusmn; 2.24 nm). The resulting hydrolysate showed a solubility of 93.98 &amp;amp;plusmn; 0.43%, compared with 89.08 &amp;amp;plusmn; 1.49% for untreated MBPI. SDS-PAGE and molecular weight distribution analyses showed that enzymatic treatment decreased the proportion of high-molecular-weight proteins and increased the low-molecular-weight fractions, with the 1&amp;amp;ndash;5 kDa fraction reaching 60% after centrifugal filtration. Compared with MBPI, LMBPI exhibited greater DPPH and ABTS radical scavenging activities and more effectively reduced nitric oxide and prostaglandin E2 production in lipopolysaccharide-stimulated RAW264.7 cells. LMBPI also showed higher tyrosinase and elastase inhibitory activities and reduced &amp;amp;alpha;-MSH-induced melanin production in B16F10 cells and UVA-induced matrix metalloproteinase-1 production in human dermal fibroblasts. These results indicate that enzymatic low-molecular-weight modification generated a smaller, lower-molecular-weight mung bean protein fraction with greater antioxidant, anti-inflammatory, anti-melanogenic, and anti-wrinkle-related activities than untreated MBPI, suggesting the potential of LMBPI as a multifunctional plant-derived cosmetic ingredient.</p>
	]]></content:encoded>

	<dc:title>Enzymatic Low-Molecular-Weight Modification of Mung Bean Protein Isolate: Effects on Physicochemical Characteristics and Cosmetic Bioactivities</dc:title>
			<dc:creator>Jiseon Lee</dc:creator>
			<dc:creator>Seonghyeon Lee</dc:creator>
			<dc:creator>Daewoo Lee</dc:creator>
			<dc:creator>Kilteak Hwang</dc:creator>
			<dc:creator>Hyejin Hong</dc:creator>
			<dc:creator>Soyoung Shin</dc:creator>
			<dc:creator>Hyo Tae Kim</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060304</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-11-05</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-11-05</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>304</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060304</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/304</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/303">

	<title>Cosmetics, Vol. 13, Pages 303: LC-OCT in Aesthetic Dermatology: Applications in Skin Aging, Cosmetic Product Assessment, and Aesthetic Procedures&amp;mdash;A Narrative Review</title>
	<link>https://www.mdpi.com/2079-9284/13/6/303</link>
	<description>Line-field confocal optical coherence tomography (LC-OCT) is a non-invasive optical imaging technique that combines cellular resolution with vertical, horizontal, and three-dimensional visualization of living skin. These features are attractive in aesthetic dermatology, where conventional clinical photography and biophysical measurements primarily assess visible changes and selected skin properties but provide limited information on tissue architecture. This narrative review examines the emerging use of LC-OCT to characterize skin aging, assess cosmetic and topical products, and monitor aesthetic procedures. Published studies demonstrate that LC-OCT, particularly when coupled with automated segmentation and artificial intelligence, can quantify epidermal organization, dermal&amp;amp;ndash;epidermal junction morphology, cellular features, pigment distribution, and superficial dermal fiber patterns. Early interventional work has applied these endpoints to brightening products, anti-aging formulations, sunscreens, and topical drugs. Procedural studies have visualized tissue responses after microdermabrasion, hydradermabrasion, chemical peeling, hair-removal lasers, fractional laser treatments, plasma radiofrequency, botulinum toxin, microwave thermolysis, and dermal filler injection. LC-OCT may therefore complement clinical outcomes by providing repeatable, in vivo microscopic endpoints and longitudinal imaging without biopsy. However, most studies remain exploratory, with small samples, short follow-up, heterogeneous acquisition protocols, and limited external validation. LC-OCT should currently be considered an advanced research and treatment-monitoring tool rather than a validated surrogate for clinical benefit. Multicenter studies, standardized acquisition protocols and blinded analyses will be required before routine adoption in aesthetic trials and practice.</description>
	<pubDate>2026-11-05</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 303: LC-OCT in Aesthetic Dermatology: Applications in Skin Aging, Cosmetic Product Assessment, and Aesthetic Procedures&amp;mdash;A Narrative Review</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/303">doi: 10.3390/cosmetics13060303</a></p>
	<p>Authors:
		Simone Soglia
		Cesare Ariasi
		Mariachiara Arisi
		Marina Venturini
		Piergiacomo Calzavara-Pinton
		</p>
	<p>Line-field confocal optical coherence tomography (LC-OCT) is a non-invasive optical imaging technique that combines cellular resolution with vertical, horizontal, and three-dimensional visualization of living skin. These features are attractive in aesthetic dermatology, where conventional clinical photography and biophysical measurements primarily assess visible changes and selected skin properties but provide limited information on tissue architecture. This narrative review examines the emerging use of LC-OCT to characterize skin aging, assess cosmetic and topical products, and monitor aesthetic procedures. Published studies demonstrate that LC-OCT, particularly when coupled with automated segmentation and artificial intelligence, can quantify epidermal organization, dermal&amp;amp;ndash;epidermal junction morphology, cellular features, pigment distribution, and superficial dermal fiber patterns. Early interventional work has applied these endpoints to brightening products, anti-aging formulations, sunscreens, and topical drugs. Procedural studies have visualized tissue responses after microdermabrasion, hydradermabrasion, chemical peeling, hair-removal lasers, fractional laser treatments, plasma radiofrequency, botulinum toxin, microwave thermolysis, and dermal filler injection. LC-OCT may therefore complement clinical outcomes by providing repeatable, in vivo microscopic endpoints and longitudinal imaging without biopsy. However, most studies remain exploratory, with small samples, short follow-up, heterogeneous acquisition protocols, and limited external validation. LC-OCT should currently be considered an advanced research and treatment-monitoring tool rather than a validated surrogate for clinical benefit. Multicenter studies, standardized acquisition protocols and blinded analyses will be required before routine adoption in aesthetic trials and practice.</p>
	]]></content:encoded>

	<dc:title>LC-OCT in Aesthetic Dermatology: Applications in Skin Aging, Cosmetic Product Assessment, and Aesthetic Procedures&amp;amp;mdash;A Narrative Review</dc:title>
			<dc:creator>Simone Soglia</dc:creator>
			<dc:creator>Cesare Ariasi</dc:creator>
			<dc:creator>Mariachiara Arisi</dc:creator>
			<dc:creator>Marina Venturini</dc:creator>
			<dc:creator>Piergiacomo Calzavara-Pinton</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060303</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-11-05</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-11-05</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>303</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060303</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/303</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/302">

	<title>Cosmetics, Vol. 13, Pages 302: From Agro-Industrial Residues to Dermocosmetic Exfoliants: A Narrative Review of Sustainable Ingredients</title>
	<link>https://www.mdpi.com/2079-9284/13/6/302</link>
	<description>Physical exfoliating ingredients are used in cosmetic formulations to remove loose and/or senescent corneocytes, improve skin texture, and enhance the performance of other topical products. Plastic-based exfoliating agents have been used in these formulations for their favorable mechanical properties, but growing environmental concerns over microplastic persistence have accelerated the search for sustainable alternatives, for example, from agro-industrial by-products. Our review examines how Circular Economy principles and upcycling strategies support the development of sustainable exfoliating ingredients, addressing the environmental impact of microplastics and the need for their replacement. Recent studies investigating biobased exfoliating materials obtained from agro-industrial and other biowaste residues, including grape pomace, spent coffee grounds, crabwood bagasse, sinami, apricot shell, Passiflora seeds, and chitin-derived particles, among others, are summarized, highlighting their physicochemical characteristics and dermocosmetic applications as exfoliating ingredients. The principal analytical, biophysical, and clinical methodologies used to evaluate exfoliating efficacy and skin barrier responses were also reviewed. A recurring gap identified across the literature is the frequent absence of direct exfoliation-efficacy assessment, underscoring a persistent methodological challenge for this class of cosmetic compounds. Despite this limitation, the available evidence indicates that sustainable exfoliating particles represent promising, though not yet fully validated, alternatives to conventional plastic microbeads; standardized safety and efficacy testing, together with industrial scale-up studies, remain necessary before their performance can be considered clinically comparable, supporting dermocosmetics that integrate skin performance with the environmentally responsible use of agro-industrial residues.</description>
	<pubDate>2026-11-05</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 302: From Agro-Industrial Residues to Dermocosmetic Exfoliants: A Narrative Review of Sustainable Ingredients</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/302">doi: 10.3390/cosmetics13060302</a></p>
	<p>Authors:
		Gabriela Peres Salzedas
		Michelle Maria Gonçalves Barão de Aguiar
		Maria Valéria Robles Velasco
		André Rolim Baby
		</p>
	<p>Physical exfoliating ingredients are used in cosmetic formulations to remove loose and/or senescent corneocytes, improve skin texture, and enhance the performance of other topical products. Plastic-based exfoliating agents have been used in these formulations for their favorable mechanical properties, but growing environmental concerns over microplastic persistence have accelerated the search for sustainable alternatives, for example, from agro-industrial by-products. Our review examines how Circular Economy principles and upcycling strategies support the development of sustainable exfoliating ingredients, addressing the environmental impact of microplastics and the need for their replacement. Recent studies investigating biobased exfoliating materials obtained from agro-industrial and other biowaste residues, including grape pomace, spent coffee grounds, crabwood bagasse, sinami, apricot shell, Passiflora seeds, and chitin-derived particles, among others, are summarized, highlighting their physicochemical characteristics and dermocosmetic applications as exfoliating ingredients. The principal analytical, biophysical, and clinical methodologies used to evaluate exfoliating efficacy and skin barrier responses were also reviewed. A recurring gap identified across the literature is the frequent absence of direct exfoliation-efficacy assessment, underscoring a persistent methodological challenge for this class of cosmetic compounds. Despite this limitation, the available evidence indicates that sustainable exfoliating particles represent promising, though not yet fully validated, alternatives to conventional plastic microbeads; standardized safety and efficacy testing, together with industrial scale-up studies, remain necessary before their performance can be considered clinically comparable, supporting dermocosmetics that integrate skin performance with the environmentally responsible use of agro-industrial residues.</p>
	]]></content:encoded>

	<dc:title>From Agro-Industrial Residues to Dermocosmetic Exfoliants: A Narrative Review of Sustainable Ingredients</dc:title>
			<dc:creator>Gabriela Peres Salzedas</dc:creator>
			<dc:creator>Michelle Maria Gonçalves Barão de Aguiar</dc:creator>
			<dc:creator>Maria Valéria Robles Velasco</dc:creator>
			<dc:creator>André Rolim Baby</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060302</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-11-05</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-11-05</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>302</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060302</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/302</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/301">

	<title>Cosmetics, Vol. 13, Pages 301: Concurrent Changes in Facial Skin Parameters, Sleep, and the Salivary Melatonin Day&amp;ndash;Night Difference During Topical Use of a Clock-Oriented Six-Botanical Formulation: An Exploratory 4-Week, Single-Arm Pilot Study</title>
	<link>https://www.mdpi.com/2079-9284/13/6/301</link>
	<description>Insufficient sleep can disrupt circadian organization and adversely affect skin condition. Perturbation of the cutaneous clock, which governs skin homeostasis, may contribute to this deterioration. In our study, a six-botanical mixture extract increased PER2 promoter-driven luciferase output in HaCaT keratinocytes, and reduced IL6 and CXCL10 expression, two PER2-associated inflammatory mediators. Separately, a 4-week single-arm pilot study evaluated a cream containing 2.00% (w/w) of a liquid preparation of this extract, applied nightly by 22 women aged 40&amp;amp;ndash;70 years with poor sleep quality. Skin indicators, sleep, mood, and salivary melatonin and cortisol were assessed as changes from baseline at week 4. The 13 skin indicators changed from baseline across the anti-aging, barrier, complexion, and dark-circle categories (Cohen&amp;amp;rsquo;s d 0.47&amp;amp;ndash;4.81). Sleep duration increased, whereas PSQI-K and PHQ-9 scores decreased; the melatonin day&amp;amp;ndash;night difference increased (d = 0.75); cortisol measures did not change significantly. No adverse skin reactions were reported. These exploratory findings do not establish product-attributable efficacy or a causal PER2-mediated mechanism; placebo, vehicle, expectancy, seasonal, behavioral, and regression-to-the-mean effects cannot be excluded. A randomized, vehicle-controlled study is required, with prespecified primary outcomes, denser circadian sampling, and clock activity measured directly in treated skin.</description>
	<pubDate>2026-11-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 301: Concurrent Changes in Facial Skin Parameters, Sleep, and the Salivary Melatonin Day&amp;ndash;Night Difference During Topical Use of a Clock-Oriented Six-Botanical Formulation: An Exploratory 4-Week, Single-Arm Pilot Study</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/301">doi: 10.3390/cosmetics13060301</a></p>
	<p>Authors:
		Miji Yeom
		Youngsu Jang
		Kyungeun Jeon
		Yoon Ji Jeong
		Soeun Cho
		Heetae Kim
		Sunhong Moon
		De-Hun Ryu
		Eunae Cho
		Deokhoon Park
		Eunsun Jung
		</p>
	<p>Insufficient sleep can disrupt circadian organization and adversely affect skin condition. Perturbation of the cutaneous clock, which governs skin homeostasis, may contribute to this deterioration. In our study, a six-botanical mixture extract increased PER2 promoter-driven luciferase output in HaCaT keratinocytes, and reduced IL6 and CXCL10 expression, two PER2-associated inflammatory mediators. Separately, a 4-week single-arm pilot study evaluated a cream containing 2.00% (w/w) of a liquid preparation of this extract, applied nightly by 22 women aged 40&amp;amp;ndash;70 years with poor sleep quality. Skin indicators, sleep, mood, and salivary melatonin and cortisol were assessed as changes from baseline at week 4. The 13 skin indicators changed from baseline across the anti-aging, barrier, complexion, and dark-circle categories (Cohen&amp;amp;rsquo;s d 0.47&amp;amp;ndash;4.81). Sleep duration increased, whereas PSQI-K and PHQ-9 scores decreased; the melatonin day&amp;amp;ndash;night difference increased (d = 0.75); cortisol measures did not change significantly. No adverse skin reactions were reported. These exploratory findings do not establish product-attributable efficacy or a causal PER2-mediated mechanism; placebo, vehicle, expectancy, seasonal, behavioral, and regression-to-the-mean effects cannot be excluded. A randomized, vehicle-controlled study is required, with prespecified primary outcomes, denser circadian sampling, and clock activity measured directly in treated skin.</p>
	]]></content:encoded>

	<dc:title>Concurrent Changes in Facial Skin Parameters, Sleep, and the Salivary Melatonin Day&amp;amp;ndash;Night Difference During Topical Use of a Clock-Oriented Six-Botanical Formulation: An Exploratory 4-Week, Single-Arm Pilot Study</dc:title>
			<dc:creator>Miji Yeom</dc:creator>
			<dc:creator>Youngsu Jang</dc:creator>
			<dc:creator>Kyungeun Jeon</dc:creator>
			<dc:creator>Yoon Ji Jeong</dc:creator>
			<dc:creator>Soeun Cho</dc:creator>
			<dc:creator>Heetae Kim</dc:creator>
			<dc:creator>Sunhong Moon</dc:creator>
			<dc:creator>De-Hun Ryu</dc:creator>
			<dc:creator>Eunae Cho</dc:creator>
			<dc:creator>Deokhoon Park</dc:creator>
			<dc:creator>Eunsun Jung</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060301</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-11-04</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-11-04</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>301</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060301</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/301</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/300">

	<title>Cosmetics, Vol. 13, Pages 300: UV Imaging-Based Method for Quantifying Sunscreen Application and Persistence</title>
	<link>https://www.mdpi.com/2079-9284/13/6/300</link>
	<description>Sunscreen effectiveness depends on formulation performance and adequate, uniform, and persistent application under real-world conditions. However, quantitatively assessing sunscreen application and persistence remains challenging. We developed a luminance-based method using ultraviolet (UV) facial imaging to derive relative image-based metrics of sunscreen application and evaluated its utility for assessing activity-related changes in sunscreen persistence. Facial UV images were acquired using the VISIA-CR&amp;amp;reg; system, and mean luminance values from UV spot images were analysed at the forehead, cheeks, nose, and chin. The UV image-derived application rate was calibrated against known application doses of cream and lotion formulations. The application dose was strongly associated with the UV image-derived application rate for both formulations, with significant Spearman correlations. The mean mass applied during unguided self-application was 0.62 g, corresponding to 77.5% of the recommended facial dose (0.8 g), although UV imaging revealed heterogeneous distribution across facial regions. In the proof-of-concept evaluation, residual rates after 30 min of running were 82.8% and 73.8% for the cream and lotion formulations, respectively; after swimming, the corresponding rates were 51.9% and 50.2%. UV imaging combined with luminance analysis may provide a practical, non-invasive approach for relatively assessing sunscreen application and detecting activity-related changes in sunscreen persistence.</description>
	<pubDate>2026-11-02</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 300: UV Imaging-Based Method for Quantifying Sunscreen Application and Persistence</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/300">doi: 10.3390/cosmetics13060300</a></p>
	<p>Authors:
		Yukiko Ueda
		Yumi Murakami
		Ryoko Yamashita
		Yumiko Saya
		Hiroshi Matsunaka
		</p>
	<p>Sunscreen effectiveness depends on formulation performance and adequate, uniform, and persistent application under real-world conditions. However, quantitatively assessing sunscreen application and persistence remains challenging. We developed a luminance-based method using ultraviolet (UV) facial imaging to derive relative image-based metrics of sunscreen application and evaluated its utility for assessing activity-related changes in sunscreen persistence. Facial UV images were acquired using the VISIA-CR&amp;amp;reg; system, and mean luminance values from UV spot images were analysed at the forehead, cheeks, nose, and chin. The UV image-derived application rate was calibrated against known application doses of cream and lotion formulations. The application dose was strongly associated with the UV image-derived application rate for both formulations, with significant Spearman correlations. The mean mass applied during unguided self-application was 0.62 g, corresponding to 77.5% of the recommended facial dose (0.8 g), although UV imaging revealed heterogeneous distribution across facial regions. In the proof-of-concept evaluation, residual rates after 30 min of running were 82.8% and 73.8% for the cream and lotion formulations, respectively; after swimming, the corresponding rates were 51.9% and 50.2%. UV imaging combined with luminance analysis may provide a practical, non-invasive approach for relatively assessing sunscreen application and detecting activity-related changes in sunscreen persistence.</p>
	]]></content:encoded>

	<dc:title>UV Imaging-Based Method for Quantifying Sunscreen Application and Persistence</dc:title>
			<dc:creator>Yukiko Ueda</dc:creator>
			<dc:creator>Yumi Murakami</dc:creator>
			<dc:creator>Ryoko Yamashita</dc:creator>
			<dc:creator>Yumiko Saya</dc:creator>
			<dc:creator>Hiroshi Matsunaka</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060300</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-11-02</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-11-02</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>300</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060300</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/300</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/299">

	<title>Cosmetics, Vol. 13, Pages 299: Optical Coherence Elastography for Real-Time Visualization of Skin Penetration, Associated Dehydration, and Barrier Function: Pilot Ex Vivo Studies and the First In Vivo Demonstration in Humans</title>
	<link>https://www.mdpi.com/2079-9284/13/6/299</link>
	<description>This study uses a recently proposed phase-sensitive optical coherence elastography (OCE) method to visualize diffusion and associated skin dehydration by reconstructing osmotically induced strains and assessing topical solution penetration in ex vivo human shin, rat dorsal, and porcine perioral skin, as well as in vivo human forearm skin, for the first time. Aqueous glycerol, ethanol, and tartrazine solutions at various concentrations were investigated. Initial penetration kinetics were characterized over the first 150 s by monitoring penetration-associated osmotic-strains. OCE revealed that, during the initial penetration phase, porcine skin is markedly more permeable than human skin, despite its greater mechanical robustness, whereas rat skin exhibits comparable permeability to human skin. OCE imaging further showed that the stratum corneum (SC), a superficial layer only several tens of micrometers thick, provides the primary skin barrier, and that partial SC removal markedly increases permeability. Enhanced skin stabilization enabled preliminary in vivo measurements by suppressing motion artifacts caused by cardiac pulsation and respiration, and the results were consistent with ex vivo findings. These results indicate that, for the hydrophilic/polar substances tested, rat skin is a more representative model of human skin permeability than porcine skin, highlighting the potential of OCE for real-time monitoring of skin penetration and associated dehydration.</description>
	<pubDate>2026-11-01</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 299: Optical Coherence Elastography for Real-Time Visualization of Skin Penetration, Associated Dehydration, and Barrier Function: Pilot Ex Vivo Studies and the First In Vivo Demonstration in Humans</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/299">doi: 10.3390/cosmetics13060299</a></p>
	<p>Authors:
		Vladimir Y. Zaitsev
		Alexander A. Sovetsky
		Maria A. Kulagina
		Ksenia S. Petrova
		Alexander L. Matveyev
		Igor E. Pogodin
		Maxim G. Ryabkov
		Dmitry V. Shabanov
		Lev A. Matveev
		Pavel V. Kulagin
		Maxim E. Darvin
		</p>
	<p>This study uses a recently proposed phase-sensitive optical coherence elastography (OCE) method to visualize diffusion and associated skin dehydration by reconstructing osmotically induced strains and assessing topical solution penetration in ex vivo human shin, rat dorsal, and porcine perioral skin, as well as in vivo human forearm skin, for the first time. Aqueous glycerol, ethanol, and tartrazine solutions at various concentrations were investigated. Initial penetration kinetics were characterized over the first 150 s by monitoring penetration-associated osmotic-strains. OCE revealed that, during the initial penetration phase, porcine skin is markedly more permeable than human skin, despite its greater mechanical robustness, whereas rat skin exhibits comparable permeability to human skin. OCE imaging further showed that the stratum corneum (SC), a superficial layer only several tens of micrometers thick, provides the primary skin barrier, and that partial SC removal markedly increases permeability. Enhanced skin stabilization enabled preliminary in vivo measurements by suppressing motion artifacts caused by cardiac pulsation and respiration, and the results were consistent with ex vivo findings. These results indicate that, for the hydrophilic/polar substances tested, rat skin is a more representative model of human skin permeability than porcine skin, highlighting the potential of OCE for real-time monitoring of skin penetration and associated dehydration.</p>
	]]></content:encoded>

	<dc:title>Optical Coherence Elastography for Real-Time Visualization of Skin Penetration, Associated Dehydration, and Barrier Function: Pilot Ex Vivo Studies and the First In Vivo Demonstration in Humans</dc:title>
			<dc:creator>Vladimir Y. Zaitsev</dc:creator>
			<dc:creator>Alexander A. Sovetsky</dc:creator>
			<dc:creator>Maria A. Kulagina</dc:creator>
			<dc:creator>Ksenia S. Petrova</dc:creator>
			<dc:creator>Alexander L. Matveyev</dc:creator>
			<dc:creator>Igor E. Pogodin</dc:creator>
			<dc:creator>Maxim G. Ryabkov</dc:creator>
			<dc:creator>Dmitry V. Shabanov</dc:creator>
			<dc:creator>Lev A. Matveev</dc:creator>
			<dc:creator>Pavel V. Kulagin</dc:creator>
			<dc:creator>Maxim E. Darvin</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060299</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-11-01</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-11-01</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>299</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060299</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/299</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/298">

	<title>Cosmetics, Vol. 13, Pages 298: Ectoine&amp;ndash;Vehicle Contrasts After Four Laser Stressors Vary Across Response Domains and Laser Procedures: An Exploratory Secondary Analysis of a Randomized Factorial Study</title>
	<link>https://www.mdpi.com/2079-9284/13/6/298</link>
	<description>Ectoine is used in peri-procedural skincare, but its effects may vary with laser procedure, concentration and application timing. This exploratory secondary analysis examined 360 ectoine&amp;amp;ndash;vehicle contrasts from a randomized within-participant d&amp;amp;eacute;colletage study involving 30 adults with Fitzpatrick phototype II. Vehicle and 1%, 5% or 7% ectoine formulations were applied before (PRE) or after (POST) fractional CO2, Er:YAG, 1064 nm Nd:YAG or picosecond 532 nm Nd:YAG exposure. Corneometry, transepidermal water loss (TEWL), erythema, melanin index and skin-surface pH were assessed immediately, at 24 h and at 14 days. Of 360 contrasts, 113 (31%) were significant after the Holm adjustment. Among 23 significant TEWL contrasts, 18 indicated lower values with ectoine; for Er:YAG, 7% POST at 24 h, the difference was &amp;amp;minus;22.71 g/m2/h (95% CI &amp;amp;minus;30.93 to &amp;amp;minus;14.50). Cross-laser directional heterogeneity occurred in 59/90 configurations (65.6%), non-monotonic concentration patterns in 74/120 (61.7%), and PRE/POST sign reversals in 83/180 (46.1%). These descriptive patterns did not establish a consistent dose&amp;amp;ndash;response relationship. Effects differed across response domains and laser procedures, but exploratory comparisons cannot establish chromophore-specific mechanisms or improvements in healing or downtime.</description>
	<pubDate>2026-11-01</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 298: Ectoine&amp;ndash;Vehicle Contrasts After Four Laser Stressors Vary Across Response Domains and Laser Procedures: An Exploratory Secondary Analysis of a Randomized Factorial Study</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/298">doi: 10.3390/cosmetics13060298</a></p>
	<p>Authors:
		Izabela Załęska
		Anna Smuda
		Urszula Goik
		Małgorzata Lis
		</p>
	<p>Ectoine is used in peri-procedural skincare, but its effects may vary with laser procedure, concentration and application timing. This exploratory secondary analysis examined 360 ectoine&amp;amp;ndash;vehicle contrasts from a randomized within-participant d&amp;amp;eacute;colletage study involving 30 adults with Fitzpatrick phototype II. Vehicle and 1%, 5% or 7% ectoine formulations were applied before (PRE) or after (POST) fractional CO2, Er:YAG, 1064 nm Nd:YAG or picosecond 532 nm Nd:YAG exposure. Corneometry, transepidermal water loss (TEWL), erythema, melanin index and skin-surface pH were assessed immediately, at 24 h and at 14 days. Of 360 contrasts, 113 (31%) were significant after the Holm adjustment. Among 23 significant TEWL contrasts, 18 indicated lower values with ectoine; for Er:YAG, 7% POST at 24 h, the difference was &amp;amp;minus;22.71 g/m2/h (95% CI &amp;amp;minus;30.93 to &amp;amp;minus;14.50). Cross-laser directional heterogeneity occurred in 59/90 configurations (65.6%), non-monotonic concentration patterns in 74/120 (61.7%), and PRE/POST sign reversals in 83/180 (46.1%). These descriptive patterns did not establish a consistent dose&amp;amp;ndash;response relationship. Effects differed across response domains and laser procedures, but exploratory comparisons cannot establish chromophore-specific mechanisms or improvements in healing or downtime.</p>
	]]></content:encoded>

	<dc:title>Ectoine&amp;amp;ndash;Vehicle Contrasts After Four Laser Stressors Vary Across Response Domains and Laser Procedures: An Exploratory Secondary Analysis of a Randomized Factorial Study</dc:title>
			<dc:creator>Izabela Załęska</dc:creator>
			<dc:creator>Anna Smuda</dc:creator>
			<dc:creator>Urszula Goik</dc:creator>
			<dc:creator>Małgorzata Lis</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060298</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-11-01</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-11-01</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>298</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060298</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/298</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/297">

	<title>Cosmetics, Vol. 13, Pages 297: Evaluating Laboratory Performance in a Proficiency Test for Antimicrobial Protection of a Cosmetic Formulation</title>
	<link>https://www.mdpi.com/2079-9284/13/6/297</link>
	<description>Accurate assessments of antimicrobial protection of cosmetic products play a crucial role in monitoring their quality and user health. The reliability of these analyses depends on the method used and the competence of cosmetic laboratories. This paper presents the design and results of a proficiency test organized in November 2023 to assess the performance of 37 laboratories participating in the determination of the logarithmic reduction in Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Candida albicans, and Aspergillus brasiliensis 7 days after inoculation in a cosmetic formulation. Participating laboratories performed their duplicate analysis on each test microorganism under repeatability conditions, using the same analytical method. In order to evaluate the consistency of laboratory performance, two trials were scheduled at a one-week interval, and they were conducted by the same analyst, applying the same analytical procedure on identical samples. The results of this study demonstrated the overall good application of the method in the determination of microbial reduction by participating laboratories and highlighted the robustness of integrating method precision assessment into proficiency testing for monitoring the analytical performance of cosmetic microbiology laboratories.</description>
	<pubDate>2026-10-30</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 297: Evaluating Laboratory Performance in a Proficiency Test for Antimicrobial Protection of a Cosmetic Formulation</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/297">doi: 10.3390/cosmetics13060297</a></p>
	<p>Authors:
		Sabrina Bouakache
		Thanh Thuy Nguyen
		Margaux François Elissalde
		Anne Tirard
		Abdelkader Boubetra
		</p>
	<p>Accurate assessments of antimicrobial protection of cosmetic products play a crucial role in monitoring their quality and user health. The reliability of these analyses depends on the method used and the competence of cosmetic laboratories. This paper presents the design and results of a proficiency test organized in November 2023 to assess the performance of 37 laboratories participating in the determination of the logarithmic reduction in Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Candida albicans, and Aspergillus brasiliensis 7 days after inoculation in a cosmetic formulation. Participating laboratories performed their duplicate analysis on each test microorganism under repeatability conditions, using the same analytical method. In order to evaluate the consistency of laboratory performance, two trials were scheduled at a one-week interval, and they were conducted by the same analyst, applying the same analytical procedure on identical samples. The results of this study demonstrated the overall good application of the method in the determination of microbial reduction by participating laboratories and highlighted the robustness of integrating method precision assessment into proficiency testing for monitoring the analytical performance of cosmetic microbiology laboratories.</p>
	]]></content:encoded>

	<dc:title>Evaluating Laboratory Performance in a Proficiency Test for Antimicrobial Protection of a Cosmetic Formulation</dc:title>
			<dc:creator>Sabrina Bouakache</dc:creator>
			<dc:creator>Thanh Thuy Nguyen</dc:creator>
			<dc:creator>Margaux François Elissalde</dc:creator>
			<dc:creator>Anne Tirard</dc:creator>
			<dc:creator>Abdelkader Boubetra</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060297</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-30</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-30</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>297</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060297</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/297</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/296">

	<title>Cosmetics, Vol. 13, Pages 296: Plant Small RNA-Rich Himalayan Anethum graveolens Extract Modulates Aging-Associated microRNA Signatures to Enhance Dermal Architecture Protein Synthesis in Human Skin</title>
	<link>https://www.mdpi.com/2079-9284/13/6/296</link>
	<description>In December 2024, scientists Victor Ambros and Gary Ruvkun were awarded the Nobel Prize in Physiology or Medicine for their novel discovery of post-transcriptional gene regulation via microRNA (miRNA). This large class of non-coding RNAs defines a new layer of gene regulation activity that can control many biological processes in multicellular organisms. This experimental study explores how Himalayan Anethum graveolens extract (HAGE), rich in small RNAs, obtained by PSR technology&amp;amp;trade;, can modulate human miRNAs and skin signaling pathways to improve dermal architecture and elastic fiber integrity for anti-aging benefits. Our epigenomic study analyzes skin biopsies from Chinese individuals according to different characteristics (chronological age, photoprotection&amp;amp;hellip;) and identifies distinct miRNA expression profiles associated with both endogenous and exogenous aging pathways using analytical and bioinformatics methodologies. Differential targeting of aging-related genes suggests that specific miRNAs may play a regulatory role in coordinating these two aging processes. Our in vitro experiments in normal human dermal fibroblasts indicate that 0.05% HAGE decreased the expression of miRNA signatures associated with intrinsic aging (miR-30c-2-3p and miR-125b-1-3p) and photoaging (miR-16-2-3p). Further in vitro and ex vivo assays, with the ex vivo findings to be regarded as preliminary, also showed increases in dermal matrix proteins such as collagen type I and III, elastin, fibrillin-1 and dermatopontin. We demonstrated that HAGE decreases key aging-associated miRNAs, including miR-30c-2-3p and miR-125b-1-3p (intrinsic aging) and miR-16-2-3p (photoaging). IGF1 and IGF1R are established miRNA targets, identified as skin endogenous aging target genes of miR-30c-2-3p and miR-125b-1-3p (invention patent ZL201810165800.7, IDP000089683) and are involved in cell growth and renewal, whereas CTGF (CCN2) is an experimentally supported target of miR-16-2-3p; however, the restoration of these target axes by HAGE was not directly measured. In ex vivo and in vitro models, HAGE increased collagen type I and III, elastin, fibrillin-1 and dermatopontin, supporting its potential regulatory impact on skin aging mechanisms. Our experiments are consistent with an epigenetic modulation model of aging prevention based on the modulation of miRNAs as aging gene-silencing agents by topical application of extracts rich in small RNAs such as HAGE. Whether plant small RNAs are taken up by and functional in human skin cells, and whether this modulation translates into clinical anti-aging benefits remains to be established.</description>
	<pubDate>2026-10-30</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 296: Plant Small RNA-Rich Himalayan Anethum graveolens Extract Modulates Aging-Associated microRNA Signatures to Enhance Dermal Architecture Protein Synthesis in Human Skin</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/296">doi: 10.3390/cosmetics13060296</a></p>
	<p>Authors:
		Youssef Maach
		Catherine Serre
		Magali Bonnans
		Laura Adam
		Laurine Bergeron
		Audrey Le Mestr
		Isabelle Imbert
		Hui Ren
		Yue Zou
		Shanshan Jiang
		</p>
	<p>In December 2024, scientists Victor Ambros and Gary Ruvkun were awarded the Nobel Prize in Physiology or Medicine for their novel discovery of post-transcriptional gene regulation via microRNA (miRNA). This large class of non-coding RNAs defines a new layer of gene regulation activity that can control many biological processes in multicellular organisms. This experimental study explores how Himalayan Anethum graveolens extract (HAGE), rich in small RNAs, obtained by PSR technology&amp;amp;trade;, can modulate human miRNAs and skin signaling pathways to improve dermal architecture and elastic fiber integrity for anti-aging benefits. Our epigenomic study analyzes skin biopsies from Chinese individuals according to different characteristics (chronological age, photoprotection&amp;amp;hellip;) and identifies distinct miRNA expression profiles associated with both endogenous and exogenous aging pathways using analytical and bioinformatics methodologies. Differential targeting of aging-related genes suggests that specific miRNAs may play a regulatory role in coordinating these two aging processes. Our in vitro experiments in normal human dermal fibroblasts indicate that 0.05% HAGE decreased the expression of miRNA signatures associated with intrinsic aging (miR-30c-2-3p and miR-125b-1-3p) and photoaging (miR-16-2-3p). Further in vitro and ex vivo assays, with the ex vivo findings to be regarded as preliminary, also showed increases in dermal matrix proteins such as collagen type I and III, elastin, fibrillin-1 and dermatopontin. We demonstrated that HAGE decreases key aging-associated miRNAs, including miR-30c-2-3p and miR-125b-1-3p (intrinsic aging) and miR-16-2-3p (photoaging). IGF1 and IGF1R are established miRNA targets, identified as skin endogenous aging target genes of miR-30c-2-3p and miR-125b-1-3p (invention patent ZL201810165800.7, IDP000089683) and are involved in cell growth and renewal, whereas CTGF (CCN2) is an experimentally supported target of miR-16-2-3p; however, the restoration of these target axes by HAGE was not directly measured. In ex vivo and in vitro models, HAGE increased collagen type I and III, elastin, fibrillin-1 and dermatopontin, supporting its potential regulatory impact on skin aging mechanisms. Our experiments are consistent with an epigenetic modulation model of aging prevention based on the modulation of miRNAs as aging gene-silencing agents by topical application of extracts rich in small RNAs such as HAGE. Whether plant small RNAs are taken up by and functional in human skin cells, and whether this modulation translates into clinical anti-aging benefits remains to be established.</p>
	]]></content:encoded>

	<dc:title>Plant Small RNA-Rich Himalayan Anethum graveolens Extract Modulates Aging-Associated microRNA Signatures to Enhance Dermal Architecture Protein Synthesis in Human Skin</dc:title>
			<dc:creator>Youssef Maach</dc:creator>
			<dc:creator>Catherine Serre</dc:creator>
			<dc:creator>Magali Bonnans</dc:creator>
			<dc:creator>Laura Adam</dc:creator>
			<dc:creator>Laurine Bergeron</dc:creator>
			<dc:creator>Audrey Le Mestr</dc:creator>
			<dc:creator>Isabelle Imbert</dc:creator>
			<dc:creator>Hui Ren</dc:creator>
			<dc:creator>Yue Zou</dc:creator>
			<dc:creator>Shanshan Jiang</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060296</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-30</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-30</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>296</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060296</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/296</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/295">

	<title>Cosmetics, Vol. 13, Pages 295: Collagen and Hyaluronic Acid Combinations Modulate Intestinal Barrier Function and Skin Extracellular Matrix Responses in a Gut&amp;ndash;Skin In Vitro Model</title>
	<link>https://www.mdpi.com/2079-9284/13/6/295</link>
	<description>Collagen and hyaluronic acid (HA) are major extracellular matrix (ECM) components involved in skin structure and tissue homeostasis. However, the biological effects of different collagen sources, when combined with HA, following intestinal passage, remain incompletely characterised. This study investigated the effects of bovine and marine collagen hydrolysates and a compositionally distinct biomimetic formulation, each combined with two distinct HA preparations (such as GreenIuronic&amp;amp;reg; and sodium hyaluronate), in an integrated gut&amp;amp;ndash;skin in vitro model. Caco-2 intestinal cells were used to assess barrier integrity, fluorescein permeability, basolateral recovery of the measured analytes, oxidative stress and tight junction-related proteins. A skin co-culture model was subsequently exposed to basolateral medium collected from treated Caco-2 cultures and analysed for cell viability and ECM-related endpoints. The tested combinations generally improved transepithelial electrical resistance, passage through the intestinal model, cell viability, and tight junction protein expression compared with untreated controls. Following exposure to basolateral medium collected from treated Caco-2 cultures, the skin co-culture model showed changes in ECM-related measurements, including collagen, elastin and measured HA levels. Combinations containing GreenIuronic&amp;amp;reg; were generally associated with stronger effects under the experimental conditions tested. Western blot analyses further supported modulation of ECM-related proteins, including COL1A1, HAS2, ELN, and MMP1, suggesting a shift towards a matrix-supportive profile. In conclusion, these findings provide preliminary in vitro evidence that collagen-HA combinations may modulate intestinal barrier-related parameters and extracellular matrix-associated measured endpoints within an integrated gut-skin model.</description>
	<pubDate>2026-10-29</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 295: Collagen and Hyaluronic Acid Combinations Modulate Intestinal Barrier Function and Skin Extracellular Matrix Responses in a Gut&amp;ndash;Skin In Vitro Model</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/295">doi: 10.3390/cosmetics13060295</a></p>
	<p>Authors:
		Francesca Parini
		Matteo Musu
		Rebecca Galla
		Simone Mulè
		Francesca Uberti
		</p>
	<p>Collagen and hyaluronic acid (HA) are major extracellular matrix (ECM) components involved in skin structure and tissue homeostasis. However, the biological effects of different collagen sources, when combined with HA, following intestinal passage, remain incompletely characterised. This study investigated the effects of bovine and marine collagen hydrolysates and a compositionally distinct biomimetic formulation, each combined with two distinct HA preparations (such as GreenIuronic&amp;amp;reg; and sodium hyaluronate), in an integrated gut&amp;amp;ndash;skin in vitro model. Caco-2 intestinal cells were used to assess barrier integrity, fluorescein permeability, basolateral recovery of the measured analytes, oxidative stress and tight junction-related proteins. A skin co-culture model was subsequently exposed to basolateral medium collected from treated Caco-2 cultures and analysed for cell viability and ECM-related endpoints. The tested combinations generally improved transepithelial electrical resistance, passage through the intestinal model, cell viability, and tight junction protein expression compared with untreated controls. Following exposure to basolateral medium collected from treated Caco-2 cultures, the skin co-culture model showed changes in ECM-related measurements, including collagen, elastin and measured HA levels. Combinations containing GreenIuronic&amp;amp;reg; were generally associated with stronger effects under the experimental conditions tested. Western blot analyses further supported modulation of ECM-related proteins, including COL1A1, HAS2, ELN, and MMP1, suggesting a shift towards a matrix-supportive profile. In conclusion, these findings provide preliminary in vitro evidence that collagen-HA combinations may modulate intestinal barrier-related parameters and extracellular matrix-associated measured endpoints within an integrated gut-skin model.</p>
	]]></content:encoded>

	<dc:title>Collagen and Hyaluronic Acid Combinations Modulate Intestinal Barrier Function and Skin Extracellular Matrix Responses in a Gut&amp;amp;ndash;Skin In Vitro Model</dc:title>
			<dc:creator>Francesca Parini</dc:creator>
			<dc:creator>Matteo Musu</dc:creator>
			<dc:creator>Rebecca Galla</dc:creator>
			<dc:creator>Simone Mulè</dc:creator>
			<dc:creator>Francesca Uberti</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060295</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-29</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-29</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>295</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060295</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/295</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/294">

	<title>Cosmetics, Vol. 13, Pages 294: Comparative Effects of Botulinum Toxin A, &amp;alpha;-Bungarotoxin, Myricetin, and a Natural Extract Blend on Neurotransmitter Levels and Gene Expression in Human Skin Explants</title>
	<link>https://www.mdpi.com/2079-9284/13/6/294</link>
	<description>Injected botulinum neurotoxins (BoNT) reduce dynamic wrinkles by cleaving SNARE proteins at the neuromuscular junction; however, their large size mostly limits their use to injectable procedures. Certain polyphenols, including myricetin, have been shown in neuronal systems to reduce acetylcholine (ACh)-induced muscle contraction via inhibition of SNARE complex zippering, suggesting potential for topical use as modulators of skin cholinergic activity. This study aimed to identify a natural extract blend similarly capable of reducing ACh levels, followed by characterization of the activity of this extract on human skin explants, alongside reference molecules BoNT/A, &amp;amp;alpha;-bungarotoxin, and myricetin. The natural extract blend (&amp;amp;ldquo;Blend 1&amp;amp;rdquo;) inhibited vesicle fusion and attenuated norepinephrine release in a cell culture system, inhibited muscle cell contraction within nerve/muscle co-culture, and reduced ACh levels consistent with myricetin and reference neurotoxins within human skin explants. Bulk transcriptomics of treated ex vivo skin explants revealed that BoNT/A, myricetin, and Blend 1 all shared a similar downregulated inflammatory and antiviral gene profile separate from &amp;amp;alpha;-bungarotoxin, but that myricetin and Blend 1 shared a large degree of overlap for upregulated genes associated with skin homeostasis and repair that was not observed for either toxin. These data support Blend 1 as a candidate for topical cosmetic use through modulation of BoNT/A-like cholinergic pathways, alongside activation of additional pathways associated with skin homeostasis and repair.</description>
	<pubDate>2026-10-28</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 294: Comparative Effects of Botulinum Toxin A, &amp;alpha;-Bungarotoxin, Myricetin, and a Natural Extract Blend on Neurotransmitter Levels and Gene Expression in Human Skin Explants</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/294">doi: 10.3390/cosmetics13060294</a></p>
	<p>Authors:
		Hyeyoun Kim
		Franck Juchaux
		Sabrine Benosmane
		Jin-Woo Min
		Young Mok Heo
		Younhwa Nho
		Chan-Yeong Heo
		Dong-Geol Lee
		Chunho Park
		Seunghyun Kang
		Richard J. Betts
		Ryang Yeo Kim
		</p>
	<p>Injected botulinum neurotoxins (BoNT) reduce dynamic wrinkles by cleaving SNARE proteins at the neuromuscular junction; however, their large size mostly limits their use to injectable procedures. Certain polyphenols, including myricetin, have been shown in neuronal systems to reduce acetylcholine (ACh)-induced muscle contraction via inhibition of SNARE complex zippering, suggesting potential for topical use as modulators of skin cholinergic activity. This study aimed to identify a natural extract blend similarly capable of reducing ACh levels, followed by characterization of the activity of this extract on human skin explants, alongside reference molecules BoNT/A, &amp;amp;alpha;-bungarotoxin, and myricetin. The natural extract blend (&amp;amp;ldquo;Blend 1&amp;amp;rdquo;) inhibited vesicle fusion and attenuated norepinephrine release in a cell culture system, inhibited muscle cell contraction within nerve/muscle co-culture, and reduced ACh levels consistent with myricetin and reference neurotoxins within human skin explants. Bulk transcriptomics of treated ex vivo skin explants revealed that BoNT/A, myricetin, and Blend 1 all shared a similar downregulated inflammatory and antiviral gene profile separate from &amp;amp;alpha;-bungarotoxin, but that myricetin and Blend 1 shared a large degree of overlap for upregulated genes associated with skin homeostasis and repair that was not observed for either toxin. These data support Blend 1 as a candidate for topical cosmetic use through modulation of BoNT/A-like cholinergic pathways, alongside activation of additional pathways associated with skin homeostasis and repair.</p>
	]]></content:encoded>

	<dc:title>Comparative Effects of Botulinum Toxin A, &amp;amp;alpha;-Bungarotoxin, Myricetin, and a Natural Extract Blend on Neurotransmitter Levels and Gene Expression in Human Skin Explants</dc:title>
			<dc:creator>Hyeyoun Kim</dc:creator>
			<dc:creator>Franck Juchaux</dc:creator>
			<dc:creator>Sabrine Benosmane</dc:creator>
			<dc:creator>Jin-Woo Min</dc:creator>
			<dc:creator>Young Mok Heo</dc:creator>
			<dc:creator>Younhwa Nho</dc:creator>
			<dc:creator>Chan-Yeong Heo</dc:creator>
			<dc:creator>Dong-Geol Lee</dc:creator>
			<dc:creator>Chunho Park</dc:creator>
			<dc:creator>Seunghyun Kang</dc:creator>
			<dc:creator>Richard J. Betts</dc:creator>
			<dc:creator>Ryang Yeo Kim</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060294</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-28</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-28</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>294</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060294</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/294</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/293">

	<title>Cosmetics, Vol. 13, Pages 293: Clinical Observation and Mechanistic Insights of Traditional Thai Oral Formulations with Herbal Cream on Psoriasis Through Molecular Docking</title>
	<link>https://www.mdpi.com/2079-9284/13/6/293</link>
	<description>Thai herbal medicine is an ancient Thai approach to the treatment of psoriasis. However, its treatment of psoriasis has no evidence of clinical study evidence, and its mechanism remains unclear. The present study investigated the therapeutic effects and mechanism of action of Thai herbal formulations in treating psoriasis. A single-arm pre&amp;amp;ndash;post design study on traditional Thai medicine was conducted with twenty psoriasis patients presenting plaque, guttate, and erythrodermic types throughout a continuous period of 12 weeks. The outcome measurements, including Psoriasis Area Severity Index (PASI), Dermatology Life Quality Index (DLQI), and hematological and safety parameters, were assessed at baseline and post-therapy. Molecular docking was employed to clarify the mechanism of action for psoriasis-targeting therapies. The preliminary clinical observations demonstrated that Thai herbal formulations significantly improved both psoriasis severity and quality of life post-therapy (p &amp;amp;lt; 0.05) for plaque, guttate, and erythrodermic psoriasis, without serious adverse effects. Additionally, molecular docking analyses indicated that Thai herbal formulations could interact with the protein targets cyclooxygenase-2 (COX-2) and interleukin (IL)-6, therefore alleviating psoriasis symptoms by modulating inflammatory pathways. The findings suggested that Thai herbal formulations may function through multi-target mechanisms, exhibiting potential as natural therapeutic medicines for psoriasis.</description>
	<pubDate>2026-10-27</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 293: Clinical Observation and Mechanistic Insights of Traditional Thai Oral Formulations with Herbal Cream on Psoriasis Through Molecular Docking</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/293">doi: 10.3390/cosmetics13060293</a></p>
	<p>Authors:
		Sudarshan Singh
		Achal Mishra
		Julalak Chorachoo Ontong
		Namkang Sripeng
		Nattaporn Kaewpraju
		Pathamapun Boonprasert
		Mantana Tinnabut
		Chadamas Promtem
		Surapa Nipatpong
		Nantikarn Athihiranrattakit
		Warunon Promchan
		Salinthip Phungtammasan
		Pimwipa Phrakha
		Somporn Chanwanitsakul
		Benjaporn Bourchum
		Sanan Subhadhirasakul
		Supayang Piyawan Voravuthikunchai
		Thanyaluck Siriyong
		</p>
	<p>Thai herbal medicine is an ancient Thai approach to the treatment of psoriasis. However, its treatment of psoriasis has no evidence of clinical study evidence, and its mechanism remains unclear. The present study investigated the therapeutic effects and mechanism of action of Thai herbal formulations in treating psoriasis. A single-arm pre&amp;amp;ndash;post design study on traditional Thai medicine was conducted with twenty psoriasis patients presenting plaque, guttate, and erythrodermic types throughout a continuous period of 12 weeks. The outcome measurements, including Psoriasis Area Severity Index (PASI), Dermatology Life Quality Index (DLQI), and hematological and safety parameters, were assessed at baseline and post-therapy. Molecular docking was employed to clarify the mechanism of action for psoriasis-targeting therapies. The preliminary clinical observations demonstrated that Thai herbal formulations significantly improved both psoriasis severity and quality of life post-therapy (p &amp;amp;lt; 0.05) for plaque, guttate, and erythrodermic psoriasis, without serious adverse effects. Additionally, molecular docking analyses indicated that Thai herbal formulations could interact with the protein targets cyclooxygenase-2 (COX-2) and interleukin (IL)-6, therefore alleviating psoriasis symptoms by modulating inflammatory pathways. The findings suggested that Thai herbal formulations may function through multi-target mechanisms, exhibiting potential as natural therapeutic medicines for psoriasis.</p>
	]]></content:encoded>

	<dc:title>Clinical Observation and Mechanistic Insights of Traditional Thai Oral Formulations with Herbal Cream on Psoriasis Through Molecular Docking</dc:title>
			<dc:creator>Sudarshan Singh</dc:creator>
			<dc:creator>Achal Mishra</dc:creator>
			<dc:creator>Julalak Chorachoo Ontong</dc:creator>
			<dc:creator>Namkang Sripeng</dc:creator>
			<dc:creator>Nattaporn Kaewpraju</dc:creator>
			<dc:creator>Pathamapun Boonprasert</dc:creator>
			<dc:creator>Mantana Tinnabut</dc:creator>
			<dc:creator>Chadamas Promtem</dc:creator>
			<dc:creator>Surapa Nipatpong</dc:creator>
			<dc:creator>Nantikarn Athihiranrattakit</dc:creator>
			<dc:creator>Warunon Promchan</dc:creator>
			<dc:creator>Salinthip Phungtammasan</dc:creator>
			<dc:creator>Pimwipa Phrakha</dc:creator>
			<dc:creator>Somporn Chanwanitsakul</dc:creator>
			<dc:creator>Benjaporn Bourchum</dc:creator>
			<dc:creator>Sanan Subhadhirasakul</dc:creator>
			<dc:creator>Supayang Piyawan Voravuthikunchai</dc:creator>
			<dc:creator>Thanyaluck Siriyong</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060293</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-27</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-27</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>293</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060293</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/293</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/292">

	<title>Cosmetics, Vol. 13, Pages 292: Improved Epidermal Bioavailability and Anti-Inflammatory Activity of Cannabidiol Encapsulated in Polypeptide-Stabilised Emulsions</title>
	<link>https://www.mdpi.com/2079-9284/13/6/292</link>
	<description>Cannabidiol (CBD) is a promising bioactive compound for skin applications; however, its topical delivery is limited by poor aqueous solubility, high lipophilicity, and chemical instability. Here, a polypeptide-stabilised oil-in-water emulsion enabling CBD encapsulation (ENC-CBD) was developed as an innovative delivery system to enhance the epidermal bioavailability and biological activity of CBD. Stable 216 nm ENC-CBD containing 175 mg/mL CBD exhibited long-term physicochemical stability over 18 months, maintaining CBD content, viscosity, density, and particle size within predefined specifications. Cytocompatibility studies in human keratinocytes (HaCaT) and dermal fibroblasts (HDF) showed concentration-dependent effects, with excellent biocompatibility at 1.75 mg/mL. In UVB-irradiated cellular models, ENC-CBD significantly reduced IL-6 and IL-8 production by 93% and 73%, respectively. Moreover, in reconstructed human epidermal tissues, ENC-CBD was non-irritant and achieved markedly greater epidermal CBD accumulation than non-encapsulated CBD, reaching approximately 11- and 7-fold higher levels after 6 h and 24 h, respectively. ENC-CBD applied to skin models significantly attenuated UV-induced inflammation characterised by overexpression of IL-6, IL-8, IL-1B, and TNF genes, while the delivery system appeared to have, to some extent, some anti-inflammatory properties. Overall, polypeptide-based emulsion carrier enhanced CBD epidermal delivery and its anti-inflammatory activity, highlighting its potential as a topical ingredient for skin inflammation.</description>
	<pubDate>2026-10-27</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 292: Improved Epidermal Bioavailability and Anti-Inflammatory Activity of Cannabidiol Encapsulated in Polypeptide-Stabilised Emulsions</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/292">doi: 10.3390/cosmetics13060292</a></p>
	<p>Authors:
		Paula Zamora
		Janire Pikabea
		Ángela Moncada-Pazos
		Iraida Loinaz
		Damien Dupin
		</p>
	<p>Cannabidiol (CBD) is a promising bioactive compound for skin applications; however, its topical delivery is limited by poor aqueous solubility, high lipophilicity, and chemical instability. Here, a polypeptide-stabilised oil-in-water emulsion enabling CBD encapsulation (ENC-CBD) was developed as an innovative delivery system to enhance the epidermal bioavailability and biological activity of CBD. Stable 216 nm ENC-CBD containing 175 mg/mL CBD exhibited long-term physicochemical stability over 18 months, maintaining CBD content, viscosity, density, and particle size within predefined specifications. Cytocompatibility studies in human keratinocytes (HaCaT) and dermal fibroblasts (HDF) showed concentration-dependent effects, with excellent biocompatibility at 1.75 mg/mL. In UVB-irradiated cellular models, ENC-CBD significantly reduced IL-6 and IL-8 production by 93% and 73%, respectively. Moreover, in reconstructed human epidermal tissues, ENC-CBD was non-irritant and achieved markedly greater epidermal CBD accumulation than non-encapsulated CBD, reaching approximately 11- and 7-fold higher levels after 6 h and 24 h, respectively. ENC-CBD applied to skin models significantly attenuated UV-induced inflammation characterised by overexpression of IL-6, IL-8, IL-1B, and TNF genes, while the delivery system appeared to have, to some extent, some anti-inflammatory properties. Overall, polypeptide-based emulsion carrier enhanced CBD epidermal delivery and its anti-inflammatory activity, highlighting its potential as a topical ingredient for skin inflammation.</p>
	]]></content:encoded>

	<dc:title>Improved Epidermal Bioavailability and Anti-Inflammatory Activity of Cannabidiol Encapsulated in Polypeptide-Stabilised Emulsions</dc:title>
			<dc:creator>Paula Zamora</dc:creator>
			<dc:creator>Janire Pikabea</dc:creator>
			<dc:creator>Ángela Moncada-Pazos</dc:creator>
			<dc:creator>Iraida Loinaz</dc:creator>
			<dc:creator>Damien Dupin</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060292</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-27</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-27</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>292</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060292</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/292</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/291">

	<title>Cosmetics, Vol. 13, Pages 291: Handelin Attenuates Ultraviolet-Induced Skin Photoaging and Associated Oxidative Stress and Extracellular Matrix Damage in Mice</title>
	<link>https://www.mdpi.com/2079-9284/13/6/291</link>
	<description>Chronic ultraviolet (UV) exposure promotes skin photoaging through oxidative stress, inflammation, autophagy-related alterations, and extracellular matrix (ECM) damage. This study evaluated the protective effects of Handelin in a chronic UV-induced mouse photoaging model. Forty male Kunming mice were assigned to Control, UV, UV + Vehicle, and UV + Handelin groups (n = 10/group). Except for the Control group, mice received combined UVA/UVB irradiation for 8 weeks, with Vehicle or Handelin administered intradermally before each exposure. Skin photoaging was assessed by macroscopic scoring, histology, ELISA, immunohistochemistry, and immunofluorescence. Compared with the UV + Vehicle group, Handelin attenuated skin roughness, wrinkle formation, epidermal thickening, and dermal collagen disorganization. Handelin also reduced the ROS-related ELISA signal and the levels of malondialdehyde, interleukin-6, tumor necrosis factor-&amp;amp;alpha;, and MMP-3; decreased p-p38 MAPK, p-mTOR, and MMP-1 immunoreactivity; and increased superoxide dismutase protein levels, Beclin-1 and TIMP-1 immunoreactivity, LC3B fluorescence intensity, and type I collagen immunoreactivity. These findings indicate that intradermal Handelin attenuates chronic UV-induced skin photoaging and ECM damage, accompanied by improvements in oxidative stress-related indices and inflammatory markers, changes in mTOR- and autophagy-related markers, and amelioration of MMP/TIMP imbalance.</description>
	<pubDate>2026-10-27</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 291: Handelin Attenuates Ultraviolet-Induced Skin Photoaging and Associated Oxidative Stress and Extracellular Matrix Damage in Mice</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/291">doi: 10.3390/cosmetics13060291</a></p>
	<p>Authors:
		Minghui Sun
		Na Deng
		Huijuan Li
		Shiyang Zhang
		Xiaojing Ren
		Jie Han
		Heng Liu
		Sujiao Sun
		</p>
	<p>Chronic ultraviolet (UV) exposure promotes skin photoaging through oxidative stress, inflammation, autophagy-related alterations, and extracellular matrix (ECM) damage. This study evaluated the protective effects of Handelin in a chronic UV-induced mouse photoaging model. Forty male Kunming mice were assigned to Control, UV, UV + Vehicle, and UV + Handelin groups (n = 10/group). Except for the Control group, mice received combined UVA/UVB irradiation for 8 weeks, with Vehicle or Handelin administered intradermally before each exposure. Skin photoaging was assessed by macroscopic scoring, histology, ELISA, immunohistochemistry, and immunofluorescence. Compared with the UV + Vehicle group, Handelin attenuated skin roughness, wrinkle formation, epidermal thickening, and dermal collagen disorganization. Handelin also reduced the ROS-related ELISA signal and the levels of malondialdehyde, interleukin-6, tumor necrosis factor-&amp;amp;alpha;, and MMP-3; decreased p-p38 MAPK, p-mTOR, and MMP-1 immunoreactivity; and increased superoxide dismutase protein levels, Beclin-1 and TIMP-1 immunoreactivity, LC3B fluorescence intensity, and type I collagen immunoreactivity. These findings indicate that intradermal Handelin attenuates chronic UV-induced skin photoaging and ECM damage, accompanied by improvements in oxidative stress-related indices and inflammatory markers, changes in mTOR- and autophagy-related markers, and amelioration of MMP/TIMP imbalance.</p>
	]]></content:encoded>

	<dc:title>Handelin Attenuates Ultraviolet-Induced Skin Photoaging and Associated Oxidative Stress and Extracellular Matrix Damage in Mice</dc:title>
			<dc:creator>Minghui Sun</dc:creator>
			<dc:creator>Na Deng</dc:creator>
			<dc:creator>Huijuan Li</dc:creator>
			<dc:creator>Shiyang Zhang</dc:creator>
			<dc:creator>Xiaojing Ren</dc:creator>
			<dc:creator>Jie Han</dc:creator>
			<dc:creator>Heng Liu</dc:creator>
			<dc:creator>Sujiao Sun</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060291</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-27</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-27</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>291</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060291</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/291</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/290">

	<title>Cosmetics, Vol. 13, Pages 290: Yeast&amp;ndash;Plant-Derived Consortia Factors Exhibit an Enriched Extracellular Metabolome with Antioxidant and Anti-Inflammatory Potential in Human Skin-Derived Cells</title>
	<link>https://www.mdpi.com/2079-9284/13/6/290</link>
	<description>Cells secrete metabolites and other bioactive factors into the extracellular environment, collectively known as the secretome. While single-species secretomes are well studied, the impact of interspecies co-culture on secretome composition remains poorly understood. Here, we investigated whether co-culturing plant and yeast cells could generate emergent secretory outputs. A yeast suspension of Ustilago cynodontis was co-cultured with plant cells derived from Ocimum sanctum (Tulsi) to produce a novel set of secretory factors termed Consortia Factors (CFx). Metabolomic profiling of the Ustilago-Tulsi CFx, termed CFx-&amp;amp;alpha;1, revealed a metabolome that was distinct from and more enriched than those of either monoculture. Statistical clustering demonstrated divergence from single-culture secretomes, with approximately one-third of enriched metabolites absent from either organism grown alone. Using an algorithm designed to identify validated antioxidant and anti-inflammatory metabolites, we found that CFx-&amp;amp;alpha;1 was significantly enriched in these metabolites, including vitamin C. Consistent with this profile, CFx-&amp;amp;alpha;1 exhibited greater intracellular antioxidant activity and more effectively attenuated lipopolysaccharide (LPS)-induced NF-&amp;amp;kappa;B nuclear localization in human skin-derived cells than either single-culture conditioned medium. CFx-&amp;amp;alpha;1 also maintained human dermal fibroblast viability across concentrations of 1&amp;amp;ndash;5%. These findings indicate that plant&amp;amp;ndash;yeast co-culture generates a distinct and functionally enriched extracellular metabolome with antioxidant and anti-inflammatory potential, highlighting consortia-based culture systems as a promising strategy for producing bioactive metabolites for cosmetic applications.</description>
	<pubDate>2026-10-26</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 290: Yeast&amp;ndash;Plant-Derived Consortia Factors Exhibit an Enriched Extracellular Metabolome with Antioxidant and Anti-Inflammatory Potential in Human Skin-Derived Cells</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/290">doi: 10.3390/cosmetics13060290</a></p>
	<p>Authors:
		Assaf Zemach
		Mikhail R. Plaza
		Melissa Palomares
		Dior Simmons
		Bong Seop Lee
		Dodanim Talavera-Adame
		Nathan Newman
		</p>
	<p>Cells secrete metabolites and other bioactive factors into the extracellular environment, collectively known as the secretome. While single-species secretomes are well studied, the impact of interspecies co-culture on secretome composition remains poorly understood. Here, we investigated whether co-culturing plant and yeast cells could generate emergent secretory outputs. A yeast suspension of Ustilago cynodontis was co-cultured with plant cells derived from Ocimum sanctum (Tulsi) to produce a novel set of secretory factors termed Consortia Factors (CFx). Metabolomic profiling of the Ustilago-Tulsi CFx, termed CFx-&amp;amp;alpha;1, revealed a metabolome that was distinct from and more enriched than those of either monoculture. Statistical clustering demonstrated divergence from single-culture secretomes, with approximately one-third of enriched metabolites absent from either organism grown alone. Using an algorithm designed to identify validated antioxidant and anti-inflammatory metabolites, we found that CFx-&amp;amp;alpha;1 was significantly enriched in these metabolites, including vitamin C. Consistent with this profile, CFx-&amp;amp;alpha;1 exhibited greater intracellular antioxidant activity and more effectively attenuated lipopolysaccharide (LPS)-induced NF-&amp;amp;kappa;B nuclear localization in human skin-derived cells than either single-culture conditioned medium. CFx-&amp;amp;alpha;1 also maintained human dermal fibroblast viability across concentrations of 1&amp;amp;ndash;5%. These findings indicate that plant&amp;amp;ndash;yeast co-culture generates a distinct and functionally enriched extracellular metabolome with antioxidant and anti-inflammatory potential, highlighting consortia-based culture systems as a promising strategy for producing bioactive metabolites for cosmetic applications.</p>
	]]></content:encoded>

	<dc:title>Yeast&amp;amp;ndash;Plant-Derived Consortia Factors Exhibit an Enriched Extracellular Metabolome with Antioxidant and Anti-Inflammatory Potential in Human Skin-Derived Cells</dc:title>
			<dc:creator>Assaf Zemach</dc:creator>
			<dc:creator>Mikhail R. Plaza</dc:creator>
			<dc:creator>Melissa Palomares</dc:creator>
			<dc:creator>Dior Simmons</dc:creator>
			<dc:creator>Bong Seop Lee</dc:creator>
			<dc:creator>Dodanim Talavera-Adame</dc:creator>
			<dc:creator>Nathan Newman</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060290</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-26</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-26</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>290</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060290</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/290</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/289">

	<title>Cosmetics, Vol. 13, Pages 289: Dermatologic Lasers in the Management of Keratinocyte Carcinoma: Lesion-Directed Treatment and Field-Directed Secondary Prevention</title>
	<link>https://www.mdpi.com/2079-9284/13/6/289</link>
	<description>Keratinocyte carcinoma (KC) is the most common malignancy worldwide, and its incidence continues to rise. In addition to direct DNA damage, ultraviolet radiation promotes immunosuppression and field cancerisation, thereby contributing to the development of actinic keratoses (AKs) and KC. Against this background, dermatologic lasers have been investigated both for the lesion-directed treatment of selected tumours and for field-directed interventions aimed at reducing the risk of new lesions in chronically photodamaged skin. This narrative review examines the evidence on lasers in KC management, summarising each study by design, numbers of patients and lesions, parameters, outcomes, follow-up and level of evidence. Pulsed dye laser and long-pulsed 1064 nm neodymium-doped yttrium aluminium garnet (Nd:YAG) laser, which differ in mechanism, penetration depth and evidence base, as well as ablative lasers, may be useful in selected low-risk basal cell carcinomas, whereas non-ablative fractional lasers mainly reduce AK burden. Among field-directed approaches, fractional ablative resurfacing shows the strongest evidence for reducing both AK and subsequent KC. However, the evidence remains limited by small studies, heterogeneous protocols, short follow-up, lesion-level analyses and frequent lack of systematic histological confirmation.</description>
	<pubDate>2026-10-26</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 289: Dermatologic Lasers in the Management of Keratinocyte Carcinoma: Lesion-Directed Treatment and Field-Directed Secondary Prevention</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/289">doi: 10.3390/cosmetics13060289</a></p>
	<p>Authors:
		Luis Alonso-Mtz de Salinas
		Jorge Naharro-Rodriguez
		Emilio García-Mouronte
		Miguel Centeno-Pons
		Jaime Company-Quiroga
		Pablo Boixeda-de Miquel
		Montserrat Fernández-Guarino
		</p>
	<p>Keratinocyte carcinoma (KC) is the most common malignancy worldwide, and its incidence continues to rise. In addition to direct DNA damage, ultraviolet radiation promotes immunosuppression and field cancerisation, thereby contributing to the development of actinic keratoses (AKs) and KC. Against this background, dermatologic lasers have been investigated both for the lesion-directed treatment of selected tumours and for field-directed interventions aimed at reducing the risk of new lesions in chronically photodamaged skin. This narrative review examines the evidence on lasers in KC management, summarising each study by design, numbers of patients and lesions, parameters, outcomes, follow-up and level of evidence. Pulsed dye laser and long-pulsed 1064 nm neodymium-doped yttrium aluminium garnet (Nd:YAG) laser, which differ in mechanism, penetration depth and evidence base, as well as ablative lasers, may be useful in selected low-risk basal cell carcinomas, whereas non-ablative fractional lasers mainly reduce AK burden. Among field-directed approaches, fractional ablative resurfacing shows the strongest evidence for reducing both AK and subsequent KC. However, the evidence remains limited by small studies, heterogeneous protocols, short follow-up, lesion-level analyses and frequent lack of systematic histological confirmation.</p>
	]]></content:encoded>

	<dc:title>Dermatologic Lasers in the Management of Keratinocyte Carcinoma: Lesion-Directed Treatment and Field-Directed Secondary Prevention</dc:title>
			<dc:creator>Luis Alonso-Mtz de Salinas</dc:creator>
			<dc:creator>Jorge Naharro-Rodriguez</dc:creator>
			<dc:creator>Emilio García-Mouronte</dc:creator>
			<dc:creator>Miguel Centeno-Pons</dc:creator>
			<dc:creator>Jaime Company-Quiroga</dc:creator>
			<dc:creator>Pablo Boixeda-de Miquel</dc:creator>
			<dc:creator>Montserrat Fernández-Guarino</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060289</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-26</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-26</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>289</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060289</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/289</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/288">

	<title>Cosmetics, Vol. 13, Pages 288: Sinomenine from Sinomenium acutum Rhizome: A Promising Bioactive Ingredient Associated with Hair-Growth Promotion</title>
	<link>https://www.mdpi.com/2079-9284/13/6/288</link>
	<description>Androgenetic alopecia (AGA) is characterized by disruption of the hair-growth cycle and alterations in growth-related and inflammatory signaling. Sinomenium acutum and its major compound, sinomenine (SIN), have been reported to possess antioxidant and anti-inflammatory activities; however, their effects on hair growth regulation remain unclear. Therefore, the aim of this study was to investigate the effects of S. acutum rhizome extract (SAE) and SIN on hair cycle transition and explore the associated molecular changes. In vivo and in vitro models were used to determine the effects of SAE and SIN and their correlation with hair-growth-promoting and inhibitory factors, as well as the associated Wnt/&amp;amp;beta;-catenin signaling pathway and inflammatory responses. Sinomenine significantly upregulated the expression of vascular endothelial growth factor, basic fibroblast growth factor, and &amp;amp;beta;-catenin but suppressed that of transforming growth factor-&amp;amp;beta;1, dickkopf-1, and proinflammatory cytokines, which was associated with anagen phase induction. It also showed concentration-dependent effects in vitro at nanomolar concentrations, suggesting that it contributes to the activity of SAE. Histopathological analyses showed an increased number of anagen follicles and improved hair shaft elongation in the treated groups, consistent with enhanced anagen entry. In addition, sinomenine attenuated dihydrotestosterone (DHT)-induced changes in human dermal papilla cells (HDPCs), which were associated with growth factor and inflammatory markers. These findings suggest that SIN is a promising bioactive compound for hair care applications, although further validation is required.</description>
	<pubDate>2026-10-26</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 288: Sinomenine from Sinomenium acutum Rhizome: A Promising Bioactive Ingredient Associated with Hair-Growth Promotion</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/288">doi: 10.3390/cosmetics13060288</a></p>
	<p>Authors:
		Chae Eun Kim
		Kyong Kim
		Chae-Heon Lee
		Eun-Young Park
		Chul Young Kim
		Yoon Sin Oh
		</p>
	<p>Androgenetic alopecia (AGA) is characterized by disruption of the hair-growth cycle and alterations in growth-related and inflammatory signaling. Sinomenium acutum and its major compound, sinomenine (SIN), have been reported to possess antioxidant and anti-inflammatory activities; however, their effects on hair growth regulation remain unclear. Therefore, the aim of this study was to investigate the effects of S. acutum rhizome extract (SAE) and SIN on hair cycle transition and explore the associated molecular changes. In vivo and in vitro models were used to determine the effects of SAE and SIN and their correlation with hair-growth-promoting and inhibitory factors, as well as the associated Wnt/&amp;amp;beta;-catenin signaling pathway and inflammatory responses. Sinomenine significantly upregulated the expression of vascular endothelial growth factor, basic fibroblast growth factor, and &amp;amp;beta;-catenin but suppressed that of transforming growth factor-&amp;amp;beta;1, dickkopf-1, and proinflammatory cytokines, which was associated with anagen phase induction. It also showed concentration-dependent effects in vitro at nanomolar concentrations, suggesting that it contributes to the activity of SAE. Histopathological analyses showed an increased number of anagen follicles and improved hair shaft elongation in the treated groups, consistent with enhanced anagen entry. In addition, sinomenine attenuated dihydrotestosterone (DHT)-induced changes in human dermal papilla cells (HDPCs), which were associated with growth factor and inflammatory markers. These findings suggest that SIN is a promising bioactive compound for hair care applications, although further validation is required.</p>
	]]></content:encoded>

	<dc:title>Sinomenine from Sinomenium acutum Rhizome: A Promising Bioactive Ingredient Associated with Hair-Growth Promotion</dc:title>
			<dc:creator>Chae Eun Kim</dc:creator>
			<dc:creator>Kyong Kim</dc:creator>
			<dc:creator>Chae-Heon Lee</dc:creator>
			<dc:creator>Eun-Young Park</dc:creator>
			<dc:creator>Chul Young Kim</dc:creator>
			<dc:creator>Yoon Sin Oh</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060288</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-26</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-26</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>288</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060288</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/288</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/287">

	<title>Cosmetics, Vol. 13, Pages 287: A Conjugate of Hyaluronic Acid and Glutamic Acid Mediates Intracellular Glutamate Delivery to Restore Mitochondrial Function in Senescent Dermal Fibroblasts and Attenuate Skin Photoaging</title>
	<link>https://www.mdpi.com/2079-9284/13/6/287</link>
	<description>Mitochondrial dysfunction is a major contributor to skin aging. Glutamic acid (Glu) acts as an anaplerotic substrate for the tricarboxylic acid cycle to support ATP production, but senescent fibroblasts take up Glu poorly due to down-regulation of membrane amino-acid transporters. This study investigated whether HA-Glu, a covalent conjugate of hyaluronic acid and glutamic acid, could improve mitochondrial function in senescent fibroblasts by facilitating intracellular glutamate delivery through an alternative uptake pathway, potentially reducing reliance on SLC1A3-mediated transport. Time-course confocal microscopy revealed progressive intracellular accumulation of FITC-tagged HA-Glu in human dermal fibroblasts, and blocking CD44 largely prevented this cellular uptake. In UVA-exposed fibroblasts, HA-Glu restored mitochondrial membrane potential, lowered mitochondrial superoxide production, and raised cellular glutathione and ATP content. These effects were stronger than those produced by equivalent doses of free Glu or glutamine. HA-Glu also reversed stress-triggered mitochondrial swelling. Pharmacological inhibition of SLC1A3 using UCPH-101 completely abrogated the anti-senescence activity of free Glu, while HA-Glu retained its protective effects and sustained the expression of type I and III collagens, elastin and fibronectin. In UVB-treated male SKH-1 hairless mice (n = 3 per group), topical HA-Glu smoothed rough skin, restored dermal collagen deposition and diminished IL-6 and MMP-1 signals. Collectively, these findings support a model in which HA-Glu improves mitochondrial function in senescent fibroblasts, potentially through CD44-associated intracellular glutamate (Glu) delivery, and may attenuate UV-induced skin photoaging.</description>
	<pubDate>2026-10-23</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 287: A Conjugate of Hyaluronic Acid and Glutamic Acid Mediates Intracellular Glutamate Delivery to Restore Mitochondrial Function in Senescent Dermal Fibroblasts and Attenuate Skin Photoaging</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/287">doi: 10.3390/cosmetics13060287</a></p>
	<p>Authors:
		Zhe Liu
		Fangru Jiang
		</p>
	<p>Mitochondrial dysfunction is a major contributor to skin aging. Glutamic acid (Glu) acts as an anaplerotic substrate for the tricarboxylic acid cycle to support ATP production, but senescent fibroblasts take up Glu poorly due to down-regulation of membrane amino-acid transporters. This study investigated whether HA-Glu, a covalent conjugate of hyaluronic acid and glutamic acid, could improve mitochondrial function in senescent fibroblasts by facilitating intracellular glutamate delivery through an alternative uptake pathway, potentially reducing reliance on SLC1A3-mediated transport. Time-course confocal microscopy revealed progressive intracellular accumulation of FITC-tagged HA-Glu in human dermal fibroblasts, and blocking CD44 largely prevented this cellular uptake. In UVA-exposed fibroblasts, HA-Glu restored mitochondrial membrane potential, lowered mitochondrial superoxide production, and raised cellular glutathione and ATP content. These effects were stronger than those produced by equivalent doses of free Glu or glutamine. HA-Glu also reversed stress-triggered mitochondrial swelling. Pharmacological inhibition of SLC1A3 using UCPH-101 completely abrogated the anti-senescence activity of free Glu, while HA-Glu retained its protective effects and sustained the expression of type I and III collagens, elastin and fibronectin. In UVB-treated male SKH-1 hairless mice (n = 3 per group), topical HA-Glu smoothed rough skin, restored dermal collagen deposition and diminished IL-6 and MMP-1 signals. Collectively, these findings support a model in which HA-Glu improves mitochondrial function in senescent fibroblasts, potentially through CD44-associated intracellular glutamate (Glu) delivery, and may attenuate UV-induced skin photoaging.</p>
	]]></content:encoded>

	<dc:title>A Conjugate of Hyaluronic Acid and Glutamic Acid Mediates Intracellular Glutamate Delivery to Restore Mitochondrial Function in Senescent Dermal Fibroblasts and Attenuate Skin Photoaging</dc:title>
			<dc:creator>Zhe Liu</dc:creator>
			<dc:creator>Fangru Jiang</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060287</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-23</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-23</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>287</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060287</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/287</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/286">

	<title>Cosmetics, Vol. 13, Pages 286: Topical Insulin in Atrophic Acne Scarring: A Systematic Review of Efficacy, Safety, and Patient Satisfaction</title>
	<link>https://www.mdpi.com/2079-9284/13/6/286</link>
	<description>Background: Atrophic acne scars are challenging to treat and have a negative psychological impact. Insulin has been tried as a topical adjuvant and stimulates fibroblast activity, collagen deposition, and keratinocyte migration. Objectives: To evaluate topical insulin for atrophic acne scars in terms of its effectiveness, safety, and patient-rated results. Methods: Five databases were searched for research on topical insulin, either alone or in conjunction with a procedure, without regard to the date. Records were screened, extracted, and evaluated in duplicate (RoB 2 or ROBINS-I) each by two independent researchers, using Covidence. Results: Fourteen studies with 619 patients, seven randomized and seven non-randomized, were qualified. All insulin arms improved from baseline (35.8% to 55.4%), but comparator arms mostly improved similarly; five studies, none at low risk of bias, favored insulin. Adverse effects were mostly local, minor, and transient, although one study reported systemic hypoglycemia-related symptoms; glucose monitoring was inconsistent, and satisfaction was high. Limitations: Meta-analysis was not possible due to heterogeneity in design, dosage, and outcome scales, and the small number of patients precludes certain conclusions. Conclusions: Although its superiority over current adjuncts has not been demonstrated, topical insulin appears to be an affordable, well-tolerated adjunct that may have a function where traditional therapies are unavailable; larger studies are needed.</description>
	<pubDate>2026-10-22</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 286: Topical Insulin in Atrophic Acne Scarring: A Systematic Review of Efficacy, Safety, and Patient Satisfaction</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/286">doi: 10.3390/cosmetics13060286</a></p>
	<p>Authors:
		Ahmed A. Yusuf Alaysereen
		Abdullah Hussain
		Bushra Hasan
		Ali Zayer
		Abdu-Alaziz Khaskieh
		Salim Fredericks
		Bindhu Nair
		Aysha Al-Moosa
		</p>
	<p>Background: Atrophic acne scars are challenging to treat and have a negative psychological impact. Insulin has been tried as a topical adjuvant and stimulates fibroblast activity, collagen deposition, and keratinocyte migration. Objectives: To evaluate topical insulin for atrophic acne scars in terms of its effectiveness, safety, and patient-rated results. Methods: Five databases were searched for research on topical insulin, either alone or in conjunction with a procedure, without regard to the date. Records were screened, extracted, and evaluated in duplicate (RoB 2 or ROBINS-I) each by two independent researchers, using Covidence. Results: Fourteen studies with 619 patients, seven randomized and seven non-randomized, were qualified. All insulin arms improved from baseline (35.8% to 55.4%), but comparator arms mostly improved similarly; five studies, none at low risk of bias, favored insulin. Adverse effects were mostly local, minor, and transient, although one study reported systemic hypoglycemia-related symptoms; glucose monitoring was inconsistent, and satisfaction was high. Limitations: Meta-analysis was not possible due to heterogeneity in design, dosage, and outcome scales, and the small number of patients precludes certain conclusions. Conclusions: Although its superiority over current adjuncts has not been demonstrated, topical insulin appears to be an affordable, well-tolerated adjunct that may have a function where traditional therapies are unavailable; larger studies are needed.</p>
	]]></content:encoded>

	<dc:title>Topical Insulin in Atrophic Acne Scarring: A Systematic Review of Efficacy, Safety, and Patient Satisfaction</dc:title>
			<dc:creator>Ahmed A. Yusuf Alaysereen</dc:creator>
			<dc:creator>Abdullah Hussain</dc:creator>
			<dc:creator>Bushra Hasan</dc:creator>
			<dc:creator>Ali Zayer</dc:creator>
			<dc:creator>Abdu-Alaziz Khaskieh</dc:creator>
			<dc:creator>Salim Fredericks</dc:creator>
			<dc:creator>Bindhu Nair</dc:creator>
			<dc:creator>Aysha Al-Moosa</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060286</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-22</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-22</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Systematic Review</prism:section>
	<prism:startingPage>286</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060286</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/286</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/285">

	<title>Cosmetics, Vol. 13, Pages 285: Sebum, but Not Hydration, Shows Steeper Age-Related Differences After Age 40 in Women: A Cross-Sectional Study of 7743 Participants in 12 Countries</title>
	<link>https://www.mdpi.com/2079-9284/13/6/285</link>
	<description>Skin changes in women around age 40 are often attributed to impaired barrier function or reduced hydration, but large-scale data comparing sebum, hydration, and transepidermal water loss (TEWL) across age groups are scarce. In this cross-sectional study, we analyzed standardized cheek measurements from 7743 women aged 20&amp;amp;ndash;59 years in 12 countries (5274 Asian and 2469 Western). Piecewise regression tested changes in age-related slopes at age 40, including differences by region. The negative age&amp;amp;ndash;sebum slope was significantly steeper from age 40 onward in both Western (slope change &amp;amp;minus;0.762 &amp;amp;micro;g/cm2/year, p = 0.010) and Asian women (&amp;amp;minus;1.256 &amp;amp;micro;g/cm2/year, p &amp;amp;lt; 0.001), a result that held with robust standard errors, log transformation, and country adjustment and was replicated at two other facial sites. Hydration showed no change in slope at age 40, and resting TEWL decreased rather than increased. Sebum was 34.9% (Asian) and 25.4% (Western) lower at 50&amp;amp;ndash;59 than at 20&amp;amp;ndash;29 years, whereas hydration differed by less than 3.5%. Men showed a different pattern, with no net sebum difference between these age groups. The regional difference in slope change was not significant (p = 0.168). After age 40, the oil&amp;amp;ndash;moisture profile of women is characterized by lower sebum with stable hydration; longitudinal studies with hormonal assessment should test whether this reflects menopause.</description>
	<pubDate>2026-10-22</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 285: Sebum, but Not Hydration, Shows Steeper Age-Related Differences After Age 40 in Women: A Cross-Sectional Study of 7743 Participants in 12 Countries</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/285">doi: 10.3390/cosmetics13060285</a></p>
	<p>Authors:
		Youngrin Kwag
		Sang Hyun Kim
		Ji Hwoon Baek
		HuiJeong Jeong
		YooRi Kang
		Min Sook Jung
		Hongseok Kim
		Wonkyu Hong
		</p>
	<p>Skin changes in women around age 40 are often attributed to impaired barrier function or reduced hydration, but large-scale data comparing sebum, hydration, and transepidermal water loss (TEWL) across age groups are scarce. In this cross-sectional study, we analyzed standardized cheek measurements from 7743 women aged 20&amp;amp;ndash;59 years in 12 countries (5274 Asian and 2469 Western). Piecewise regression tested changes in age-related slopes at age 40, including differences by region. The negative age&amp;amp;ndash;sebum slope was significantly steeper from age 40 onward in both Western (slope change &amp;amp;minus;0.762 &amp;amp;micro;g/cm2/year, p = 0.010) and Asian women (&amp;amp;minus;1.256 &amp;amp;micro;g/cm2/year, p &amp;amp;lt; 0.001), a result that held with robust standard errors, log transformation, and country adjustment and was replicated at two other facial sites. Hydration showed no change in slope at age 40, and resting TEWL decreased rather than increased. Sebum was 34.9% (Asian) and 25.4% (Western) lower at 50&amp;amp;ndash;59 than at 20&amp;amp;ndash;29 years, whereas hydration differed by less than 3.5%. Men showed a different pattern, with no net sebum difference between these age groups. The regional difference in slope change was not significant (p = 0.168). After age 40, the oil&amp;amp;ndash;moisture profile of women is characterized by lower sebum with stable hydration; longitudinal studies with hormonal assessment should test whether this reflects menopause.</p>
	]]></content:encoded>

	<dc:title>Sebum, but Not Hydration, Shows Steeper Age-Related Differences After Age 40 in Women: A Cross-Sectional Study of 7743 Participants in 12 Countries</dc:title>
			<dc:creator>Youngrin Kwag</dc:creator>
			<dc:creator>Sang Hyun Kim</dc:creator>
			<dc:creator>Ji Hwoon Baek</dc:creator>
			<dc:creator>HuiJeong Jeong</dc:creator>
			<dc:creator>YooRi Kang</dc:creator>
			<dc:creator>Min Sook Jung</dc:creator>
			<dc:creator>Hongseok Kim</dc:creator>
			<dc:creator>Wonkyu Hong</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060285</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-22</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-22</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>285</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060285</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/285</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/6/284">

	<title>Cosmetics, Vol. 13, Pages 284: AI and Holographic Technology for Healthy Aging and Personalized Beauty: A Systematic Review of Current Research Findings and Future Prospects</title>
	<link>https://www.mdpi.com/2079-9284/13/6/284</link>
	<description>This systematic review investigated the medical potential of using artificial intelligence (AI) and holograms to improve body image as a means of maintaining sustainable and healthy beauty in the era of the longevity revolution. Although this review is a systematic review, it was conducted by individually setting related keywords according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) 2020 flowchart guidelines. The search method was as follows: PubMed, Google Scholar, Scopus and IEEE Xplore were searched with the keywords &amp;amp;ldquo;longevity revolution,&amp;amp;rdquo; &amp;amp;ldquo;artificial intelligence,&amp;amp;rdquo; &amp;amp;ldquo;Customized beauty device,&amp;amp;rdquo; &amp;amp;ldquo;Customized Cosmetics,&amp;amp;rdquo;, &amp;amp;ldquo;body image,&amp;amp;rdquo; &amp;amp;ldquo;hologram,&amp;amp;rdquo; &amp;amp;ldquo;hologram health,&amp;amp;rdquo; &amp;amp;ldquo;AI hologram,&amp;amp;rdquo; and &amp;amp;ldquo;healthy body image.&amp;amp;rdquo; Accordingly, a total of 11,117 articles were searched. In the final stage, 56 articles were selected and included in the paper. The results of this study suggest that the world is moving towards the longevity revolution era due to the development of biotechnology, genetic engineering, and medicine, and that healthy beauty is needed in response to this. In addition, the development and use of AI and holograms in the medical field are continuing, suggesting the possibility of using them for obesity and body shape health management diet management. Therefore, this represents the AI domain of sustainable human security. It suggests the future necessity of developing personalized physical health management utilizing AI and holograms, as well as the infinite potential of customized beauty devices and cosmetics.</description>
	<pubDate>2026-10-22</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 284: AI and Holographic Technology for Healthy Aging and Personalized Beauty: A Systematic Review of Current Research Findings and Future Prospects</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/6/284">doi: 10.3390/cosmetics13060284</a></p>
	<p>Authors:
		Jinkyung Lee
		Ki Han Kwon
		</p>
	<p>This systematic review investigated the medical potential of using artificial intelligence (AI) and holograms to improve body image as a means of maintaining sustainable and healthy beauty in the era of the longevity revolution. Although this review is a systematic review, it was conducted by individually setting related keywords according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) 2020 flowchart guidelines. The search method was as follows: PubMed, Google Scholar, Scopus and IEEE Xplore were searched with the keywords &amp;amp;ldquo;longevity revolution,&amp;amp;rdquo; &amp;amp;ldquo;artificial intelligence,&amp;amp;rdquo; &amp;amp;ldquo;Customized beauty device,&amp;amp;rdquo; &amp;amp;ldquo;Customized Cosmetics,&amp;amp;rdquo;, &amp;amp;ldquo;body image,&amp;amp;rdquo; &amp;amp;ldquo;hologram,&amp;amp;rdquo; &amp;amp;ldquo;hologram health,&amp;amp;rdquo; &amp;amp;ldquo;AI hologram,&amp;amp;rdquo; and &amp;amp;ldquo;healthy body image.&amp;amp;rdquo; Accordingly, a total of 11,117 articles were searched. In the final stage, 56 articles were selected and included in the paper. The results of this study suggest that the world is moving towards the longevity revolution era due to the development of biotechnology, genetic engineering, and medicine, and that healthy beauty is needed in response to this. In addition, the development and use of AI and holograms in the medical field are continuing, suggesting the possibility of using them for obesity and body shape health management diet management. Therefore, this represents the AI domain of sustainable human security. It suggests the future necessity of developing personalized physical health management utilizing AI and holograms, as well as the infinite potential of customized beauty devices and cosmetics.</p>
	]]></content:encoded>

	<dc:title>AI and Holographic Technology for Healthy Aging and Personalized Beauty: A Systematic Review of Current Research Findings and Future Prospects</dc:title>
			<dc:creator>Jinkyung Lee</dc:creator>
			<dc:creator>Ki Han Kwon</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13060284</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-22</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-22</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Systematic Review</prism:section>
	<prism:startingPage>284</prism:startingPage>
		<prism:doi>10.3390/cosmetics13060284</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/6/284</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/282">

	<title>Cosmetics, Vol. 13, Pages 282: Zinc Oxide Sunscreens: The Role of Formulation and Residual Film in Photoprotective Performance</title>
	<link>https://www.mdpi.com/2079-9284/13/5/282</link>
	<description>Zinc oxide (ZnO) is increasingly used as a mineral UV filter, but its efficacy may be underestimated by conventional spectrophotometric in vitro methods based on mass application. This study investigated whether this underestimation reflects intrinsic ZnO performance or the residual film formed on the test substrate. Two formulations containing 10% w/w ZnO&amp;amp;mdash;an oil-in-water (O/W) emulsion and an anhydrous formulation&amp;amp;mdash;were compared with an O/W formulation containing organic UV filters, all targeting SPF 15. Dry-residue analysis showed approximately 99% mass retention for the anhydrous formulation versus 41% for the O/W ZnO emulsion, corresponding to estimated residual film thicknesses of ~12 and ~4 &amp;amp;micro;m, respectively. ISO 24443-derived SPF values were 13.8 and 7.1, whereas the Helio2 method yielded 15.2 and 17.3, respectively. UVA-induced intracellular ROS in HaCaT keratinocytes showed significant protection with the anhydrous ZnO and organic-filter formulations, but not with the O/W ZnO emulsion. The BASF Sunscreen Simulator also underestimated both ZnO formulations (SPF 5). These findings suggest that poor performance of the O/W ZnO emulsion primarily reflects formation of a thin, discontinuous residual film rather than lower intrinsic ZnO efficacy, highlighting limitations of current in vitro and in silico approaches.</description>
	<pubDate>2026-10-21</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 282: Zinc Oxide Sunscreens: The Role of Formulation and Residual Film in Photoprotective Performance</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/282">doi: 10.3390/cosmetics13050282</a></p>
	<p>Authors:
		Mattia Battistin
		Ilenia Gugel
		Stefano Manfredini
		Sveva Sbrissa
		Anna Baldisserotto
		Gaia Bellonzi
		Elisa Durini
		Elena Torreggiani
		Jean-Claude Hubaud
		Silvia Vertuani
		</p>
	<p>Zinc oxide (ZnO) is increasingly used as a mineral UV filter, but its efficacy may be underestimated by conventional spectrophotometric in vitro methods based on mass application. This study investigated whether this underestimation reflects intrinsic ZnO performance or the residual film formed on the test substrate. Two formulations containing 10% w/w ZnO&amp;amp;mdash;an oil-in-water (O/W) emulsion and an anhydrous formulation&amp;amp;mdash;were compared with an O/W formulation containing organic UV filters, all targeting SPF 15. Dry-residue analysis showed approximately 99% mass retention for the anhydrous formulation versus 41% for the O/W ZnO emulsion, corresponding to estimated residual film thicknesses of ~12 and ~4 &amp;amp;micro;m, respectively. ISO 24443-derived SPF values were 13.8 and 7.1, whereas the Helio2 method yielded 15.2 and 17.3, respectively. UVA-induced intracellular ROS in HaCaT keratinocytes showed significant protection with the anhydrous ZnO and organic-filter formulations, but not with the O/W ZnO emulsion. The BASF Sunscreen Simulator also underestimated both ZnO formulations (SPF 5). These findings suggest that poor performance of the O/W ZnO emulsion primarily reflects formation of a thin, discontinuous residual film rather than lower intrinsic ZnO efficacy, highlighting limitations of current in vitro and in silico approaches.</p>
	]]></content:encoded>

	<dc:title>Zinc Oxide Sunscreens: The Role of Formulation and Residual Film in Photoprotective Performance</dc:title>
			<dc:creator>Mattia Battistin</dc:creator>
			<dc:creator>Ilenia Gugel</dc:creator>
			<dc:creator>Stefano Manfredini</dc:creator>
			<dc:creator>Sveva Sbrissa</dc:creator>
			<dc:creator>Anna Baldisserotto</dc:creator>
			<dc:creator>Gaia Bellonzi</dc:creator>
			<dc:creator>Elisa Durini</dc:creator>
			<dc:creator>Elena Torreggiani</dc:creator>
			<dc:creator>Jean-Claude Hubaud</dc:creator>
			<dc:creator>Silvia Vertuani</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050282</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-21</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-21</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>282</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050282</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/282</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/283">

	<title>Cosmetics, Vol. 13, Pages 283: When Good Science Leads to Bad Assumptions: Misconceptions in Cosmetic Product Development</title>
	<link>https://www.mdpi.com/2079-9284/13/5/283</link>
	<description>Good science does not automatically translate into a good cosmetic product. In this Perspective, we examine four recurring misconceptions: that ingredient evidence can stand in for finished-product performance; that more actives, higher concentrations or greater complexity necessarily improve outcomes; that a product that remains safe and physically acceptable is therefore functionally unchanged; and that microbiome compatibility can be inferred from ingredient selection. These assumptions share a common error: properties of ingredients, formulations or regulatory status are treated as proxies for the behaviour of the finished product. Stability and microbiome science illustrate the consequences particularly well. Sensitive actives may degrade without obvious physical failure, while microbiome effects depend on the complete formulation, exposure pattern and target-site context. Regulatory compliance is essential but does not itself establish retention of every functionally relevant active throughout product life. We therefore argue for a finished-product perspective in which intended function, target-site biology, formulation architecture, packaging, storage and use conditions are treated as one integrated system and performance is verified at finished-product level using function-relevant methods under representative conditions of storage and use. Building on established systems-development principles, including Quality by Design, we term one approach to operationalising this perspective Function First: separating the starting opportunity from the primary design objective and optimising the complete product system around intended function.</description>
	<pubDate>2026-10-21</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 283: When Good Science Leads to Bad Assumptions: Misconceptions in Cosmetic Product Development</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/283">doi: 10.3390/cosmetics13050283</a></p>
	<p>Authors:
		Ulf Åkerström
		Johanna Maria Gillbro
		</p>
	<p>Good science does not automatically translate into a good cosmetic product. In this Perspective, we examine four recurring misconceptions: that ingredient evidence can stand in for finished-product performance; that more actives, higher concentrations or greater complexity necessarily improve outcomes; that a product that remains safe and physically acceptable is therefore functionally unchanged; and that microbiome compatibility can be inferred from ingredient selection. These assumptions share a common error: properties of ingredients, formulations or regulatory status are treated as proxies for the behaviour of the finished product. Stability and microbiome science illustrate the consequences particularly well. Sensitive actives may degrade without obvious physical failure, while microbiome effects depend on the complete formulation, exposure pattern and target-site context. Regulatory compliance is essential but does not itself establish retention of every functionally relevant active throughout product life. We therefore argue for a finished-product perspective in which intended function, target-site biology, formulation architecture, packaging, storage and use conditions are treated as one integrated system and performance is verified at finished-product level using function-relevant methods under representative conditions of storage and use. Building on established systems-development principles, including Quality by Design, we term one approach to operationalising this perspective Function First: separating the starting opportunity from the primary design objective and optimising the complete product system around intended function.</p>
	]]></content:encoded>

	<dc:title>When Good Science Leads to Bad Assumptions: Misconceptions in Cosmetic Product Development</dc:title>
			<dc:creator>Ulf Åkerström</dc:creator>
			<dc:creator>Johanna Maria Gillbro</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050283</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-21</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-21</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Perspective</prism:section>
	<prism:startingPage>283</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050283</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/283</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/281">

	<title>Cosmetics, Vol. 13, Pages 281: Development of Multiple Emulsions Containing Corn Husk Extracts for Cosmetic Applications</title>
	<link>https://www.mdpi.com/2079-9284/13/5/281</link>
	<description>Corn (Zea mays) is a widely used agricultural crop in various industries such as food, animal feed, biofuels, and cosmetics. However, corn processing often generates a large amount of agricultural waste, especially corn husks. This research aims to prepare a corn husk extract using ultrasonic extraction techniques to develop a multiple emulsion formulation. A high-energy method was employed to enhance the stability and efficacy of active compounds in the corn husk extract. Experiments showed that the extraction of corn husks using distilled water as a solvent for 1 h yielded an extraction rate of 2.43%. For antioxidant activity, the extract exhibited a FRAP value of 1.62 &amp;amp;plusmn; 0.01 mM Fe2+/mg, comparable to ascorbic acid. The ABTS free radical scavenging percentage was 99.24%, comparable to that of ascorbic acid, and the chelating activity was 25.61%. The extract was then incorporated into water-in-oil nanoemulsions. The most stable formulation consisted of a 20% (2.3 w/w%) corn husk extract solution, a surfactant mixture of Tween 80 and Span80 (24.9 w/w%), and olive oil (72.8 w/w%). The physical properties of the formulation showed a droplet size of 21.63 &amp;amp;plusmn; 1.04 nm, a polydispersity index of 0.31 &amp;amp;plusmn; 0.02, and an encapsulation efficiency of 94.20 &amp;amp;plusmn; 0.50%, confirming good encapsulation performance. The extract was then mixed into multiple emulsions. The most stable formulation consisted of a nanoemulsion containing a 20% (20 w/w%) solution of corn husk extract, a mixed surfactant of Tween 80 (1.25 w/w%), and water (78.75 w/w%). The physical properties of the formulation showed a droplet size of 169.97 &amp;amp;plusmn; 0.31 nm, a polydispersity index of 0.22 &amp;amp;plusmn; 0.01, and a zeta potential of &amp;amp;minus;81.17 &amp;amp;plusmn; 0.25 mV; the release study showed a cumulative release of 72% after 12 h. This research highlights the potential of preparing corn husk extract for development into complex emulsion formulations for cosmetic applications.</description>
	<pubDate>2026-10-20</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 281: Development of Multiple Emulsions Containing Corn Husk Extracts for Cosmetic Applications</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/281">doi: 10.3390/cosmetics13050281</a></p>
	<p>Authors:
		Kanyaphat Pamuangmul
		Wantida Chaiyana
		Mathukorn Sainakham
		</p>
	<p>Corn (Zea mays) is a widely used agricultural crop in various industries such as food, animal feed, biofuels, and cosmetics. However, corn processing often generates a large amount of agricultural waste, especially corn husks. This research aims to prepare a corn husk extract using ultrasonic extraction techniques to develop a multiple emulsion formulation. A high-energy method was employed to enhance the stability and efficacy of active compounds in the corn husk extract. Experiments showed that the extraction of corn husks using distilled water as a solvent for 1 h yielded an extraction rate of 2.43%. For antioxidant activity, the extract exhibited a FRAP value of 1.62 &amp;amp;plusmn; 0.01 mM Fe2+/mg, comparable to ascorbic acid. The ABTS free radical scavenging percentage was 99.24%, comparable to that of ascorbic acid, and the chelating activity was 25.61%. The extract was then incorporated into water-in-oil nanoemulsions. The most stable formulation consisted of a 20% (2.3 w/w%) corn husk extract solution, a surfactant mixture of Tween 80 and Span80 (24.9 w/w%), and olive oil (72.8 w/w%). The physical properties of the formulation showed a droplet size of 21.63 &amp;amp;plusmn; 1.04 nm, a polydispersity index of 0.31 &amp;amp;plusmn; 0.02, and an encapsulation efficiency of 94.20 &amp;amp;plusmn; 0.50%, confirming good encapsulation performance. The extract was then mixed into multiple emulsions. The most stable formulation consisted of a nanoemulsion containing a 20% (20 w/w%) solution of corn husk extract, a mixed surfactant of Tween 80 (1.25 w/w%), and water (78.75 w/w%). The physical properties of the formulation showed a droplet size of 169.97 &amp;amp;plusmn; 0.31 nm, a polydispersity index of 0.22 &amp;amp;plusmn; 0.01, and a zeta potential of &amp;amp;minus;81.17 &amp;amp;plusmn; 0.25 mV; the release study showed a cumulative release of 72% after 12 h. This research highlights the potential of preparing corn husk extract for development into complex emulsion formulations for cosmetic applications.</p>
	]]></content:encoded>

	<dc:title>Development of Multiple Emulsions Containing Corn Husk Extracts for Cosmetic Applications</dc:title>
			<dc:creator>Kanyaphat Pamuangmul</dc:creator>
			<dc:creator>Wantida Chaiyana</dc:creator>
			<dc:creator>Mathukorn Sainakham</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050281</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-20</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-20</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>281</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050281</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/281</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/280">

	<title>Cosmetics, Vol. 13, Pages 280: Generative AI-Based Virtual Hand Skin Tone and Nail Art Color Harmony: An Integrative Review Toward Personalized Nail Color Selection Guidelines</title>
	<link>https://www.mdpi.com/2079-9284/13/5/280</link>
	<description>Nail art has evolved from a decorative beauty practice into a personalized cosmetic service that reflects individual image, style, and self-expression. Nevertheless, nail color selection remains largely dependent on personal preference, fashion trends, social-media images, and practitioner experience rather than standardized color-harmony criteria. This integrative review examines how objective skin color science, nail art design characteristics, personal color concepts, and generative artificial intelligence (AI) can be combined to establish a methodological basis for personalized nail color selection. The literature on human skin color measurement, CIELAB colorimetry, color-difference analysis, personal color and nail color matching, virtual beauty technologies, and skin-tone bias in AI-generated imagery was synthesized. The evidence supports representing hand skin color as a multidimensional profile based on L*, a*, b*, chroma, and hue angle rather than relying solely on warm/cool or seasonal categories. Nail art should likewise be described using colorimetric, optical, reflective, decorative, and compositional features. Generative AI offers a scalable means of creating standardized virtual hand&amp;amp;ndash;nail stimuli, but current evidence demonstrates substantial skin-tone imbalance and potential color inaccuracy in generated images. We therefore propose a six-stage framework: hand skin-color profiling, nail-art feature classification, generative AI-based virtual image generation, colorimetric accuracy and bias validation, skin&amp;amp;ndash;nail harmony modeling, and personalized guideline development. This framework should be regarded as hypothesis-generating rather than as a validated recommendation system. External validation using objectively measured human hand skin color and perceptual evaluation is required before clinical, commercial, or professional implementation.</description>
	<pubDate>2026-10-20</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 280: Generative AI-Based Virtual Hand Skin Tone and Nail Art Color Harmony: An Integrative Review Toward Personalized Nail Color Selection Guidelines</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/280">doi: 10.3390/cosmetics13050280</a></p>
	<p>Authors:
		Seon-Young Yi
		Min-Gyeong Song
		Da-Bin Choi
		Ye-Jin Kim
		Sokho Kim
		In-Ah Lee
		</p>
	<p>Nail art has evolved from a decorative beauty practice into a personalized cosmetic service that reflects individual image, style, and self-expression. Nevertheless, nail color selection remains largely dependent on personal preference, fashion trends, social-media images, and practitioner experience rather than standardized color-harmony criteria. This integrative review examines how objective skin color science, nail art design characteristics, personal color concepts, and generative artificial intelligence (AI) can be combined to establish a methodological basis for personalized nail color selection. The literature on human skin color measurement, CIELAB colorimetry, color-difference analysis, personal color and nail color matching, virtual beauty technologies, and skin-tone bias in AI-generated imagery was synthesized. The evidence supports representing hand skin color as a multidimensional profile based on L*, a*, b*, chroma, and hue angle rather than relying solely on warm/cool or seasonal categories. Nail art should likewise be described using colorimetric, optical, reflective, decorative, and compositional features. Generative AI offers a scalable means of creating standardized virtual hand&amp;amp;ndash;nail stimuli, but current evidence demonstrates substantial skin-tone imbalance and potential color inaccuracy in generated images. We therefore propose a six-stage framework: hand skin-color profiling, nail-art feature classification, generative AI-based virtual image generation, colorimetric accuracy and bias validation, skin&amp;amp;ndash;nail harmony modeling, and personalized guideline development. This framework should be regarded as hypothesis-generating rather than as a validated recommendation system. External validation using objectively measured human hand skin color and perceptual evaluation is required before clinical, commercial, or professional implementation.</p>
	]]></content:encoded>

	<dc:title>Generative AI-Based Virtual Hand Skin Tone and Nail Art Color Harmony: An Integrative Review Toward Personalized Nail Color Selection Guidelines</dc:title>
			<dc:creator>Seon-Young Yi</dc:creator>
			<dc:creator>Min-Gyeong Song</dc:creator>
			<dc:creator>Da-Bin Choi</dc:creator>
			<dc:creator>Ye-Jin Kim</dc:creator>
			<dc:creator>Sokho Kim</dc:creator>
			<dc:creator>In-Ah Lee</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050280</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-20</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-20</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>280</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050280</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/280</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/279">

	<title>Cosmetics, Vol. 13, Pages 279: Sweetpotato-Derived Cosmetic Actives: Chemistry, Skin Mechanisms, and Formulation</title>
	<link>https://www.mdpi.com/2079-9284/13/5/279</link>
	<description>This narrative review evaluates sweetpotato (Ipomoea batatas L.) leaves and pigmented roots as sources of cosmetic ingredients. The foliage, largely discarded after root harvest, is rich in caffeoylquinic acids (CQAs), including 3,4,5-tricaffeoylquinic acid, and purple- and orange-fleshed roots supply acylated anthocyanins and &amp;amp;beta;-carotene. We distinguish evidence by material and model. Purified CQAs, mostly obtained from other plant sources, reduce UV-induced collagen degradation and inflammatory signaling in skin cells, whereas direct evidence for sweetpotato extracts is limited to spectrophotometric sun protection factor estimates, the increased UV absorbance of creams, and inhibition of bacterial growth and biofilm formation at concentrations above those tolerated by keratinocytes. Translation is constrained by the molecular size and polarity (di- and tri-CQAs, 516&amp;amp;ndash;679 Da), acyl migration and oxidation at near-neutral pH, pH-dependent anthocyanin color, and reliance on surrogate enzymes such as mushroom tyrosinase. We propose a tiered workflow with mandatory and claim-dependent steps covering extract specification, human-target assays, skin models, permeation, stability, non-animal safety assessments, and claim substantiation under United States and European Union rules. Current evidence supports positioning these extracts as antioxidant and SPF-supporting ingredients, not as UV filters or antimicrobial actives.</description>
	<pubDate>2026-10-20</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 279: Sweetpotato-Derived Cosmetic Actives: Chemistry, Skin Mechanisms, and Formulation</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/279">doi: 10.3390/cosmetics13050279</a></p>
	<p>Authors:
		Shahidul Islam
		</p>
	<p>This narrative review evaluates sweetpotato (Ipomoea batatas L.) leaves and pigmented roots as sources of cosmetic ingredients. The foliage, largely discarded after root harvest, is rich in caffeoylquinic acids (CQAs), including 3,4,5-tricaffeoylquinic acid, and purple- and orange-fleshed roots supply acylated anthocyanins and &amp;amp;beta;-carotene. We distinguish evidence by material and model. Purified CQAs, mostly obtained from other plant sources, reduce UV-induced collagen degradation and inflammatory signaling in skin cells, whereas direct evidence for sweetpotato extracts is limited to spectrophotometric sun protection factor estimates, the increased UV absorbance of creams, and inhibition of bacterial growth and biofilm formation at concentrations above those tolerated by keratinocytes. Translation is constrained by the molecular size and polarity (di- and tri-CQAs, 516&amp;amp;ndash;679 Da), acyl migration and oxidation at near-neutral pH, pH-dependent anthocyanin color, and reliance on surrogate enzymes such as mushroom tyrosinase. We propose a tiered workflow with mandatory and claim-dependent steps covering extract specification, human-target assays, skin models, permeation, stability, non-animal safety assessments, and claim substantiation under United States and European Union rules. Current evidence supports positioning these extracts as antioxidant and SPF-supporting ingredients, not as UV filters or antimicrobial actives.</p>
	]]></content:encoded>

	<dc:title>Sweetpotato-Derived Cosmetic Actives: Chemistry, Skin Mechanisms, and Formulation</dc:title>
			<dc:creator>Shahidul Islam</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050279</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-20</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-20</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>279</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050279</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/279</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/278">

	<title>Cosmetics, Vol. 13, Pages 278: Antifungal Activity and Safety of Physalis angulata Extract, Its Fraction, and Their Nanoemulsions as Candidate Cosmetic Ingredients: A Preliminary In Vitro Study</title>
	<link>https://www.mdpi.com/2079-9284/13/5/278</link>
	<description>Physalis angulata L. is a source of lipophilic bioactive metabolites of interest for cosmetic research, but the antifungal behavior of its fractions in nanoemulsions remains poorly characterized. This study evaluated the antioxidant, antifungal, irritant, and cytotoxic activity of a chloroform extract (E) and a hexane&amp;amp;ndash;ethyl acetate (6:4) fraction (F) from P. angulata, and their nanoemulsions (NE-E, NE-F), using HPLC-UV, DPPH, microdilution, HET-CAM and HaCaT assays. HPLC-UV showed major peaks at 39&amp;amp;ndash;41 min, predominant in F. E showed moderate antioxidant activity (EC50 = 415 &amp;amp;micro;g/mL), while F showed limited activity. F was active against all six microorganisms tested (T. rubrum, T. mentagrophytes, M. canis, C. albicans, C. krusei, C. parapsilosis), most potently against M. canis (MIC = 0.07 mg/mL). NE-F retained reduced activity against the dermatophytes but not against Candida. Samples showed no HET-CAM irritant effect. In HaCaT cells, NE-F showed an IC50 of 173.1 &amp;amp;micro;g/mL; its MIC against M. canis (310 &amp;amp;micro;g/mL) exceeded this value, indicating a limited cellular safety margin. The nanoemulsions remained in the nanometric range over 30 days, although NE-F showed a transient increase in PDI on Day 7. These results demonstrate the antifungal potential of fraction F and show that nanoemulsification partially preserved dermatophyte activity, supporting further investigation of F as a candidate cosmetic ingredient.</description>
	<pubDate>2026-10-20</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 278: Antifungal Activity and Safety of Physalis angulata Extract, Its Fraction, and Their Nanoemulsions as Candidate Cosmetic Ingredients: A Preliminary In Vitro Study</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/278">doi: 10.3390/cosmetics13050278</a></p>
	<p>Authors:
		Camila Cristina Baccetti Medeiros
		Rodrigo Sorrechia
		Maria Leonor Beneli Donadon
		Winner Duque Rodrigues
		André Gonzaga dos Santos
		Jonatas Duarte Lobato
		Marlus Chorilli
		Ana Luísa Rodriguez Gini
		Pamela Souza Tada da Cunha
		Cauê Benito Scarim
		Fabiano Guimarães Silva
		Ana Helena Januário
		Ana Melero
		Rosemeire Cristina Linhari Rodrigues Pietro
		</p>
	<p>Physalis angulata L. is a source of lipophilic bioactive metabolites of interest for cosmetic research, but the antifungal behavior of its fractions in nanoemulsions remains poorly characterized. This study evaluated the antioxidant, antifungal, irritant, and cytotoxic activity of a chloroform extract (E) and a hexane&amp;amp;ndash;ethyl acetate (6:4) fraction (F) from P. angulata, and their nanoemulsions (NE-E, NE-F), using HPLC-UV, DPPH, microdilution, HET-CAM and HaCaT assays. HPLC-UV showed major peaks at 39&amp;amp;ndash;41 min, predominant in F. E showed moderate antioxidant activity (EC50 = 415 &amp;amp;micro;g/mL), while F showed limited activity. F was active against all six microorganisms tested (T. rubrum, T. mentagrophytes, M. canis, C. albicans, C. krusei, C. parapsilosis), most potently against M. canis (MIC = 0.07 mg/mL). NE-F retained reduced activity against the dermatophytes but not against Candida. Samples showed no HET-CAM irritant effect. In HaCaT cells, NE-F showed an IC50 of 173.1 &amp;amp;micro;g/mL; its MIC against M. canis (310 &amp;amp;micro;g/mL) exceeded this value, indicating a limited cellular safety margin. The nanoemulsions remained in the nanometric range over 30 days, although NE-F showed a transient increase in PDI on Day 7. These results demonstrate the antifungal potential of fraction F and show that nanoemulsification partially preserved dermatophyte activity, supporting further investigation of F as a candidate cosmetic ingredient.</p>
	]]></content:encoded>

	<dc:title>Antifungal Activity and Safety of Physalis angulata Extract, Its Fraction, and Their Nanoemulsions as Candidate Cosmetic Ingredients: A Preliminary In Vitro Study</dc:title>
			<dc:creator>Camila Cristina Baccetti Medeiros</dc:creator>
			<dc:creator>Rodrigo Sorrechia</dc:creator>
			<dc:creator>Maria Leonor Beneli Donadon</dc:creator>
			<dc:creator>Winner Duque Rodrigues</dc:creator>
			<dc:creator>André Gonzaga dos Santos</dc:creator>
			<dc:creator>Jonatas Duarte Lobato</dc:creator>
			<dc:creator>Marlus Chorilli</dc:creator>
			<dc:creator>Ana Luísa Rodriguez Gini</dc:creator>
			<dc:creator>Pamela Souza Tada da Cunha</dc:creator>
			<dc:creator>Cauê Benito Scarim</dc:creator>
			<dc:creator>Fabiano Guimarães Silva</dc:creator>
			<dc:creator>Ana Helena Januário</dc:creator>
			<dc:creator>Ana Melero</dc:creator>
			<dc:creator>Rosemeire Cristina Linhari Rodrigues Pietro</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050278</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-20</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-20</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>278</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050278</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/278</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/277">

	<title>Cosmetics, Vol. 13, Pages 277: A Multicomponent Bioactive Cosmetic After Radiofrequency Microneedling: Effects on Skin Barrier, Downtime, and Multi-Domain Skin Parameters in a Randomized, Split-Face, Controlled Trial</title>
	<link>https://www.mdpi.com/2079-9284/13/5/277</link>
	<description>This prospective, single-center, randomized, split-face controlled trial evaluated whether a multicomponent investigational cosmetic serum (ISCE) applied immediately after radiofrequency microneedling (RF-MN) provides additional benefit over RF-MN alone. In 22 healthy Korean women aged 40&amp;amp;ndash;69 years, one hemiface was randomly assigned by a computer-generated sequence to RF-MN plus ISCE and the other to RF-MN alone, in two sessions 3 weeks apart; outcome assessors and statisticians were blinded. Primary endpoints were transepidermal water loss (TEWL) and procedure-induced erythema; secondary endpoints were hydration, elastic recoil, elasticity, density, wrinkles, pores, and pigmentation. Twenty participants were analyzed. TEWL decreased more on the combination side from the first session (between-side difference &amp;amp;minus;0.50 g/m2&amp;amp;middot;h, 95% CI &amp;amp;minus;0.68 to &amp;amp;minus;0.33; p &amp;amp;lt; 0.001), and the procedure-induced increase in erythema was smaller after the second session (&amp;amp;minus;1.07 A.U., 95% CI &amp;amp;minus;2.08 to &amp;amp;minus;0.05; nominal p = 0.041). After the second session, all exploratory secondary endpoints favored the combination side (unadjusted p &amp;amp;lt; 0.05). No adverse events occurred. ISCE after RF-MN yielded a greater short-term reduction in TEWL than RF-MN alone, whereas the erythema finding is preliminary and requires confirmation; because no vehicle control was included, the TEWL benefit is attributable to the formulation as a whole. The trial was not registered in a trial registry.</description>
	<pubDate>2026-10-16</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 277: A Multicomponent Bioactive Cosmetic After Radiofrequency Microneedling: Effects on Skin Barrier, Downtime, and Multi-Domain Skin Parameters in a Randomized, Split-Face, Controlled Trial</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/277">doi: 10.3390/cosmetics13050277</a></p>
	<p>Authors:
		Kyoungjin Park
		Yunhyang Nam
		Fei Qu
		YooRi Kang
		Hongseok Kim
		Wonkyu Hong
		Youngrin Kwag
		</p>
	<p>This prospective, single-center, randomized, split-face controlled trial evaluated whether a multicomponent investigational cosmetic serum (ISCE) applied immediately after radiofrequency microneedling (RF-MN) provides additional benefit over RF-MN alone. In 22 healthy Korean women aged 40&amp;amp;ndash;69 years, one hemiface was randomly assigned by a computer-generated sequence to RF-MN plus ISCE and the other to RF-MN alone, in two sessions 3 weeks apart; outcome assessors and statisticians were blinded. Primary endpoints were transepidermal water loss (TEWL) and procedure-induced erythema; secondary endpoints were hydration, elastic recoil, elasticity, density, wrinkles, pores, and pigmentation. Twenty participants were analyzed. TEWL decreased more on the combination side from the first session (between-side difference &amp;amp;minus;0.50 g/m2&amp;amp;middot;h, 95% CI &amp;amp;minus;0.68 to &amp;amp;minus;0.33; p &amp;amp;lt; 0.001), and the procedure-induced increase in erythema was smaller after the second session (&amp;amp;minus;1.07 A.U., 95% CI &amp;amp;minus;2.08 to &amp;amp;minus;0.05; nominal p = 0.041). After the second session, all exploratory secondary endpoints favored the combination side (unadjusted p &amp;amp;lt; 0.05). No adverse events occurred. ISCE after RF-MN yielded a greater short-term reduction in TEWL than RF-MN alone, whereas the erythema finding is preliminary and requires confirmation; because no vehicle control was included, the TEWL benefit is attributable to the formulation as a whole. The trial was not registered in a trial registry.</p>
	]]></content:encoded>

	<dc:title>A Multicomponent Bioactive Cosmetic After Radiofrequency Microneedling: Effects on Skin Barrier, Downtime, and Multi-Domain Skin Parameters in a Randomized, Split-Face, Controlled Trial</dc:title>
			<dc:creator>Kyoungjin Park</dc:creator>
			<dc:creator>Yunhyang Nam</dc:creator>
			<dc:creator>Fei Qu</dc:creator>
			<dc:creator>YooRi Kang</dc:creator>
			<dc:creator>Hongseok Kim</dc:creator>
			<dc:creator>Wonkyu Hong</dc:creator>
			<dc:creator>Youngrin Kwag</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050277</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-16</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-16</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>277</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050277</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/277</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/276">

	<title>Cosmetics, Vol. 13, Pages 276: Multi-Wavelength LED Photobiomodulation Improves Photoaged Skin of the Face, Neck, and D&amp;eacute;collet&amp;eacute;</title>
	<link>https://www.mdpi.com/2079-9284/13/5/276</link>
	<description>Photoageing of the face, neck, and d&amp;amp;eacute;collet&amp;amp;eacute; is driven predominantly by chronic ultraviolet exposure and can cause substantial aesthetic and psychosocial burden. Although red and near-infrared photobiomodulation (PBM) may improve wrinkles and skin quality, the effects of simultaneous 633, 830, 1072 nm light delivered by at-home light-emitting diode (LED) devices across these regions have not been evaluated in women. This study assessed biophysical, clinical and participant-reported effects of multi-wavelength PBM. Thirty-three women aged 41&amp;amp;ndash;55 years with dry, photoaged skin were enrolled. Thirty-one completed 56 days of treatment. Participants used face, neck and d&amp;amp;eacute;collet&amp;amp;eacute; masks containing Veritace&amp;amp;reg;-tested LEDs for 10 min per session, five times weekly. Endpoints included skin texture, elasticity, firmness, hydration, barrier function, colour, and erythema. A dermatologist graded fine lines and wrinkles at baseline and day 56, and participants completed satisfaction questionnaires. By day 56, significant improvements were observed in skin texture, elasticity, hydration, barrier function, erythema, and colourimetric indices. Dermatologist-assessed fine lines and wrinkles decreased significantly across all sites. Participants reported improved hydration, smoothness, radiance, firmness, and overall appearance. At-home mask use was associated with improvements in multiple measures of photoaged skin, but the study is limited by absence of a control group.</description>
	<pubDate>2026-10-14</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 276: Multi-Wavelength LED Photobiomodulation Improves Photoaged Skin of the Face, Neck, and D&amp;eacute;collet&amp;eacute;</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/276">doi: 10.3390/cosmetics13050276</a></p>
	<p>Authors:
		Ellis Bradbury
		Abigail K. Langton
		</p>
	<p>Photoageing of the face, neck, and d&amp;amp;eacute;collet&amp;amp;eacute; is driven predominantly by chronic ultraviolet exposure and can cause substantial aesthetic and psychosocial burden. Although red and near-infrared photobiomodulation (PBM) may improve wrinkles and skin quality, the effects of simultaneous 633, 830, 1072 nm light delivered by at-home light-emitting diode (LED) devices across these regions have not been evaluated in women. This study assessed biophysical, clinical and participant-reported effects of multi-wavelength PBM. Thirty-three women aged 41&amp;amp;ndash;55 years with dry, photoaged skin were enrolled. Thirty-one completed 56 days of treatment. Participants used face, neck and d&amp;amp;eacute;collet&amp;amp;eacute; masks containing Veritace&amp;amp;reg;-tested LEDs for 10 min per session, five times weekly. Endpoints included skin texture, elasticity, firmness, hydration, barrier function, colour, and erythema. A dermatologist graded fine lines and wrinkles at baseline and day 56, and participants completed satisfaction questionnaires. By day 56, significant improvements were observed in skin texture, elasticity, hydration, barrier function, erythema, and colourimetric indices. Dermatologist-assessed fine lines and wrinkles decreased significantly across all sites. Participants reported improved hydration, smoothness, radiance, firmness, and overall appearance. At-home mask use was associated with improvements in multiple measures of photoaged skin, but the study is limited by absence of a control group.</p>
	]]></content:encoded>

	<dc:title>Multi-Wavelength LED Photobiomodulation Improves Photoaged Skin of the Face, Neck, and D&amp;amp;eacute;collet&amp;amp;eacute;</dc:title>
			<dc:creator>Ellis Bradbury</dc:creator>
			<dc:creator>Abigail K. Langton</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050276</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-14</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-14</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>276</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050276</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/276</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/275">

	<title>Cosmetics, Vol. 13, Pages 275: Correction: Alcones, A.M.; Gano, T.J.B. Phytochemical Screening and Antibacterial Activity of Jatropha multifida L. (Coral Bush) Leaf Extract-Based Soap Against Staphylococcus aureus and Escherichia coli. Cosmetics 2026, 13, 193</title>
	<link>https://www.mdpi.com/2079-9284/13/5/275</link>
	<description>In the original publication [...]</description>
	<pubDate>2026-10-14</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 275: Correction: Alcones, A.M.; Gano, T.J.B. Phytochemical Screening and Antibacterial Activity of Jatropha multifida L. (Coral Bush) Leaf Extract-Based Soap Against Staphylococcus aureus and Escherichia coli. Cosmetics 2026, 13, 193</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/275">doi: 10.3390/cosmetics13050275</a></p>
	<p>Authors:
		Ariel M. Alcones
		Trixie Joy B. Gano
		</p>
	<p>In the original publication [...]</p>
	]]></content:encoded>

	<dc:title>Correction: Alcones, A.M.; Gano, T.J.B. Phytochemical Screening and Antibacterial Activity of Jatropha multifida L. (Coral Bush) Leaf Extract-Based Soap Against Staphylococcus aureus and Escherichia coli. Cosmetics 2026, 13, 193</dc:title>
			<dc:creator>Ariel M. Alcones</dc:creator>
			<dc:creator>Trixie Joy B. Gano</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050275</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-14</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-14</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Correction</prism:section>
	<prism:startingPage>275</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050275</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/275</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/274">

	<title>Cosmetics, Vol. 13, Pages 274: Planning the Surgical Correction of Age-Related Changes in the Chin Region and Neck Based on Digital and Radiological Imaging Methods: A Literature Review</title>
	<link>https://www.mdpi.com/2079-9284/13/5/274</link>
	<description>Age-related changes to the chin region and neck are among the most common reasons for consulting a plastic surgeon, and the outcome of rejuvenation surgery largely depends on the accuracy of preoperative planning. Digital imaging methods allow for an objective assessment of individual anatomical features, personalization of the surgical strategy, and improved predictability of the result. In this narrative review, based on a structured, PRISMA-informed search (PubMed, Scopus, Google Scholar, and eLibrary; 65 publications included), we systematize contemporary digital and radiological imaging methods for the chin region and neck—two-dimensional photography, three-dimensional photogrammetry, computed tomography and magnetic resonance imaging, cone-beam computed tomography (CBCT), CAD/CAM technologies, virtual and mixed reality, and artificial intelligence tools—and assess their diagnostic value for planning rejuvenation surgery. Available preliminary, predominantly single-centre evidence suggests that CBCT performed in the upright patient position may be the most informative modality for this task: by capturing bony landmarks together with the position and outer contours of the relevant soft-tissue structures under gravitational load, it supports an objective assessment of the contribution of individual structures to age-related deformities and well-founded, individualized surgical planning. Its intrinsic soft-tissue contrast resolution is nevertheless limited compared with MRI. The integration of digital and radiological imaging methods is a vital part of modern planning of aesthetic surgery for the chin region and neck.</description>
	<pubDate>2026-10-13</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 274: Planning the Surgical Correction of Age-Related Changes in the Chin Region and Neck Based on Digital and Radiological Imaging Methods: A Literature Review</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/274">doi: 10.3390/cosmetics13050274</a></p>
	<p>Authors:
		Anastasiya Borisenko
		Valentin Sharobaro
		Alexey Avdeev
		Sergey Golovanov
		Nigora Burkhonova
		</p>
	<p>Age-related changes to the chin region and neck are among the most common reasons for consulting a plastic surgeon, and the outcome of rejuvenation surgery largely depends on the accuracy of preoperative planning. Digital imaging methods allow for an objective assessment of individual anatomical features, personalization of the surgical strategy, and improved predictability of the result. In this narrative review, based on a structured, PRISMA-informed search (PubMed, Scopus, Google Scholar, and eLibrary; 65 publications included), we systematize contemporary digital and radiological imaging methods for the chin region and neck—two-dimensional photography, three-dimensional photogrammetry, computed tomography and magnetic resonance imaging, cone-beam computed tomography (CBCT), CAD/CAM technologies, virtual and mixed reality, and artificial intelligence tools—and assess their diagnostic value for planning rejuvenation surgery. Available preliminary, predominantly single-centre evidence suggests that CBCT performed in the upright patient position may be the most informative modality for this task: by capturing bony landmarks together with the position and outer contours of the relevant soft-tissue structures under gravitational load, it supports an objective assessment of the contribution of individual structures to age-related deformities and well-founded, individualized surgical planning. Its intrinsic soft-tissue contrast resolution is nevertheless limited compared with MRI. The integration of digital and radiological imaging methods is a vital part of modern planning of aesthetic surgery for the chin region and neck.</p>
	]]></content:encoded>

	<dc:title>Planning the Surgical Correction of Age-Related Changes in the Chin Region and Neck Based on Digital and Radiological Imaging Methods: A Literature Review</dc:title>
			<dc:creator>Anastasiya Borisenko</dc:creator>
			<dc:creator>Valentin Sharobaro</dc:creator>
			<dc:creator>Alexey Avdeev</dc:creator>
			<dc:creator>Sergey Golovanov</dc:creator>
			<dc:creator>Nigora Burkhonova</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050274</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-13</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-13</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>274</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050274</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/274</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/273">

	<title>Cosmetics, Vol. 13, Pages 273: Pomegranate Peel Bioactive Compounds for Topical Anti-Acne Cosmeceuticals: Phytochemistry, Biological Evidence, and Formulation Challenges&amp;mdash;A Comprehensive Review</title>
	<link>https://www.mdpi.com/2079-9284/13/5/273</link>
	<description>Acne vulgaris is a prevalent chronic inflammatory disease of the pilosebaceous unit driven by a multifactorial pathogenesis involving excess sebum production, follicular hyperkeratinisation, Cutibacterium acnes proliferation, oxidative stress, and immune-mediated inflammation. Conventional therapies, such as topical retinoids, benzoyl peroxide, antibiotics, hormonal agents, and isotretinoin, remain the standard of care; however, their clinical utility is frequently limited by local irritation, dryness, poor tolerability, post-treatment relapse, and the rising threat of antimicrobial resistance. In this review, the anti-acne benefits of pomegranate peel as a botanical agent have been discussed with respect to phytochemical composition, biological activities, and formulation difficulties. The phytochemistry of pomegranate peel includes bioactive polyphenols, such as hydrolyzable tannins (e.g., punicalagin and ellagic acid), phenolic acids (e.g., gallic acid), flavonoids, and anthocyanins, with a range of biological properties such as synergistic antibacterial, antioxidant, anti-inflammatory, and enzyme-inhibitory activities, which act on different steps involved in the process of acne development. Currently, the biological activity of pomegranate peel extracts includes inhibition of bacteria associated with acne, decreased lipase activity of bacteria, antioxidant action, and modification of inflammatory pathways, thus allowing its use as a multi-targeted botanical agent. However, there are still several formulation difficulties, including emulsion stabilization, prevention of syneresis, efficacy of preservatives, and optimal release of active compounds, which should be taken into account in the development of anti-acne pomegranate formulations.</description>
	<pubDate>2026-10-12</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 273: Pomegranate Peel Bioactive Compounds for Topical Anti-Acne Cosmeceuticals: Phytochemistry, Biological Evidence, and Formulation Challenges&amp;mdash;A Comprehensive Review</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/273">doi: 10.3390/cosmetics13050273</a></p>
	<p>Authors:
		Su Xin Jie
		Saeid Mezail Mawazi
		</p>
	<p>Acne vulgaris is a prevalent chronic inflammatory disease of the pilosebaceous unit driven by a multifactorial pathogenesis involving excess sebum production, follicular hyperkeratinisation, Cutibacterium acnes proliferation, oxidative stress, and immune-mediated inflammation. Conventional therapies, such as topical retinoids, benzoyl peroxide, antibiotics, hormonal agents, and isotretinoin, remain the standard of care; however, their clinical utility is frequently limited by local irritation, dryness, poor tolerability, post-treatment relapse, and the rising threat of antimicrobial resistance. In this review, the anti-acne benefits of pomegranate peel as a botanical agent have been discussed with respect to phytochemical composition, biological activities, and formulation difficulties. The phytochemistry of pomegranate peel includes bioactive polyphenols, such as hydrolyzable tannins (e.g., punicalagin and ellagic acid), phenolic acids (e.g., gallic acid), flavonoids, and anthocyanins, with a range of biological properties such as synergistic antibacterial, antioxidant, anti-inflammatory, and enzyme-inhibitory activities, which act on different steps involved in the process of acne development. Currently, the biological activity of pomegranate peel extracts includes inhibition of bacteria associated with acne, decreased lipase activity of bacteria, antioxidant action, and modification of inflammatory pathways, thus allowing its use as a multi-targeted botanical agent. However, there are still several formulation difficulties, including emulsion stabilization, prevention of syneresis, efficacy of preservatives, and optimal release of active compounds, which should be taken into account in the development of anti-acne pomegranate formulations.</p>
	]]></content:encoded>

	<dc:title>Pomegranate Peel Bioactive Compounds for Topical Anti-Acne Cosmeceuticals: Phytochemistry, Biological Evidence, and Formulation Challenges&amp;amp;mdash;A Comprehensive Review</dc:title>
			<dc:creator>Su Xin Jie</dc:creator>
			<dc:creator>Saeid Mezail Mawazi</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050273</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-12</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-12</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>273</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050273</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/273</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/272">

	<title>Cosmetics, Vol. 13, Pages 272: Effects of an Electroporation-Based At-Home Beauty Device Used with a Cosmetic Product on Skin Appearance and Quality</title>
	<link>https://www.mdpi.com/2079-9284/13/5/272</link>
	<description>Electroporation (EP) can modulate the skin barrier, but clinical evidence for EP-based at-home beauty devices used with cosmetic products remains limited. This exploratory study evaluated whether adding an EP-based at-home beauty device to a polydeoxyribonucleotide (PDRN)-containing cosmetic product was associated with additional changes. Permeability was assessed in a cultured human skin tissue model using caffeine, a small-molecule model compound. A 4-week split-face study was conducted in 22 healthy Korean women. The cosmetic product was applied to the entire face, and the device was applied only to the left side. In the tissue model, caffeine permeability was significantly higher in the test group at all time points after Holm adjustment. In the human study, the device&amp;amp;ndash;cosmetic side showed greater improvements than the cosmetic side in skin gloss (mean change difference, 5.091 SGU; 95% CI, 2.917&amp;amp;ndash;7.265), melanin content (&amp;amp;minus;4.897 A.U.; 95% CI, &amp;amp;minus;7.333 to &amp;amp;minus;2.461), and skin brightness, although the L* difference was small (0.618 A.U.; 95% CI, 0.286&amp;amp;ndash;0.950) (p &amp;amp;lt; 0.05). No product-related adverse skin reactions were reported. These findings suggest supportive effects of EP-based devices under cosmetic-use conditions; however, caffeine results cannot be directly extrapolated to macromolecules such as PDRN, and direct intradermal absorption and long-term effects require further evaluation.</description>
	<pubDate>2026-10-09</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 272: Effects of an Electroporation-Based At-Home Beauty Device Used with a Cosmetic Product on Skin Appearance and Quality</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/272">doi: 10.3390/cosmetics13050272</a></p>
	<p>Authors:
		Jihee Park
		Danbi Im
		Serim Park
		Jaewoo Shin
		Donghee Park
		</p>
	<p>Electroporation (EP) can modulate the skin barrier, but clinical evidence for EP-based at-home beauty devices used with cosmetic products remains limited. This exploratory study evaluated whether adding an EP-based at-home beauty device to a polydeoxyribonucleotide (PDRN)-containing cosmetic product was associated with additional changes. Permeability was assessed in a cultured human skin tissue model using caffeine, a small-molecule model compound. A 4-week split-face study was conducted in 22 healthy Korean women. The cosmetic product was applied to the entire face, and the device was applied only to the left side. In the tissue model, caffeine permeability was significantly higher in the test group at all time points after Holm adjustment. In the human study, the device&amp;amp;ndash;cosmetic side showed greater improvements than the cosmetic side in skin gloss (mean change difference, 5.091 SGU; 95% CI, 2.917&amp;amp;ndash;7.265), melanin content (&amp;amp;minus;4.897 A.U.; 95% CI, &amp;amp;minus;7.333 to &amp;amp;minus;2.461), and skin brightness, although the L* difference was small (0.618 A.U.; 95% CI, 0.286&amp;amp;ndash;0.950) (p &amp;amp;lt; 0.05). No product-related adverse skin reactions were reported. These findings suggest supportive effects of EP-based devices under cosmetic-use conditions; however, caffeine results cannot be directly extrapolated to macromolecules such as PDRN, and direct intradermal absorption and long-term effects require further evaluation.</p>
	]]></content:encoded>

	<dc:title>Effects of an Electroporation-Based At-Home Beauty Device Used with a Cosmetic Product on Skin Appearance and Quality</dc:title>
			<dc:creator>Jihee Park</dc:creator>
			<dc:creator>Danbi Im</dc:creator>
			<dc:creator>Serim Park</dc:creator>
			<dc:creator>Jaewoo Shin</dc:creator>
			<dc:creator>Donghee Park</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050272</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-09</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-09</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>272</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050272</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/272</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/271">

	<title>Cosmetics, Vol. 13, Pages 271: Effects of Ethanol Concentration and Pulsed Electric Field Parameters on Bioactive Compound Recovery and Cosmetic-Relevant Activities of Theobroma cacao Pod Husk Extracts</title>
	<link>https://www.mdpi.com/2079-9284/13/5/271</link>
	<description>This study aimed to investigate pulsed electric field (PEF)-assisted extraction of cocoa pod husk (CPH) and to evaluate its antioxidant and hyaluronidase inhibitory activities. CPH was extracted using 0&amp;amp;ndash;100% v/v ethanol at an electric field strength of 5 kV/cm with 1000, 3000, or 5000 pulses. The extracts were analyzed for their total content of phenolic, flavonoid, tannin, and saponin, as well as antioxidant, hyaluronidase inhibitory, and elastase inhibitory activities. Selected extracts were further evaluated for irritation potential using the hen&amp;amp;rsquo;s egg test&amp;amp;ndash;chorioallantoic membrane (HET&amp;amp;ndash;CAM) assay and chemical composition by liquid chromatography&amp;amp;ndash;mass spectrometry (LC&amp;amp;ndash;MS). Ethanol concentration significantly influenced phytochemical recovery, with 25% ethanol generally favoring phenolic and flavonoid extraction, whereas higher ethanol concentrations promoted selected enzyme-inhibitory activities. The highest hyaluronidase inhibition was obtained with 25% ethanol and 5000 pulses (60.57 &amp;amp;plusmn; 5.56%). The 25% ethanol/1000-pulse extract showed strong elastase inhibition (74.70 &amp;amp;plusmn; 4.00%). LC&amp;amp;ndash;MS tentatively annotated several bioactive compounds, including kojic acid, procyanidin, gallic acid, caffeic acid, rutin, and quercetin glucoside. In conclusion, ethanol concentration and PEF pulse number affected the phytochemical recovery and biological activities of CPH extracts, while the resulting extracts may serve as candidates for further investigation as cosmetic ingredients.</description>
	<pubDate>2026-10-09</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 271: Effects of Ethanol Concentration and Pulsed Electric Field Parameters on Bioactive Compound Recovery and Cosmetic-Relevant Activities of Theobroma cacao Pod Husk Extracts</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/271">doi: 10.3390/cosmetics13050271</a></p>
	<p>Authors:
		Tanongsak Sassa-deepaeng
		Waranya Tharawatchruk
		Pat Pranamormkrit
		Chatchawan Kantala
		Jirasit Inthorn
		Saranya Juntrapirom
		Watchara Kanjanakawinkul
		Wantida Chaiyana
		</p>
	<p>This study aimed to investigate pulsed electric field (PEF)-assisted extraction of cocoa pod husk (CPH) and to evaluate its antioxidant and hyaluronidase inhibitory activities. CPH was extracted using 0&amp;amp;ndash;100% v/v ethanol at an electric field strength of 5 kV/cm with 1000, 3000, or 5000 pulses. The extracts were analyzed for their total content of phenolic, flavonoid, tannin, and saponin, as well as antioxidant, hyaluronidase inhibitory, and elastase inhibitory activities. Selected extracts were further evaluated for irritation potential using the hen&amp;amp;rsquo;s egg test&amp;amp;ndash;chorioallantoic membrane (HET&amp;amp;ndash;CAM) assay and chemical composition by liquid chromatography&amp;amp;ndash;mass spectrometry (LC&amp;amp;ndash;MS). Ethanol concentration significantly influenced phytochemical recovery, with 25% ethanol generally favoring phenolic and flavonoid extraction, whereas higher ethanol concentrations promoted selected enzyme-inhibitory activities. The highest hyaluronidase inhibition was obtained with 25% ethanol and 5000 pulses (60.57 &amp;amp;plusmn; 5.56%). The 25% ethanol/1000-pulse extract showed strong elastase inhibition (74.70 &amp;amp;plusmn; 4.00%). LC&amp;amp;ndash;MS tentatively annotated several bioactive compounds, including kojic acid, procyanidin, gallic acid, caffeic acid, rutin, and quercetin glucoside. In conclusion, ethanol concentration and PEF pulse number affected the phytochemical recovery and biological activities of CPH extracts, while the resulting extracts may serve as candidates for further investigation as cosmetic ingredients.</p>
	]]></content:encoded>

	<dc:title>Effects of Ethanol Concentration and Pulsed Electric Field Parameters on Bioactive Compound Recovery and Cosmetic-Relevant Activities of Theobroma cacao Pod Husk Extracts</dc:title>
			<dc:creator>Tanongsak Sassa-deepaeng</dc:creator>
			<dc:creator>Waranya Tharawatchruk</dc:creator>
			<dc:creator>Pat Pranamormkrit</dc:creator>
			<dc:creator>Chatchawan Kantala</dc:creator>
			<dc:creator>Jirasit Inthorn</dc:creator>
			<dc:creator>Saranya Juntrapirom</dc:creator>
			<dc:creator>Watchara Kanjanakawinkul</dc:creator>
			<dc:creator>Wantida Chaiyana</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050271</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-09</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-09</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>271</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050271</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/271</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/270">

	<title>Cosmetics, Vol. 13, Pages 270: Antioxidant and Anti-Inflammatory Properties of Natural Compounds&amp;mdash;2nd Edition</title>
	<link>https://www.mdpi.com/2079-9284/13/5/270</link>
	<description>Plant natural remedies have formed the cornerstone of traditional healthcare, particularly in skincare, since antiquity, spanning Traditional Chinese Medicine, Ayurveda, Greco-Roman rituals, and Mediterranean practices [...]</description>
	<pubDate>2026-10-09</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 270: Antioxidant and Anti-Inflammatory Properties of Natural Compounds&amp;mdash;2nd Edition</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/270">doi: 10.3390/cosmetics13050270</a></p>
	<p>Authors:
		Othmane Merah
		</p>
	<p>Plant natural remedies have formed the cornerstone of traditional healthcare, particularly in skincare, since antiquity, spanning Traditional Chinese Medicine, Ayurveda, Greco-Roman rituals, and Mediterranean practices [...]</p>
	]]></content:encoded>

	<dc:title>Antioxidant and Anti-Inflammatory Properties of Natural Compounds&amp;amp;mdash;2nd Edition</dc:title>
			<dc:creator>Othmane Merah</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050270</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-09</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-09</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Editorial</prism:section>
	<prism:startingPage>270</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050270</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/270</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/269">

	<title>Cosmetics, Vol. 13, Pages 269: Next-Generation UV Filters and Delivery Systems: Safety, Photostability, and Environmental Sustainability</title>
	<link>https://www.mdpi.com/2079-9284/13/5/269</link>
	<description>Sunscreens are essential for protecting the skin against harmful ultraviolet (UV) radiation; however, conventional UV filters may exhibit limited photostability, skin penetration, and environmental concerns. Next-generation photoprotective systems, including liposomes, solid lipid nanoparticles, nanostructured lipid carriers, nanoemulsions, polymeric nanoparticles, and cyclodextrin-based systems, have shown improved photostability, improved skin retention, and reduced undesired permeation while maintaining photoprotective efficacy. Advanced formulations have shown encapsulation efficiencies of approximately 60&amp;amp;ndash;99% and improvements in SPF compared with corresponding free-filter formulations. In addition, chemical strategies such as glycosylation can modify the physicochemical properties, formulation compatibility, and stability of hydrophobic or bioactive photoprotective compounds, although their large-scale application remains limited by synthetic complexity and scalability. This review emphasizes recent literature published between 2020 and 2026 while incorporating selected earlier foundational studies where necessary to provide mechanistic and historical context. Particular emphasis is placed on the balance between photoprotective efficacy, dermal retention, systemic exposure, environmental safety, and translational feasibility. Overall, next-generation sunscreen technologies offer promising strategies for developing safer and more sustainable photoprotection, but standardized safety assessment, scalable manufacturing, and regulatory harmonization remain essential for successful translation.</description>
	<pubDate>2026-10-08</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 269: Next-Generation UV Filters and Delivery Systems: Safety, Photostability, and Environmental Sustainability</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/269">doi: 10.3390/cosmetics13050269</a></p>
	<p>Authors:
		Muhammad Raza
		Hyang-Yeol Lee
		</p>
	<p>Sunscreens are essential for protecting the skin against harmful ultraviolet (UV) radiation; however, conventional UV filters may exhibit limited photostability, skin penetration, and environmental concerns. Next-generation photoprotective systems, including liposomes, solid lipid nanoparticles, nanostructured lipid carriers, nanoemulsions, polymeric nanoparticles, and cyclodextrin-based systems, have shown improved photostability, improved skin retention, and reduced undesired permeation while maintaining photoprotective efficacy. Advanced formulations have shown encapsulation efficiencies of approximately 60&amp;amp;ndash;99% and improvements in SPF compared with corresponding free-filter formulations. In addition, chemical strategies such as glycosylation can modify the physicochemical properties, formulation compatibility, and stability of hydrophobic or bioactive photoprotective compounds, although their large-scale application remains limited by synthetic complexity and scalability. This review emphasizes recent literature published between 2020 and 2026 while incorporating selected earlier foundational studies where necessary to provide mechanistic and historical context. Particular emphasis is placed on the balance between photoprotective efficacy, dermal retention, systemic exposure, environmental safety, and translational feasibility. Overall, next-generation sunscreen technologies offer promising strategies for developing safer and more sustainable photoprotection, but standardized safety assessment, scalable manufacturing, and regulatory harmonization remain essential for successful translation.</p>
	]]></content:encoded>

	<dc:title>Next-Generation UV Filters and Delivery Systems: Safety, Photostability, and Environmental Sustainability</dc:title>
			<dc:creator>Muhammad Raza</dc:creator>
			<dc:creator>Hyang-Yeol Lee</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050269</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-08</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-08</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>269</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050269</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/269</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/268">

	<title>Cosmetics, Vol. 13, Pages 268: Instrumental Evaluation of Skin Structural Parameters After 56 Days of Use of a Home-Use LED Photobiomodulation Device</title>
	<link>https://www.mdpi.com/2079-9284/13/5/268</link>
	<description>Light-emitting diode (LED) photobiomodulation has emerged as a non-invasive approach for skin quality improvement and reduction in visible aging signs. This study evaluated the efficacy and tolerability of a combined skincare regimen consisting of a home-use silicone LED facial mask emitting red light used together with a cosmetic serum for skin rejuvenation. An open, single-centre clinical study without a control group was conducted in 20 healthy female volunteers aged 40&amp;amp;ndash;55 years presenting visible facial wrinkles and skin imperfections. Participants used the LED mask twice daily for 10 min over 56 days, each session being followed by application of a standardized cosmetic serum, so that the LED device and the serum were evaluated as a single combined regimen. Skin evaluations were performed at baseline (D0), after 28 days (D28), and after 56 days (D56) using three-dimensional skin topography (AEVA-HE), high-frequency ultrasound imaging (Ultrascan&amp;amp;reg; UC22), biomechanical measurements (Cutometer&amp;amp;reg; dual MPA 580), and pigmentation analysis (Mexameter&amp;amp;reg; MX18). In the exploratory analysis, a statistically significant improvement in the Cutometer firmness parameter (F4) was observed at D56 compared with baseline (p = 0.03). Changes in elasticity, pigmentation, wrinkle-related topographic measurements and dermal thickness did not reach statistical significance and are reported only as non-significant numerical trends. The treatment was well tolerated, with no significant skin reactions observed. These preliminary findings suggest that a combined regimen incorporating home-use LED photobiomodulation and a cosmetic serum may be associated with an improvement in skin firmness. Because the study was uncontrolled and the LED device was used together with a serum, the observed changes cannot be attributed to photobiomodulation alone and should be interpreted as preliminary.</description>
	<pubDate>2026-10-07</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 268: Instrumental Evaluation of Skin Structural Parameters After 56 Days of Use of a Home-Use LED Photobiomodulation Device</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/268">doi: 10.3390/cosmetics13050268</a></p>
	<p>Authors:
		Mar Miñano Núñez
		</p>
	<p>Light-emitting diode (LED) photobiomodulation has emerged as a non-invasive approach for skin quality improvement and reduction in visible aging signs. This study evaluated the efficacy and tolerability of a combined skincare regimen consisting of a home-use silicone LED facial mask emitting red light used together with a cosmetic serum for skin rejuvenation. An open, single-centre clinical study without a control group was conducted in 20 healthy female volunteers aged 40&amp;amp;ndash;55 years presenting visible facial wrinkles and skin imperfections. Participants used the LED mask twice daily for 10 min over 56 days, each session being followed by application of a standardized cosmetic serum, so that the LED device and the serum were evaluated as a single combined regimen. Skin evaluations were performed at baseline (D0), after 28 days (D28), and after 56 days (D56) using three-dimensional skin topography (AEVA-HE), high-frequency ultrasound imaging (Ultrascan&amp;amp;reg; UC22), biomechanical measurements (Cutometer&amp;amp;reg; dual MPA 580), and pigmentation analysis (Mexameter&amp;amp;reg; MX18). In the exploratory analysis, a statistically significant improvement in the Cutometer firmness parameter (F4) was observed at D56 compared with baseline (p = 0.03). Changes in elasticity, pigmentation, wrinkle-related topographic measurements and dermal thickness did not reach statistical significance and are reported only as non-significant numerical trends. The treatment was well tolerated, with no significant skin reactions observed. These preliminary findings suggest that a combined regimen incorporating home-use LED photobiomodulation and a cosmetic serum may be associated with an improvement in skin firmness. Because the study was uncontrolled and the LED device was used together with a serum, the observed changes cannot be attributed to photobiomodulation alone and should be interpreted as preliminary.</p>
	]]></content:encoded>

	<dc:title>Instrumental Evaluation of Skin Structural Parameters After 56 Days of Use of a Home-Use LED Photobiomodulation Device</dc:title>
			<dc:creator>Mar Miñano Núñez</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050268</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-07</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-07</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>268</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050268</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/268</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/267">

	<title>Cosmetics, Vol. 13, Pages 267: Formulation, Stability, and Safety Evaluation of a Facial Wash Containing Yellowfin Tuna (Thunnus albacares) Bone-Derived Marine Collagen Peptide and Light Fraction Patchouli Oil</title>
	<link>https://www.mdpi.com/2079-9284/13/5/267</link>
	<description>Yellowfin tuna (Thunnus albacares) bone by-products represent an underutilized, sustainable source of marine collagen for cosmetic applications. This study developed a gel-based facial wash combining tuna bone-derived marine collagen peptide (MCP) with light fraction patchouli oil (Pogostemon cablin Benth.) and evaluated its physicochemical properties, stability, and safety. Acid-soluble collagen (85.2% protein) was extracted and hydrolyzed with pepsin, yielding a low-molecular-weight MCP (&amp;amp;lt;30 kDa) with a degree of hydrolysis of 27.4 &amp;amp;plusmn; 1.8%; FTIR confirmed the preservation of characteristic type I collagen amide bands. Four formulations containing xanthan or guar gum were evaluated under freeze&amp;amp;ndash;thaw cycling and three-month storage at 30 and 40 &amp;amp;deg;C. The formulation containing 1% guar gum (F4) showed the most favorable profile, maintaining pH 5.60&amp;amp;ndash;5.87, viscosity 8884&amp;amp;ndash;9223 mPa&amp;amp;middot;s, spreadability 5.36&amp;amp;ndash;6.41 cm, and homogeneity across all conditions. F4 met Indonesian regulatory requirements, with microbial counts below 10 CFU/g, absence of pathogens, and trace levels of arsenic (0.0051 mg/kg) and lead (0.0171 mg/kg). Skin testing in 20 volunteers yielded a Primary Skin Irritation Index of 0.1 (negligible irritant). These findings establish tuna bone collagen peptide as a viable rinse-off cosmetic ingredient and demonstrate a practical route for valorizing fisheries by-products.</description>
	<pubDate>2026-10-06</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 267: Formulation, Stability, and Safety Evaluation of a Facial Wash Containing Yellowfin Tuna (Thunnus albacares) Bone-Derived Marine Collagen Peptide and Light Fraction Patchouli Oil</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/267">doi: 10.3390/cosmetics13050267</a></p>
	<p>Authors:
		Nadia Isnaini
		Vicky Prajaputra
		Ernawati Ernawati
		Lydia Septa Desiyana
		Tedy Kurniawan Bakri
		Dara Meutia Panggabean
		Cutwan Annura Rezkina
		</p>
	<p>Yellowfin tuna (Thunnus albacares) bone by-products represent an underutilized, sustainable source of marine collagen for cosmetic applications. This study developed a gel-based facial wash combining tuna bone-derived marine collagen peptide (MCP) with light fraction patchouli oil (Pogostemon cablin Benth.) and evaluated its physicochemical properties, stability, and safety. Acid-soluble collagen (85.2% protein) was extracted and hydrolyzed with pepsin, yielding a low-molecular-weight MCP (&amp;amp;lt;30 kDa) with a degree of hydrolysis of 27.4 &amp;amp;plusmn; 1.8%; FTIR confirmed the preservation of characteristic type I collagen amide bands. Four formulations containing xanthan or guar gum were evaluated under freeze&amp;amp;ndash;thaw cycling and three-month storage at 30 and 40 &amp;amp;deg;C. The formulation containing 1% guar gum (F4) showed the most favorable profile, maintaining pH 5.60&amp;amp;ndash;5.87, viscosity 8884&amp;amp;ndash;9223 mPa&amp;amp;middot;s, spreadability 5.36&amp;amp;ndash;6.41 cm, and homogeneity across all conditions. F4 met Indonesian regulatory requirements, with microbial counts below 10 CFU/g, absence of pathogens, and trace levels of arsenic (0.0051 mg/kg) and lead (0.0171 mg/kg). Skin testing in 20 volunteers yielded a Primary Skin Irritation Index of 0.1 (negligible irritant). These findings establish tuna bone collagen peptide as a viable rinse-off cosmetic ingredient and demonstrate a practical route for valorizing fisheries by-products.</p>
	]]></content:encoded>

	<dc:title>Formulation, Stability, and Safety Evaluation of a Facial Wash Containing Yellowfin Tuna (Thunnus albacares) Bone-Derived Marine Collagen Peptide and Light Fraction Patchouli Oil</dc:title>
			<dc:creator>Nadia Isnaini</dc:creator>
			<dc:creator>Vicky Prajaputra</dc:creator>
			<dc:creator>Ernawati Ernawati</dc:creator>
			<dc:creator>Lydia Septa Desiyana</dc:creator>
			<dc:creator>Tedy Kurniawan Bakri</dc:creator>
			<dc:creator>Dara Meutia Panggabean</dc:creator>
			<dc:creator>Cutwan Annura Rezkina</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050267</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-06</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-06</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>267</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050267</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/267</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/266">

	<title>Cosmetics, Vol. 13, Pages 266: A Photoprotective Cosmetic Formulation Assessment Containing a Standardized Extract of Marcetia latifolia</title>
	<link>https://www.mdpi.com/2079-9284/13/5/266</link>
	<description>The Marcetia species are well adapted to semi-arid regions and stand out as promising sources of phenolic compounds, including flavonoids, with potential photoprotective properties. The aim of this study was to investigate the photoprotective potential of a standardized extract of Marcetia latifolia leaves for potential application in a sunscreen formulation (UV-A and UV-B). The crude ethanolic extract of M. latifolia leaves (EEML) was standardized to contain 16.48 g of quercetin and 5.23 g of calycopterin per kg of plant and incorporated into a lotion based on Polawax&amp;amp;reg;. The EEML was evaluated for its photoprotective potential by determining its flavonoid content, antioxidant activity, in vitro SPF and toxicity, with a view to its subsequent incorporation into a cosmetic formulation. The extract showed high flavonoid content, combined with relevant antioxidant activity and SPF values (13 and 7.12 at concentrations of 250 and 125 &amp;amp;mu;g/&amp;amp;mu;L, respectively). It also showed UVA photoprotective potential, with only 7.62% degradation of the RVS. In the HET-CAM test, EEML showed low irritant potential (IS: 2.43). The formulations containing the EEML showed satisfactory physicochemical characteristics after organoleptic, centrifugation and spreadability tests. The formulations showed satisfactory SPF and photoprotective performance. These results indicate the feasibility of using the EEML as a sunscreen in pharmaceutical preparations.</description>
	<pubDate>2026-10-05</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 266: A Photoprotective Cosmetic Formulation Assessment Containing a Standardized Extract of Marcetia latifolia</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/266">doi: 10.3390/cosmetics13050266</a></p>
	<p>Authors:
		Annabel Azevedo-Silva
		Sônia Carine Costa Cova
		Carla Rodrigues Cardoso Branco
		Isabella Mary Alves Reis
		Tânia Regina dos Santos Silva
		Mariana Borges Botura
		Alexsandro Branco
		</p>
	<p>The Marcetia species are well adapted to semi-arid regions and stand out as promising sources of phenolic compounds, including flavonoids, with potential photoprotective properties. The aim of this study was to investigate the photoprotective potential of a standardized extract of Marcetia latifolia leaves for potential application in a sunscreen formulation (UV-A and UV-B). The crude ethanolic extract of M. latifolia leaves (EEML) was standardized to contain 16.48 g of quercetin and 5.23 g of calycopterin per kg of plant and incorporated into a lotion based on Polawax&amp;amp;reg;. The EEML was evaluated for its photoprotective potential by determining its flavonoid content, antioxidant activity, in vitro SPF and toxicity, with a view to its subsequent incorporation into a cosmetic formulation. The extract showed high flavonoid content, combined with relevant antioxidant activity and SPF values (13 and 7.12 at concentrations of 250 and 125 &amp;amp;mu;g/&amp;amp;mu;L, respectively). It also showed UVA photoprotective potential, with only 7.62% degradation of the RVS. In the HET-CAM test, EEML showed low irritant potential (IS: 2.43). The formulations containing the EEML showed satisfactory physicochemical characteristics after organoleptic, centrifugation and spreadability tests. The formulations showed satisfactory SPF and photoprotective performance. These results indicate the feasibility of using the EEML as a sunscreen in pharmaceutical preparations.</p>
	]]></content:encoded>

	<dc:title>A Photoprotective Cosmetic Formulation Assessment Containing a Standardized Extract of Marcetia latifolia</dc:title>
			<dc:creator>Annabel Azevedo-Silva</dc:creator>
			<dc:creator>Sônia Carine Costa Cova</dc:creator>
			<dc:creator>Carla Rodrigues Cardoso Branco</dc:creator>
			<dc:creator>Isabella Mary Alves Reis</dc:creator>
			<dc:creator>Tânia Regina dos Santos Silva</dc:creator>
			<dc:creator>Mariana Borges Botura</dc:creator>
			<dc:creator>Alexsandro Branco</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050266</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-05</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-05</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>266</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050266</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/266</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/265">

	<title>Cosmetics, Vol. 13, Pages 265: Oleogel-Based Formulations for Cosmetics and Pharmaceutical Applications: Current Landscape and Future Directions</title>
	<link>https://www.mdpi.com/2079-9284/13/5/265</link>
	<description>Oleogels have attracted considerable interest as structured lipid systems due to their ability to immobilize liquid oils and tailor the physicochemical properties of formulations. Although much of the fundamental knowledge on oleogel development derives from food-related research, the unique structural, rheological, and textural properties of these systems have increasingly supported their exploration also for cosmetic and pharmaceutical purposes. This review aims to explore the relevance of oleogels in these industries by compiling and critically evaluating the current knowledge on cosmetic and pharmaceutical formulations, with particular emphasis on their composition, preparation methods, and the rationale underlying their selection and use. Studies on oleogels for cosmetic uses are limited, while in pharmaceuticals, oleogels have been extensively studied for topical drug delivery, being their use in oral, transdermal, and intraocular delivery less explored. Oleogels are versatile and biocompatible delivery systems, ideal for transporting lipophilic active ingredients. Their inner structure modulates drug delivery, making them promising vehicles for innovative cosmetic and pharmaceutical applications.</description>
	<pubDate>2026-10-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 265: Oleogel-Based Formulations for Cosmetics and Pharmaceutical Applications: Current Landscape and Future Directions</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/265">doi: 10.3390/cosmetics13050265</a></p>
	<p>Authors:
		Ana Torres
		Elisbeth J. Gomes
		Ana Jesus
		Honorina Cidade
		Susana Casal
		Isabel F. Almeida
		</p>
	<p>Oleogels have attracted considerable interest as structured lipid systems due to their ability to immobilize liquid oils and tailor the physicochemical properties of formulations. Although much of the fundamental knowledge on oleogel development derives from food-related research, the unique structural, rheological, and textural properties of these systems have increasingly supported their exploration also for cosmetic and pharmaceutical purposes. This review aims to explore the relevance of oleogels in these industries by compiling and critically evaluating the current knowledge on cosmetic and pharmaceutical formulations, with particular emphasis on their composition, preparation methods, and the rationale underlying their selection and use. Studies on oleogels for cosmetic uses are limited, while in pharmaceuticals, oleogels have been extensively studied for topical drug delivery, being their use in oral, transdermal, and intraocular delivery less explored. Oleogels are versatile and biocompatible delivery systems, ideal for transporting lipophilic active ingredients. Their inner structure modulates drug delivery, making them promising vehicles for innovative cosmetic and pharmaceutical applications.</p>
	]]></content:encoded>

	<dc:title>Oleogel-Based Formulations for Cosmetics and Pharmaceutical Applications: Current Landscape and Future Directions</dc:title>
			<dc:creator>Ana Torres</dc:creator>
			<dc:creator>Elisbeth J. Gomes</dc:creator>
			<dc:creator>Ana Jesus</dc:creator>
			<dc:creator>Honorina Cidade</dc:creator>
			<dc:creator>Susana Casal</dc:creator>
			<dc:creator>Isabel F. Almeida</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050265</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-04</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-04</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>265</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050265</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/265</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/264">

	<title>Cosmetics, Vol. 13, Pages 264: Efficacy of 7% Ectoine Cream for Facial Seborrheic Dermatitis: A Randomized Controlled Trial of Acute and Maintenance Phases</title>
	<link>https://www.mdpi.com/2079-9284/13/5/264</link>
	<description>Background: Seborrheic dermatitis is a chronic, relapsing inflammatory condition requiring acute and maintenance treatment. Ectoine, a natural extremolyte with barrier-supportive and anti-inflammatory properties, offers a potential non-steroidal option. Methods: In this double-blind randomized controlled trial, 40 participants received 7% ectoine or 1% hydrocortisone cream twice daily for up to 4 weeks. Responders entered a 12-week maintenance phase and were re-randomized to ectoine or placebo. Outcomes included change in Seborrheic Dermatitis Area and Severity Index (SEDASI) from baseline, Investigator&amp;amp;rsquo;s Global Assessment (IGA), remission and relapse rates, time to relapse, and adverse events. Results: SEDASI decreased from baseline in both groups. The reduction was larger with hydrocortisone, but the between-group mean difference at Week 4 was &amp;amp;minus;2.01 (95% CI, &amp;amp;minus;4.81 to 0.78; p = 0.151). Median time to relapse was 56 versus 28 days with ectoine and placebo, respectively (log-rank p = 0.066). Adverse events were mild. Conclusions: Overall, 7% Ectoine reduced disease severity during the acute phase, though numerically less than 1% hydrocortisone; the non-significant difference does not exclude a clinically relevant advantage of hydrocortisone. Ectoine showed a non-significant trend toward longer time to relapse.</description>
	<pubDate>2026-10-03</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 264: Efficacy of 7% Ectoine Cream for Facial Seborrheic Dermatitis: A Randomized Controlled Trial of Acute and Maintenance Phases</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/264">doi: 10.3390/cosmetics13050264</a></p>
	<p>Authors:
		Nirynya Jitarayameth
		Nanticha Faromkao
		Chotinij Lertphanichkul
		Chantalck Muennarong
		Montree Udompataikul
		</p>
	<p>Background: Seborrheic dermatitis is a chronic, relapsing inflammatory condition requiring acute and maintenance treatment. Ectoine, a natural extremolyte with barrier-supportive and anti-inflammatory properties, offers a potential non-steroidal option. Methods: In this double-blind randomized controlled trial, 40 participants received 7% ectoine or 1% hydrocortisone cream twice daily for up to 4 weeks. Responders entered a 12-week maintenance phase and were re-randomized to ectoine or placebo. Outcomes included change in Seborrheic Dermatitis Area and Severity Index (SEDASI) from baseline, Investigator&amp;amp;rsquo;s Global Assessment (IGA), remission and relapse rates, time to relapse, and adverse events. Results: SEDASI decreased from baseline in both groups. The reduction was larger with hydrocortisone, but the between-group mean difference at Week 4 was &amp;amp;minus;2.01 (95% CI, &amp;amp;minus;4.81 to 0.78; p = 0.151). Median time to relapse was 56 versus 28 days with ectoine and placebo, respectively (log-rank p = 0.066). Adverse events were mild. Conclusions: Overall, 7% Ectoine reduced disease severity during the acute phase, though numerically less than 1% hydrocortisone; the non-significant difference does not exclude a clinically relevant advantage of hydrocortisone. Ectoine showed a non-significant trend toward longer time to relapse.</p>
	]]></content:encoded>

	<dc:title>Efficacy of 7% Ectoine Cream for Facial Seborrheic Dermatitis: A Randomized Controlled Trial of Acute and Maintenance Phases</dc:title>
			<dc:creator>Nirynya Jitarayameth</dc:creator>
			<dc:creator>Nanticha Faromkao</dc:creator>
			<dc:creator>Chotinij Lertphanichkul</dc:creator>
			<dc:creator>Chantalck Muennarong</dc:creator>
			<dc:creator>Montree Udompataikul</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050264</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-03</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-03</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>264</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050264</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/264</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/263">

	<title>Cosmetics, Vol. 13, Pages 263: The Changing Landscape of Science Published by a Cross-Section of 15 Leading Beauty Companies, 2015&amp;ndash;2025: A Bibliometric Analysis</title>
	<link>https://www.mdpi.com/2079-9284/13/5/263</link>
	<description>Science is central to the beauty business, but how has the peer-reviewed science published by leading companies changed? This bibliometric analysis examined 2571 peer-reviewed papers authored or coauthored by scientists affiliated with a cross-section of 15 leading beauty companies. The study period was divided into 2015&amp;amp;ndash;2020 (early) and 2021&amp;amp;ndash;2025 (late). Annual publication output rose 16.4%. After a blinded repeat-classification check and full-dataset quality-control review, the later portfolio included more clinical or other human research and less biological, mechanistic, or preclinical research, while the latter remained the largest category; papers linking laboratory and human work also increased. The study additionally assessed whether publications increasingly evaluated products, ingredients, or methods relevant to consumer-facing claims. The estimated share rose from about one-quarter to more than two-fifths, and the increase persisted with narrower claim-oriented definitions. Median field-weighted citation impact (FWCI) declined from 1.15 to 1.02, although later-period papers appeared among the top 10% of comparable publications at about twice the expected rate. The increase in claim-oriented research did not explain the citation decline. Thus, within this 15-company cross-section, peer-reviewed publishing became more abundant and increasingly human- and claim-oriented while mechanistic research remained the largest component; normalized scholarly influence declined from an unusually strong early position but remained above benchmark.</description>
	<pubDate>2026-10-03</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 263: The Changing Landscape of Science Published by a Cross-Section of 15 Leading Beauty Companies, 2015&amp;ndash;2025: A Bibliometric Analysis</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/263">doi: 10.3390/cosmetics13050263</a></p>
	<p>Authors:
		Seth J. Orlow
		</p>
	<p>Science is central to the beauty business, but how has the peer-reviewed science published by leading companies changed? This bibliometric analysis examined 2571 peer-reviewed papers authored or coauthored by scientists affiliated with a cross-section of 15 leading beauty companies. The study period was divided into 2015&amp;amp;ndash;2020 (early) and 2021&amp;amp;ndash;2025 (late). Annual publication output rose 16.4%. After a blinded repeat-classification check and full-dataset quality-control review, the later portfolio included more clinical or other human research and less biological, mechanistic, or preclinical research, while the latter remained the largest category; papers linking laboratory and human work also increased. The study additionally assessed whether publications increasingly evaluated products, ingredients, or methods relevant to consumer-facing claims. The estimated share rose from about one-quarter to more than two-fifths, and the increase persisted with narrower claim-oriented definitions. Median field-weighted citation impact (FWCI) declined from 1.15 to 1.02, although later-period papers appeared among the top 10% of comparable publications at about twice the expected rate. The increase in claim-oriented research did not explain the citation decline. Thus, within this 15-company cross-section, peer-reviewed publishing became more abundant and increasingly human- and claim-oriented while mechanistic research remained the largest component; normalized scholarly influence declined from an unusually strong early position but remained above benchmark.</p>
	]]></content:encoded>

	<dc:title>The Changing Landscape of Science Published by a Cross-Section of 15 Leading Beauty Companies, 2015&amp;amp;ndash;2025: A Bibliometric Analysis</dc:title>
			<dc:creator>Seth J. Orlow</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050263</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-03</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-03</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>263</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050263</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/263</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/262">

	<title>Cosmetics, Vol. 13, Pages 262: R&amp;amp;D and Innovation to Drive Healthy Beauty, Wellness, Wellbeing, Wealth and Longevity: The Novel Tissue-Carriers</title>
	<link>https://www.mdpi.com/2079-9284/13/5/262</link>
	<description>R&amp;amp;amp;D is a fundamental means for driving innovation in the market, maintaining competitive advantages and ensuring long-term business and sustainability. For this purpose, it is considered necessary to find new opportunities for making novel products in the fields of cosmetics (cosmeceuticals) and diet supplements (nutraceuticals), remembering that scientific research is organized in three phases: basic, applied and industrial. After explaining the significance of these phases, this paper will discuss the physical, mental, spiritual, emotional, social, economic and environmental global conditions for trying to achieve healthy beauty together with wellness, wellbeing, wealth and longevity by the so-called Beauty from Within (BW) notion, following actual consumer demand and the cosme-nutraceutical market. According to the BW rules, in fact, to obtain real healthy beauty, it is necessary to simultaneously use the same ingredients applied on the skin surface via a cosmetic product (cosmeceutical) and taken via the oral route through a specific diet supplement (nutraceutical). For this purpose, our research group is proposing specialized tissue-carriers to be used as alternative vehicles in partial substitution of the actual emulsions. The effectiveness of these novel natural and biodegradable skin- and eco-friendly vehicles, used to load, carry and release selected active ingredients by innovative cosme-nutraceuticals, has been supported and controlled by in vitro and in vivo studies. Therefore, they might be useful for safeguarding global human health and the body&amp;amp;rsquo;s microbiome and maintaining environmental integrity. The majority of cosmetics and diet supplements, in fact, are using various emulsions as vehicles that contain different kinds of chemicals, such as preservatives, emulsifiers, fragrances and other ingredients, which often cause skin allergies and sensitization phenomena. Moreover, the majority of these cosme-nutraceuticals are packed in non-biodegradable plastic containers, unlike our proposed products, which are packed in biodegradable paper or aluminum foil. Thus, these novel cosme-nutraceuticals, made from natural polymers and ingredients and packed in plastic-free containers, are 100% biodegradable and characterized by significant effectiveness and safety. Moreover, this category of cosmetics seems capable of supporting cell adhesion, proliferation and differentiation, reinforcing their intercommunication, increasing ECM activity, maintaining AMP activity, and reducing the onset of the reported irritative phenomena, thus safeguarding the environmental microbiome&amp;amp;rsquo;s integrity and the Earth&amp;amp;rsquo;s biodiversity. This statement was supported by different in vitro and in vivo studies regarding both the ingredients and packaging used.</description>
	<pubDate>2026-10-01</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 262: R&amp;amp;D and Innovation to Drive Healthy Beauty, Wellness, Wellbeing, Wealth and Longevity: The Novel Tissue-Carriers</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/262">doi: 10.3390/cosmetics13050262</a></p>
	<p>Authors:
		Pierfrancesco Morganti
		Hong-Duo Chen
		Vladimir E. Yudin
		Xinghua Gao
		</p>
	<p>R&amp;amp;amp;D is a fundamental means for driving innovation in the market, maintaining competitive advantages and ensuring long-term business and sustainability. For this purpose, it is considered necessary to find new opportunities for making novel products in the fields of cosmetics (cosmeceuticals) and diet supplements (nutraceuticals), remembering that scientific research is organized in three phases: basic, applied and industrial. After explaining the significance of these phases, this paper will discuss the physical, mental, spiritual, emotional, social, economic and environmental global conditions for trying to achieve healthy beauty together with wellness, wellbeing, wealth and longevity by the so-called Beauty from Within (BW) notion, following actual consumer demand and the cosme-nutraceutical market. According to the BW rules, in fact, to obtain real healthy beauty, it is necessary to simultaneously use the same ingredients applied on the skin surface via a cosmetic product (cosmeceutical) and taken via the oral route through a specific diet supplement (nutraceutical). For this purpose, our research group is proposing specialized tissue-carriers to be used as alternative vehicles in partial substitution of the actual emulsions. The effectiveness of these novel natural and biodegradable skin- and eco-friendly vehicles, used to load, carry and release selected active ingredients by innovative cosme-nutraceuticals, has been supported and controlled by in vitro and in vivo studies. Therefore, they might be useful for safeguarding global human health and the body&amp;amp;rsquo;s microbiome and maintaining environmental integrity. The majority of cosmetics and diet supplements, in fact, are using various emulsions as vehicles that contain different kinds of chemicals, such as preservatives, emulsifiers, fragrances and other ingredients, which often cause skin allergies and sensitization phenomena. Moreover, the majority of these cosme-nutraceuticals are packed in non-biodegradable plastic containers, unlike our proposed products, which are packed in biodegradable paper or aluminum foil. Thus, these novel cosme-nutraceuticals, made from natural polymers and ingredients and packed in plastic-free containers, are 100% biodegradable and characterized by significant effectiveness and safety. Moreover, this category of cosmetics seems capable of supporting cell adhesion, proliferation and differentiation, reinforcing their intercommunication, increasing ECM activity, maintaining AMP activity, and reducing the onset of the reported irritative phenomena, thus safeguarding the environmental microbiome&amp;amp;rsquo;s integrity and the Earth&amp;amp;rsquo;s biodiversity. This statement was supported by different in vitro and in vivo studies regarding both the ingredients and packaging used.</p>
	]]></content:encoded>

	<dc:title>R&amp;amp;amp;D and Innovation to Drive Healthy Beauty, Wellness, Wellbeing, Wealth and Longevity: The Novel Tissue-Carriers</dc:title>
			<dc:creator>Pierfrancesco Morganti</dc:creator>
			<dc:creator>Hong-Duo Chen</dc:creator>
			<dc:creator>Vladimir E. Yudin</dc:creator>
			<dc:creator>Xinghua Gao</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050262</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-01</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-01</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>262</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050262</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/262</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/261">

	<title>Cosmetics, Vol. 13, Pages 261: Efficacy and Tolerability of a Topical Gel Containing Milk-Derived miRNA-Enriched Exosomes in Androgenetic Alopecia and Telogen Effluvium: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial</title>
	<link>https://www.mdpi.com/2079-9284/13/5/261</link>
	<description>Androgenetic alopecia (AGA) and chronic telogen effluvium (TE) are common hair loss disorders with substantial psychosocial impact and limited effective topical options beyond minoxidil. MicroRNAs (miRNAs) have emerged as promising modulators of hair follicle cycling via Wnt/&amp;amp;beta;-catenin and related pathways. In this multicenter, randomized, double-blind, placebo-controlled clinical trial, adults aged 18&amp;amp;ndash;60 years with AGA, female AGA, or TE were allocated 1:1 to receive a topical gel containing bovine milk-derived exosomes enriched in specific miRNAs (MEV-miRNA gels) or placebo once weekly for 12 weeks. Primary endpoints were changes in anagen hair percentage, anagen/telogen ratio, and hair shaft diameter assessed by digital photo-trichogram at week 8 and week 12 versus baseline; secondary endpoints included patient-reported outcomes, global clinical assessment, and safety/tolerability. Of 40 randomized subjects, 39 (97.5%) completed the study. In the MEV-miRNA gel group, anagen hair percentage increased from 58% at baseline to 70% at week 8 and 78% at week 12, with corresponding improvements in anagen/telogen ratio (from 1.45 to 2.46 and 3.63) and mean hair shaft diameter (from 47.5 &amp;amp;micro;m to 65.3 &amp;amp;micro;m and 70.6 &amp;amp;micro;m; all p &amp;amp;lt; 0.05 vs. baseline and vs. placebo). The placebo did not show significant changes in trichoscopic parameters. At week 12, most MEV-miRNA-treated patients reported stronger hair, reduced shedding, and improved overall hair quality, with high satisfaction rates and no treatment-related serious adverse events. Once-weekly application of a topical gel containing bovine milk-derived microRNA-enriched exosomes significantly improved trichoscopic and patient-reported outcomes in AGA and TE over 12 weeks, with a favorable short-term tolerability profile. These findings support exosome-based microRNA delivery as a novel, non-pharmacologic therapeutic approach for hair loss disorders.</description>
	<pubDate>2026-10-01</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 261: Efficacy and Tolerability of a Topical Gel Containing Milk-Derived miRNA-Enriched Exosomes in Androgenetic Alopecia and Telogen Effluvium: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/261">doi: 10.3390/cosmetics13050261</a></p>
	<p>Authors:
		Daniela Pinto
		Maria Fortuna
		Marco Andrea Tomassini
		Giammaria Giuliani
		Fabio Rinaldi
		</p>
	<p>Androgenetic alopecia (AGA) and chronic telogen effluvium (TE) are common hair loss disorders with substantial psychosocial impact and limited effective topical options beyond minoxidil. MicroRNAs (miRNAs) have emerged as promising modulators of hair follicle cycling via Wnt/&amp;amp;beta;-catenin and related pathways. In this multicenter, randomized, double-blind, placebo-controlled clinical trial, adults aged 18&amp;amp;ndash;60 years with AGA, female AGA, or TE were allocated 1:1 to receive a topical gel containing bovine milk-derived exosomes enriched in specific miRNAs (MEV-miRNA gels) or placebo once weekly for 12 weeks. Primary endpoints were changes in anagen hair percentage, anagen/telogen ratio, and hair shaft diameter assessed by digital photo-trichogram at week 8 and week 12 versus baseline; secondary endpoints included patient-reported outcomes, global clinical assessment, and safety/tolerability. Of 40 randomized subjects, 39 (97.5%) completed the study. In the MEV-miRNA gel group, anagen hair percentage increased from 58% at baseline to 70% at week 8 and 78% at week 12, with corresponding improvements in anagen/telogen ratio (from 1.45 to 2.46 and 3.63) and mean hair shaft diameter (from 47.5 &amp;amp;micro;m to 65.3 &amp;amp;micro;m and 70.6 &amp;amp;micro;m; all p &amp;amp;lt; 0.05 vs. baseline and vs. placebo). The placebo did not show significant changes in trichoscopic parameters. At week 12, most MEV-miRNA-treated patients reported stronger hair, reduced shedding, and improved overall hair quality, with high satisfaction rates and no treatment-related serious adverse events. Once-weekly application of a topical gel containing bovine milk-derived microRNA-enriched exosomes significantly improved trichoscopic and patient-reported outcomes in AGA and TE over 12 weeks, with a favorable short-term tolerability profile. These findings support exosome-based microRNA delivery as a novel, non-pharmacologic therapeutic approach for hair loss disorders.</p>
	]]></content:encoded>

	<dc:title>Efficacy and Tolerability of a Topical Gel Containing Milk-Derived miRNA-Enriched Exosomes in Androgenetic Alopecia and Telogen Effluvium: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial</dc:title>
			<dc:creator>Daniela Pinto</dc:creator>
			<dc:creator>Maria Fortuna</dc:creator>
			<dc:creator>Marco Andrea Tomassini</dc:creator>
			<dc:creator>Giammaria Giuliani</dc:creator>
			<dc:creator>Fabio Rinaldi</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050261</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-01</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-01</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>261</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050261</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/261</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/260">

	<title>Cosmetics, Vol. 13, Pages 260: A Data-Driven Analysis of Core Dermocosmetic Formulation Patterns for Inflammatory and Barrier-Impaired Skin Conditions</title>
	<link>https://www.mdpi.com/2079-9284/13/5/260</link>
	<description>Dermocosmetic products for chronic inflammatory and barrier-impaired skin conditions sit in an underexamined space between cosmetics and pharmaceutical care: widely marketed, yet what actually drives their formulation is rarely made explicit or checked against evidence-based standards. This study analyzes 73 products across six major indications involving chronic inflammatory and barrier-impaired skin conditions, with ingredient composition data extracted directly from product packaging and manufacturer documentation and analyzed using ingredient-level profiling and benchmarking against current dermatology guidelines. The results identify a stable, shared formulation core across product categories, with distinct therapeutic adaptations layered on top: ceramide-rich barrier support in atopic dermatitis, mechanism-specific actives distinguishing psoriasis, rosacea and wound-healing formulas. Guideline comparison surfaces both strong alignment and specific gaps, including under-used, well-evidenced ingredients in xerosis products and guideline-flagged irritants present in sensitive-skin formulations. Together, these findings offer manufacturers a validated formulation baseline and a way to spot genuine innovation gaps, give clinicians a mechanism-based reference for product selection and help consumers gain a clearer, evidence-anchored basis for evaluating products in an increasingly crowded and claims-saturated market. The methodology is designed for reuse, offering a practical foundation for evidence-based advancement across formulation, clinical practice and product choice in dermocosmetics.</description>
	<pubDate>2026-10-01</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 260: A Data-Driven Analysis of Core Dermocosmetic Formulation Patterns for Inflammatory and Barrier-Impaired Skin Conditions</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/260">doi: 10.3390/cosmetics13050260</a></p>
	<p>Authors:
		Delia Turcov
		Mădălina Paraschiv
		Anca-Irina Galaction
		Bianca-Iulia Ciubotaru
		Anca Zbranca-Toporaş
		</p>
	<p>Dermocosmetic products for chronic inflammatory and barrier-impaired skin conditions sit in an underexamined space between cosmetics and pharmaceutical care: widely marketed, yet what actually drives their formulation is rarely made explicit or checked against evidence-based standards. This study analyzes 73 products across six major indications involving chronic inflammatory and barrier-impaired skin conditions, with ingredient composition data extracted directly from product packaging and manufacturer documentation and analyzed using ingredient-level profiling and benchmarking against current dermatology guidelines. The results identify a stable, shared formulation core across product categories, with distinct therapeutic adaptations layered on top: ceramide-rich barrier support in atopic dermatitis, mechanism-specific actives distinguishing psoriasis, rosacea and wound-healing formulas. Guideline comparison surfaces both strong alignment and specific gaps, including under-used, well-evidenced ingredients in xerosis products and guideline-flagged irritants present in sensitive-skin formulations. Together, these findings offer manufacturers a validated formulation baseline and a way to spot genuine innovation gaps, give clinicians a mechanism-based reference for product selection and help consumers gain a clearer, evidence-anchored basis for evaluating products in an increasingly crowded and claims-saturated market. The methodology is designed for reuse, offering a practical foundation for evidence-based advancement across formulation, clinical practice and product choice in dermocosmetics.</p>
	]]></content:encoded>

	<dc:title>A Data-Driven Analysis of Core Dermocosmetic Formulation Patterns for Inflammatory and Barrier-Impaired Skin Conditions</dc:title>
			<dc:creator>Delia Turcov</dc:creator>
			<dc:creator>Mădălina Paraschiv</dc:creator>
			<dc:creator>Anca-Irina Galaction</dc:creator>
			<dc:creator>Bianca-Iulia Ciubotaru</dc:creator>
			<dc:creator>Anca Zbranca-Toporaş</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050260</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-10-01</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-10-01</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>260</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050260</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/260</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/259">

	<title>Cosmetics, Vol. 13, Pages 259: Multidimensional In Vivo Assessment of Skin Performance Following Repeated Application of a Multi-Step Cosmetic Regimen</title>
	<link>https://www.mdpi.com/2079-9284/13/5/259</link>
	<description>Background/Objectives: Topical cosmetic actives are increasingly delivered through multi-step regimens intended to improve skin hydration, barrier function, biomechanical properties, and visible signs of aging. Because the performance of such systems cannot be fully captured by a single endpoint, multidimensional approaches are useful to describe skin responses across complementary instrumental and subjective endpoints. This exploratory study aimed to develop and apply an in vivo assessment framework for evaluating skin changes associated with use of a multi-product topical cosmetic regimen targeting signs of skin aging. Methods: A 30-day exploratory, open-label, uncontrolled study was conducted using a four-step facial routine comprising a serum, an eye contour treatment, a day cream, and a night cream as a model of sequential topical administration. The evaluation integrated instrumental and subjective endpoints, including transepidermal water loss for barrier function, superficial and deep hydration measurements, elastometry for skin elasticity, colorimetric analysis for brightness, Antera&amp;amp;reg; 3D-CS imaging for wrinkles and fine lines, roughness parameters for skin texture, and self-assessment questionnaires for perceived efficacy and cosmetic acceptability. Results: After 30 days of repeated application, statistically significant within-study changes from baseline were observed in transepidermal water loss, superficial hydration, brightness, deep hydration, elasticity, wrinkle length, wrinkle index, fine-line length, fine-line index, and surface roughness. Subject-reported outcomes were consistent with the instrumental results, particularly regarding perceived hydration, smoothness, and overall skin quality. Conclusions: The proposed uncontrolled exploratory multidimensional in vivo framework enabled the descriptive assessment of skin performance changes during repeated use of a multi-step cosmetic regimen. The combined instrumental and self-assessment approach supports a broader characterization of cosmetic-related skin changes in hydration, barrier function, elasticity, texture, and visible signs of aging.</description>
	<pubDate>2026-09-27</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 259: Multidimensional In Vivo Assessment of Skin Performance Following Repeated Application of a Multi-Step Cosmetic Regimen</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/259">doi: 10.3390/cosmetics13050259</a></p>
	<p>Authors:
		Orion Jucja
		Dolores Vargas Peregrina
		Lucrezia Di Nicolantonio
		Cristina Casadidio
		Roberta Censi
		</p>
	<p>Background/Objectives: Topical cosmetic actives are increasingly delivered through multi-step regimens intended to improve skin hydration, barrier function, biomechanical properties, and visible signs of aging. Because the performance of such systems cannot be fully captured by a single endpoint, multidimensional approaches are useful to describe skin responses across complementary instrumental and subjective endpoints. This exploratory study aimed to develop and apply an in vivo assessment framework for evaluating skin changes associated with use of a multi-product topical cosmetic regimen targeting signs of skin aging. Methods: A 30-day exploratory, open-label, uncontrolled study was conducted using a four-step facial routine comprising a serum, an eye contour treatment, a day cream, and a night cream as a model of sequential topical administration. The evaluation integrated instrumental and subjective endpoints, including transepidermal water loss for barrier function, superficial and deep hydration measurements, elastometry for skin elasticity, colorimetric analysis for brightness, Antera&amp;amp;reg; 3D-CS imaging for wrinkles and fine lines, roughness parameters for skin texture, and self-assessment questionnaires for perceived efficacy and cosmetic acceptability. Results: After 30 days of repeated application, statistically significant within-study changes from baseline were observed in transepidermal water loss, superficial hydration, brightness, deep hydration, elasticity, wrinkle length, wrinkle index, fine-line length, fine-line index, and surface roughness. Subject-reported outcomes were consistent with the instrumental results, particularly regarding perceived hydration, smoothness, and overall skin quality. Conclusions: The proposed uncontrolled exploratory multidimensional in vivo framework enabled the descriptive assessment of skin performance changes during repeated use of a multi-step cosmetic regimen. The combined instrumental and self-assessment approach supports a broader characterization of cosmetic-related skin changes in hydration, barrier function, elasticity, texture, and visible signs of aging.</p>
	]]></content:encoded>

	<dc:title>Multidimensional In Vivo Assessment of Skin Performance Following Repeated Application of a Multi-Step Cosmetic Regimen</dc:title>
			<dc:creator>Orion Jucja</dc:creator>
			<dc:creator>Dolores Vargas Peregrina</dc:creator>
			<dc:creator>Lucrezia Di Nicolantonio</dc:creator>
			<dc:creator>Cristina Casadidio</dc:creator>
			<dc:creator>Roberta Censi</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050259</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-27</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-27</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>259</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050259</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/259</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/258">

	<title>Cosmetics, Vol. 13, Pages 258: Design, Multiparametric Stability, Antioxidant Activity and Release Behavior of an Oil-in-Water Cosmetic Emulsion Co-Loaded with Tyrosol and Kynurenic Acid</title>
	<link>https://www.mdpi.com/2079-9284/13/5/258</link>
	<description>Tyrosol and kynurenic acid (KYNA) are natural antioxidants with complementary radical-scavenging and photo-absorbing properties, but their combined performance in a cosmetic formulation has not been reported. We developed an oil-in-water (O/W) emulsion containing tyrosol, KYNA, or a 1:1 mixture, using an unloaded emulsion as control. Formulations were evaluated for four weeks at 4, 25, and 40 &amp;amp;deg;C using differential scanning calorimetry (DSC), rheology, spreadability, centrifugation, pH, DPPH antioxidant activity, HPLC quantification and release through a dialysis membrane; compositional stability was assessed by elemental (CHN) analysis. Chemical equilibrium parameters showed a consistent trend: the first week represented a maturation phase, likely reflecting redistribution of actives within the matrix, followed by a stable equilibrium state. The results are therefore discussed as initial versus equilibrated conditions. At equilibrium, the binary formulation maintained a skin-compatible pH (4.40 &amp;amp;plusmn; 0.04) with lower variability than single-active systems. HPLC confirmed nominal loading without degradation (0.89 &amp;amp;plusmn; 0.08% tyrosol, 0.97 &amp;amp;plusmn; 0.10% KYNA, and 1.00 &amp;amp;plusmn; 0.18% total in the mixture). DPPH analysis of standards revealed cooperative antioxidant enhancement in the mixture, exceeding the activity of either compound alone. In the creams, this produced a modest but reproducible antioxidant effect (9.00 &amp;amp;plusmn; 3.94%, 8.91 &amp;amp;plusmn; 3.56%, and 7.02 &amp;amp;plusmn; 3.59% inhibition for tyrosol, KYNA, and the mixture, respectively, versus 0.67 &amp;amp;plusmn; 4.80% for the control). The mixture showed a significant sub-additive interaction only at 4 &amp;amp;deg;C (p = 0.014). Mechanical stability depended mainly on storage temperature: centrifugation-induced phase separation increased from 8% to 28% between weeks 2 and 4 and was largely prevented at room temperature or above. In the dialysis model, the mixture markedly increased tyrosol release while reducing KYNA release, a behavior tentatively attributed to proton-exchange/keto&amp;amp;ndash;enol interactions. Overall, room temperature was the optimal storage condition, and the tyrosol-KYNA combination emerged as a stable, skin-compatible antioxidant system for topical application.</description>
	<pubDate>2026-09-25</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 258: Design, Multiparametric Stability, Antioxidant Activity and Release Behavior of an Oil-in-Water Cosmetic Emulsion Co-Loaded with Tyrosol and Kynurenic Acid</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/258">doi: 10.3390/cosmetics13050258</a></p>
	<p>Authors:
		Stefano Di Palma
		Salvatore Baldino
		Fabrizio Caldera
		Francesco Trotta
		Adrián Matencio
		</p>
	<p>Tyrosol and kynurenic acid (KYNA) are natural antioxidants with complementary radical-scavenging and photo-absorbing properties, but their combined performance in a cosmetic formulation has not been reported. We developed an oil-in-water (O/W) emulsion containing tyrosol, KYNA, or a 1:1 mixture, using an unloaded emulsion as control. Formulations were evaluated for four weeks at 4, 25, and 40 &amp;amp;deg;C using differential scanning calorimetry (DSC), rheology, spreadability, centrifugation, pH, DPPH antioxidant activity, HPLC quantification and release through a dialysis membrane; compositional stability was assessed by elemental (CHN) analysis. Chemical equilibrium parameters showed a consistent trend: the first week represented a maturation phase, likely reflecting redistribution of actives within the matrix, followed by a stable equilibrium state. The results are therefore discussed as initial versus equilibrated conditions. At equilibrium, the binary formulation maintained a skin-compatible pH (4.40 &amp;amp;plusmn; 0.04) with lower variability than single-active systems. HPLC confirmed nominal loading without degradation (0.89 &amp;amp;plusmn; 0.08% tyrosol, 0.97 &amp;amp;plusmn; 0.10% KYNA, and 1.00 &amp;amp;plusmn; 0.18% total in the mixture). DPPH analysis of standards revealed cooperative antioxidant enhancement in the mixture, exceeding the activity of either compound alone. In the creams, this produced a modest but reproducible antioxidant effect (9.00 &amp;amp;plusmn; 3.94%, 8.91 &amp;amp;plusmn; 3.56%, and 7.02 &amp;amp;plusmn; 3.59% inhibition for tyrosol, KYNA, and the mixture, respectively, versus 0.67 &amp;amp;plusmn; 4.80% for the control). The mixture showed a significant sub-additive interaction only at 4 &amp;amp;deg;C (p = 0.014). Mechanical stability depended mainly on storage temperature: centrifugation-induced phase separation increased from 8% to 28% between weeks 2 and 4 and was largely prevented at room temperature or above. In the dialysis model, the mixture markedly increased tyrosol release while reducing KYNA release, a behavior tentatively attributed to proton-exchange/keto&amp;amp;ndash;enol interactions. Overall, room temperature was the optimal storage condition, and the tyrosol-KYNA combination emerged as a stable, skin-compatible antioxidant system for topical application.</p>
	]]></content:encoded>

	<dc:title>Design, Multiparametric Stability, Antioxidant Activity and Release Behavior of an Oil-in-Water Cosmetic Emulsion Co-Loaded with Tyrosol and Kynurenic Acid</dc:title>
			<dc:creator>Stefano Di Palma</dc:creator>
			<dc:creator>Salvatore Baldino</dc:creator>
			<dc:creator>Fabrizio Caldera</dc:creator>
			<dc:creator>Francesco Trotta</dc:creator>
			<dc:creator>Adrián Matencio</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050258</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-25</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-25</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>258</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050258</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/258</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/257">

	<title>Cosmetics, Vol. 13, Pages 257: Calcium Hydroxylapatite in Facial Rejuvenation: A Review from Multi-Layered Aging Mechanisms to Material-Property-Guided Clinical Practice</title>
	<link>https://www.mdpi.com/2079-9284/13/5/257</link>
	<description>Contemporary research on facial aging is undergoing a profound paradigm shift, transitioning from macroscopic descriptive phenotyping to refined cellular-molecular mechanistic dissection. This review reveals these frontiers across multi-omics and structural dimensions, highlighting single-cell transcriptomic alterations (e.g., KLF6 and HES1 dysregulation), proteomic hubs (e.g., KNG1), epigenetic causal chains, and microbiome community succession within the cutaneous microenvironment. Concurrently, we map the progressive biomechanical failure of deeper tissues, including sequential adipose atrophy, SMAS-muscle complex degeneration, and sex-specific skeletal remodeling. Within the evolving landscape of regenerative aesthetics, calcium hydroxylapatite (CaHA) has emerged not merely as a passive space-occupying volumizer but as a dynamic biostimulatory material. We examine how CaHA&amp;amp;rsquo;s morphology and rheological properties govern its biological behavior. Human histological studies provide evidence that CaHA is associated with fibroblast activity and temporal extracellular-matrix remodeling, particularly changes in type III and type I collagen expression. Changes in elastin- and angiogenesis-related markers have also been reported, whereas the mechanotransduction and immune-regulatory pathways proposed to underlie these responses remain supported predominantly by in vitro, ex vivo, and preclinical evidence and have not been fully validated in human facial tissue. Finally, we translate these material-driven interactions into advanced clinical strategies, including rheologically programmed dilution, layer-specific vectoring, and synergistic therapies. By bridging intricate aging biology with material-guided regeneration, this review provides a robust conceptual framework for individualized and precise rejuvenation.</description>
	<pubDate>2026-09-25</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 257: Calcium Hydroxylapatite in Facial Rejuvenation: A Review from Multi-Layered Aging Mechanisms to Material-Property-Guided Clinical Practice</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/257">doi: 10.3390/cosmetics13050257</a></p>
	<p>Authors:
		Yao Jia
		Yangchun Xie
		</p>
	<p>Contemporary research on facial aging is undergoing a profound paradigm shift, transitioning from macroscopic descriptive phenotyping to refined cellular-molecular mechanistic dissection. This review reveals these frontiers across multi-omics and structural dimensions, highlighting single-cell transcriptomic alterations (e.g., KLF6 and HES1 dysregulation), proteomic hubs (e.g., KNG1), epigenetic causal chains, and microbiome community succession within the cutaneous microenvironment. Concurrently, we map the progressive biomechanical failure of deeper tissues, including sequential adipose atrophy, SMAS-muscle complex degeneration, and sex-specific skeletal remodeling. Within the evolving landscape of regenerative aesthetics, calcium hydroxylapatite (CaHA) has emerged not merely as a passive space-occupying volumizer but as a dynamic biostimulatory material. We examine how CaHA&amp;amp;rsquo;s morphology and rheological properties govern its biological behavior. Human histological studies provide evidence that CaHA is associated with fibroblast activity and temporal extracellular-matrix remodeling, particularly changes in type III and type I collagen expression. Changes in elastin- and angiogenesis-related markers have also been reported, whereas the mechanotransduction and immune-regulatory pathways proposed to underlie these responses remain supported predominantly by in vitro, ex vivo, and preclinical evidence and have not been fully validated in human facial tissue. Finally, we translate these material-driven interactions into advanced clinical strategies, including rheologically programmed dilution, layer-specific vectoring, and synergistic therapies. By bridging intricate aging biology with material-guided regeneration, this review provides a robust conceptual framework for individualized and precise rejuvenation.</p>
	]]></content:encoded>

	<dc:title>Calcium Hydroxylapatite in Facial Rejuvenation: A Review from Multi-Layered Aging Mechanisms to Material-Property-Guided Clinical Practice</dc:title>
			<dc:creator>Yao Jia</dc:creator>
			<dc:creator>Yangchun Xie</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050257</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-25</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-25</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>257</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050257</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/257</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/256">

	<title>Cosmetics, Vol. 13, Pages 256: Skin-Protective Effects of a Rhamnose-Enriched Fraction Isolated from Halocynthia roretzi Tunics Against Particulate Matter-Induced Oxidative and Barrier Damage</title>
	<link>https://www.mdpi.com/2079-9284/13/5/256</link>
	<description>Particulate matter (PM) is a major environmental pollutant that induces excessive reactive oxygen species (ROS) production in the skin, leading to inflammatory responses and disruption of skin barrier integrity. The tunic of Halocynthia roretzi, an underutilized marine by-product rich in bioactive polysaccharides, represents a promising sustainable resource for the development of functional biomaterials. In this study, a rhamnose-rich polysaccharide fraction (HTVE-2) was obtained from H. roretzi tunics through enzymatic extraction followed by ethanol fractionation, and its protective effects against PM-induced skin damage were investigated in HaCaT keratinocytes and zebrafish models. In PM-stimulated HaCaT cells, HTVE-2 significantly reduced intracellular ROS production, suppressed inflammatory responses, and restored the expression of skin barrier-related proteins, including tight junction-associated proteins. Notably, PM exposure increased intracellular ROS levels to 279.4% of the control level, whereas treatment with the highest tested concentration of HTVE-2 reduced ROS levels to 184.1%. The protective effects of HTVE-2 were further validated in vivo using zebrafish embryos, in which HTVE-2 exhibited no apparent developmental toxicity and dose-dependently attenuated PM-induced ROS generation. PM exposure increased ROS levels to 236.1% of the control level in zebrafish embryos, while treatment with the highest concentration of HTVE-2 reduced ROS levels to 147.1%. Collectively, these findings demonstrate that the rhamnose-rich HTVE-2 fraction derived from H. roretzi tunics protects against PM-induced oxidative stress, inflammatory responses, and skin barrier dysfunction. These results highlight the potential of HTVE-2 as a marine-derived functional ingredient for protecting the skin against PM-induced damage while providing a value-added approach for the sustainable utilization of H. roretzi tunic by-products.</description>
	<pubDate>2026-09-25</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 256: Skin-Protective Effects of a Rhamnose-Enriched Fraction Isolated from Halocynthia roretzi Tunics Against Particulate Matter-Induced Oxidative and Barrier Damage</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/256">doi: 10.3390/cosmetics13050256</a></p>
	<p>Authors:
		Seo-Rin Jung
		Wook-Chul Kim
		Yun-Su Lee
		Seok-Chun Ko
		Mi-Jin Yim
		Jeong Min Lee
		Seung-Hong Lee
		</p>
	<p>Particulate matter (PM) is a major environmental pollutant that induces excessive reactive oxygen species (ROS) production in the skin, leading to inflammatory responses and disruption of skin barrier integrity. The tunic of Halocynthia roretzi, an underutilized marine by-product rich in bioactive polysaccharides, represents a promising sustainable resource for the development of functional biomaterials. In this study, a rhamnose-rich polysaccharide fraction (HTVE-2) was obtained from H. roretzi tunics through enzymatic extraction followed by ethanol fractionation, and its protective effects against PM-induced skin damage were investigated in HaCaT keratinocytes and zebrafish models. In PM-stimulated HaCaT cells, HTVE-2 significantly reduced intracellular ROS production, suppressed inflammatory responses, and restored the expression of skin barrier-related proteins, including tight junction-associated proteins. Notably, PM exposure increased intracellular ROS levels to 279.4% of the control level, whereas treatment with the highest tested concentration of HTVE-2 reduced ROS levels to 184.1%. The protective effects of HTVE-2 were further validated in vivo using zebrafish embryos, in which HTVE-2 exhibited no apparent developmental toxicity and dose-dependently attenuated PM-induced ROS generation. PM exposure increased ROS levels to 236.1% of the control level in zebrafish embryos, while treatment with the highest concentration of HTVE-2 reduced ROS levels to 147.1%. Collectively, these findings demonstrate that the rhamnose-rich HTVE-2 fraction derived from H. roretzi tunics protects against PM-induced oxidative stress, inflammatory responses, and skin barrier dysfunction. These results highlight the potential of HTVE-2 as a marine-derived functional ingredient for protecting the skin against PM-induced damage while providing a value-added approach for the sustainable utilization of H. roretzi tunic by-products.</p>
	]]></content:encoded>

	<dc:title>Skin-Protective Effects of a Rhamnose-Enriched Fraction Isolated from Halocynthia roretzi Tunics Against Particulate Matter-Induced Oxidative and Barrier Damage</dc:title>
			<dc:creator>Seo-Rin Jung</dc:creator>
			<dc:creator>Wook-Chul Kim</dc:creator>
			<dc:creator>Yun-Su Lee</dc:creator>
			<dc:creator>Seok-Chun Ko</dc:creator>
			<dc:creator>Mi-Jin Yim</dc:creator>
			<dc:creator>Jeong Min Lee</dc:creator>
			<dc:creator>Seung-Hong Lee</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050256</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-25</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-25</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>256</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050256</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/256</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/255">

	<title>Cosmetics, Vol. 13, Pages 255: Niacinamide, Prebiotic, and Postbiotic Emollient Versus Urea 10% Cream for EGFR Inhibitor-Induced Xerosis and Pruritus: A Double-Blind Randomized Trial</title>
	<link>https://www.mdpi.com/2079-9284/13/5/255</link>
	<description>Background: Xerosis and pruritus are frequent and burdensome adverse effects of epidermal growth factor receptor inhibitors (EGFRIs), reflecting a therapy-induced disruption of epidermal barrier integrity and keratinocyte homeostasis. While urea-based emollients are widely recommended, emerging dermocosmetic strategies targeting barrier repair and microbiome modulation may offer alternative or complementary benefits. Objective: To compare the efficacy and tolerability of a niacinamide-, prebiotic-, and postbiotic-enriched emollient with a standard 10% urea cream in the management of EGFRI-induced xerosis and pruritus. Methods: In this prospective, randomized, double-blind, parallel-group trial, 44 patients receiving EGFR inhibitors and presenting with clinically significant xerosis and pruritus were assigned to receive either a 10% urea cream or a formulation containing 4% niacinamide, &amp;amp;alpha;-glucan oligosaccharide, and Lactobacillus ferment lysate. Treatments were applied twice daily for 12 weeks. Outcomes included reflectance confocal microscopy (RCM) assessment of epidermal microstructure, pruritus intensity measured by visual analog scale (VAS), and quality of life evaluated by Dermatology Life Quality Index (DLQI) and Skindex-16. Results: Both treatments induced significant improvements across all endpoints. RCM demonstrated restoration of stratum corneum organization and epidermal architecture in both groups, with no significant between-group differences. Pruritus decreased markedly, with VAS scores declining from approximately 6.5 at baseline to 2.36 in the niacinamide-based group and 2.48 in the urea group at week 12. Quality-of-life measures improved substantially, with DLQI reductions of 66% and 61% in the niacinamide and urea groups, respectively. Skindex-16 scores showed comparable improvements. No statistically significant differences were observed between treatments for any outcome measure. Both formulations were well tolerated, with no relevant adverse events. Conclusions: A niacinamide-, prebiotic-, and postbiotic-containing emollient demonstrated efficacy comparable to that of a standard 10% urea cream in improving EGFRI-induced xerosis and pruritus over 12 weeks. These findings support the formulation as a viable option for supportive oncodermatologic care, while proposed effects on epidermal barrier pathways, inflammation, and microbiota-host interactions remain biologically plausible mechanisms that were not directly assessed in this trial.</description>
	<pubDate>2026-09-23</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 255: Niacinamide, Prebiotic, and Postbiotic Emollient Versus Urea 10% Cream for EGFR Inhibitor-Induced Xerosis and Pruritus: A Double-Blind Randomized Trial</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/255">doi: 10.3390/cosmetics13050255</a></p>
	<p>Authors:
		Daniele Omar Traini
		Gerardo Palmisano
		Alessandro Di Stefani
		Marica Di Ciurcio
		Ketty Peris
		Pietro Sollena
		</p>
	<p>Background: Xerosis and pruritus are frequent and burdensome adverse effects of epidermal growth factor receptor inhibitors (EGFRIs), reflecting a therapy-induced disruption of epidermal barrier integrity and keratinocyte homeostasis. While urea-based emollients are widely recommended, emerging dermocosmetic strategies targeting barrier repair and microbiome modulation may offer alternative or complementary benefits. Objective: To compare the efficacy and tolerability of a niacinamide-, prebiotic-, and postbiotic-enriched emollient with a standard 10% urea cream in the management of EGFRI-induced xerosis and pruritus. Methods: In this prospective, randomized, double-blind, parallel-group trial, 44 patients receiving EGFR inhibitors and presenting with clinically significant xerosis and pruritus were assigned to receive either a 10% urea cream or a formulation containing 4% niacinamide, &amp;amp;alpha;-glucan oligosaccharide, and Lactobacillus ferment lysate. Treatments were applied twice daily for 12 weeks. Outcomes included reflectance confocal microscopy (RCM) assessment of epidermal microstructure, pruritus intensity measured by visual analog scale (VAS), and quality of life evaluated by Dermatology Life Quality Index (DLQI) and Skindex-16. Results: Both treatments induced significant improvements across all endpoints. RCM demonstrated restoration of stratum corneum organization and epidermal architecture in both groups, with no significant between-group differences. Pruritus decreased markedly, with VAS scores declining from approximately 6.5 at baseline to 2.36 in the niacinamide-based group and 2.48 in the urea group at week 12. Quality-of-life measures improved substantially, with DLQI reductions of 66% and 61% in the niacinamide and urea groups, respectively. Skindex-16 scores showed comparable improvements. No statistically significant differences were observed between treatments for any outcome measure. Both formulations were well tolerated, with no relevant adverse events. Conclusions: A niacinamide-, prebiotic-, and postbiotic-containing emollient demonstrated efficacy comparable to that of a standard 10% urea cream in improving EGFRI-induced xerosis and pruritus over 12 weeks. These findings support the formulation as a viable option for supportive oncodermatologic care, while proposed effects on epidermal barrier pathways, inflammation, and microbiota-host interactions remain biologically plausible mechanisms that were not directly assessed in this trial.</p>
	]]></content:encoded>

	<dc:title>Niacinamide, Prebiotic, and Postbiotic Emollient Versus Urea 10% Cream for EGFR Inhibitor-Induced Xerosis and Pruritus: A Double-Blind Randomized Trial</dc:title>
			<dc:creator>Daniele Omar Traini</dc:creator>
			<dc:creator>Gerardo Palmisano</dc:creator>
			<dc:creator>Alessandro Di Stefani</dc:creator>
			<dc:creator>Marica Di Ciurcio</dc:creator>
			<dc:creator>Ketty Peris</dc:creator>
			<dc:creator>Pietro Sollena</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050255</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-23</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-23</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>255</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050255</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/255</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/254">

	<title>Cosmetics, Vol. 13, Pages 254: Indications and Contraindications for Minimally Invasive Rib Remodeling</title>
	<link>https://www.mdpi.com/2079-9284/13/5/254</link>
	<description>Background: A narrow waist is one of the central objectives of esthetic body contouring, and it is closely tied to the waist-to-hip ratio that observers associate with a feminine silhouette. Conventional soft-tissue techniques such as liposuction and liposculpture are constrained by patient-specific anatomy, including the pattern of adipose tissue distribution and the transverse dimensions of the bony rib cage. Minimally invasive rib remodeling was developed to overcome these constraints and to produce a more pronounced waist-narrowing effect without rib removal. The factors that determine the magnitude of the result and patient satisfaction have not been characterized in sufficient detail. Methods: A combined retrospective&amp;amp;ndash;prospective single-center study was conducted on 60 female patients aged 22 to 55 years (mean age, 35.5 years) who underwent minimally invasive rib remodeling using the Kudzaev technique between 2017 and 2025. The variables assessed included anthropometric measurements, body mass index (BMI), subcutaneous and visceral adipose distribution, body shape, endocrine status, and psychological readiness to adhere to the postoperative regimen. Outcomes were evaluated at three months on the basis of the change in waist circumference, standardized photographic documentation, and patient satisfaction (five-point scale) and the BODY-Q Satisfaction with body scale. Safety was assessed clinically during the first postoperative day and at every follow-up contact, and union of the osteotomies was assessed by computed tomography at three months. Results: The mean reduction in waist circumference was 7.82 &amp;amp;plusmn; 2.14 cm. Both the reduction and patient satisfaction decreased with increasing BMI (Pearson r = &amp;amp;minus;0.30, p = 0.02 and r = &amp;amp;minus;0.42, p &amp;amp;lt; 0.001 respectively): patients with a BMI &amp;amp;le; 25 kg/m2 (n = 59) achieved a mean reduction of 7.86 &amp;amp;plusmn; 2.12 cm and a satisfaction score of 4.25 &amp;amp;plusmn; 0.96, whereas the single patient with a BMI &amp;amp;gt; 25 kg/m2 obtained a smaller reduction (5 cm) and the lowest satisfaction score. The BODY-Q Satisfaction with body scale corroborated these results (Rasch-transformed score, 82.6 &amp;amp;plusmn; 18.1) and correlated strongly with the five-point rating (Pearson r = 0.90). Elevated BMI and a pronounced visceral fat component were associated with a less favorable esthetic outcome. Endocrine disease, in particular hyperparathyroidism, was associated with delayed rib consolidation and lower satisfaction. Poor postoperative compliance, especially inconsistent corset wear, was linked to unsatisfactory results. No pulmonary, pleural or infectious complications occurred. Access by needle puncture left no scars, analgesic use lasted two to four days, and computed tomography at three months showed consolidation in 58 of the 60 patients. No patient reported loss of the achieved narrowing during subsequent contact. Conclusions: The effectiveness of minimally invasive rib remodeling depends substantially on patient selection. The most favorable outcomes were obtained in patients with a normal BMI, minimal adipose tissue, and a high level of compliance. Elevated BMI, excess visceral fat, parathyroid disease and low motivation were each associated with a smaller effect and lower satisfaction, and identify patients in whom the procedure is less likely to satisfy. These findings support rigorous preoperative selection that accounts for both somatic and behavioral characteristics.</description>
	<pubDate>2026-09-22</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 254: Indications and Contraindications for Minimally Invasive Rib Remodeling</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/254">doi: 10.3390/cosmetics13050254</a></p>
	<p>Authors:
		Kazbek Kudzaev
		Valentin Sharobaro
		Kazbek Gaparov
		Igor Kraiushkin
		</p>
	<p>Background: A narrow waist is one of the central objectives of esthetic body contouring, and it is closely tied to the waist-to-hip ratio that observers associate with a feminine silhouette. Conventional soft-tissue techniques such as liposuction and liposculpture are constrained by patient-specific anatomy, including the pattern of adipose tissue distribution and the transverse dimensions of the bony rib cage. Minimally invasive rib remodeling was developed to overcome these constraints and to produce a more pronounced waist-narrowing effect without rib removal. The factors that determine the magnitude of the result and patient satisfaction have not been characterized in sufficient detail. Methods: A combined retrospective&amp;amp;ndash;prospective single-center study was conducted on 60 female patients aged 22 to 55 years (mean age, 35.5 years) who underwent minimally invasive rib remodeling using the Kudzaev technique between 2017 and 2025. The variables assessed included anthropometric measurements, body mass index (BMI), subcutaneous and visceral adipose distribution, body shape, endocrine status, and psychological readiness to adhere to the postoperative regimen. Outcomes were evaluated at three months on the basis of the change in waist circumference, standardized photographic documentation, and patient satisfaction (five-point scale) and the BODY-Q Satisfaction with body scale. Safety was assessed clinically during the first postoperative day and at every follow-up contact, and union of the osteotomies was assessed by computed tomography at three months. Results: The mean reduction in waist circumference was 7.82 &amp;amp;plusmn; 2.14 cm. Both the reduction and patient satisfaction decreased with increasing BMI (Pearson r = &amp;amp;minus;0.30, p = 0.02 and r = &amp;amp;minus;0.42, p &amp;amp;lt; 0.001 respectively): patients with a BMI &amp;amp;le; 25 kg/m2 (n = 59) achieved a mean reduction of 7.86 &amp;amp;plusmn; 2.12 cm and a satisfaction score of 4.25 &amp;amp;plusmn; 0.96, whereas the single patient with a BMI &amp;amp;gt; 25 kg/m2 obtained a smaller reduction (5 cm) and the lowest satisfaction score. The BODY-Q Satisfaction with body scale corroborated these results (Rasch-transformed score, 82.6 &amp;amp;plusmn; 18.1) and correlated strongly with the five-point rating (Pearson r = 0.90). Elevated BMI and a pronounced visceral fat component were associated with a less favorable esthetic outcome. Endocrine disease, in particular hyperparathyroidism, was associated with delayed rib consolidation and lower satisfaction. Poor postoperative compliance, especially inconsistent corset wear, was linked to unsatisfactory results. No pulmonary, pleural or infectious complications occurred. Access by needle puncture left no scars, analgesic use lasted two to four days, and computed tomography at three months showed consolidation in 58 of the 60 patients. No patient reported loss of the achieved narrowing during subsequent contact. Conclusions: The effectiveness of minimally invasive rib remodeling depends substantially on patient selection. The most favorable outcomes were obtained in patients with a normal BMI, minimal adipose tissue, and a high level of compliance. Elevated BMI, excess visceral fat, parathyroid disease and low motivation were each associated with a smaller effect and lower satisfaction, and identify patients in whom the procedure is less likely to satisfy. These findings support rigorous preoperative selection that accounts for both somatic and behavioral characteristics.</p>
	]]></content:encoded>

	<dc:title>Indications and Contraindications for Minimally Invasive Rib Remodeling</dc:title>
			<dc:creator>Kazbek Kudzaev</dc:creator>
			<dc:creator>Valentin Sharobaro</dc:creator>
			<dc:creator>Kazbek Gaparov</dc:creator>
			<dc:creator>Igor Kraiushkin</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050254</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-22</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-22</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>254</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050254</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/254</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/253">

	<title>Cosmetics, Vol. 13, Pages 253: Effects of an Oral Multi-Ingredient Supplement on Crow&amp;rsquo;s-Feet Wrinkles and Skin Hydration: A 56-Day Open-Label Exploratory Study</title>
	<link>https://www.mdpi.com/2079-9284/13/5/253</link>
	<description>Oral nutricosmetic supplements are widely used to support skin appearance, but finished multi-ingredient products require dedicated clinical evaluation because their performance cannot be inferred from ingredient-level data alone. This prospective, single-centre, open-label, single-arm exploratory study evaluated NatureU&amp;amp;reg; Mind Care BeautyU Caps, a capsule containing quercetin, cranberry-derived proanthocyanidins, pyrroloquinoline quinone (PQQ), and ergothioneine. A total of 33 healthy women aged 36&amp;amp;ndash;56 years, eligible only if baseline cheek hydration was below 60 corneometer units, took one capsule daily for 56 days, with 31 women completing the full protocol. Instrumental assessments at days 0, 28, and 56 covered crow&amp;amp;rsquo;s-feet wrinkle parameters (PRIMOS CR); stratum corneum hydration (Corneometer CM 825); and biomechanical, radiance, pigmentation, and dermal-structure measures. The prespecified primary endpoint, wrinkle count, fell from 965 &amp;amp;plusmn; 334 to 514 &amp;amp;plusmn; 171 (&amp;amp;minus;46.73%) and hydration rose from 44.3 &amp;amp;plusmn; 7.8 to 70.3 &amp;amp;plusmn; 9.9 (+58.57%); both changes occurred in all 31 completers. Wrinkle depth changed only non-significantly. Individual-participant data show that the reduction in wrinkle count was almost exactly proportional across a 5.9-fold range of baseline values (D56/D0 ratio 0.535 &amp;amp;plusmn; 0.041) and was complete by day 28, a pattern more consistent with a systematic difference between imaging sessions than with a biological effect; the analysis parameters needed to exclude this were not available. No adverse reactions occurred. Because there was no control arm, because enrolment selected the low end of the hydration distribution, and because count-based profilometry is threshold-dependent, these magnitudes are upper-bound within-participant observations subject to regression to the mean and to expectancy effects; the hydration finding is hypothesis-generating, and the wrinkle-count finding should not be treated as evidence of efficacy. Confirmation in randomized, placebo-controlled trials is required.</description>
	<pubDate>2026-09-21</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 253: Effects of an Oral Multi-Ingredient Supplement on Crow&amp;rsquo;s-Feet Wrinkles and Skin Hydration: A 56-Day Open-Label Exploratory Study</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/253">doi: 10.3390/cosmetics13050253</a></p>
	<p>Authors:
		Lorry Luo
		Luke Law
		</p>
	<p>Oral nutricosmetic supplements are widely used to support skin appearance, but finished multi-ingredient products require dedicated clinical evaluation because their performance cannot be inferred from ingredient-level data alone. This prospective, single-centre, open-label, single-arm exploratory study evaluated NatureU&amp;amp;reg; Mind Care BeautyU Caps, a capsule containing quercetin, cranberry-derived proanthocyanidins, pyrroloquinoline quinone (PQQ), and ergothioneine. A total of 33 healthy women aged 36&amp;amp;ndash;56 years, eligible only if baseline cheek hydration was below 60 corneometer units, took one capsule daily for 56 days, with 31 women completing the full protocol. Instrumental assessments at days 0, 28, and 56 covered crow&amp;amp;rsquo;s-feet wrinkle parameters (PRIMOS CR); stratum corneum hydration (Corneometer CM 825); and biomechanical, radiance, pigmentation, and dermal-structure measures. The prespecified primary endpoint, wrinkle count, fell from 965 &amp;amp;plusmn; 334 to 514 &amp;amp;plusmn; 171 (&amp;amp;minus;46.73%) and hydration rose from 44.3 &amp;amp;plusmn; 7.8 to 70.3 &amp;amp;plusmn; 9.9 (+58.57%); both changes occurred in all 31 completers. Wrinkle depth changed only non-significantly. Individual-participant data show that the reduction in wrinkle count was almost exactly proportional across a 5.9-fold range of baseline values (D56/D0 ratio 0.535 &amp;amp;plusmn; 0.041) and was complete by day 28, a pattern more consistent with a systematic difference between imaging sessions than with a biological effect; the analysis parameters needed to exclude this were not available. No adverse reactions occurred. Because there was no control arm, because enrolment selected the low end of the hydration distribution, and because count-based profilometry is threshold-dependent, these magnitudes are upper-bound within-participant observations subject to regression to the mean and to expectancy effects; the hydration finding is hypothesis-generating, and the wrinkle-count finding should not be treated as evidence of efficacy. Confirmation in randomized, placebo-controlled trials is required.</p>
	]]></content:encoded>

	<dc:title>Effects of an Oral Multi-Ingredient Supplement on Crow&amp;amp;rsquo;s-Feet Wrinkles and Skin Hydration: A 56-Day Open-Label Exploratory Study</dc:title>
			<dc:creator>Lorry Luo</dc:creator>
			<dc:creator>Luke Law</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050253</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-21</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-21</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>253</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050253</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/253</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/252">

	<title>Cosmetics, Vol. 13, Pages 252: Phytochemical Profiling, Antioxidant and Anti-Inflammatory Activities, and Nano-Spray Development for Muscle Pain Relief from Thai Ma-Khwaen Zanthoxylum rhetsa (Roxb.) DC.</title>
	<link>https://www.mdpi.com/2079-9284/13/5/252</link>
	<description>Zanthoxylum rhetsa (Roxb.) DC. (Ma-Khwaen) is an economically important medicinal plant traditionally used for pain and inflammatory disorders. This study explored its phytochemical composition, biological activities, and potential for nano-spray product development. Methods: Ethanolic fruit extracts collected from five provinces in Northern Thailand were evaluated for extraction yield, total phenolic content (TPC), total flavonoid content (TFC), antioxidant activity, and anti-inflammatory activity. Extracts from Nan Province were further selected for DPPH radical scavenging, GC&amp;amp;ndash;MS characterization, nitric oxide (NO) inhibition assay in LPS stimulated RAW 264.7 macrophages, nano-spray formulation development, and stability assessment. Results: Considerable phytochemical variation was observed among geographical origins, with TPC and TFC ranging from 19.47 to 103.09 mg GAE/g extract and 28.57 to 400.72 mg QE/g extract, respectively. The Nan whole-fruit extract exhibited the highest extraction yield (20.81%), whereas the pericarp extract showed the strongest antioxidant activity (IC50 = 111.78 &amp;amp;mu;g/mL). GC&amp;amp;ndash;MS analysis revealed anti-inflammatory phytochemicals, predominantly &amp;amp;alpha;-terpineol, geranyl acetate, n-hexadecanoic acid, oleic acid, and linalool. The selected extract demonstrated potent anti-inflammatory activity (IC50 = 6.95 &amp;amp;plusmn; 0.44 &amp;amp;mu;g/mL), exceeding that of prednisolone, and was successfully incorporated into a physically stable nano-spray formulation with 60-day storage stability. Conclusions: These findings provide scientific validation for the traditional use of Ma-Khwaen and support its development as a stable nano-spray formulation for muscle pain relief and inflammation alleviation.</description>
	<pubDate>2026-09-21</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 252: Phytochemical Profiling, Antioxidant and Anti-Inflammatory Activities, and Nano-Spray Development for Muscle Pain Relief from Thai Ma-Khwaen Zanthoxylum rhetsa (Roxb.) DC.</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/252">doi: 10.3390/cosmetics13050252</a></p>
	<p>Authors:
		Keng Chaichana
		Phanit Srisuttha
		Raweephun Sunanta
		Phadungnaree Saenmuang
		Wannita Sakulwattana
		Wichida Lasomsri
		Pakorn Pusuwan
		Sakesun Thongtip
		Pannatat Suttirak
		Pitakpong Panta
		Ubonwan Saesiw
		Teerapong Yata
		Monchanok Choowanthanapakorn
		</p>
	<p>Zanthoxylum rhetsa (Roxb.) DC. (Ma-Khwaen) is an economically important medicinal plant traditionally used for pain and inflammatory disorders. This study explored its phytochemical composition, biological activities, and potential for nano-spray product development. Methods: Ethanolic fruit extracts collected from five provinces in Northern Thailand were evaluated for extraction yield, total phenolic content (TPC), total flavonoid content (TFC), antioxidant activity, and anti-inflammatory activity. Extracts from Nan Province were further selected for DPPH radical scavenging, GC&amp;amp;ndash;MS characterization, nitric oxide (NO) inhibition assay in LPS stimulated RAW 264.7 macrophages, nano-spray formulation development, and stability assessment. Results: Considerable phytochemical variation was observed among geographical origins, with TPC and TFC ranging from 19.47 to 103.09 mg GAE/g extract and 28.57 to 400.72 mg QE/g extract, respectively. The Nan whole-fruit extract exhibited the highest extraction yield (20.81%), whereas the pericarp extract showed the strongest antioxidant activity (IC50 = 111.78 &amp;amp;mu;g/mL). GC&amp;amp;ndash;MS analysis revealed anti-inflammatory phytochemicals, predominantly &amp;amp;alpha;-terpineol, geranyl acetate, n-hexadecanoic acid, oleic acid, and linalool. The selected extract demonstrated potent anti-inflammatory activity (IC50 = 6.95 &amp;amp;plusmn; 0.44 &amp;amp;mu;g/mL), exceeding that of prednisolone, and was successfully incorporated into a physically stable nano-spray formulation with 60-day storage stability. Conclusions: These findings provide scientific validation for the traditional use of Ma-Khwaen and support its development as a stable nano-spray formulation for muscle pain relief and inflammation alleviation.</p>
	]]></content:encoded>

	<dc:title>Phytochemical Profiling, Antioxidant and Anti-Inflammatory Activities, and Nano-Spray Development for Muscle Pain Relief from Thai Ma-Khwaen Zanthoxylum rhetsa (Roxb.) DC.</dc:title>
			<dc:creator>Keng Chaichana</dc:creator>
			<dc:creator>Phanit Srisuttha</dc:creator>
			<dc:creator>Raweephun Sunanta</dc:creator>
			<dc:creator>Phadungnaree Saenmuang</dc:creator>
			<dc:creator>Wannita Sakulwattana</dc:creator>
			<dc:creator>Wichida Lasomsri</dc:creator>
			<dc:creator>Pakorn Pusuwan</dc:creator>
			<dc:creator>Sakesun Thongtip</dc:creator>
			<dc:creator>Pannatat Suttirak</dc:creator>
			<dc:creator>Pitakpong Panta</dc:creator>
			<dc:creator>Ubonwan Saesiw</dc:creator>
			<dc:creator>Teerapong Yata</dc:creator>
			<dc:creator>Monchanok Choowanthanapakorn</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050252</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-21</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-21</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>252</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050252</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/252</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/251">

	<title>Cosmetics, Vol. 13, Pages 251: Influence of Extraction Solvents on the Biological Activities of Callisia fragrans Leaf Extracts for Skin-Related Cosmetic Applications</title>
	<link>https://www.mdpi.com/2079-9284/13/5/251</link>
	<description>Callisia fragrans (Lindl.) Woodson has been reported to possess several biological activities; however, its potential for skin-related applications remains limited. This study aimed to evaluate C. fragrans leaf extracts prepared using different extraction solvents for their potential for skin-related applications. The extracts were comparatively evaluated for extraction yield, total phenolic and flavonoid contents, and antioxidant activities. The selected 50% (v/v) ethanolic and propylene glycol extracts were further evaluated for cytocompatibility and biological activities in human dermal fibroblasts (HDFs) and RAW 264.7 macrophages. The 50% (v/v) ethanolic extract exhibited the most favorable overall antioxidant profile among the dried extracts. Both selected extracts were cytocompatible at the tested concentrations. The 50% (v/v) ethanolic extract increased HDF cellular metabolic activity to 2.57-fold and markedly reduced UV-induced intracellular ROS production in HDFs and RAW 264.7 macrophages. It also exhibited greater inhibition of LPS-induced nitric oxide production than the propylene glycol extract. However, neither extract enhanced hydroxyproline accumulation under the present experimental conditions. Overall, the 50% (v/v) ethanolic extract exhibited greater biological responses than the propylene glycol extract, particularly in HDF cellular metabolic activity and the inhibition of intracellular ROS and nitric oxide production. These findings suggest that the 50% (v/v) ethanolic extract of C. fragrans leaves has potential for further development as a natural cosmetic ingredient for skin-related applications.</description>
	<pubDate>2026-09-21</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 251: Influence of Extraction Solvents on the Biological Activities of Callisia fragrans Leaf Extracts for Skin-Related Cosmetic Applications</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/251">doi: 10.3390/cosmetics13050251</a></p>
	<p>Authors:
		Nont Thitilertdecha
		</p>
	<p>Callisia fragrans (Lindl.) Woodson has been reported to possess several biological activities; however, its potential for skin-related applications remains limited. This study aimed to evaluate C. fragrans leaf extracts prepared using different extraction solvents for their potential for skin-related applications. The extracts were comparatively evaluated for extraction yield, total phenolic and flavonoid contents, and antioxidant activities. The selected 50% (v/v) ethanolic and propylene glycol extracts were further evaluated for cytocompatibility and biological activities in human dermal fibroblasts (HDFs) and RAW 264.7 macrophages. The 50% (v/v) ethanolic extract exhibited the most favorable overall antioxidant profile among the dried extracts. Both selected extracts were cytocompatible at the tested concentrations. The 50% (v/v) ethanolic extract increased HDF cellular metabolic activity to 2.57-fold and markedly reduced UV-induced intracellular ROS production in HDFs and RAW 264.7 macrophages. It also exhibited greater inhibition of LPS-induced nitric oxide production than the propylene glycol extract. However, neither extract enhanced hydroxyproline accumulation under the present experimental conditions. Overall, the 50% (v/v) ethanolic extract exhibited greater biological responses than the propylene glycol extract, particularly in HDF cellular metabolic activity and the inhibition of intracellular ROS and nitric oxide production. These findings suggest that the 50% (v/v) ethanolic extract of C. fragrans leaves has potential for further development as a natural cosmetic ingredient for skin-related applications.</p>
	]]></content:encoded>

	<dc:title>Influence of Extraction Solvents on the Biological Activities of Callisia fragrans Leaf Extracts for Skin-Related Cosmetic Applications</dc:title>
			<dc:creator>Nont Thitilertdecha</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050251</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-21</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-21</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>251</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050251</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/251</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/250">

	<title>Cosmetics, Vol. 13, Pages 250: The Dermal Echo-Void (DEV) Index: A Reproducible Computer-Assisted High-Frequency Ultrasound Measure of Superficial-Dermis Structure Beyond Skin Density</title>
	<link>https://www.mdpi.com/2079-9284/13/5/250</link>
	<description>Background: High-frequency ultrasound (HFUS) quantifies dermal skin density well, yet the low-echogenic (hypoechoic) regions in the image have not been treated as having informative value. Analyzing HFUS B-scans, we found that skins with near-identical aggregate density can differ markedly in their hypoechoic area fraction. To capture this, we introduce the dermal echo-void (DEV) area fraction index, a computer-assisted parameter measuring hypoechoic voids within a fixed 0.45 mm superficial-dermis band (T45), and assess its reproducibility and non-redundancy with skin density. Methods: In a single-arm proof-of-concept study of 23 Korean women, DEV and density were computed from the same 22 MHz B-scans. Results: DEV was reproducible across analysis-band depths (ICC = 0.93, 95% CI 0.86&amp;amp;ndash;0.97). Although DEV correlated inversely with density (r = &amp;amp;minus;0.675), the two measures were non-redundant: among 39 density-matched pairs (&amp;amp;Delta; &amp;amp;le; 1 percentage point), DEV differed by a mean of 5.6 percentage points. After one application, density rose +16.44% and DEV fell &amp;amp;minus;35.75% (both p &amp;amp;lt; 0.001). A secondary density&amp;amp;ndash;pigmentation association was non-significant (Spearman &amp;amp;rho; = &amp;amp;minus;0.224, p = 0.485). Conclusions: DEV is a reproducible, spatially resolved complement to HFUS skin density that captures dermal structure beyond an aggregate value. How the hypoechoic fraction relates to melanocyte-associated dermal processes warrants histologically validated study.</description>
	<pubDate>2026-09-21</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 250: The Dermal Echo-Void (DEV) Index: A Reproducible Computer-Assisted High-Frequency Ultrasound Measure of Superficial-Dermis Structure Beyond Skin Density</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/250">doi: 10.3390/cosmetics13050250</a></p>
	<p>Authors:
		Youngrin Kwag
		Seok Hwan Oh
		HuiJeong Jeong
		YooRi Kang
		Min Sook Jung
		Hongseok Kim
		Wonkyu Hong
		</p>
	<p>Background: High-frequency ultrasound (HFUS) quantifies dermal skin density well, yet the low-echogenic (hypoechoic) regions in the image have not been treated as having informative value. Analyzing HFUS B-scans, we found that skins with near-identical aggregate density can differ markedly in their hypoechoic area fraction. To capture this, we introduce the dermal echo-void (DEV) area fraction index, a computer-assisted parameter measuring hypoechoic voids within a fixed 0.45 mm superficial-dermis band (T45), and assess its reproducibility and non-redundancy with skin density. Methods: In a single-arm proof-of-concept study of 23 Korean women, DEV and density were computed from the same 22 MHz B-scans. Results: DEV was reproducible across analysis-band depths (ICC = 0.93, 95% CI 0.86&amp;amp;ndash;0.97). Although DEV correlated inversely with density (r = &amp;amp;minus;0.675), the two measures were non-redundant: among 39 density-matched pairs (&amp;amp;Delta; &amp;amp;le; 1 percentage point), DEV differed by a mean of 5.6 percentage points. After one application, density rose +16.44% and DEV fell &amp;amp;minus;35.75% (both p &amp;amp;lt; 0.001). A secondary density&amp;amp;ndash;pigmentation association was non-significant (Spearman &amp;amp;rho; = &amp;amp;minus;0.224, p = 0.485). Conclusions: DEV is a reproducible, spatially resolved complement to HFUS skin density that captures dermal structure beyond an aggregate value. How the hypoechoic fraction relates to melanocyte-associated dermal processes warrants histologically validated study.</p>
	]]></content:encoded>

	<dc:title>The Dermal Echo-Void (DEV) Index: A Reproducible Computer-Assisted High-Frequency Ultrasound Measure of Superficial-Dermis Structure Beyond Skin Density</dc:title>
			<dc:creator>Youngrin Kwag</dc:creator>
			<dc:creator>Seok Hwan Oh</dc:creator>
			<dc:creator>HuiJeong Jeong</dc:creator>
			<dc:creator>YooRi Kang</dc:creator>
			<dc:creator>Min Sook Jung</dc:creator>
			<dc:creator>Hongseok Kim</dc:creator>
			<dc:creator>Wonkyu Hong</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050250</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-21</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-21</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>250</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050250</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/250</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/249">

	<title>Cosmetics, Vol. 13, Pages 249: Formulation of Functional Creams Enriched with Aloe Vera Gel, Eucalyptus Essential Oil, and Vitamin E: Mixture-Design Optimization of Antioxidant Activity and Evaluation of Consumer Acceptability</title>
	<link>https://www.mdpi.com/2079-9284/13/5/249</link>
	<description>The development of multifunctional cosmetic creams requires balancing functional performance with consumer acceptability. This study aimed to develop cream formulations containing aloe vera gel, eucalyptus essential oil, and vitamin E. Their relative proportions were optimized using mixture-design methodology. Ten formulations were prepared, and antioxidant activity was evaluated using the DPPH radical scavenging assay. A special cubic mixture model was fitted to the experimental data, followed by numerical optimization. The formulations were further characterized in terms of pH, microstructure, sensory attributes, and microbiological quality during refrigerated storage. Antioxidant activity varied among creams, with significant aloe vera &amp;amp;times; eucalyptus essential oil and aloe vera &amp;amp;times; vitamin E interactions. The model showed high explanatory capacity (R2 = 93.14%) and predicted an optimum mixture of 30.3% aloe vera gel, 29.3% eucalyptus essential oil, and 40.4% vitamin E. The pH of the creams remained within 4.74&amp;amp;ndash;5.18, while most sensory attributes were comparable among formulations. Odor and cooling sensation were formulation-dependent, while willingness to use exceeded 60% for several formulations and reached approximately 71% for BIO8. Microbial counts remained below the applicable quantitative acceptance criterion during the 60-day refrigerated storage assessment, while the specified target microorganisms were not detected under the microbiological methods employed. The findings support further investigation of ternary formulations under formulation and stability conditions relevant to cosmetic use.</description>
	<pubDate>2026-09-20</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 249: Formulation of Functional Creams Enriched with Aloe Vera Gel, Eucalyptus Essential Oil, and Vitamin E: Mixture-Design Optimization of Antioxidant Activity and Evaluation of Consumer Acceptability</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/249">doi: 10.3390/cosmetics13050249</a></p>
	<p>Authors:
		Nikolaos Bostoganasvili
		Eugenia Papadaki
		</p>
	<p>The development of multifunctional cosmetic creams requires balancing functional performance with consumer acceptability. This study aimed to develop cream formulations containing aloe vera gel, eucalyptus essential oil, and vitamin E. Their relative proportions were optimized using mixture-design methodology. Ten formulations were prepared, and antioxidant activity was evaluated using the DPPH radical scavenging assay. A special cubic mixture model was fitted to the experimental data, followed by numerical optimization. The formulations were further characterized in terms of pH, microstructure, sensory attributes, and microbiological quality during refrigerated storage. Antioxidant activity varied among creams, with significant aloe vera &amp;amp;times; eucalyptus essential oil and aloe vera &amp;amp;times; vitamin E interactions. The model showed high explanatory capacity (R2 = 93.14%) and predicted an optimum mixture of 30.3% aloe vera gel, 29.3% eucalyptus essential oil, and 40.4% vitamin E. The pH of the creams remained within 4.74&amp;amp;ndash;5.18, while most sensory attributes were comparable among formulations. Odor and cooling sensation were formulation-dependent, while willingness to use exceeded 60% for several formulations and reached approximately 71% for BIO8. Microbial counts remained below the applicable quantitative acceptance criterion during the 60-day refrigerated storage assessment, while the specified target microorganisms were not detected under the microbiological methods employed. The findings support further investigation of ternary formulations under formulation and stability conditions relevant to cosmetic use.</p>
	]]></content:encoded>

	<dc:title>Formulation of Functional Creams Enriched with Aloe Vera Gel, Eucalyptus Essential Oil, and Vitamin E: Mixture-Design Optimization of Antioxidant Activity and Evaluation of Consumer Acceptability</dc:title>
			<dc:creator>Nikolaos Bostoganasvili</dc:creator>
			<dc:creator>Eugenia Papadaki</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050249</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-20</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-20</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>249</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050249</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/249</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/248">

	<title>Cosmetics, Vol. 13, Pages 248: Topical Skin Boosters in Aesthetic Practice: Pharmacokinetic Challenges, Delivery Platforms, Evidence Gaps, and Future Directions</title>
	<link>https://www.mdpi.com/2079-9284/13/5/248</link>
	<description>Although the term &amp;amp;ldquo;topical skin booster&amp;amp;rdquo; has gained significant traction in Korean aesthetic medicine, the category remains loosely defined and often disconnected from established principles of transdermal pharmacology. To address this ambiguity, we critically reviewed the mechanistic foundations and clinical evidence surrounding these formulations, using the 500 Da permeability heuristic as an initial physicochemical screening framework rather than an absolute cutoff. We assessed key delivery platforms, including microneedling, ablative fractional lasers, radiofrequency microneedling, and cold atmospheric plasma. The available evidence indicates that macromolecular actives such as hyaluronic acid and polydeoxyribonucleotides generally face substantial barriers to passive penetration, whereas small-molecule agents have a stronger physicochemical rationale for topical use. We propose a hypothesis-generating &amp;amp;ldquo;signal-and-support&amp;amp;rdquo; framework for biologically plausible multi-ingredient formulation design. The field remains constrained by inconsistent, claim-specific verification of cutaneous exposure and dermal delivery, particularly for macromolecular actives. More rigorous target-compartment pharmacokinetic and target-engagement studies are needed to distinguish mechanistic plausibility from verified dermal delivery and clinical benefit.</description>
	<pubDate>2026-09-19</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 248: Topical Skin Boosters in Aesthetic Practice: Pharmacokinetic Challenges, Delivery Platforms, Evidence Gaps, and Future Directions</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/248">doi: 10.3390/cosmetics13050248</a></p>
	<p>Authors:
		Nark-Kyoung Rho
		Hee-Dae Jeon
		Hyun-Jun Park
		</p>
	<p>Although the term &amp;amp;ldquo;topical skin booster&amp;amp;rdquo; has gained significant traction in Korean aesthetic medicine, the category remains loosely defined and often disconnected from established principles of transdermal pharmacology. To address this ambiguity, we critically reviewed the mechanistic foundations and clinical evidence surrounding these formulations, using the 500 Da permeability heuristic as an initial physicochemical screening framework rather than an absolute cutoff. We assessed key delivery platforms, including microneedling, ablative fractional lasers, radiofrequency microneedling, and cold atmospheric plasma. The available evidence indicates that macromolecular actives such as hyaluronic acid and polydeoxyribonucleotides generally face substantial barriers to passive penetration, whereas small-molecule agents have a stronger physicochemical rationale for topical use. We propose a hypothesis-generating &amp;amp;ldquo;signal-and-support&amp;amp;rdquo; framework for biologically plausible multi-ingredient formulation design. The field remains constrained by inconsistent, claim-specific verification of cutaneous exposure and dermal delivery, particularly for macromolecular actives. More rigorous target-compartment pharmacokinetic and target-engagement studies are needed to distinguish mechanistic plausibility from verified dermal delivery and clinical benefit.</p>
	]]></content:encoded>

	<dc:title>Topical Skin Boosters in Aesthetic Practice: Pharmacokinetic Challenges, Delivery Platforms, Evidence Gaps, and Future Directions</dc:title>
			<dc:creator>Nark-Kyoung Rho</dc:creator>
			<dc:creator>Hee-Dae Jeon</dc:creator>
			<dc:creator>Hyun-Jun Park</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050248</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-19</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-19</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>248</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050248</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/248</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/247">

	<title>Cosmetics, Vol. 13, Pages 247: Combined Approach to Nasolabial Fold Rejuvenation: Hyaluronic Acid Fillers and DAO Botulinum Toxin Injection</title>
	<link>https://www.mdpi.com/2079-9284/13/5/247</link>
	<description>(1) Background: The nasolabial fold is a key determinant of midfacial aging, influenced by both static volume loss and dynamic muscular activity. Botulinum toxin type A (BoNT-A) and hyaluronic acid (HA) fillers are widely used in aesthetic medicine, but limited evidence exists regarding the sequential use of these treatments to address both static and dynamic components of the nasolabial fold. (2) Methods: This prospective interventional case series included 23 patients with clinically evident nasolabial folds and depressor anguli oris (DAO) hyperactivity. All patients received BoNT-A injections into the DAO muscle, followed by HA filler augmentation in selected cases according to baseline severity. Patients were classified into three treatment groups in accordance with the treatment strategy selected at baseline: BoNT-A alone, BoNT-A plus 0.5 mL HA per side, and BoNT-A plus 1 mL HA per side. Outcomes were assessed using the Wrinkle Severity Rating Scale (WSRS) in both static and dynamic conditions and the Global Aesthetic Improvement Scale (GAIS), evaluated by two independent blinded physicians. (3) Results: All treatment groups demonstrated a reduction in dynamic WSRS scores following BoNT-A injection, reflecting decreased DAO activity and reduced dynamic accentuation of the nasolabial fold. Patients receiving combined BoNT-A and HA treatment showed additional improvement in static fold severity. Overall, GAIS scores indicated much to very much aesthetic improvement, with the highest outcomes observed in patients receiving 1 mL HA augmentation. Interobserver agreement was good across evaluations. (4) Conclusions: Botulinum toxin treatment of the DAO was linked to reduced dynamic accentuation of the nasolabial fold, while hyaluronic acid augmentation led to additional improvement in static fold severity. These preliminary findings indicate that sequential treatment might address both dynamic and static components of nasolabial fold appearance. However, larger randomized studies with longer follow-up are necessary to confirm these findings.</description>
	<pubDate>2026-09-19</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 247: Combined Approach to Nasolabial Fold Rejuvenation: Hyaluronic Acid Fillers and DAO Botulinum Toxin Injection</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/247">doi: 10.3390/cosmetics13050247</a></p>
	<p>Authors:
		Ioan Constantin Pop
		Radu Alexandru Ilieș
		Vasile Pop
		Paula Alexandra Popa
		Sara Saidi
		Maximilian Vlad Muntean
		</p>
	<p>(1) Background: The nasolabial fold is a key determinant of midfacial aging, influenced by both static volume loss and dynamic muscular activity. Botulinum toxin type A (BoNT-A) and hyaluronic acid (HA) fillers are widely used in aesthetic medicine, but limited evidence exists regarding the sequential use of these treatments to address both static and dynamic components of the nasolabial fold. (2) Methods: This prospective interventional case series included 23 patients with clinically evident nasolabial folds and depressor anguli oris (DAO) hyperactivity. All patients received BoNT-A injections into the DAO muscle, followed by HA filler augmentation in selected cases according to baseline severity. Patients were classified into three treatment groups in accordance with the treatment strategy selected at baseline: BoNT-A alone, BoNT-A plus 0.5 mL HA per side, and BoNT-A plus 1 mL HA per side. Outcomes were assessed using the Wrinkle Severity Rating Scale (WSRS) in both static and dynamic conditions and the Global Aesthetic Improvement Scale (GAIS), evaluated by two independent blinded physicians. (3) Results: All treatment groups demonstrated a reduction in dynamic WSRS scores following BoNT-A injection, reflecting decreased DAO activity and reduced dynamic accentuation of the nasolabial fold. Patients receiving combined BoNT-A and HA treatment showed additional improvement in static fold severity. Overall, GAIS scores indicated much to very much aesthetic improvement, with the highest outcomes observed in patients receiving 1 mL HA augmentation. Interobserver agreement was good across evaluations. (4) Conclusions: Botulinum toxin treatment of the DAO was linked to reduced dynamic accentuation of the nasolabial fold, while hyaluronic acid augmentation led to additional improvement in static fold severity. These preliminary findings indicate that sequential treatment might address both dynamic and static components of nasolabial fold appearance. However, larger randomized studies with longer follow-up are necessary to confirm these findings.</p>
	]]></content:encoded>

	<dc:title>Combined Approach to Nasolabial Fold Rejuvenation: Hyaluronic Acid Fillers and DAO Botulinum Toxin Injection</dc:title>
			<dc:creator>Ioan Constantin Pop</dc:creator>
			<dc:creator>Radu Alexandru Ilieș</dc:creator>
			<dc:creator>Vasile Pop</dc:creator>
			<dc:creator>Paula Alexandra Popa</dc:creator>
			<dc:creator>Sara Saidi</dc:creator>
			<dc:creator>Maximilian Vlad Muntean</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050247</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-19</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-19</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>247</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050247</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/247</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/246">

	<title>Cosmetics, Vol. 13, Pages 246: Lotion Containing Fermented Honey and Chamomile Liquid Improves Facial Skin Hydration: A Double-Blind, Split-Face, Placebo-Controlled Clinical Trial</title>
	<link>https://www.mdpi.com/2079-9284/13/5/246</link>
	<description>This study evaluated the effects of a lotion containing honey and chamomile fermented with Apilactobacillus kunkeei (A. kunkeei) YB38 on facial skin in healthy Japanese adults. Honey and chamomile extracts (EHC) were fermented with A. kunkeei YB38 to prepare fermented honey and chamomile extract (FHC). To confirm that FHC was fermented, component analysis was performed by HPLC and compared with EHC. Healthy Japanese adults (n = 35) were administered a lotion containing FHC (FHC-Lo) and a placebo lotion (PLBO-Lo) for four weeks in a placebo-controlled, double-blind, split-face trial. Stratum corneum (SC) water content, transepidermal water loss, and skin elasticity were measured before and after application. The presence of lactic and acetic acids indicated FHC fermentation. Applying FHC-Lo for 4 weeks significantly increased SC water content compared to PLBO-Lo (FHC-Lo: from 31.22 &amp;amp;plusmn; 1.47 to 37.4 &amp;amp;plusmn; 4.68 AU vs. PLBO-Lo: from 31.10 &amp;amp;plusmn; 1.52 to 32.4 &amp;amp;plusmn; 3.73 AU, p = 5.90 &amp;amp;times; 10&amp;amp;minus;6), with no adverse events observed. This mechanism might involve the action of lactic acid increased by fermentation.</description>
	<pubDate>2026-09-17</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 246: Lotion Containing Fermented Honey and Chamomile Liquid Improves Facial Skin Hydration: A Double-Blind, Split-Face, Placebo-Controlled Clinical Trial</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/246">doi: 10.3390/cosmetics13050246</a></p>
	<p>Authors:
		Chizuru Fujikura
		Hiroko Nagai
		Nobuaki Okumura
		Ayanori Yamaki
		Norihiro Shigematsu
		Akio Ohkuma
		Kayoko Numano
		</p>
	<p>This study evaluated the effects of a lotion containing honey and chamomile fermented with Apilactobacillus kunkeei (A. kunkeei) YB38 on facial skin in healthy Japanese adults. Honey and chamomile extracts (EHC) were fermented with A. kunkeei YB38 to prepare fermented honey and chamomile extract (FHC). To confirm that FHC was fermented, component analysis was performed by HPLC and compared with EHC. Healthy Japanese adults (n = 35) were administered a lotion containing FHC (FHC-Lo) and a placebo lotion (PLBO-Lo) for four weeks in a placebo-controlled, double-blind, split-face trial. Stratum corneum (SC) water content, transepidermal water loss, and skin elasticity were measured before and after application. The presence of lactic and acetic acids indicated FHC fermentation. Applying FHC-Lo for 4 weeks significantly increased SC water content compared to PLBO-Lo (FHC-Lo: from 31.22 &amp;amp;plusmn; 1.47 to 37.4 &amp;amp;plusmn; 4.68 AU vs. PLBO-Lo: from 31.10 &amp;amp;plusmn; 1.52 to 32.4 &amp;amp;plusmn; 3.73 AU, p = 5.90 &amp;amp;times; 10&amp;amp;minus;6), with no adverse events observed. This mechanism might involve the action of lactic acid increased by fermentation.</p>
	]]></content:encoded>

	<dc:title>Lotion Containing Fermented Honey and Chamomile Liquid Improves Facial Skin Hydration: A Double-Blind, Split-Face, Placebo-Controlled Clinical Trial</dc:title>
			<dc:creator>Chizuru Fujikura</dc:creator>
			<dc:creator>Hiroko Nagai</dc:creator>
			<dc:creator>Nobuaki Okumura</dc:creator>
			<dc:creator>Ayanori Yamaki</dc:creator>
			<dc:creator>Norihiro Shigematsu</dc:creator>
			<dc:creator>Akio Ohkuma</dc:creator>
			<dc:creator>Kayoko Numano</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050246</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-17</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-17</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>246</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050246</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/246</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/245">

	<title>Cosmetics, Vol. 13, Pages 245: Assessment of Ocimum gratissimum L. Leaf Extracts as Potent Anti-Aging and Skin-Lightening Agents for Food Supplement and Cosmeceutical Applications</title>
	<link>https://www.mdpi.com/2079-9284/13/5/245</link>
	<description>Ocimum gratissimum L. (OGL) is a medicinal plant known for various therapeutic properties, yet its potential in genetic-level skin anti-aging remains underexplored. This study aimed to evaluate the phytochemical profiles, antioxidant activities, and anti-aging potential of OGL leaf extracts obtained via aqueous boiling (OGL-B) and ethanolic maceration (OGL-M). Total phenolic and flavonoid contents were quantified using colorimetric assays, while rutin, catechin, and quercetin were analyzed using HPLC. Biological activities were assessed using antioxidant models, tyrosinase inhibition, and B16F10 anti-melanogenesis assays, while skin regenerative potential was evaluated through collagen biosynthesis and expression of longevity-related genes (SIRT1, FOXO1, TERT, and KLOTHO) in human skin fibroblasts. OGL-B provided a significantly higher extraction yield (14.70%) and superior multifunctional antioxidant capacity than OGL-M. OGL-M showed higher phenolic content and cell-free tyrosinase inhibition, whereas OGL-B demonstrated greater cellular anti-melanogenic efficacy and more than twofold higher collagen stimulatory effects than L-ascorbic acid. OGL-B significantly upregulated mRNA expression (271.25 &amp;amp;plusmn; 0.21%), exceeding the reference activator resveratrol, and enhanced fibroblast viability to 121.53 &amp;amp;plusmn; 3.85% at 1 mg/mL, indicating high biocompatibility. These findings suggest that OGL-B is a multifunctional extract capable of modulating longevity-related pathways, with potential for advanced anti-aging food supplement and cosmeceutical applications.</description>
	<pubDate>2026-09-16</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 245: Assessment of Ocimum gratissimum L. Leaf Extracts as Potent Anti-Aging and Skin-Lightening Agents for Food Supplement and Cosmeceutical Applications</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/245">doi: 10.3390/cosmetics13050245</a></p>
	<p>Authors:
		Nipaporn Kangkawisut
		Thanachai Taka
		Saranrat Phuangborisut
		Warintorn Ruksiriwanich
		Romchat Chutoprapat
		Wirinda Chompoo
		Kitrawi Samothai
		Korawinwich Boonpisuttinant
		</p>
	<p>Ocimum gratissimum L. (OGL) is a medicinal plant known for various therapeutic properties, yet its potential in genetic-level skin anti-aging remains underexplored. This study aimed to evaluate the phytochemical profiles, antioxidant activities, and anti-aging potential of OGL leaf extracts obtained via aqueous boiling (OGL-B) and ethanolic maceration (OGL-M). Total phenolic and flavonoid contents were quantified using colorimetric assays, while rutin, catechin, and quercetin were analyzed using HPLC. Biological activities were assessed using antioxidant models, tyrosinase inhibition, and B16F10 anti-melanogenesis assays, while skin regenerative potential was evaluated through collagen biosynthesis and expression of longevity-related genes (SIRT1, FOXO1, TERT, and KLOTHO) in human skin fibroblasts. OGL-B provided a significantly higher extraction yield (14.70%) and superior multifunctional antioxidant capacity than OGL-M. OGL-M showed higher phenolic content and cell-free tyrosinase inhibition, whereas OGL-B demonstrated greater cellular anti-melanogenic efficacy and more than twofold higher collagen stimulatory effects than L-ascorbic acid. OGL-B significantly upregulated mRNA expression (271.25 &amp;amp;plusmn; 0.21%), exceeding the reference activator resveratrol, and enhanced fibroblast viability to 121.53 &amp;amp;plusmn; 3.85% at 1 mg/mL, indicating high biocompatibility. These findings suggest that OGL-B is a multifunctional extract capable of modulating longevity-related pathways, with potential for advanced anti-aging food supplement and cosmeceutical applications.</p>
	]]></content:encoded>

	<dc:title>Assessment of Ocimum gratissimum L. Leaf Extracts as Potent Anti-Aging and Skin-Lightening Agents for Food Supplement and Cosmeceutical Applications</dc:title>
			<dc:creator>Nipaporn Kangkawisut</dc:creator>
			<dc:creator>Thanachai Taka</dc:creator>
			<dc:creator>Saranrat Phuangborisut</dc:creator>
			<dc:creator>Warintorn Ruksiriwanich</dc:creator>
			<dc:creator>Romchat Chutoprapat</dc:creator>
			<dc:creator>Wirinda Chompoo</dc:creator>
			<dc:creator>Kitrawi Samothai</dc:creator>
			<dc:creator>Korawinwich Boonpisuttinant</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050245</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-16</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-16</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>245</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050245</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/245</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/244">

	<title>Cosmetics, Vol. 13, Pages 244: From Phytochemistry to Skin Regeneration: Therapeutic Potential of Copaifera-Derived Bioactive Compounds for Wound Healing and Dermocosmetic Applications&amp;mdash;A Systematic Review</title>
	<link>https://www.mdpi.com/2079-9284/13/5/244</link>
	<description>Cutaneous wound healing is a complex biological process that remains challenging, particularly in chronic wounds requiring effective and safe therapeutic strategies. Copaifera species are rich sources of bioactive terpenoids with recognized pharmacological properties and increasing potential for dermocosmetic applications. This systematic review aimed to critically evaluate the phytochemical composition and wound-healing activities of Copaifera-derived products. The review followed the PRISMA 2020 guidelines and searched MEDLINE/PubMed, SciELO, PEDro, and Scopus. Studies published between 2015 and 2025 were screened, and 20 studies met the eligibility criteria for qualitative synthesis. The available evidence demonstrated that Copaifera-derived products, particularly oleoresins, exhibit anti-inflammatory, antioxidant, antimicrobial, antinociceptive, and regenerative activities that promote wound contraction, re-epithelialization, collagen deposition, and extracellular matrix remodeling. &amp;amp;beta;-Caryophyllene was the most frequently identified phytochemical, followed by &amp;amp;beta;-bisabolene, &amp;amp;alpha;-humulene, &amp;amp;alpha;-bergamotene, copalic acid, and kaurenoic acid. Recent investigations also indicated the incorporation of Copaifera bioactive compounds into biomaterials and nanotechnology-based delivery systems to increase topical therapeutic performance. Despite these promising findings, the current evidence remains predominantly preclinical and is limited by methodological heterogeneity and the scarcity of clinical trials. Overall, Copaifera represents a promising natural source for developing innovative wound-healing therapies and dermocosmetic formulations.</description>
	<pubDate>2026-09-15</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 244: From Phytochemistry to Skin Regeneration: Therapeutic Potential of Copaifera-Derived Bioactive Compounds for Wound Healing and Dermocosmetic Applications&amp;mdash;A Systematic Review</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/244">doi: 10.3390/cosmetics13050244</a></p>
	<p>Authors:
		José Bezerra Góes Neto
		Thalita Avelino Custódio Góes
		José Ednésio da Cruz Freire
		Raquel Martins de Freitas
		Stela Mirla da Silva Felipe Acácio
		Pedro Everson Alexandre de Aquino
		Renata Carmo de Assis
		Savyo Mikael Lacerda Gomes
		Jonathan Elias Rodrigues Martins
		Paulo Elesson Guimarães de Oliveira
		Valdevane Rocha Araújo
		Vânia Marilande Ceccatto
		</p>
	<p>Cutaneous wound healing is a complex biological process that remains challenging, particularly in chronic wounds requiring effective and safe therapeutic strategies. Copaifera species are rich sources of bioactive terpenoids with recognized pharmacological properties and increasing potential for dermocosmetic applications. This systematic review aimed to critically evaluate the phytochemical composition and wound-healing activities of Copaifera-derived products. The review followed the PRISMA 2020 guidelines and searched MEDLINE/PubMed, SciELO, PEDro, and Scopus. Studies published between 2015 and 2025 were screened, and 20 studies met the eligibility criteria for qualitative synthesis. The available evidence demonstrated that Copaifera-derived products, particularly oleoresins, exhibit anti-inflammatory, antioxidant, antimicrobial, antinociceptive, and regenerative activities that promote wound contraction, re-epithelialization, collagen deposition, and extracellular matrix remodeling. &amp;amp;beta;-Caryophyllene was the most frequently identified phytochemical, followed by &amp;amp;beta;-bisabolene, &amp;amp;alpha;-humulene, &amp;amp;alpha;-bergamotene, copalic acid, and kaurenoic acid. Recent investigations also indicated the incorporation of Copaifera bioactive compounds into biomaterials and nanotechnology-based delivery systems to increase topical therapeutic performance. Despite these promising findings, the current evidence remains predominantly preclinical and is limited by methodological heterogeneity and the scarcity of clinical trials. Overall, Copaifera represents a promising natural source for developing innovative wound-healing therapies and dermocosmetic formulations.</p>
	]]></content:encoded>

	<dc:title>From Phytochemistry to Skin Regeneration: Therapeutic Potential of Copaifera-Derived Bioactive Compounds for Wound Healing and Dermocosmetic Applications&amp;amp;mdash;A Systematic Review</dc:title>
			<dc:creator>José Bezerra Góes Neto</dc:creator>
			<dc:creator>Thalita Avelino Custódio Góes</dc:creator>
			<dc:creator>José Ednésio da Cruz Freire</dc:creator>
			<dc:creator>Raquel Martins de Freitas</dc:creator>
			<dc:creator>Stela Mirla da Silva Felipe Acácio</dc:creator>
			<dc:creator>Pedro Everson Alexandre de Aquino</dc:creator>
			<dc:creator>Renata Carmo de Assis</dc:creator>
			<dc:creator>Savyo Mikael Lacerda Gomes</dc:creator>
			<dc:creator>Jonathan Elias Rodrigues Martins</dc:creator>
			<dc:creator>Paulo Elesson Guimarães de Oliveira</dc:creator>
			<dc:creator>Valdevane Rocha Araújo</dc:creator>
			<dc:creator>Vânia Marilande Ceccatto</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050244</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-15</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-15</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Systematic Review</prism:section>
	<prism:startingPage>244</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050244</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/244</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/243">

	<title>Cosmetics, Vol. 13, Pages 243: Investigator-Based Responder Efficacy and Durability of Botulinum Toxin Type A for Upper Facial Lines: A Timepoint-Specific Systematic Review of Randomized Placebo-Controlled Trials</title>
	<link>https://www.mdpi.com/2079-9284/13/5/243</link>
	<description>Botulinum toxin type A (BoNT-A) is widely used for upper facial lines, but investigator-based responder efficacy and durability across formulations, doses, and assessment methods remain inconsistently reported. In a post hoc analysis of randomized placebo-controlled trials, we evaluated timepoint-specific responder prevalence from clinician assessments at maximum frown and at rest. Four binary responder definitions from ordinal wrinkle severity scales were analyzed separately: none or mild severity (G0&amp;amp;ndash;1), &amp;amp;ge;1-point improvement, conversion from G2&amp;amp;ndash;3 to G0&amp;amp;ndash;1, and &amp;amp;ge;2-point improvement. Proportions were pooled by random-effects meta-analysis, separately at each reported time point, and for each formulation/dose. Heterogeneity was quantified using I2. Estimates required at least two contributing study arms, and formulations were not compared with one another. At maximum frown, pooled G0&amp;amp;ndash;1 prevalence with daxibotulinumtoxinA 40 U was 97% at week 1, 99% at month 1, and 41% at month 6. OnabotulinumtoxinA showed dose-dependent patterns, declining from 95% at week 2 to 8% at month 6 at 40 U, and from 80% at week 1 to 34% at month 4 at 20 U. AbobotulinumtoxinA 50 U declined from 83% at month 1 to 16% at month 6. More restrictive endpoints declined more steeply. At rest, temporal patterns were similar, and the two conditions were not formally compared. Responder prevalence was high early and attenuated substantially by 6 months, with a month 6 prevalence of 41% for daxibotulinumtoxinA 40 U and 8% to 23% for other combinations. These are descriptive formulation-specific observations, not evidence of comparative superiority, because potency units are not interchangeable between products. Timepoint-specific responder reporting is needed in BoNT-A trials.</description>
	<pubDate>2026-09-15</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 243: Investigator-Based Responder Efficacy and Durability of Botulinum Toxin Type A for Upper Facial Lines: A Timepoint-Specific Systematic Review of Randomized Placebo-Controlled Trials</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/243">doi: 10.3390/cosmetics13050243</a></p>
	<p>Authors:
		Alaa Safia
		Ramzy Batheesh
		Naji Bathish
		</p>
	<p>Botulinum toxin type A (BoNT-A) is widely used for upper facial lines, but investigator-based responder efficacy and durability across formulations, doses, and assessment methods remain inconsistently reported. In a post hoc analysis of randomized placebo-controlled trials, we evaluated timepoint-specific responder prevalence from clinician assessments at maximum frown and at rest. Four binary responder definitions from ordinal wrinkle severity scales were analyzed separately: none or mild severity (G0&amp;amp;ndash;1), &amp;amp;ge;1-point improvement, conversion from G2&amp;amp;ndash;3 to G0&amp;amp;ndash;1, and &amp;amp;ge;2-point improvement. Proportions were pooled by random-effects meta-analysis, separately at each reported time point, and for each formulation/dose. Heterogeneity was quantified using I2. Estimates required at least two contributing study arms, and formulations were not compared with one another. At maximum frown, pooled G0&amp;amp;ndash;1 prevalence with daxibotulinumtoxinA 40 U was 97% at week 1, 99% at month 1, and 41% at month 6. OnabotulinumtoxinA showed dose-dependent patterns, declining from 95% at week 2 to 8% at month 6 at 40 U, and from 80% at week 1 to 34% at month 4 at 20 U. AbobotulinumtoxinA 50 U declined from 83% at month 1 to 16% at month 6. More restrictive endpoints declined more steeply. At rest, temporal patterns were similar, and the two conditions were not formally compared. Responder prevalence was high early and attenuated substantially by 6 months, with a month 6 prevalence of 41% for daxibotulinumtoxinA 40 U and 8% to 23% for other combinations. These are descriptive formulation-specific observations, not evidence of comparative superiority, because potency units are not interchangeable between products. Timepoint-specific responder reporting is needed in BoNT-A trials.</p>
	]]></content:encoded>

	<dc:title>Investigator-Based Responder Efficacy and Durability of Botulinum Toxin Type A for Upper Facial Lines: A Timepoint-Specific Systematic Review of Randomized Placebo-Controlled Trials</dc:title>
			<dc:creator>Alaa Safia</dc:creator>
			<dc:creator>Ramzy Batheesh</dc:creator>
			<dc:creator>Naji Bathish</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050243</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-15</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-15</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Systematic Review</prism:section>
	<prism:startingPage>243</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050243</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/243</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/242">

	<title>Cosmetics, Vol. 13, Pages 242: Glutathione Trisulphide Suppresses UVB-Induced Melanogenesis and Improves Skin Brightness in a Three-Dimensional Skin Model</title>
	<link>https://www.mdpi.com/2079-9284/13/5/242</link>
	<description>Ultraviolet B (UVB) irradiation induces hyperpigmentation and contributes to skin photoaging. Glutathione trisulphide (GSSSG), a naturally occurring supersulphide with anti-inflammatory and antioxidant properties, has been shown to suppress &amp;amp;alpha;-melanocyte-stimulating hormone-induced melanogenesis and improve skin brightness. However, its efficacy under physiologically relevant UVB-induced pigmentation conditions and its skin-brightening potential in human skin-like systems remain unclear. Therefore, this study evaluated the anti-melanogenic effects of GSSSG in UVB-stimulated melanogenesis and assessed its skin-brightening efficacy in a three-dimensional (3D) skin model while investigating the relationship between melanogenesis and intracellular endogenous supersulphide levels. UVB irradiation increased melanin production while decreasing intracellular supersulphide levels. GSSSG suppressed UVB-induced melanogenesis and restored intracellular supersulphide levels. Furthermore, Cars2 knockdown reduced intracellular supersulphide levels and melanin production, suggesting a role for endogenous supersulphides in pigmentation. In addition, 0.1% GSSSG significantly improved skin brightness in a 3D skin model. These findings demonstrate the efficacy of GSSSG in both UVB-induced melanogenesis and a human skin-like model and suggest that supersulphides play context-dependent roles in melanogenesis, suppressing excessive pigmentation while supporting physiological melanin synthesis.</description>
	<pubDate>2026-09-13</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 242: Glutathione Trisulphide Suppresses UVB-Induced Melanogenesis and Improves Skin Brightness in a Three-Dimensional Skin Model</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/242">doi: 10.3390/cosmetics13050242</a></p>
	<p>Authors:
		Yoshiaki Uchida
		Katsuya Sato
		Masayuki Ito
		Toshiya Sato
		</p>
	<p>Ultraviolet B (UVB) irradiation induces hyperpigmentation and contributes to skin photoaging. Glutathione trisulphide (GSSSG), a naturally occurring supersulphide with anti-inflammatory and antioxidant properties, has been shown to suppress &amp;amp;alpha;-melanocyte-stimulating hormone-induced melanogenesis and improve skin brightness. However, its efficacy under physiologically relevant UVB-induced pigmentation conditions and its skin-brightening potential in human skin-like systems remain unclear. Therefore, this study evaluated the anti-melanogenic effects of GSSSG in UVB-stimulated melanogenesis and assessed its skin-brightening efficacy in a three-dimensional (3D) skin model while investigating the relationship between melanogenesis and intracellular endogenous supersulphide levels. UVB irradiation increased melanin production while decreasing intracellular supersulphide levels. GSSSG suppressed UVB-induced melanogenesis and restored intracellular supersulphide levels. Furthermore, Cars2 knockdown reduced intracellular supersulphide levels and melanin production, suggesting a role for endogenous supersulphides in pigmentation. In addition, 0.1% GSSSG significantly improved skin brightness in a 3D skin model. These findings demonstrate the efficacy of GSSSG in both UVB-induced melanogenesis and a human skin-like model and suggest that supersulphides play context-dependent roles in melanogenesis, suppressing excessive pigmentation while supporting physiological melanin synthesis.</p>
	]]></content:encoded>

	<dc:title>Glutathione Trisulphide Suppresses UVB-Induced Melanogenesis and Improves Skin Brightness in a Three-Dimensional Skin Model</dc:title>
			<dc:creator>Yoshiaki Uchida</dc:creator>
			<dc:creator>Katsuya Sato</dc:creator>
			<dc:creator>Masayuki Ito</dc:creator>
			<dc:creator>Toshiya Sato</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050242</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-13</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-13</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>242</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050242</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/242</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/241">

	<title>Cosmetics, Vol. 13, Pages 241: Prospective, Exploratory Pilot Study on Integrating Genetic Profiling with AI Algorithm and Phenotype Questionnaire in Personalized Skincare</title>
	<link>https://www.mdpi.com/2079-9284/13/5/241</link>
	<description>The rapid transition toward real-world personalized skincare strategies is based on the integration of molecular pathway analysis, laboratory skin models, advanced technologies, clinical data, (epi)genomics testing, and AI. In this perspective, we designed a prospective, exploratory, uncontrolled pilot study with an educational component, integrating genetic testing of relevant skin-aging biomarkers and telomere length with AI and a phenotypic questionnaire to provide individualized skincare guidance. Our study also aimed to implement an innovative academic teaching method based on this integrative patient-centered skin health; therefore, we enrolled 44 students from the Faculty of Pharmacy Iasi. We present the genetic profiling of all 44 subjects according to genetic biomarkers for extrinsic and intrinsic skin aging (ASIP and SOD2 polymorphisms, respectively), while a telomere length analysis was conducted only for 20 enrolled participants due to financial constraints at the study&amp;amp;rsquo;s initiation. Based on the possible combination of these polymorphisms, we performed a genetic stratification of the study cohort. After the integration of the genetic results with the individual responses, and with Perfect AI assessment performed for the whole cohort, we provided optimized skincare counselling to all 44 enrolled subjects; here, we selected some case reports as examples of personalized skincare routines and cosmetic ingredients for each genotype segment. Our pilot exploratory study finished up with a follow-up questionnaire and a satellite workshop on ethical aspects. Finally, we compared the design and insights of our pilot study with those of other cosmetic clinical trials that focus on integrative patient-tailored skincare.</description>
	<pubDate>2026-09-12</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 241: Prospective, Exploratory Pilot Study on Integrating Genetic Profiling with AI Algorithm and Phenotype Questionnaire in Personalized Skincare</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/241">doi: 10.3390/cosmetics13050241</a></p>
	<p>Authors:
		Roxana-Georgiana Taușer
		Oana-Maria Chirliu
		Maria Apotrosoaei
		Florentina-Geanina Lupașcu
		Bianca-Ștefania Profire
		Andreea-Teodora Iacob
		Ioana-Mirela Vasincu
		Dan Lupașcu
		Lenuța Profire
		</p>
	<p>The rapid transition toward real-world personalized skincare strategies is based on the integration of molecular pathway analysis, laboratory skin models, advanced technologies, clinical data, (epi)genomics testing, and AI. In this perspective, we designed a prospective, exploratory, uncontrolled pilot study with an educational component, integrating genetic testing of relevant skin-aging biomarkers and telomere length with AI and a phenotypic questionnaire to provide individualized skincare guidance. Our study also aimed to implement an innovative academic teaching method based on this integrative patient-centered skin health; therefore, we enrolled 44 students from the Faculty of Pharmacy Iasi. We present the genetic profiling of all 44 subjects according to genetic biomarkers for extrinsic and intrinsic skin aging (ASIP and SOD2 polymorphisms, respectively), while a telomere length analysis was conducted only for 20 enrolled participants due to financial constraints at the study&amp;amp;rsquo;s initiation. Based on the possible combination of these polymorphisms, we performed a genetic stratification of the study cohort. After the integration of the genetic results with the individual responses, and with Perfect AI assessment performed for the whole cohort, we provided optimized skincare counselling to all 44 enrolled subjects; here, we selected some case reports as examples of personalized skincare routines and cosmetic ingredients for each genotype segment. Our pilot exploratory study finished up with a follow-up questionnaire and a satellite workshop on ethical aspects. Finally, we compared the design and insights of our pilot study with those of other cosmetic clinical trials that focus on integrative patient-tailored skincare.</p>
	]]></content:encoded>

	<dc:title>Prospective, Exploratory Pilot Study on Integrating Genetic Profiling with AI Algorithm and Phenotype Questionnaire in Personalized Skincare</dc:title>
			<dc:creator>Roxana-Georgiana Taușer</dc:creator>
			<dc:creator>Oana-Maria Chirliu</dc:creator>
			<dc:creator>Maria Apotrosoaei</dc:creator>
			<dc:creator>Florentina-Geanina Lupașcu</dc:creator>
			<dc:creator>Bianca-Ștefania Profire</dc:creator>
			<dc:creator>Andreea-Teodora Iacob</dc:creator>
			<dc:creator>Ioana-Mirela Vasincu</dc:creator>
			<dc:creator>Dan Lupașcu</dc:creator>
			<dc:creator>Lenuța Profire</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050241</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-12</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-12</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>241</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050241</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/241</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/240">

	<title>Cosmetics, Vol. 13, Pages 240: Safflower Seed Oil Ameliorates AFL-Induced Epidermal Lipid Loss Partially via the PPAR&amp;gamma; Signaling Pathway</title>
	<link>https://www.mdpi.com/2079-9284/13/5/240</link>
	<description>Objective: Ablative fractional laser (AFL) therapy impairs epidermal barrier integrity through the disruption of stratum corneum lipids and keratinocyte differentiation, resulting in increased transepidermal water loss (TEWL) and delayed functional recovery. This study aims to develop a more effective barrier repair strategy and evaluate the efficacy of topical safflower seed oil (SSO) in promoting post-AFL barrier restoration. Methods: An optimized murine AFL model (20 W, 0.5 ms pulse delay, and 0.7 mm spot spacing) was established to investigate skin repair mechanisms. SSO composition was characterized by gas chromatography&amp;amp;ndash;mass spectrometry (GC-MS). Epidermal repair was assessed using confocal laser scanning microscopy, while Oil Red O staining and immunofluorescence were employed to evaluate lipid formation and the expression of lipid synthesis-related genes, respectively. Results: GC-MS analysis identified SSO as a rich natural source of linoleic acid (69.1%) and oleic acid (18.7%). Over the 7-day period of AFL exposure alone, TEWL rose by 4&amp;amp;ndash;6 fold in mouse skin, accompanied by a near-complete loss of epidermal lipid synthesis. However, upon SSO administration, a marked reduction in TEWL was observed from day 1, and epidermal lipid synthesis recovered by day 7. Moreover, SSO treatment significantly upregulated epidermal PPAR&amp;amp;gamma; expression in AFL-injured skin. Pharmacological inhibition of PPAR&amp;amp;gamma; (T0070907) largely abrogated the lipid synthesis and barrier repair effects of SSO, while PPAR&amp;amp;alpha; antagonism (GW6471) showed no obvious interference with SSO&amp;amp;rsquo;s therapeutic efficacy, suggesting a potential association between PPAR&amp;amp;gamma; signaling modulation and SSO-mediated skin barrier restoration. Conclusions: These findings suggest that SSO is a promising natural agent for post-AFL skin care, which improves AFL-impaired skin barrier function by remodeling lipid metabolism, at least in part through PPAR&amp;amp;gamma; signaling, and warrants further preclinical and clinical investigation.</description>
	<pubDate>2026-09-11</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 240: Safflower Seed Oil Ameliorates AFL-Induced Epidermal Lipid Loss Partially via the PPAR&amp;gamma; Signaling Pathway</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/240">doi: 10.3390/cosmetics13050240</a></p>
	<p>Authors:
		Jinjin Liu
		Qian Wang
		Jialin Zhong
		Xiaoqing Wang
		Haidong Jia
		Yushu Wang
		Yuanyuan Chen
		Runshuang Lu
		Gang Ma
		</p>
	<p>Objective: Ablative fractional laser (AFL) therapy impairs epidermal barrier integrity through the disruption of stratum corneum lipids and keratinocyte differentiation, resulting in increased transepidermal water loss (TEWL) and delayed functional recovery. This study aims to develop a more effective barrier repair strategy and evaluate the efficacy of topical safflower seed oil (SSO) in promoting post-AFL barrier restoration. Methods: An optimized murine AFL model (20 W, 0.5 ms pulse delay, and 0.7 mm spot spacing) was established to investigate skin repair mechanisms. SSO composition was characterized by gas chromatography&amp;amp;ndash;mass spectrometry (GC-MS). Epidermal repair was assessed using confocal laser scanning microscopy, while Oil Red O staining and immunofluorescence were employed to evaluate lipid formation and the expression of lipid synthesis-related genes, respectively. Results: GC-MS analysis identified SSO as a rich natural source of linoleic acid (69.1%) and oleic acid (18.7%). Over the 7-day period of AFL exposure alone, TEWL rose by 4&amp;amp;ndash;6 fold in mouse skin, accompanied by a near-complete loss of epidermal lipid synthesis. However, upon SSO administration, a marked reduction in TEWL was observed from day 1, and epidermal lipid synthesis recovered by day 7. Moreover, SSO treatment significantly upregulated epidermal PPAR&amp;amp;gamma; expression in AFL-injured skin. Pharmacological inhibition of PPAR&amp;amp;gamma; (T0070907) largely abrogated the lipid synthesis and barrier repair effects of SSO, while PPAR&amp;amp;alpha; antagonism (GW6471) showed no obvious interference with SSO&amp;amp;rsquo;s therapeutic efficacy, suggesting a potential association between PPAR&amp;amp;gamma; signaling modulation and SSO-mediated skin barrier restoration. Conclusions: These findings suggest that SSO is a promising natural agent for post-AFL skin care, which improves AFL-impaired skin barrier function by remodeling lipid metabolism, at least in part through PPAR&amp;amp;gamma; signaling, and warrants further preclinical and clinical investigation.</p>
	]]></content:encoded>

	<dc:title>Safflower Seed Oil Ameliorates AFL-Induced Epidermal Lipid Loss Partially via the PPAR&amp;amp;gamma; Signaling Pathway</dc:title>
			<dc:creator>Jinjin Liu</dc:creator>
			<dc:creator>Qian Wang</dc:creator>
			<dc:creator>Jialin Zhong</dc:creator>
			<dc:creator>Xiaoqing Wang</dc:creator>
			<dc:creator>Haidong Jia</dc:creator>
			<dc:creator>Yushu Wang</dc:creator>
			<dc:creator>Yuanyuan Chen</dc:creator>
			<dc:creator>Runshuang Lu</dc:creator>
			<dc:creator>Gang Ma</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050240</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-11</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-11</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>240</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050240</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/240</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/239">

	<title>Cosmetics, Vol. 13, Pages 239: Polydeoxyribonucleotide (PDRN) from Diverse Biological Sources: Comparative Biochemistry, Biotechnological Production, and Translational Potential</title>
	<link>https://www.mdpi.com/2079-9284/13/5/239</link>
	<description>Polydeoxyribonucleotide (PDRN) has emerged as a promising bioactive biomaterial with broad applications in regenerative medicine because of its anti-inflammatory, angiogenic, and tissue-repair properties. Traditionally obtained from salmonid sperm DNA, it has been reported to promote tissue regeneration primarily by activating adenosine A2A receptors and the nucleotide salvage pathway, thereby stimulating fibroblast proliferation, extracellular matrix remodeling, collagen synthesis, and angiogenesis. This review provides a comprehensive overview of the biochemical characteristics, mechanisms of action, extraction methods, and translational potential of PDRN from different biological sources. In addition to conventional animal-derived PDRN, recent advances have introduced plant-derived (PhytoPDRN) and microbial- or algae-derived alternatives, offering improved sustainability, scalability, and reduced environmental impact. Preliminary in vitro evidence suggests that these emerging sources may exhibit regenerative and antioxidant activities; however, differences in molecular characteristics, experimental models, and study designs currently preclude establishing biological or clinical equivalence with salmon-derived PDRN. Finally, the translational perspectives, industrial challenges, and future research directions are analyzed, highlighting the need for standardized manufacturing processes, comparative clinical trials, and sustainable production strategies. Overall, PDRN is a DNA-derived biomaterial of growing interest in regenerative medicine and cosmetic applications. At the same time, novel biological sources may contribute to the development of more sustainable and clinically effective next-generation PDRN-based therapies.</description>
	<pubDate>2026-09-11</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 239: Polydeoxyribonucleotide (PDRN) from Diverse Biological Sources: Comparative Biochemistry, Biotechnological Production, and Translational Potential</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/239">doi: 10.3390/cosmetics13050239</a></p>
	<p>Authors:
		José de Jesús Rodríguez-Aleriano
		Odessa Magallón-Chávez
		Jose Navarro-Partida
		Luisa Fernanda Briones-Márquez
		Edgar J. López-Naranjo
		Juan Antonio Rivas-Loaiza
		</p>
	<p>Polydeoxyribonucleotide (PDRN) has emerged as a promising bioactive biomaterial with broad applications in regenerative medicine because of its anti-inflammatory, angiogenic, and tissue-repair properties. Traditionally obtained from salmonid sperm DNA, it has been reported to promote tissue regeneration primarily by activating adenosine A2A receptors and the nucleotide salvage pathway, thereby stimulating fibroblast proliferation, extracellular matrix remodeling, collagen synthesis, and angiogenesis. This review provides a comprehensive overview of the biochemical characteristics, mechanisms of action, extraction methods, and translational potential of PDRN from different biological sources. In addition to conventional animal-derived PDRN, recent advances have introduced plant-derived (PhytoPDRN) and microbial- or algae-derived alternatives, offering improved sustainability, scalability, and reduced environmental impact. Preliminary in vitro evidence suggests that these emerging sources may exhibit regenerative and antioxidant activities; however, differences in molecular characteristics, experimental models, and study designs currently preclude establishing biological or clinical equivalence with salmon-derived PDRN. Finally, the translational perspectives, industrial challenges, and future research directions are analyzed, highlighting the need for standardized manufacturing processes, comparative clinical trials, and sustainable production strategies. Overall, PDRN is a DNA-derived biomaterial of growing interest in regenerative medicine and cosmetic applications. At the same time, novel biological sources may contribute to the development of more sustainable and clinically effective next-generation PDRN-based therapies.</p>
	]]></content:encoded>

	<dc:title>Polydeoxyribonucleotide (PDRN) from Diverse Biological Sources: Comparative Biochemistry, Biotechnological Production, and Translational Potential</dc:title>
			<dc:creator>José de Jesús Rodríguez-Aleriano</dc:creator>
			<dc:creator>Odessa Magallón-Chávez</dc:creator>
			<dc:creator>Jose Navarro-Partida</dc:creator>
			<dc:creator>Luisa Fernanda Briones-Márquez</dc:creator>
			<dc:creator>Edgar J. López-Naranjo</dc:creator>
			<dc:creator>Juan Antonio Rivas-Loaiza</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050239</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-11</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-11</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>239</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050239</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/239</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/238">

	<title>Cosmetics, Vol. 13, Pages 238: Combined Effects of Tripeptide-3 and Hexapeptide-9 in Activating AMPK&amp;alpha; to Inhibit D-Galactose-Induced Human Dermal Fibroblast Senescence</title>
	<link>https://www.mdpi.com/2079-9284/13/5/238</link>
	<description>Dermatological senescence, characterized by functional deterioration and the accumulation of senescent fibroblasts, has prompted the investigation of safe and effective anti-ageing agents. The present study investigates the role of Tripeptide-3 (T-3) and Hexapeptide-9 (H-9) in countering D-galactose-induced senescence in human dermal fibroblasts (HDFs). Using a D-gal-induced senescence model, we found that non-cytotoxic concentrations of T-3 and H-9, both individually and in combination, led to a substantial reduction in senescence-associated &amp;amp;beta;-galactosidase activity and concomitant downregulation of p21 expression. Notably, the combination exhibited superior anti-senescence effects. Mechanistically, both peptides activated the AMPK&amp;amp;alpha; pathway by increasing phosphorylation at Thr172, with their combination showing enhanced activation. It is of particular significance that the AMPK&amp;amp;alpha; inhibitor Compound C served to nullify these protective effects, thereby establishing AMPK&amp;amp;alpha; activation as a critical contributing pathway in the combined anti-senescence effect of T-3 and H-9. This study provides novel evidence that T-3 and H-9 inhibit fibroblast senescence via AMPK&amp;amp;alpha; activation, thus providing a mechanistic basis for the development of peptide-based anti-ageing skincare formulations.</description>
	<pubDate>2026-09-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 238: Combined Effects of Tripeptide-3 and Hexapeptide-9 in Activating AMPK&amp;alpha; to Inhibit D-Galactose-Induced Human Dermal Fibroblast Senescence</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/238">doi: 10.3390/cosmetics13050238</a></p>
	<p>Authors:
		Yuan Cao
		Jun Wang
		Yongkuan Pan
		Liming Hou
		Yan Jin
		Changwei Cai
		Fuquan Jiang
		Quan-Cheng Chen
		</p>
	<p>Dermatological senescence, characterized by functional deterioration and the accumulation of senescent fibroblasts, has prompted the investigation of safe and effective anti-ageing agents. The present study investigates the role of Tripeptide-3 (T-3) and Hexapeptide-9 (H-9) in countering D-galactose-induced senescence in human dermal fibroblasts (HDFs). Using a D-gal-induced senescence model, we found that non-cytotoxic concentrations of T-3 and H-9, both individually and in combination, led to a substantial reduction in senescence-associated &amp;amp;beta;-galactosidase activity and concomitant downregulation of p21 expression. Notably, the combination exhibited superior anti-senescence effects. Mechanistically, both peptides activated the AMPK&amp;amp;alpha; pathway by increasing phosphorylation at Thr172, with their combination showing enhanced activation. It is of particular significance that the AMPK&amp;amp;alpha; inhibitor Compound C served to nullify these protective effects, thereby establishing AMPK&amp;amp;alpha; activation as a critical contributing pathway in the combined anti-senescence effect of T-3 and H-9. This study provides novel evidence that T-3 and H-9 inhibit fibroblast senescence via AMPK&amp;amp;alpha; activation, thus providing a mechanistic basis for the development of peptide-based anti-ageing skincare formulations.</p>
	]]></content:encoded>

	<dc:title>Combined Effects of Tripeptide-3 and Hexapeptide-9 in Activating AMPK&amp;amp;alpha; to Inhibit D-Galactose-Induced Human Dermal Fibroblast Senescence</dc:title>
			<dc:creator>Yuan Cao</dc:creator>
			<dc:creator>Jun Wang</dc:creator>
			<dc:creator>Yongkuan Pan</dc:creator>
			<dc:creator>Liming Hou</dc:creator>
			<dc:creator>Yan Jin</dc:creator>
			<dc:creator>Changwei Cai</dc:creator>
			<dc:creator>Fuquan Jiang</dc:creator>
			<dc:creator>Quan-Cheng Chen</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050238</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-10</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-10</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>238</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050238</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/238</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/237">

	<title>Cosmetics, Vol. 13, Pages 237: Enhanced Anti-Hair Loss Activity of Kelp (Laminaria japonica) Induced by Fermentation Using Saccharomyces cerevisiae</title>
	<link>https://www.mdpi.com/2079-9284/13/5/237</link>
	<description>Oxidative stress contributes to hair follicle degeneration by inducing inflammation and apoptosis in dermal papilla cells. This study investigated whether Saccharomyces cerevisiae fermentation enhances the anti-hair loss potential of Laminaria japonica (kelp) by-products by improving their antioxidant, anti-inflammatory, and cytoprotective activities. Fermentation significantly increased the superoxide dismutase (SOD) activity of kelp. In H2O2-stimulated human hair follicle dermal papilla cells, fermented kelp culture (KF) dose-dependently protected against oxidative-stress-induced cytotoxicity, reduced IL-6 and IL-8 secretion, inhibited NF&amp;amp;kappa;B phosphorylation, restored insulin-like growth factor-1 (IGF-1) expression, enhanced AKT phosphorylation, reduced Bax expression, and restored total caspase-3 expression. These findings indicate that KF attenuates oxidative-stress-induced inflammation and apoptosis while preserving dermal papilla cell function. A four-week application study further showed that a shampoo containing KF reduced hair loss and improved hair gloss, scalp sebum, and scalp scaling. Together, these findings suggest that S. cerevisiae fermentation enhances the biological activity of kelp by-products and supports the potential of KF as a functional cosmetic ingredient for anti-hair loss applications.</description>
	<pubDate>2026-09-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 237: Enhanced Anti-Hair Loss Activity of Kelp (Laminaria japonica) Induced by Fermentation Using Saccharomyces cerevisiae</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/237">doi: 10.3390/cosmetics13050237</a></p>
	<p>Authors:
		Seul-Ki Mun
		Jin-Yeong Choi
		Si-Eun Lee
		Kyung-Yun Kang
		Yun-Seo Oh
		Jeong-Ho Kim
		Jun-Ki Park
		Ho-Yeol Jang
		Beom-Gyun Jeong
		Mi-Rim Jang
		Jang-Mi Suk
		Kyung-Wuk Park
		</p>
	<p>Oxidative stress contributes to hair follicle degeneration by inducing inflammation and apoptosis in dermal papilla cells. This study investigated whether Saccharomyces cerevisiae fermentation enhances the anti-hair loss potential of Laminaria japonica (kelp) by-products by improving their antioxidant, anti-inflammatory, and cytoprotective activities. Fermentation significantly increased the superoxide dismutase (SOD) activity of kelp. In H2O2-stimulated human hair follicle dermal papilla cells, fermented kelp culture (KF) dose-dependently protected against oxidative-stress-induced cytotoxicity, reduced IL-6 and IL-8 secretion, inhibited NF&amp;amp;kappa;B phosphorylation, restored insulin-like growth factor-1 (IGF-1) expression, enhanced AKT phosphorylation, reduced Bax expression, and restored total caspase-3 expression. These findings indicate that KF attenuates oxidative-stress-induced inflammation and apoptosis while preserving dermal papilla cell function. A four-week application study further showed that a shampoo containing KF reduced hair loss and improved hair gloss, scalp sebum, and scalp scaling. Together, these findings suggest that S. cerevisiae fermentation enhances the biological activity of kelp by-products and supports the potential of KF as a functional cosmetic ingredient for anti-hair loss applications.</p>
	]]></content:encoded>

	<dc:title>Enhanced Anti-Hair Loss Activity of Kelp (Laminaria japonica) Induced by Fermentation Using Saccharomyces cerevisiae</dc:title>
			<dc:creator>Seul-Ki Mun</dc:creator>
			<dc:creator>Jin-Yeong Choi</dc:creator>
			<dc:creator>Si-Eun Lee</dc:creator>
			<dc:creator>Kyung-Yun Kang</dc:creator>
			<dc:creator>Yun-Seo Oh</dc:creator>
			<dc:creator>Jeong-Ho Kim</dc:creator>
			<dc:creator>Jun-Ki Park</dc:creator>
			<dc:creator>Ho-Yeol Jang</dc:creator>
			<dc:creator>Beom-Gyun Jeong</dc:creator>
			<dc:creator>Mi-Rim Jang</dc:creator>
			<dc:creator>Jang-Mi Suk</dc:creator>
			<dc:creator>Kyung-Wuk Park</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050237</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-10</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-10</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>237</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050237</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/237</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/236">

	<title>Cosmetics, Vol. 13, Pages 236: Nanostructured Lipid Carriers Enhance In Vitro Skin Delivery of Enzymatically Extracted Bombyx mori Silk Cocoon Bioactives: Development and Clinical Evaluation of an Anti-Aging Facial Serum</title>
	<link>https://www.mdpi.com/2079-9284/13/5/236</link>
	<description>Background/Objectives: This study investigated the potential of nanostructured lipid carriers (NLCs) to improve the in vitro skin delivery and retention of bioactive compounds derived from Bombyx mori silk cocoon. Furthermore, an NLC-based facial serum was developed and clinically evaluated for its efficacy and safety. Methods: Silk cocoons from Nang Lai (NL) and Lueang Saraburi (LS) were extracted using aqueous and enzymatic methods. Extracts were evaluated for protein, phenolic, and flavonoid contents, antioxidant activity, collagenase inhibition, and irritation potential. The most active extract was incorporated into NLCs and assessed for their physicochemical properties, entrapment efficiency, release, and Strat-M&amp;amp;reg; membrane permeation and retention. The selected NLC was subsequently incorporated into a facial serum and clinically evaluated in 30 volunteers over 28 days for its effects on skin hydration and roughness using a Corneometer&amp;amp;reg; and Visioscan&amp;amp;reg;, respectively. Results: Enzymatic extraction markedly increased phenolic and flavonoid contents, resulting in stronger antioxidant and collagenase inhibitory activities than aqueous extraction. LS enzymatic extract (LS-EN) exhibited the most favorable overall bioactivities and was selected for NLC formulation, which showed a particle size of 149 &amp;amp;plusmn; 1 nm, low polydispersity index (0.263 &amp;amp;plusmn; 0.05), a zeta potential of &amp;amp;minus;48 &amp;amp;plusmn; 1 mV, and an entrapment efficiency of 83%. Compared with the solution, the NLCs showed sustained release and approximately 3.7-fold higher membrane retention (5.45 &amp;amp;plusmn; 0.59% versus 1.47 &amp;amp;plusmn; 0.59%). The NLC-based facial serum demonstrated good skin tolerability and high user satisfaction, with skin moisture increasing by 7.05% and skin roughness significantly decreasing by 6.74&amp;amp;ndash;7.29% after 28 days of application (p &amp;amp;lt; 0.05). Conclusions: Enzymatic extraction combined with NLC encapsulation enhanced the cosmeceutical potential of silk cocoon bioactive by enabling sustained release and localized retention, while the NLC-based facial serum demonstrated good skin tolerability and improved skin hydration and roughness, supporting its potential as a promising anti-aging cosmeceuticals.</description>
	<pubDate>2026-09-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 236: Nanostructured Lipid Carriers Enhance In Vitro Skin Delivery of Enzymatically Extracted Bombyx mori Silk Cocoon Bioactives: Development and Clinical Evaluation of an Anti-Aging Facial Serum</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/236">doi: 10.3390/cosmetics13050236</a></p>
	<p>Authors:
		Sarocha Chareegun
		Wantida Chaiyana
		</p>
	<p>Background/Objectives: This study investigated the potential of nanostructured lipid carriers (NLCs) to improve the in vitro skin delivery and retention of bioactive compounds derived from Bombyx mori silk cocoon. Furthermore, an NLC-based facial serum was developed and clinically evaluated for its efficacy and safety. Methods: Silk cocoons from Nang Lai (NL) and Lueang Saraburi (LS) were extracted using aqueous and enzymatic methods. Extracts were evaluated for protein, phenolic, and flavonoid contents, antioxidant activity, collagenase inhibition, and irritation potential. The most active extract was incorporated into NLCs and assessed for their physicochemical properties, entrapment efficiency, release, and Strat-M&amp;amp;reg; membrane permeation and retention. The selected NLC was subsequently incorporated into a facial serum and clinically evaluated in 30 volunteers over 28 days for its effects on skin hydration and roughness using a Corneometer&amp;amp;reg; and Visioscan&amp;amp;reg;, respectively. Results: Enzymatic extraction markedly increased phenolic and flavonoid contents, resulting in stronger antioxidant and collagenase inhibitory activities than aqueous extraction. LS enzymatic extract (LS-EN) exhibited the most favorable overall bioactivities and was selected for NLC formulation, which showed a particle size of 149 &amp;amp;plusmn; 1 nm, low polydispersity index (0.263 &amp;amp;plusmn; 0.05), a zeta potential of &amp;amp;minus;48 &amp;amp;plusmn; 1 mV, and an entrapment efficiency of 83%. Compared with the solution, the NLCs showed sustained release and approximately 3.7-fold higher membrane retention (5.45 &amp;amp;plusmn; 0.59% versus 1.47 &amp;amp;plusmn; 0.59%). The NLC-based facial serum demonstrated good skin tolerability and high user satisfaction, with skin moisture increasing by 7.05% and skin roughness significantly decreasing by 6.74&amp;amp;ndash;7.29% after 28 days of application (p &amp;amp;lt; 0.05). Conclusions: Enzymatic extraction combined with NLC encapsulation enhanced the cosmeceutical potential of silk cocoon bioactive by enabling sustained release and localized retention, while the NLC-based facial serum demonstrated good skin tolerability and improved skin hydration and roughness, supporting its potential as a promising anti-aging cosmeceuticals.</p>
	]]></content:encoded>

	<dc:title>Nanostructured Lipid Carriers Enhance In Vitro Skin Delivery of Enzymatically Extracted Bombyx mori Silk Cocoon Bioactives: Development and Clinical Evaluation of an Anti-Aging Facial Serum</dc:title>
			<dc:creator>Sarocha Chareegun</dc:creator>
			<dc:creator>Wantida Chaiyana</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050236</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-10</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-10</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>236</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050236</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/236</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/235">

	<title>Cosmetics, Vol. 13, Pages 235: Microwave-Assisted Extraction of a Quercetin-Containing Onion Leaf Extract for Potential Anti-Aging Cosmetic Applications</title>
	<link>https://www.mdpi.com/2079-9284/13/5/235</link>
	<description>Onion (Allium cepa L.) is one of the most widely cultivated vegetables worldwide, while its leaves are discarded as agricultural waste despite being a valuable source of bioactive compounds. This study aims to investigate anti-aging cosmetic potential of onion leaf extract obtained by microwave-assisted extraction (MAE). Under optimized conditions (50% ethanol, 50 &amp;amp;deg;C, 15 min, and a 1:20 solid-to-solvent ratio), the total flavonoid content obtained by MAE was approximately 1.34-fold higher than that achieved by conventional maceration. HPLC analysis of the extract identified and quantified quercetin as a major constituent (2.51 &amp;amp;plusmn; 0.02 mg/g sample), while LC-QTOF-MS profiling identified 56 bioactive compounds, including flavonoids, phenolic acids, and sulfur-containing groups. The extract showed a total phenolic content of 45.1 &amp;amp;plusmn; 1.47 mg GAE/g sample, total flavonoid content of 13.2 &amp;amp;plusmn; 2.52 mg QE/g sample, antioxidant activity (DPPH IC50 = 97.1 &amp;amp;plusmn; 7.12 &amp;amp;micro;g/mL), anti-glycation activity (IC50 = 213 &amp;amp;plusmn; 4.6 &amp;amp;micro;g/mL), tyrosinase inhibitory activity (IC50 = 50.66 &amp;amp;plusmn; 2.52 &amp;amp;micro;g/mL), and anti-collagenase activity (IC50 of 2.84 &amp;amp;plusmn; 0.03 mg/mL). Cell-based assays using human keratinocytes (HaCat) cells demonstrated that the extract was non-cytotoxic at concentrations up to 100 &amp;amp;micro;g/mL after 24 and 48 h of exposure. Furthermore, cells treated with the extract showed visually lower H2DCFDA fluorescence following hydrogen peroxide exposure, suggesting a possible reduction in intracellular ROS accumulation. Overall, onion leaves represent a promising natural source of bioactive compounds and could be valorized as a potentially anti-aging cosmetic ingredient.</description>
	<pubDate>2026-09-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 235: Microwave-Assisted Extraction of a Quercetin-Containing Onion Leaf Extract for Potential Anti-Aging Cosmetic Applications</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/235">doi: 10.3390/cosmetics13050235</a></p>
	<p>Authors:
		Aknarin Anatachodwanit
		Wuttichai Jaidee
		Setinee Chanpirom
		Thapakorn Tree-Udom
		Benjaporn Noppradit
		Punita Thammachot
		Nann Kain Kham
		Cholpisut Tantapakul
		Naphatsorn Ditthawutthikul
		Rawiwan Charoensup
		Chittipong Tipbunjong
		Maria Pilar Vinardell
		Tawanun Sripisut
		</p>
	<p>Onion (Allium cepa L.) is one of the most widely cultivated vegetables worldwide, while its leaves are discarded as agricultural waste despite being a valuable source of bioactive compounds. This study aims to investigate anti-aging cosmetic potential of onion leaf extract obtained by microwave-assisted extraction (MAE). Under optimized conditions (50% ethanol, 50 &amp;amp;deg;C, 15 min, and a 1:20 solid-to-solvent ratio), the total flavonoid content obtained by MAE was approximately 1.34-fold higher than that achieved by conventional maceration. HPLC analysis of the extract identified and quantified quercetin as a major constituent (2.51 &amp;amp;plusmn; 0.02 mg/g sample), while LC-QTOF-MS profiling identified 56 bioactive compounds, including flavonoids, phenolic acids, and sulfur-containing groups. The extract showed a total phenolic content of 45.1 &amp;amp;plusmn; 1.47 mg GAE/g sample, total flavonoid content of 13.2 &amp;amp;plusmn; 2.52 mg QE/g sample, antioxidant activity (DPPH IC50 = 97.1 &amp;amp;plusmn; 7.12 &amp;amp;micro;g/mL), anti-glycation activity (IC50 = 213 &amp;amp;plusmn; 4.6 &amp;amp;micro;g/mL), tyrosinase inhibitory activity (IC50 = 50.66 &amp;amp;plusmn; 2.52 &amp;amp;micro;g/mL), and anti-collagenase activity (IC50 of 2.84 &amp;amp;plusmn; 0.03 mg/mL). Cell-based assays using human keratinocytes (HaCat) cells demonstrated that the extract was non-cytotoxic at concentrations up to 100 &amp;amp;micro;g/mL after 24 and 48 h of exposure. Furthermore, cells treated with the extract showed visually lower H2DCFDA fluorescence following hydrogen peroxide exposure, suggesting a possible reduction in intracellular ROS accumulation. Overall, onion leaves represent a promising natural source of bioactive compounds and could be valorized as a potentially anti-aging cosmetic ingredient.</p>
	]]></content:encoded>

	<dc:title>Microwave-Assisted Extraction of a Quercetin-Containing Onion Leaf Extract for Potential Anti-Aging Cosmetic Applications</dc:title>
			<dc:creator>Aknarin Anatachodwanit</dc:creator>
			<dc:creator>Wuttichai Jaidee</dc:creator>
			<dc:creator>Setinee Chanpirom</dc:creator>
			<dc:creator>Thapakorn Tree-Udom</dc:creator>
			<dc:creator>Benjaporn Noppradit</dc:creator>
			<dc:creator>Punita Thammachot</dc:creator>
			<dc:creator>Nann Kain Kham</dc:creator>
			<dc:creator>Cholpisut Tantapakul</dc:creator>
			<dc:creator>Naphatsorn Ditthawutthikul</dc:creator>
			<dc:creator>Rawiwan Charoensup</dc:creator>
			<dc:creator>Chittipong Tipbunjong</dc:creator>
			<dc:creator>Maria Pilar Vinardell</dc:creator>
			<dc:creator>Tawanun Sripisut</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050235</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-10</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-10</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>235</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050235</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/235</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/234">

	<title>Cosmetics, Vol. 13, Pages 234: Repeated Moisturizer Use Narrows the Surface-to-Deep Hydration Gap over Time: The Hydration Gap Index (HGI)</title>
	<link>https://www.mdpi.com/2079-9284/13/5/234</link>
	<description>Skin hydration is not uniform: it is low at the surface and rises with depth, and the standard capacitance probe (Corneometer) samples only the outermost layer. How the surface&amp;amp;ndash;deep relationship evolves under repeated moisturizer use is not captured by a single metric. Using the Hydration Gap Index (HGI = |surface &amp;amp;minus; deep (0.5 mm)|), this relationship was tracked in 22 healthy adults, measuring surface hydration (Corneometer) and depth-resolved deep hydration (Moisturemeter D; 0.5&amp;amp;ndash;5.0 mm) at baseline, after one application, and after two weeks. Surface hydration rose sharply after one application (30.9 &amp;amp;rarr; 64.0 A.U.), then partially declined by two weeks (43.5 A.U.; all p &amp;amp;lt; 0.001), whereas deeper readings were essentially unchanged (&amp;amp;le;5.1%), consistent with a stable deep compartment. The per-subject surface&amp;amp;ndash;deep gap first widened (13.1 &amp;amp;rarr; 18.0) then narrowed to &amp;amp;asymp;5.1 A.U. (19/22 subjects; group-mean 2.0). Surface and deep compartments varied independently (baseline r = &amp;amp;minus;0.14; change r = +0.05), and the surface-dominant response was reproduced with a different surface instrument in the same cohort (surface +102%, deep +4%). The apparent depth gradient steepened only through this shallow-layer gain (&amp;amp;minus;3.66 &amp;amp;rarr; &amp;amp;minus;3.93 A.U./mm, p &amp;amp;lt; 0.0001). Thus, repeated use reflected equilibration of the superficial layer toward the 0.5 mm compartment, not a uniform rise; the HGI provides a compact index of this surface-to-deep equilibration.</description>
	<pubDate>2026-09-09</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 234: Repeated Moisturizer Use Narrows the Surface-to-Deep Hydration Gap over Time: The Hydration Gap Index (HGI)</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/234">doi: 10.3390/cosmetics13050234</a></p>
	<p>Authors:
		Youngrin Kwag
		Seok Hwan Oh
		Sang hyun Kim
		Ji Hwoon Baek
		HuiJeong Jeong
		YooRi Kang
		Hongseok Kim
		Wonkyu Hong
		</p>
	<p>Skin hydration is not uniform: it is low at the surface and rises with depth, and the standard capacitance probe (Corneometer) samples only the outermost layer. How the surface&amp;amp;ndash;deep relationship evolves under repeated moisturizer use is not captured by a single metric. Using the Hydration Gap Index (HGI = |surface &amp;amp;minus; deep (0.5 mm)|), this relationship was tracked in 22 healthy adults, measuring surface hydration (Corneometer) and depth-resolved deep hydration (Moisturemeter D; 0.5&amp;amp;ndash;5.0 mm) at baseline, after one application, and after two weeks. Surface hydration rose sharply after one application (30.9 &amp;amp;rarr; 64.0 A.U.), then partially declined by two weeks (43.5 A.U.; all p &amp;amp;lt; 0.001), whereas deeper readings were essentially unchanged (&amp;amp;le;5.1%), consistent with a stable deep compartment. The per-subject surface&amp;amp;ndash;deep gap first widened (13.1 &amp;amp;rarr; 18.0) then narrowed to &amp;amp;asymp;5.1 A.U. (19/22 subjects; group-mean 2.0). Surface and deep compartments varied independently (baseline r = &amp;amp;minus;0.14; change r = +0.05), and the surface-dominant response was reproduced with a different surface instrument in the same cohort (surface +102%, deep +4%). The apparent depth gradient steepened only through this shallow-layer gain (&amp;amp;minus;3.66 &amp;amp;rarr; &amp;amp;minus;3.93 A.U./mm, p &amp;amp;lt; 0.0001). Thus, repeated use reflected equilibration of the superficial layer toward the 0.5 mm compartment, not a uniform rise; the HGI provides a compact index of this surface-to-deep equilibration.</p>
	]]></content:encoded>

	<dc:title>Repeated Moisturizer Use Narrows the Surface-to-Deep Hydration Gap over Time: The Hydration Gap Index (HGI)</dc:title>
			<dc:creator>Youngrin Kwag</dc:creator>
			<dc:creator>Seok Hwan Oh</dc:creator>
			<dc:creator>Sang hyun Kim</dc:creator>
			<dc:creator>Ji Hwoon Baek</dc:creator>
			<dc:creator>HuiJeong Jeong</dc:creator>
			<dc:creator>YooRi Kang</dc:creator>
			<dc:creator>Hongseok Kim</dc:creator>
			<dc:creator>Wonkyu Hong</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050234</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-09</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-09</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>234</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050234</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/234</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/233">

	<title>Cosmetics, Vol. 13, Pages 233: In Vitro Characterization of Hom pathum Rice Extract and Exploratory Evaluation of an Extract-Containing Facial Mask in Adults Aged 30&amp;ndash;50 Years: A Randomized Controlled Trial</title>
	<link>https://www.mdpi.com/2079-9284/13/5/233</link>
	<description>This study characterized the in vitro properties of a Hom pathum rice extract and explored the clinical performance of a facial mask containing the extract. In this single-center, assessor-blinded, two-arm randomized controlled trial, 60 patch-test-negative healthy adults aged 30&amp;amp;ndash;50 years were allocated 1:1 to a no-treatment control group or to a treatment group that applied a multi-ingredient facial mask containing 0.27% (w/w) Hom pathum rice extract for 30 min twice weekly for 12 weeks. Hydration, elasticity, oiliness, melanin, and erythema were assessed at the forehead, cheek, and chin. Complete-case week-12 comparisons used ANCOVA adjusted for the corresponding baseline value, age, and sex, followed by Benjamini&amp;amp;ndash;Hochberg correction across the 15 between-group comparisons. Forty-nine participants completed follow-up (control, 24; treatment, 25). The ethanolic extract showed 55% DPPH radical-scavenging activity, an IC50 of 2.29 &amp;amp;plusmn; 0.02 mg/mL, and a total phenolic content of 0.01 &amp;amp;plusmn; 0.00 mg GAE/mg extract; total flavonoids were below the assay detection limit at 5 mg/mL. Six comparisons were nominally significant, of which three remained significant after false-discovery-rate correction: higher forehead hydration (adjusted mean difference, 9.42 AU; 95% CI, 2.79 to 16.06; p = 0.007; q = 0.033), lower chin oiliness (&amp;amp;minus;33.15 &amp;amp;mu;g/cm2; 95% CI, &amp;amp;minus;52.40 to &amp;amp;minus;13.89; p = 0.001; q = 0.022), and lower cheek melanin (&amp;amp;minus;68.65 AU; 95% CI, &amp;amp;minus;112.89 to &amp;amp;minus;24.41; p = 0.003; q = 0.026). However, none of the 15 comparisons reached nominal or FDR-adjusted significance in the intention-to-treat multiple-imputation sensitivity analysis (all p &amp;amp;ge; 0.092). No intervention-related adverse effects were recorded among the enrolled patch-test-negative participants. These findings apply to the formulation and application procedure as a whole and were not statistically confirmed in the intention-to-treat sensitivity analysis; they therefore warrant confirmation in an adequately powered, double-blind, vehicle-controlled trial with a prespecified primary outcome. ClinicalTrials.gov: NCT06475222. Funding: Burapha University, Thailand Science Research and Innovation, and the National Science Research and Innovation Fund.</description>
	<pubDate>2026-09-09</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 233: In Vitro Characterization of Hom pathum Rice Extract and Exploratory Evaluation of an Extract-Containing Facial Mask in Adults Aged 30&amp;ndash;50 Years: A Randomized Controlled Trial</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/233">doi: 10.3390/cosmetics13050233</a></p>
	<p>Authors:
		Sirigoon Kuamsub
		Yothin Teethaisong
		Suwipa Intakhiao
		Thirapit Subongkot
		Thanchanok Sirirak
		Kulwara Poolpol
		Waranurin Yisarakun
		Piyapong Prasertsri
		</p>
	<p>This study characterized the in vitro properties of a Hom pathum rice extract and explored the clinical performance of a facial mask containing the extract. In this single-center, assessor-blinded, two-arm randomized controlled trial, 60 patch-test-negative healthy adults aged 30&amp;amp;ndash;50 years were allocated 1:1 to a no-treatment control group or to a treatment group that applied a multi-ingredient facial mask containing 0.27% (w/w) Hom pathum rice extract for 30 min twice weekly for 12 weeks. Hydration, elasticity, oiliness, melanin, and erythema were assessed at the forehead, cheek, and chin. Complete-case week-12 comparisons used ANCOVA adjusted for the corresponding baseline value, age, and sex, followed by Benjamini&amp;amp;ndash;Hochberg correction across the 15 between-group comparisons. Forty-nine participants completed follow-up (control, 24; treatment, 25). The ethanolic extract showed 55% DPPH radical-scavenging activity, an IC50 of 2.29 &amp;amp;plusmn; 0.02 mg/mL, and a total phenolic content of 0.01 &amp;amp;plusmn; 0.00 mg GAE/mg extract; total flavonoids were below the assay detection limit at 5 mg/mL. Six comparisons were nominally significant, of which three remained significant after false-discovery-rate correction: higher forehead hydration (adjusted mean difference, 9.42 AU; 95% CI, 2.79 to 16.06; p = 0.007; q = 0.033), lower chin oiliness (&amp;amp;minus;33.15 &amp;amp;mu;g/cm2; 95% CI, &amp;amp;minus;52.40 to &amp;amp;minus;13.89; p = 0.001; q = 0.022), and lower cheek melanin (&amp;amp;minus;68.65 AU; 95% CI, &amp;amp;minus;112.89 to &amp;amp;minus;24.41; p = 0.003; q = 0.026). However, none of the 15 comparisons reached nominal or FDR-adjusted significance in the intention-to-treat multiple-imputation sensitivity analysis (all p &amp;amp;ge; 0.092). No intervention-related adverse effects were recorded among the enrolled patch-test-negative participants. These findings apply to the formulation and application procedure as a whole and were not statistically confirmed in the intention-to-treat sensitivity analysis; they therefore warrant confirmation in an adequately powered, double-blind, vehicle-controlled trial with a prespecified primary outcome. ClinicalTrials.gov: NCT06475222. Funding: Burapha University, Thailand Science Research and Innovation, and the National Science Research and Innovation Fund.</p>
	]]></content:encoded>

	<dc:title>In Vitro Characterization of Hom pathum Rice Extract and Exploratory Evaluation of an Extract-Containing Facial Mask in Adults Aged 30&amp;amp;ndash;50 Years: A Randomized Controlled Trial</dc:title>
			<dc:creator>Sirigoon Kuamsub</dc:creator>
			<dc:creator>Yothin Teethaisong</dc:creator>
			<dc:creator>Suwipa Intakhiao</dc:creator>
			<dc:creator>Thirapit Subongkot</dc:creator>
			<dc:creator>Thanchanok Sirirak</dc:creator>
			<dc:creator>Kulwara Poolpol</dc:creator>
			<dc:creator>Waranurin Yisarakun</dc:creator>
			<dc:creator>Piyapong Prasertsri</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050233</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-09</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-09</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>233</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050233</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/233</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/232">

	<title>Cosmetics, Vol. 13, Pages 232: Physicochemical Characterization and In Vitro Skin-Related Biological Activities of Hydrolyzed Collagen Derived from Chicken Sternum</title>
	<link>https://www.mdpi.com/2079-9284/13/5/232</link>
	<description>Hydrolyzed collagen preparations have attracted increasing attention because their biological properties may vary according to collagen source, peptide composition, and physicochemical characteristics. In this study, Richi I II III Collagen (HTCP), a hydrolyzed type I, II, and III collagen preparation derived from chicken sternum (keel) and manufactured by CNABIOTECH Co., Ltd. (Cheongju-si, Republic of Korea), was physicochemically characterized and evaluated for antioxidant and skin-related biological activities. Physicochemical characterization included analyses of amino acid composition and molecular weight distribution, while biological activities were assessed using ABTS and DPPH radical scavenging assays and human skin cell-based models. HTCP showed distinct responses in the two radical scavenging assays, with ABTS radical scavenging activity reaching 80.4 &amp;amp;plusmn; 0.0% at 100 mg/mL, whereas DPPH radical scavenging activity remained comparatively low (13.1 &amp;amp;plusmn; 4.6%). No cytotoxicity was detected in human dermal fibroblasts (HDF) or human epidermal keratinocytes (HEKn) at the concentrations tested. HTCP exhibited 101.65 &amp;amp;plusmn; 1.28% collagenase inhibition at 10% and significantly increased type I collagen, type III collagen, elastin, hyaluronic acid (HA), HAS2, and HAS3 levels, while reducing MMP-1 and HYAL1 levels. Collectively, these findings demonstrate changes in selected ECM- and HA-related protein levels in human skin cells following HTCP treatment under in vitro conditions, supporting further investigation of HTCP as a collagen-derived ingredient for skin-related applications.</description>
	<pubDate>2026-09-08</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 232: Physicochemical Characterization and In Vitro Skin-Related Biological Activities of Hydrolyzed Collagen Derived from Chicken Sternum</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/232">doi: 10.3390/cosmetics13050232</a></p>
	<p>Authors:
		Kyong Jin Lee
		Mi-Jin Lee
		Hari Jang
		Woo-Yong Song
		Eunjandi Go
		Hyun Min Kim
		Boo-Sik Jang
		</p>
	<p>Hydrolyzed collagen preparations have attracted increasing attention because their biological properties may vary according to collagen source, peptide composition, and physicochemical characteristics. In this study, Richi I II III Collagen (HTCP), a hydrolyzed type I, II, and III collagen preparation derived from chicken sternum (keel) and manufactured by CNABIOTECH Co., Ltd. (Cheongju-si, Republic of Korea), was physicochemically characterized and evaluated for antioxidant and skin-related biological activities. Physicochemical characterization included analyses of amino acid composition and molecular weight distribution, while biological activities were assessed using ABTS and DPPH radical scavenging assays and human skin cell-based models. HTCP showed distinct responses in the two radical scavenging assays, with ABTS radical scavenging activity reaching 80.4 &amp;amp;plusmn; 0.0% at 100 mg/mL, whereas DPPH radical scavenging activity remained comparatively low (13.1 &amp;amp;plusmn; 4.6%). No cytotoxicity was detected in human dermal fibroblasts (HDF) or human epidermal keratinocytes (HEKn) at the concentrations tested. HTCP exhibited 101.65 &amp;amp;plusmn; 1.28% collagenase inhibition at 10% and significantly increased type I collagen, type III collagen, elastin, hyaluronic acid (HA), HAS2, and HAS3 levels, while reducing MMP-1 and HYAL1 levels. Collectively, these findings demonstrate changes in selected ECM- and HA-related protein levels in human skin cells following HTCP treatment under in vitro conditions, supporting further investigation of HTCP as a collagen-derived ingredient for skin-related applications.</p>
	]]></content:encoded>

	<dc:title>Physicochemical Characterization and In Vitro Skin-Related Biological Activities of Hydrolyzed Collagen Derived from Chicken Sternum</dc:title>
			<dc:creator>Kyong Jin Lee</dc:creator>
			<dc:creator>Mi-Jin Lee</dc:creator>
			<dc:creator>Hari Jang</dc:creator>
			<dc:creator>Woo-Yong Song</dc:creator>
			<dc:creator>Eunjandi Go</dc:creator>
			<dc:creator>Hyun Min Kim</dc:creator>
			<dc:creator>Boo-Sik Jang</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050232</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-08</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-08</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>232</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050232</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/232</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/231">

	<title>Cosmetics, Vol. 13, Pages 231: Multiple Bleaching of Hair: Fatigue Failure Investigations and Weibull Analyses</title>
	<link>https://www.mdpi.com/2079-9284/13/5/231</link>
	<description>The fatigue failure (F/F) test is an important method for evaluating hair strength. In this study, we evaluate commercial European hair after up to four bleaches. F/F-data were directly fitted using a two-parameter cumulative Weibull distribution (CWD) function, described by lifetime index (&amp;amp;lambda;) and shape factor (&amp;amp;beta;). Fibre samples taken from treated tresses (T) exhibited stable F/F behaviour across multiple treatments, while treated single fibres (S) showed early breakage if treated more than twice. We attribute this effect mainly to the liquor ratio during treatment. In this context, we suggest a strategy to estimate a treatment-related apparent decay constant for &amp;amp;lambda;. The constant for T-samples was determined as kn = 0.095. This is consistent with DSC results in the literature for the denaturation enthalpy. This may indicate an important role for intermediate filaments in fatigue failure. To possibly establish a link with hair breakage during combing, we investigated the properties of the hazard function for T-samples based on &amp;amp;beta; = 0.92. The model calculations indicate that early failure risks are low but increase exponentially with repeated bleaches. The correspondence with the literature results leads to the hypothesis of a relationship between F/F and combing tests.</description>
	<pubDate>2026-09-08</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 231: Multiple Bleaching of Hair: Fatigue Failure Investigations and Weibull Analyses</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/231">doi: 10.3390/cosmetics13050231</a></p>
	<p>Authors:
		Franz J. Wortmann
		Jessica Welzel
		Leila Berriche
		Svitlana Sirenko
		Gabriele Wortmann
		Volkmar Vill
		</p>
	<p>The fatigue failure (F/F) test is an important method for evaluating hair strength. In this study, we evaluate commercial European hair after up to four bleaches. F/F-data were directly fitted using a two-parameter cumulative Weibull distribution (CWD) function, described by lifetime index (&amp;amp;lambda;) and shape factor (&amp;amp;beta;). Fibre samples taken from treated tresses (T) exhibited stable F/F behaviour across multiple treatments, while treated single fibres (S) showed early breakage if treated more than twice. We attribute this effect mainly to the liquor ratio during treatment. In this context, we suggest a strategy to estimate a treatment-related apparent decay constant for &amp;amp;lambda;. The constant for T-samples was determined as kn = 0.095. This is consistent with DSC results in the literature for the denaturation enthalpy. This may indicate an important role for intermediate filaments in fatigue failure. To possibly establish a link with hair breakage during combing, we investigated the properties of the hazard function for T-samples based on &amp;amp;beta; = 0.92. The model calculations indicate that early failure risks are low but increase exponentially with repeated bleaches. The correspondence with the literature results leads to the hypothesis of a relationship between F/F and combing tests.</p>
	]]></content:encoded>

	<dc:title>Multiple Bleaching of Hair: Fatigue Failure Investigations and Weibull Analyses</dc:title>
			<dc:creator>Franz J. Wortmann</dc:creator>
			<dc:creator>Jessica Welzel</dc:creator>
			<dc:creator>Leila Berriche</dc:creator>
			<dc:creator>Svitlana Sirenko</dc:creator>
			<dc:creator>Gabriele Wortmann</dc:creator>
			<dc:creator>Volkmar Vill</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050231</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-08</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-08</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>231</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050231</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/231</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/230">

	<title>Cosmetics, Vol. 13, Pages 230: Effect of Formulation Matrix, Temperature, and Time on Formaldehyde Release from Formaldehyde-Releasing Preservatives</title>
	<link>https://www.mdpi.com/2079-9284/13/5/230</link>
	<description>Formaldehyde is a chemical compound historically used for its antimicrobial and preservative properties. Due to its classification as a carcinogen and skin sensitizer, its use in cosmetics is restricted; however, formaldehyde-releasing preservatives are still permitted under specific conditions. The release of formaldehyde in cosmetic products may be influenced by factors such as temperature, storage time, and formulation matrix, raising potential safety and regulatory concerns. In this study, a full factorial design was applied to evaluate formaldehyde release in aqueous solutions at 40, 70, and 90 &amp;amp;deg;C over 15, 30, and 60 min. In cosmetic matrices, temperatures of 40 and 70 &amp;amp;deg;C were assessed at 0, 15, 30, and 60 min. Additionally, a three-month accelerated stability study was conducted to evaluate formaldehyde release over time in three different formulations. Formaldehyde release increased with both temperature and time in aqueous solutions, with diazolidinyl urea showing the highest levels, followed by DMDM hydantoin and imidazolidinyl urea. In cosmetic matrices, lower release levels were observed compared to aqueous systems; however, all formulations exceeded the 0.001% threshold established by European regulations. Under accelerated stability conditions, the emulsion exhibited the highest formaldehyde release, which may be associated with increased water availability promoting preservative hydrolysis. Overall, formaldehyde release was influenced by preservative structure, formulation matrix, temperature, and time. These findings highlight the importance of considering formulation composition and storage conditions in the evaluation of formaldehyde-releasing preservatives and may be relevant for safety assessment and regulatory compliance.</description>
	<pubDate>2026-09-07</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 230: Effect of Formulation Matrix, Temperature, and Time on Formaldehyde Release from Formaldehyde-Releasing Preservatives</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/230">doi: 10.3390/cosmetics13050230</a></p>
	<p>Authors:
		Paula Juliana Eraso-Calvachi
		Isabella Rivera-Montoya
		Daniela Bustamante-López
		Juan Camilo Mejía-Giraldo
		</p>
	<p>Formaldehyde is a chemical compound historically used for its antimicrobial and preservative properties. Due to its classification as a carcinogen and skin sensitizer, its use in cosmetics is restricted; however, formaldehyde-releasing preservatives are still permitted under specific conditions. The release of formaldehyde in cosmetic products may be influenced by factors such as temperature, storage time, and formulation matrix, raising potential safety and regulatory concerns. In this study, a full factorial design was applied to evaluate formaldehyde release in aqueous solutions at 40, 70, and 90 &amp;amp;deg;C over 15, 30, and 60 min. In cosmetic matrices, temperatures of 40 and 70 &amp;amp;deg;C were assessed at 0, 15, 30, and 60 min. Additionally, a three-month accelerated stability study was conducted to evaluate formaldehyde release over time in three different formulations. Formaldehyde release increased with both temperature and time in aqueous solutions, with diazolidinyl urea showing the highest levels, followed by DMDM hydantoin and imidazolidinyl urea. In cosmetic matrices, lower release levels were observed compared to aqueous systems; however, all formulations exceeded the 0.001% threshold established by European regulations. Under accelerated stability conditions, the emulsion exhibited the highest formaldehyde release, which may be associated with increased water availability promoting preservative hydrolysis. Overall, formaldehyde release was influenced by preservative structure, formulation matrix, temperature, and time. These findings highlight the importance of considering formulation composition and storage conditions in the evaluation of formaldehyde-releasing preservatives and may be relevant for safety assessment and regulatory compliance.</p>
	]]></content:encoded>

	<dc:title>Effect of Formulation Matrix, Temperature, and Time on Formaldehyde Release from Formaldehyde-Releasing Preservatives</dc:title>
			<dc:creator>Paula Juliana Eraso-Calvachi</dc:creator>
			<dc:creator>Isabella Rivera-Montoya</dc:creator>
			<dc:creator>Daniela Bustamante-López</dc:creator>
			<dc:creator>Juan Camilo Mejía-Giraldo</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050230</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-07</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-07</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>230</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050230</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/230</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/229">

	<title>Cosmetics, Vol. 13, Pages 229: Localised Alopecia Associated with Hairstyling Accessories: A Multicentre Case Series with Clinical, Trichoscopic, and Histopathological Evidence of Mixed Mechanical Injury</title>
	<link>https://www.mdpi.com/2079-9284/13/5/229</link>
	<description>Mechanical forces generated by hairstyling practices are recognised causes of hair and scalp disorders, particularly traction alopecia, but the effects of prolonged, localised exposure to hairstyling accessories remain poorly characterised. We conducted a multicentre retrospective study of 10 women evaluated at five centres with chronic localised alopecia anatomically corresponding to the site of repeated accessory contact, analysing clinical, trichoscopic, histopathological and outcome data. Mean age was 51.3 years and mean disease duration 5.8 years; nine patients had vertex involvement, and one had an interparietal patch. Trichoscopy showed vellus hairs, with variable broken hairs, black and yellow dots, dystrophic, bent and coiled hairs, perifollicular casts and loss of follicular openings. Histopathology, available in seven patients, showed scarring alopecia in four and non-scarring alopecia in three. Implicated exposures included hairpins, clips, buns, rollers and a hair prosthesis. After accessory removal and variable treatment, four patients showed partial regrowth, four remained stable, one worsened, and follow-up was unavailable for one. The anatomical correspondence between alopecic patches and accessory exposure, with overlapping pressure, traction and friction-related features, is consistent with a proposed mixed mechanical injury from chronic low-intensity stress. Recognising hairstyling accessories as a potential cause of localised alopecia may facilitate diagnosis and prevent progression to irreversible damage.</description>
	<pubDate>2026-09-07</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 229: Localised Alopecia Associated with Hairstyling Accessories: A Multicentre Case Series with Clinical, Trichoscopic, and Histopathological Evidence of Mixed Mechanical Injury</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/229">doi: 10.3390/cosmetics13050229</a></p>
	<p>Authors:
		Cristina Romera-de Blas
		Alba Gómez-Zubiaur
		Rocío Gil-Redondo
		Juan Francisco Mir-Bonafé
		Natalia Aranda-Sánchez
		David Vega-Díez
		José María Ricart-Vayá
		</p>
	<p>Mechanical forces generated by hairstyling practices are recognised causes of hair and scalp disorders, particularly traction alopecia, but the effects of prolonged, localised exposure to hairstyling accessories remain poorly characterised. We conducted a multicentre retrospective study of 10 women evaluated at five centres with chronic localised alopecia anatomically corresponding to the site of repeated accessory contact, analysing clinical, trichoscopic, histopathological and outcome data. Mean age was 51.3 years and mean disease duration 5.8 years; nine patients had vertex involvement, and one had an interparietal patch. Trichoscopy showed vellus hairs, with variable broken hairs, black and yellow dots, dystrophic, bent and coiled hairs, perifollicular casts and loss of follicular openings. Histopathology, available in seven patients, showed scarring alopecia in four and non-scarring alopecia in three. Implicated exposures included hairpins, clips, buns, rollers and a hair prosthesis. After accessory removal and variable treatment, four patients showed partial regrowth, four remained stable, one worsened, and follow-up was unavailable for one. The anatomical correspondence between alopecic patches and accessory exposure, with overlapping pressure, traction and friction-related features, is consistent with a proposed mixed mechanical injury from chronic low-intensity stress. Recognising hairstyling accessories as a potential cause of localised alopecia may facilitate diagnosis and prevent progression to irreversible damage.</p>
	]]></content:encoded>

	<dc:title>Localised Alopecia Associated with Hairstyling Accessories: A Multicentre Case Series with Clinical, Trichoscopic, and Histopathological Evidence of Mixed Mechanical Injury</dc:title>
			<dc:creator>Cristina Romera-de Blas</dc:creator>
			<dc:creator>Alba Gómez-Zubiaur</dc:creator>
			<dc:creator>Rocío Gil-Redondo</dc:creator>
			<dc:creator>Juan Francisco Mir-Bonafé</dc:creator>
			<dc:creator>Natalia Aranda-Sánchez</dc:creator>
			<dc:creator>David Vega-Díez</dc:creator>
			<dc:creator>José María Ricart-Vayá</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050229</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-07</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-07</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>229</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050229</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/229</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/228">

	<title>Cosmetics, Vol. 13, Pages 228: Comparative Evaluation of Cosmeceutical Cream Containing Solanum lycopersicum Versus Kligman&amp;rsquo;s Formula in Melasma Treatment</title>
	<link>https://www.mdpi.com/2079-9284/13/5/228</link>
	<description>Background: Melasma is a common pigmentary disorder, for which Kligman&amp;amp;rsquo;s Formula is a standard topical therapy, though adverse effects limit prolonged use. Cosmeceutical alternatives with antioxidant properties may present potential benefits for long-term management. Aims: To compare the efficacy of a cosmeceutical cream containing Solanum lycopersicum (tomato) extract with Kligman&amp;amp;rsquo;s Formula in the treatment of facial melasma. Methods: In this single-blind, split-face, pilot randomized controlled trial, patients with melasma received either Kligman&amp;amp;rsquo;s Formula or the tomato extract-based cosmeceutical cream for 56 days. Main outcomes were changes in modified Melasma Area and Severity Index (mMASI) and Melasma Severity Scale (MSS) scores. Safety was assessed based on the incidence of adverse events. Results: Both creams significantly reduced mMASI scores after 56 days (Kligman&amp;amp;rsquo;s Formula: &amp;amp;minus;1.394, p &amp;amp;lt; 0.001; cosmeceutical cream: &amp;amp;minus;1.471, p &amp;amp;lt; 0.001), suggestive of comparable efficacy, as this pilot study was not formally powered for non-inferiority testing, this finding should be interpreted as hypothesis-generating. MSS scores were not statistically analyzed due to the ordinal, small-range nature of the data. The proportion of patients with moderate to severe melasma (MSS &amp;amp;ge; 2) decreased by day 56 for both treatments. At day 56, patient-rated MSS scores &amp;amp;ge; 2 declined from 100% to 59.3% with Kligman&amp;amp;rsquo;s Formula and from 96.3% to 66.7% with the cosmeceutical cream. Reported adverse events were mild and self-limiting in both groups. Conclusions: Preliminary findings suggest the cosmeceutical cream containing Solanum lycopersicum is comparable to Kligman&amp;amp;rsquo;s Formula in improving melasma severity. Its antioxidant-rich, well-tolerated profile in this short-term pilot warrants further investigation as a potential safe option for long-term or adjunctive therapy in melasma.</description>
	<pubDate>2026-09-07</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 228: Comparative Evaluation of Cosmeceutical Cream Containing Solanum lycopersicum Versus Kligman&amp;rsquo;s Formula in Melasma Treatment</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/228">doi: 10.3390/cosmetics13050228</a></p>
	<p>Authors:
		Foong Weng Kei
		Shanxi Alexandra Jen
		Jessica Lee Ling Jing
		Steven Thng Tien Guan
		</p>
	<p>Background: Melasma is a common pigmentary disorder, for which Kligman&amp;amp;rsquo;s Formula is a standard topical therapy, though adverse effects limit prolonged use. Cosmeceutical alternatives with antioxidant properties may present potential benefits for long-term management. Aims: To compare the efficacy of a cosmeceutical cream containing Solanum lycopersicum (tomato) extract with Kligman&amp;amp;rsquo;s Formula in the treatment of facial melasma. Methods: In this single-blind, split-face, pilot randomized controlled trial, patients with melasma received either Kligman&amp;amp;rsquo;s Formula or the tomato extract-based cosmeceutical cream for 56 days. Main outcomes were changes in modified Melasma Area and Severity Index (mMASI) and Melasma Severity Scale (MSS) scores. Safety was assessed based on the incidence of adverse events. Results: Both creams significantly reduced mMASI scores after 56 days (Kligman&amp;amp;rsquo;s Formula: &amp;amp;minus;1.394, p &amp;amp;lt; 0.001; cosmeceutical cream: &amp;amp;minus;1.471, p &amp;amp;lt; 0.001), suggestive of comparable efficacy, as this pilot study was not formally powered for non-inferiority testing, this finding should be interpreted as hypothesis-generating. MSS scores were not statistically analyzed due to the ordinal, small-range nature of the data. The proportion of patients with moderate to severe melasma (MSS &amp;amp;ge; 2) decreased by day 56 for both treatments. At day 56, patient-rated MSS scores &amp;amp;ge; 2 declined from 100% to 59.3% with Kligman&amp;amp;rsquo;s Formula and from 96.3% to 66.7% with the cosmeceutical cream. Reported adverse events were mild and self-limiting in both groups. Conclusions: Preliminary findings suggest the cosmeceutical cream containing Solanum lycopersicum is comparable to Kligman&amp;amp;rsquo;s Formula in improving melasma severity. Its antioxidant-rich, well-tolerated profile in this short-term pilot warrants further investigation as a potential safe option for long-term or adjunctive therapy in melasma.</p>
	]]></content:encoded>

	<dc:title>Comparative Evaluation of Cosmeceutical Cream Containing Solanum lycopersicum Versus Kligman&amp;amp;rsquo;s Formula in Melasma Treatment</dc:title>
			<dc:creator>Foong Weng Kei</dc:creator>
			<dc:creator>Shanxi Alexandra Jen</dc:creator>
			<dc:creator>Jessica Lee Ling Jing</dc:creator>
			<dc:creator>Steven Thng Tien Guan</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050228</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-07</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-07</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>228</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050228</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/228</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/227">

	<title>Cosmetics, Vol. 13, Pages 227: Effect of Topical HealFast Silver Ointment on Pain and Early Wound-Healing Parameters After Caesarean Section: A Randomized Placebo-Controlled Clinical Trial</title>
	<link>https://www.mdpi.com/2079-9284/13/5/227</link>
	<description>Background: Caesarean section is associated with postoperative pain and wound-related morbidity. Topical agents that promote early wound healing may enhance postoperative recovery. This randomized, placebo-controlled clinical trial evaluated the effect of HealFast Silver Ointment on pain and early wound-healing parameters after Caesarean section. Methods: Two hundred women who underwent Caesarean section were randomly allocated into two groups: a placebo group and a HealFast Silver Ointment group, each consisting of 100 women. The intervention was applied topically three times daily for three weeks. Outcomes were assessed at baseline, week 1, and week 3, and included pain intensity using the Visual Analogue Scale, transepidermal water loss, tissue oxygenation assessment, and wound surface morphology using Visioscan. Results: Baseline characteristics were comparable between groups. At week 3, the Visual Analogue Scale score decreased from 8.13 &amp;amp;plusmn; 0.93 to 1.33 &amp;amp;plusmn; 0.71 in the treated group, compared with 8.15 &amp;amp;plusmn; 1.47 to 7.03 &amp;amp;plusmn; 1.95 in the placebo group. Transepidermal water loss decreased from 34.13 &amp;amp;plusmn; 6.89 to 6.84 &amp;amp;plusmn; 3.99 in the treated group, compared with 32.70 &amp;amp;plusmn; 6.67 to 30.77 &amp;amp;plusmn; 6.69 in the placebo group. O2C increased from 40.08 &amp;amp;plusmn; 6.36 to 57.48 &amp;amp;plusmn; 7.19 in the treated group, compared with 40.80 &amp;amp;plusmn; 6.70 to 45.00 &amp;amp;plusmn; 6.84 in the placebo group. Significant time &amp;amp;times; group interactions were observed for the main clinical and physiological outcomes. Conclusions: HealFast Silver Ointment was associated with reduced postoperative pain, improved epidermal barrier recovery, increased tissue oxygenation, and improved wound surface morphology during the first three weeks after Caesarean section. Larger registered multicenter trials with longer follow-ups are needed to confirm these findings.</description>
	<pubDate>2026-09-03</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 227: Effect of Topical HealFast Silver Ointment on Pain and Early Wound-Healing Parameters After Caesarean Section: A Randomized Placebo-Controlled Clinical Trial</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/227">doi: 10.3390/cosmetics13050227</a></p>
	<p>Authors:
		Wafaa Uthman Ahmed
		Bafreen hawez Hamadameen
		Dastan Abdullah Salih
		Shukur Wasman Smail
		Abubakr Mohammed Amin
		Mohammed Awat Ali
		</p>
	<p>Background: Caesarean section is associated with postoperative pain and wound-related morbidity. Topical agents that promote early wound healing may enhance postoperative recovery. This randomized, placebo-controlled clinical trial evaluated the effect of HealFast Silver Ointment on pain and early wound-healing parameters after Caesarean section. Methods: Two hundred women who underwent Caesarean section were randomly allocated into two groups: a placebo group and a HealFast Silver Ointment group, each consisting of 100 women. The intervention was applied topically three times daily for three weeks. Outcomes were assessed at baseline, week 1, and week 3, and included pain intensity using the Visual Analogue Scale, transepidermal water loss, tissue oxygenation assessment, and wound surface morphology using Visioscan. Results: Baseline characteristics were comparable between groups. At week 3, the Visual Analogue Scale score decreased from 8.13 &amp;amp;plusmn; 0.93 to 1.33 &amp;amp;plusmn; 0.71 in the treated group, compared with 8.15 &amp;amp;plusmn; 1.47 to 7.03 &amp;amp;plusmn; 1.95 in the placebo group. Transepidermal water loss decreased from 34.13 &amp;amp;plusmn; 6.89 to 6.84 &amp;amp;plusmn; 3.99 in the treated group, compared with 32.70 &amp;amp;plusmn; 6.67 to 30.77 &amp;amp;plusmn; 6.69 in the placebo group. O2C increased from 40.08 &amp;amp;plusmn; 6.36 to 57.48 &amp;amp;plusmn; 7.19 in the treated group, compared with 40.80 &amp;amp;plusmn; 6.70 to 45.00 &amp;amp;plusmn; 6.84 in the placebo group. Significant time &amp;amp;times; group interactions were observed for the main clinical and physiological outcomes. Conclusions: HealFast Silver Ointment was associated with reduced postoperative pain, improved epidermal barrier recovery, increased tissue oxygenation, and improved wound surface morphology during the first three weeks after Caesarean section. Larger registered multicenter trials with longer follow-ups are needed to confirm these findings.</p>
	]]></content:encoded>

	<dc:title>Effect of Topical HealFast Silver Ointment on Pain and Early Wound-Healing Parameters After Caesarean Section: A Randomized Placebo-Controlled Clinical Trial</dc:title>
			<dc:creator>Wafaa Uthman Ahmed</dc:creator>
			<dc:creator>Bafreen hawez Hamadameen</dc:creator>
			<dc:creator>Dastan Abdullah Salih</dc:creator>
			<dc:creator>Shukur Wasman Smail</dc:creator>
			<dc:creator>Abubakr Mohammed Amin</dc:creator>
			<dc:creator>Mohammed Awat Ali</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050227</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-03</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-03</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>227</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050227</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/227</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/226">

	<title>Cosmetics, Vol. 13, Pages 226: Mesoporous Silica-Supported TiO2 Composite Sunscreen: Combining Low Whitening, Reduced Photoactivity, and Favorable Cytocompatibility</title>
	<link>https://www.mdpi.com/2079-9284/13/5/226</link>
	<description>Titanium dioxide, a traditional physical sunscreen agent, has long faced persistent challenges related to light transmission (manifesting as whitening and an unnatural white cast on the skin), high photocatalytic activity, and cytocompatibility concerns. In this work, a composite sunscreen material, mesoporous silica (MSN)@TiO2, was designed and synthesized by loading titanium dioxide (TiO2) onto dendritic mesoporous silica. Leveraging the high transparency of dendritic mesoporous silica, MSN@TiO2 exhibits 30% higher visible light transmittance than commercially available titanium dioxide. In addition, encapsulation within the silica carrier reduces the photocatalytic activity of MSN@TiO2 to one-seventh of that of commercially available titanium dioxide. Furthermore, we evaluated the cytocompatibility of MSN@TiO2. Cell Counting Kit-8 (CCK-8) assay results demonstrate that MSN@TiO2 has a less pronounced effect on L929 cells proliferation compared with commercial TiO2, indicating favorable L929 cell-based cytocompatibility. This strategy demonstrates that MSN@TiO2 combines a natural appearance with low photocatalytic activity, offering distinct advantages over conventional titanium dioxide in composite sunscreen materials.</description>
	<pubDate>2026-09-02</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 226: Mesoporous Silica-Supported TiO2 Composite Sunscreen: Combining Low Whitening, Reduced Photoactivity, and Favorable Cytocompatibility</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/226">doi: 10.3390/cosmetics13050226</a></p>
	<p>Authors:
		Haijun Zheng
		Yanmiao Li
		Kaixin Wu
		Ting Ouyang
		Nian Fu
		Qinfang Zheng
		Zhiyong Cai
		Yi Liu
		</p>
	<p>Titanium dioxide, a traditional physical sunscreen agent, has long faced persistent challenges related to light transmission (manifesting as whitening and an unnatural white cast on the skin), high photocatalytic activity, and cytocompatibility concerns. In this work, a composite sunscreen material, mesoporous silica (MSN)@TiO2, was designed and synthesized by loading titanium dioxide (TiO2) onto dendritic mesoporous silica. Leveraging the high transparency of dendritic mesoporous silica, MSN@TiO2 exhibits 30% higher visible light transmittance than commercially available titanium dioxide. In addition, encapsulation within the silica carrier reduces the photocatalytic activity of MSN@TiO2 to one-seventh of that of commercially available titanium dioxide. Furthermore, we evaluated the cytocompatibility of MSN@TiO2. Cell Counting Kit-8 (CCK-8) assay results demonstrate that MSN@TiO2 has a less pronounced effect on L929 cells proliferation compared with commercial TiO2, indicating favorable L929 cell-based cytocompatibility. This strategy demonstrates that MSN@TiO2 combines a natural appearance with low photocatalytic activity, offering distinct advantages over conventional titanium dioxide in composite sunscreen materials.</p>
	]]></content:encoded>

	<dc:title>Mesoporous Silica-Supported TiO2 Composite Sunscreen: Combining Low Whitening, Reduced Photoactivity, and Favorable Cytocompatibility</dc:title>
			<dc:creator>Haijun Zheng</dc:creator>
			<dc:creator>Yanmiao Li</dc:creator>
			<dc:creator>Kaixin Wu</dc:creator>
			<dc:creator>Ting Ouyang</dc:creator>
			<dc:creator>Nian Fu</dc:creator>
			<dc:creator>Qinfang Zheng</dc:creator>
			<dc:creator>Zhiyong Cai</dc:creator>
			<dc:creator>Yi Liu</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050226</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-09-02</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-09-02</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>226</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050226</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/226</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/225">

	<title>Cosmetics, Vol. 13, Pages 225: Berberine Chloride Suppresses Melanogenesis in B16-F1 Melanoma Cells in Association with ERK and Autophagy-Related Signaling</title>
	<link>https://www.mdpi.com/2079-9284/13/5/225</link>
	<description>Skin pigmentation is regulated by intrinsic and extrinsic factors and is closely associated with melanogenesis and cellular homeostasis. Autophagy is a cellular self-digestion process that contributes to homeostatic regulation, but its role in melanogenesis remains to be further clarified. This study investigated whether berberine chloride (BBC), an isoquinoline alkaloid, modulates melanin production through autophagy-related signaling in B16-F1 melanoma cells. Tyrosinase activity was examined by tyrosinase zymography, extracellular melanin levels in the culture supernatant were measured after BBC treatment, and the expression of melanogenesis-, mitogen-activated protein kinase (MAPK)-, and autophagy-related proteins was analyzed by Western blotting. BBC inhibited tyrosinase activity and reduced extracellular melanin levels in a dose-dependent manner. BBC also increased phosphorylated extracellular signal-regulated kinase (p-ERK) levels while decreasing melanogenesis-related protein expression. In addition, BBC modulated MAPK signaling and the expression of autophagy-associated proteins. Small interfering RNA-mediated knockdown of Atg5, Beclin1, or ERK partially restored extracellular melanin levels in BBC-treated cells. These findings suggest that BBC suppresses melanogenesis in B16-F1 melanoma cells in association with ERK and autophagy-related signaling.</description>
	<pubDate>2026-08-31</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 225: Berberine Chloride Suppresses Melanogenesis in B16-F1 Melanoma Cells in Association with ERK and Autophagy-Related Signaling</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/225">doi: 10.3390/cosmetics13050225</a></p>
	<p>Authors:
		HwaJeong Ryu
		Ho Jae Lim
		Jung Eun Park
		</p>
	<p>Skin pigmentation is regulated by intrinsic and extrinsic factors and is closely associated with melanogenesis and cellular homeostasis. Autophagy is a cellular self-digestion process that contributes to homeostatic regulation, but its role in melanogenesis remains to be further clarified. This study investigated whether berberine chloride (BBC), an isoquinoline alkaloid, modulates melanin production through autophagy-related signaling in B16-F1 melanoma cells. Tyrosinase activity was examined by tyrosinase zymography, extracellular melanin levels in the culture supernatant were measured after BBC treatment, and the expression of melanogenesis-, mitogen-activated protein kinase (MAPK)-, and autophagy-related proteins was analyzed by Western blotting. BBC inhibited tyrosinase activity and reduced extracellular melanin levels in a dose-dependent manner. BBC also increased phosphorylated extracellular signal-regulated kinase (p-ERK) levels while decreasing melanogenesis-related protein expression. In addition, BBC modulated MAPK signaling and the expression of autophagy-associated proteins. Small interfering RNA-mediated knockdown of Atg5, Beclin1, or ERK partially restored extracellular melanin levels in BBC-treated cells. These findings suggest that BBC suppresses melanogenesis in B16-F1 melanoma cells in association with ERK and autophagy-related signaling.</p>
	]]></content:encoded>

	<dc:title>Berberine Chloride Suppresses Melanogenesis in B16-F1 Melanoma Cells in Association with ERK and Autophagy-Related Signaling</dc:title>
			<dc:creator>HwaJeong Ryu</dc:creator>
			<dc:creator>Ho Jae Lim</dc:creator>
			<dc:creator>Jung Eun Park</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050225</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-08-31</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-08-31</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>225</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050225</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/225</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/224">

	<title>Cosmetics, Vol. 13, Pages 224: Niosomal Serum Containing an Optimized Blend of Thai Herbal Extracts: Physicochemical Characterization and Clinical Performance on Skin Hydration and Pigmentation</title>
	<link>https://www.mdpi.com/2079-9284/13/5/224</link>
	<description>This study optimized a Thai herbal blend inhibiting tyrosinase and evaluated its delivery in niosomal serum versus a corresponding non-niosomal (free extract) serum. The physicochemical properties, antioxidant and tyrosinase-inhibitory activities, stability, and clinical effects of the two serums were assessed in an 8-week study in healthy volunteers. Herbal combinations were screened using a two-level, five-factor design with tyrosinase inhibition as the response, and the optimized extract ratio (3:2:3:2:2, w/w) was incorporated into conventional, liposomal, and niosomal formulations. Vesicle characterization and in vitro performance supported the niosomal serum for clinical comparison with the corresponding non-niosomal product. The niosomal serum showed appreciable DPPH radical-scavenging activity (IC50 32 mg/mL), whereas the conventional serum exhibited the highest tyrosinase inhibition (IC50 8.3 mg/mL). Clinically, 30 of 50 randomized volunteers completed the 8-week trial and were included in the efficacy analysis. The niosomal serum produced more consistent improvements in skin hydration and transepidermal water loss, with significant benefits over the non-niosomal (free extract) serum at selected mid-to-late time points. Erythema decreased significantly with both formulations, whereas melanin reduction was modest. These findings support the use of niosomal formulations containing combined Thai herbal extracts as a practical strategy to enhance moisturization and barrier support in skincare formulations.</description>
	<pubDate>2026-08-29</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 224: Niosomal Serum Containing an Optimized Blend of Thai Herbal Extracts: Physicochemical Characterization and Clinical Performance on Skin Hydration and Pigmentation</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/224">doi: 10.3390/cosmetics13050224</a></p>
	<p>Authors:
		Oraphan Anurukvorakun
		Witchuda Sukjoi
		Jaroenporn Chokboribal
		</p>
	<p>This study optimized a Thai herbal blend inhibiting tyrosinase and evaluated its delivery in niosomal serum versus a corresponding non-niosomal (free extract) serum. The physicochemical properties, antioxidant and tyrosinase-inhibitory activities, stability, and clinical effects of the two serums were assessed in an 8-week study in healthy volunteers. Herbal combinations were screened using a two-level, five-factor design with tyrosinase inhibition as the response, and the optimized extract ratio (3:2:3:2:2, w/w) was incorporated into conventional, liposomal, and niosomal formulations. Vesicle characterization and in vitro performance supported the niosomal serum for clinical comparison with the corresponding non-niosomal product. The niosomal serum showed appreciable DPPH radical-scavenging activity (IC50 32 mg/mL), whereas the conventional serum exhibited the highest tyrosinase inhibition (IC50 8.3 mg/mL). Clinically, 30 of 50 randomized volunteers completed the 8-week trial and were included in the efficacy analysis. The niosomal serum produced more consistent improvements in skin hydration and transepidermal water loss, with significant benefits over the non-niosomal (free extract) serum at selected mid-to-late time points. Erythema decreased significantly with both formulations, whereas melanin reduction was modest. These findings support the use of niosomal formulations containing combined Thai herbal extracts as a practical strategy to enhance moisturization and barrier support in skincare formulations.</p>
	]]></content:encoded>

	<dc:title>Niosomal Serum Containing an Optimized Blend of Thai Herbal Extracts: Physicochemical Characterization and Clinical Performance on Skin Hydration and Pigmentation</dc:title>
			<dc:creator>Oraphan Anurukvorakun</dc:creator>
			<dc:creator>Witchuda Sukjoi</dc:creator>
			<dc:creator>Jaroenporn Chokboribal</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050224</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-08-29</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-08-29</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>224</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050224</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/224</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/223">

	<title>Cosmetics, Vol. 13, Pages 223: Nanoindentation-Informed Skin Bilayer Modeling Links Stiffness Heterogeneity to Curvature Localization Under Glycation and Carbonyl Stress</title>
	<link>https://www.mdpi.com/2079-9284/13/5/223</link>
	<description>Glycation and reactive carbonyl stress are protein-modifying processes associated with skin aging, but how they alter local tissue mechanics and deformation-prone behavior remains unclear. Here, reconstructed human epidermis (RHE) and three-dimensional (3D) collagen gels were used as epidermal-like and collagen-rich skin surrogate compartments. Nanoindentation mapping showed that accelerated glycation and carbonyl stress increased the effective Young&amp;amp;rsquo;s modulus and stiffness heterogeneity in both models, with 2.34&amp;amp;ndash;5.85-fold increases in the mean modulus and 1.09&amp;amp;ndash;1.31-fold increases in normalized neighbor contrast across four treatment&amp;amp;ndash;model combinations: glycated RHE, glycated 3D collagen gel, carbonyl-stressed RHE and carbonyl-stressed 3D collagen gel. Nanoindentation-derived stiffness profiles were incorporated into reduced-order virtual bilayer nonlinear post-buckling simulations. Under imposed end-shortening strains of 1%, 5%, and 10%, glycation- and carbonyl-stress-informed bilayers showed increased predicted peak curvature and localized folding index values. Profile-control simulations were then used to separate average stiffening from spatial stiffness variation. Uniform-mean profiles failed to reproduce the curvature localization response, whereas heterogeneity-preserving mean-matched profiles retained elevated curvature-based outputs. These findings suggest that spatial stiffness heterogeneity, rather than stiffening alone, contributes to predicted curvature localization in skin surrogate bilayers. Beyond mechanistic insight, the nanoindentation&amp;amp;ndash;simulation workflow may provide a mechanics-based readout for evaluating prospective cosmetic interventions.</description>
	<pubDate>2026-08-28</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 223: Nanoindentation-Informed Skin Bilayer Modeling Links Stiffness Heterogeneity to Curvature Localization Under Glycation and Carbonyl Stress</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/223">doi: 10.3390/cosmetics13050223</a></p>
	<p>Authors:
		Yiwen Li
		Feng Cao
		Qianwen Fan
		Xi Yang
		Yulan Qu
		Xiangjun Gong
		Jian Cao
		Guangwen He
		Robert Maidhof
		Huanjun Zhou
		</p>
	<p>Glycation and reactive carbonyl stress are protein-modifying processes associated with skin aging, but how they alter local tissue mechanics and deformation-prone behavior remains unclear. Here, reconstructed human epidermis (RHE) and three-dimensional (3D) collagen gels were used as epidermal-like and collagen-rich skin surrogate compartments. Nanoindentation mapping showed that accelerated glycation and carbonyl stress increased the effective Young&amp;amp;rsquo;s modulus and stiffness heterogeneity in both models, with 2.34&amp;amp;ndash;5.85-fold increases in the mean modulus and 1.09&amp;amp;ndash;1.31-fold increases in normalized neighbor contrast across four treatment&amp;amp;ndash;model combinations: glycated RHE, glycated 3D collagen gel, carbonyl-stressed RHE and carbonyl-stressed 3D collagen gel. Nanoindentation-derived stiffness profiles were incorporated into reduced-order virtual bilayer nonlinear post-buckling simulations. Under imposed end-shortening strains of 1%, 5%, and 10%, glycation- and carbonyl-stress-informed bilayers showed increased predicted peak curvature and localized folding index values. Profile-control simulations were then used to separate average stiffening from spatial stiffness variation. Uniform-mean profiles failed to reproduce the curvature localization response, whereas heterogeneity-preserving mean-matched profiles retained elevated curvature-based outputs. These findings suggest that spatial stiffness heterogeneity, rather than stiffening alone, contributes to predicted curvature localization in skin surrogate bilayers. Beyond mechanistic insight, the nanoindentation&amp;amp;ndash;simulation workflow may provide a mechanics-based readout for evaluating prospective cosmetic interventions.</p>
	]]></content:encoded>

	<dc:title>Nanoindentation-Informed Skin Bilayer Modeling Links Stiffness Heterogeneity to Curvature Localization Under Glycation and Carbonyl Stress</dc:title>
			<dc:creator>Yiwen Li</dc:creator>
			<dc:creator>Feng Cao</dc:creator>
			<dc:creator>Qianwen Fan</dc:creator>
			<dc:creator>Xi Yang</dc:creator>
			<dc:creator>Yulan Qu</dc:creator>
			<dc:creator>Xiangjun Gong</dc:creator>
			<dc:creator>Jian Cao</dc:creator>
			<dc:creator>Guangwen He</dc:creator>
			<dc:creator>Robert Maidhof</dc:creator>
			<dc:creator>Huanjun Zhou</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050223</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-08-28</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-08-28</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>223</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050223</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/223</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/222">

	<title>Cosmetics, Vol. 13, Pages 222: Herbal Hair Dye Shampoo with Effective Hair Coloration, Color Durability, Low Irritation Potential, and Favorable Hair Morphology</title>
	<link>https://www.mdpi.com/2079-9284/13/5/222</link>
	<description>Background: Chemical hair dyes provide effective and durable coloration but are frequently associated with hair damage and irritation. Therefore, this study aimed to develop herbal-based hair dye products that combine effective coloration with low irritation potential. Methods: The combination of Lawsonia inermis, Clitoria ternatea, and Indigofera tinctoria was incorporated into different formulations (solution, shampoo, and conditioner) and evaluated for physicochemical properties, accelerated stability, and hair dyeing performance. The effects of herbal mixture concentration (10, 20, and 30% w/w) were further investigated for hair dyeing, foaming properties, washing fastness, and color stability under ambient natural-light conditions. The most suitable shampoo was evaluated for irritation potential using the hen&amp;amp;rsquo;s egg test&amp;amp;ndash;chorioallantoic membrane (HET-CAM) assay, hair morphology by scanning electron microscopy, and hair chemical characteristics using Fourier-transform infrared (FT-IR) spectroscopy. Results: Herbal hair dye formulations were successfully developed. Although the solution achieved the greatest hair dyeing performance, the shampoo provided more practical convenience. Increasing the herbal mixture concentration significantly enhanced dyeing performance, with the 30% w/w formulation producing the greatest dyeing performance, with stable color maintained after five washing cycles and excellent resistance to light-induced fading. Interestingly, the herbal shampoo exhibited significantly lower irritation potential than the chemical hair dye shampoo (irritation score: 4.9 &amp;amp;plusmn; 0.4 vs. 14.2 &amp;amp;plusmn; 0.4, p &amp;amp;lt; 0.05) and better-preserved hair cuticle integrity. FT-IR analysis showed retention of major keratin-associated bands, indicating no complete disruption of the fundamental keratin structure. Conclusions: The herbal hair dye shampoo offers a promising alternative to conventional hair dye, providing effective and durable hair coloration with favorable preservation of hair surface morphology and lower irritation potential.</description>
	<pubDate>2026-08-27</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 222: Herbal Hair Dye Shampoo with Effective Hair Coloration, Color Durability, Low Irritation Potential, and Favorable Hair Morphology</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/222">doi: 10.3390/cosmetics13050222</a></p>
	<p>Authors:
		Kodpaka Lueadnakrob
		Suttida Changprasoed
		Thitichaya Prakobwaitayakit
		Saranya Juntrapirom
		Watchara Kanjanakawinkul
		Wantida Chaiyana
		</p>
	<p>Background: Chemical hair dyes provide effective and durable coloration but are frequently associated with hair damage and irritation. Therefore, this study aimed to develop herbal-based hair dye products that combine effective coloration with low irritation potential. Methods: The combination of Lawsonia inermis, Clitoria ternatea, and Indigofera tinctoria was incorporated into different formulations (solution, shampoo, and conditioner) and evaluated for physicochemical properties, accelerated stability, and hair dyeing performance. The effects of herbal mixture concentration (10, 20, and 30% w/w) were further investigated for hair dyeing, foaming properties, washing fastness, and color stability under ambient natural-light conditions. The most suitable shampoo was evaluated for irritation potential using the hen&amp;amp;rsquo;s egg test&amp;amp;ndash;chorioallantoic membrane (HET-CAM) assay, hair morphology by scanning electron microscopy, and hair chemical characteristics using Fourier-transform infrared (FT-IR) spectroscopy. Results: Herbal hair dye formulations were successfully developed. Although the solution achieved the greatest hair dyeing performance, the shampoo provided more practical convenience. Increasing the herbal mixture concentration significantly enhanced dyeing performance, with the 30% w/w formulation producing the greatest dyeing performance, with stable color maintained after five washing cycles and excellent resistance to light-induced fading. Interestingly, the herbal shampoo exhibited significantly lower irritation potential than the chemical hair dye shampoo (irritation score: 4.9 &amp;amp;plusmn; 0.4 vs. 14.2 &amp;amp;plusmn; 0.4, p &amp;amp;lt; 0.05) and better-preserved hair cuticle integrity. FT-IR analysis showed retention of major keratin-associated bands, indicating no complete disruption of the fundamental keratin structure. Conclusions: The herbal hair dye shampoo offers a promising alternative to conventional hair dye, providing effective and durable hair coloration with favorable preservation of hair surface morphology and lower irritation potential.</p>
	]]></content:encoded>

	<dc:title>Herbal Hair Dye Shampoo with Effective Hair Coloration, Color Durability, Low Irritation Potential, and Favorable Hair Morphology</dc:title>
			<dc:creator>Kodpaka Lueadnakrob</dc:creator>
			<dc:creator>Suttida Changprasoed</dc:creator>
			<dc:creator>Thitichaya Prakobwaitayakit</dc:creator>
			<dc:creator>Saranya Juntrapirom</dc:creator>
			<dc:creator>Watchara Kanjanakawinkul</dc:creator>
			<dc:creator>Wantida Chaiyana</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050222</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-08-27</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-08-27</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>222</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050222</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/222</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/221">

	<title>Cosmetics, Vol. 13, Pages 221: Combined Fractional Radiofrequency Microneedling and High-Intensity Focused Ultrasound with Focus Dual for Facial Skin Rejuvenation: A 37-Patient Case Series</title>
	<link>https://www.mdpi.com/2079-9284/13/5/221</link>
	<description>Background: Non-invasive energy-based technologies, including high-intensity focused ultrasound (HIFU) and fractional radiofrequency microneedling (RF-MN), are increasingly used for facial rejuvenation due to their ability to induce dermal remodeling and neocollagenesis, although evidence on combined protocols remains limited. Objective: To evaluate the clinical outcomes and safety of a combined treatment protocol using HIFU and RF-MN delivered via the Focus Dual&amp;amp;reg; device for facial skin rejuvenation in patients with moderate-to-severe photo- and chrono-aging. Methods: This observational case series included 37 patients (52&amp;amp;ndash;85 years) treated with a combined regimen of HIFU and RF-MN over a 6-month period, consisting of two HIFU sessions and six RF-MN sessions; clinical outcomes were assessed using the Wrinkle Assessment Scale (WAS) across 11 facial anatomical regions and the Global Aesthetic Improvement Scale (GAIS), with evaluations performed on standardized photographs by two blinded independent assessors and safety monitored throughout. Statistical analysis was primarily descriptive and exploratory, including calculation of mean WAS scores, absolute and relative changes, inter-rater reliability assessment, and Pearson&amp;amp;rsquo;s correlation analysis. Results: The combined treatment was associated with a measurable improvement in wrinkle severity, with median global WAS decreasing from 4.53 at baseline to 3.98 post-treatment, corresponding to a 12.1% overall improvement; the greatest improvements were observed in anatomically lax regions such as the cheeks (25.36%), periorbital lines (25.14%), nasolabial folds (23.92%), neck (23.77%), and marionette lines (21.36%) and corner of mouth lines (20.98%), while dynamic regions such as the glabellar and frontal areas showed a more limited response; a positive correlation between baseline severity and treatment response was observed (r = 0.73), with excellent inter-rater reliability (&amp;amp;kappa; = 0.93&amp;amp;ndash;0.95) and no serious adverse events reported. Conclusions: The combined use of HIFU and RF-MN via the Focus Dual&amp;amp;reg; device appears to be a safe and well-tolerated non-invasive approach for facial rejuvenation associated with clinical improvements in wrinkle severity with a region- and severity-dependent response profile; the interaction between deep structural tightening (HIFU) and superficial dermal remodeling (RF-MN) suggests a complementary mechanism of action, although further controlled studies are warranted to confirm these findings and evaluate long-term outcomes.</description>
	<pubDate>2026-08-27</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 221: Combined Fractional Radiofrequency Microneedling and High-Intensity Focused Ultrasound with Focus Dual for Facial Skin Rejuvenation: A 37-Patient Case Series</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/221">doi: 10.3390/cosmetics13050221</a></p>
	<p>Authors:
		Ornella Rossi
		Giovanna Perrotti
		Massimo Del Fabbro
		Tiziano Testori
		</p>
	<p>Background: Non-invasive energy-based technologies, including high-intensity focused ultrasound (HIFU) and fractional radiofrequency microneedling (RF-MN), are increasingly used for facial rejuvenation due to their ability to induce dermal remodeling and neocollagenesis, although evidence on combined protocols remains limited. Objective: To evaluate the clinical outcomes and safety of a combined treatment protocol using HIFU and RF-MN delivered via the Focus Dual&amp;amp;reg; device for facial skin rejuvenation in patients with moderate-to-severe photo- and chrono-aging. Methods: This observational case series included 37 patients (52&amp;amp;ndash;85 years) treated with a combined regimen of HIFU and RF-MN over a 6-month period, consisting of two HIFU sessions and six RF-MN sessions; clinical outcomes were assessed using the Wrinkle Assessment Scale (WAS) across 11 facial anatomical regions and the Global Aesthetic Improvement Scale (GAIS), with evaluations performed on standardized photographs by two blinded independent assessors and safety monitored throughout. Statistical analysis was primarily descriptive and exploratory, including calculation of mean WAS scores, absolute and relative changes, inter-rater reliability assessment, and Pearson&amp;amp;rsquo;s correlation analysis. Results: The combined treatment was associated with a measurable improvement in wrinkle severity, with median global WAS decreasing from 4.53 at baseline to 3.98 post-treatment, corresponding to a 12.1% overall improvement; the greatest improvements were observed in anatomically lax regions such as the cheeks (25.36%), periorbital lines (25.14%), nasolabial folds (23.92%), neck (23.77%), and marionette lines (21.36%) and corner of mouth lines (20.98%), while dynamic regions such as the glabellar and frontal areas showed a more limited response; a positive correlation between baseline severity and treatment response was observed (r = 0.73), with excellent inter-rater reliability (&amp;amp;kappa; = 0.93&amp;amp;ndash;0.95) and no serious adverse events reported. Conclusions: The combined use of HIFU and RF-MN via the Focus Dual&amp;amp;reg; device appears to be a safe and well-tolerated non-invasive approach for facial rejuvenation associated with clinical improvements in wrinkle severity with a region- and severity-dependent response profile; the interaction between deep structural tightening (HIFU) and superficial dermal remodeling (RF-MN) suggests a complementary mechanism of action, although further controlled studies are warranted to confirm these findings and evaluate long-term outcomes.</p>
	]]></content:encoded>

	<dc:title>Combined Fractional Radiofrequency Microneedling and High-Intensity Focused Ultrasound with Focus Dual for Facial Skin Rejuvenation: A 37-Patient Case Series</dc:title>
			<dc:creator>Ornella Rossi</dc:creator>
			<dc:creator>Giovanna Perrotti</dc:creator>
			<dc:creator>Massimo Del Fabbro</dc:creator>
			<dc:creator>Tiziano Testori</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050221</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-08-27</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-08-27</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Case Report</prism:section>
	<prism:startingPage>221</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050221</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/221</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/220">

	<title>Cosmetics, Vol. 13, Pages 220: A Well-Tolerated Supercritical CO2 Extract Derived from Helichrysum italicum Distillation Co-Products with Retinoid-Associated Anti-Aging Activity</title>
	<link>https://www.mdpi.com/2079-9284/13/5/220</link>
	<description>Skin aging is characterized by various changes, including epidermal thinning, barrier dysfunction, dermis alteration, and dermal&amp;amp;ndash;epidermal junction flattening. These changes lead to wrinkles and loss of skin radiance. This study investigates the potential of a supercritical CO2 extract derived from Helichrysum italicum distillation co-products (CO2SC extract) to serve as a botanical anti-aging product, targeting epidermal renewal, barrier reinforcement, dermal&amp;amp;ndash;epidermal junction organization, and engagement of retinoid-related gene networks. CO2SC extract&amp;amp;rsquo;s effects were examined at 0.005% in aged-human-skin equivalents via histology, immunohistology, and transcriptomics. Furthermore, CO2SC extract was investigated at 0.1% in human skin explants using label-free proteomics in comparison with retinol (ROL) at 0.1% and 0.3%. The clinical effectiveness and tolerability of 0.1% CO2SC extract were determined by conducting a randomized, intra-individual comparison with a 0.1% ROL formulation. In aged-human-skin equivalents, CO2SC extract at 0.005% increased epidermal thickness, enhanced expression of differentiation- and barrier-related genes, and stimulated dermal remodeling by increasing type I and III collagens while promoting type VII collagen at the dermal&amp;amp;ndash;epidermal junction. Transcriptomic analysis revealed upregulation of genes involved in ROL metabolism and retinoic-acid-responsive signaling. Proteomic profiling further highlighted treatment-associated molecular signatures in comparison with ROL. Clinically, 0.1% CO2SC extract significantly improved wrinkles by day 28, with improvements of comparable magnitude to those observed with the 0.1% ROL arm under the tested conditions and good tolerability, with no signs of irritation reported, including in sensitive-skin participants. CO2SC extract displays anti-aging activity at the molecular, histological, and clinical levels under the tested conditions, modulating gene networks related to ROL metabolism and retinoid signaling while reinforcing barrier integrity and dermal regeneration. Together with its favorable tolerability profile, these findings suggest that this CO2SC extract triggers retinoid-associated programs while maintaining a molecular profile distinct from that of ROL, supporting further evaluation as a botanical anti-aging ingredient agent.</description>
	<pubDate>2026-08-26</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 220: A Well-Tolerated Supercritical CO2 Extract Derived from Helichrysum italicum Distillation Co-Products with Retinoid-Associated Anti-Aging Activity</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/220">doi: 10.3390/cosmetics13050220</a></p>
	<p>Authors:
		Géraldine Lemaire
		Malvina Olivero
		Virginie Rouquet
		Stéphanie Rivoire
		Amélie Thepot
		Morgan Dos Santos
		Pascal Portes
		Valérie Cenizo
		</p>
	<p>Skin aging is characterized by various changes, including epidermal thinning, barrier dysfunction, dermis alteration, and dermal&amp;amp;ndash;epidermal junction flattening. These changes lead to wrinkles and loss of skin radiance. This study investigates the potential of a supercritical CO2 extract derived from Helichrysum italicum distillation co-products (CO2SC extract) to serve as a botanical anti-aging product, targeting epidermal renewal, barrier reinforcement, dermal&amp;amp;ndash;epidermal junction organization, and engagement of retinoid-related gene networks. CO2SC extract&amp;amp;rsquo;s effects were examined at 0.005% in aged-human-skin equivalents via histology, immunohistology, and transcriptomics. Furthermore, CO2SC extract was investigated at 0.1% in human skin explants using label-free proteomics in comparison with retinol (ROL) at 0.1% and 0.3%. The clinical effectiveness and tolerability of 0.1% CO2SC extract were determined by conducting a randomized, intra-individual comparison with a 0.1% ROL formulation. In aged-human-skin equivalents, CO2SC extract at 0.005% increased epidermal thickness, enhanced expression of differentiation- and barrier-related genes, and stimulated dermal remodeling by increasing type I and III collagens while promoting type VII collagen at the dermal&amp;amp;ndash;epidermal junction. Transcriptomic analysis revealed upregulation of genes involved in ROL metabolism and retinoic-acid-responsive signaling. Proteomic profiling further highlighted treatment-associated molecular signatures in comparison with ROL. Clinically, 0.1% CO2SC extract significantly improved wrinkles by day 28, with improvements of comparable magnitude to those observed with the 0.1% ROL arm under the tested conditions and good tolerability, with no signs of irritation reported, including in sensitive-skin participants. CO2SC extract displays anti-aging activity at the molecular, histological, and clinical levels under the tested conditions, modulating gene networks related to ROL metabolism and retinoid signaling while reinforcing barrier integrity and dermal regeneration. Together with its favorable tolerability profile, these findings suggest that this CO2SC extract triggers retinoid-associated programs while maintaining a molecular profile distinct from that of ROL, supporting further evaluation as a botanical anti-aging ingredient agent.</p>
	]]></content:encoded>

	<dc:title>A Well-Tolerated Supercritical CO2 Extract Derived from Helichrysum italicum Distillation Co-Products with Retinoid-Associated Anti-Aging Activity</dc:title>
			<dc:creator>Géraldine Lemaire</dc:creator>
			<dc:creator>Malvina Olivero</dc:creator>
			<dc:creator>Virginie Rouquet</dc:creator>
			<dc:creator>Stéphanie Rivoire</dc:creator>
			<dc:creator>Amélie Thepot</dc:creator>
			<dc:creator>Morgan Dos Santos</dc:creator>
			<dc:creator>Pascal Portes</dc:creator>
			<dc:creator>Valérie Cenizo</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050220</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-08-26</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-08-26</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>220</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050220</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/220</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/219">

	<title>Cosmetics, Vol. 13, Pages 219: Integrated Phytochemical Characterization, Formulation Engineering, and Stability Assessment of a Spray-Based Dermocosmetic Delivery System Incorporating Plectranthus amboinicus Leaf Extract</title>
	<link>https://www.mdpi.com/2079-9284/13/5/219</link>
	<description>The increasing demand for natural and sustainable cosmetic ingredients has stimulated interest in medicinal plants as sources of multifunctional bioactive compounds. This study aimed to develop and evaluate a low-viscosity spray-based cosmetic formulation containing Plectranthus amboinicus leaf extract through phytochemical characterization, antioxidant evaluation, formulation engineering, and physicochemical stability assessment. The novelty of this work lies in evaluating the feasibility of incorporating P. amboinicus extract into a spray-based delivery system while maintaining acceptable physicochemical formulation stability. Ethanol extracts were characterized for extraction yield, total phenolic content (TPC), and 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity. Four formulations containing 0%, 1%, 3%, and 5% (w/v) extract were evaluated for appearance, pH, homogeneity, and short-term stability. The extract exhibited measurable antioxidant activity and detectable phenolic content. All formulations remained homogeneous, showed no phase separation, and maintained physiological skin pH (5.5&amp;amp;ndash;6.0) throughout storage. Only the 5% formulation showed a slight reduction in transparency without compromising physical stability. These findings demonstrate the feasibility of incorporating P. amboinicus extract into a spray-based cosmetic formulation while maintaining acceptable short-term physicochemical stability. The study provides preliminary formulation evidence rather than biological efficacy, and further phytochemical, rheological, spray-performance, biological, and long-term stability studies are warranted. Accordingly, the present findings demonstrate formulation feasibility only and should not be interpreted as confirmation of clinical skin benefits, dermocosmetic efficacy, or spray-device performance.</description>
	<pubDate>2026-08-26</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 219: Integrated Phytochemical Characterization, Formulation Engineering, and Stability Assessment of a Spray-Based Dermocosmetic Delivery System Incorporating Plectranthus amboinicus Leaf Extract</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/219">doi: 10.3390/cosmetics13050219</a></p>
	<p>Authors:
		Nustha Kitprathaung
		Pongthep Poungthong
		Othmane Merah
		</p>
	<p>The increasing demand for natural and sustainable cosmetic ingredients has stimulated interest in medicinal plants as sources of multifunctional bioactive compounds. This study aimed to develop and evaluate a low-viscosity spray-based cosmetic formulation containing Plectranthus amboinicus leaf extract through phytochemical characterization, antioxidant evaluation, formulation engineering, and physicochemical stability assessment. The novelty of this work lies in evaluating the feasibility of incorporating P. amboinicus extract into a spray-based delivery system while maintaining acceptable physicochemical formulation stability. Ethanol extracts were characterized for extraction yield, total phenolic content (TPC), and 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity. Four formulations containing 0%, 1%, 3%, and 5% (w/v) extract were evaluated for appearance, pH, homogeneity, and short-term stability. The extract exhibited measurable antioxidant activity and detectable phenolic content. All formulations remained homogeneous, showed no phase separation, and maintained physiological skin pH (5.5&amp;amp;ndash;6.0) throughout storage. Only the 5% formulation showed a slight reduction in transparency without compromising physical stability. These findings demonstrate the feasibility of incorporating P. amboinicus extract into a spray-based cosmetic formulation while maintaining acceptable short-term physicochemical stability. The study provides preliminary formulation evidence rather than biological efficacy, and further phytochemical, rheological, spray-performance, biological, and long-term stability studies are warranted. Accordingly, the present findings demonstrate formulation feasibility only and should not be interpreted as confirmation of clinical skin benefits, dermocosmetic efficacy, or spray-device performance.</p>
	]]></content:encoded>

	<dc:title>Integrated Phytochemical Characterization, Formulation Engineering, and Stability Assessment of a Spray-Based Dermocosmetic Delivery System Incorporating Plectranthus amboinicus Leaf Extract</dc:title>
			<dc:creator>Nustha Kitprathaung</dc:creator>
			<dc:creator>Pongthep Poungthong</dc:creator>
			<dc:creator>Othmane Merah</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050219</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-08-26</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-08-26</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>219</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050219</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/219</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/218">

	<title>Cosmetics, Vol. 13, Pages 218: Reliability and Consistency of the IEC Ultrasound Staging System for Stage III Cellulite: An Image-Based Validation Study</title>
	<link>https://www.mdpi.com/2079-9284/13/5/218</link>
	<description>Background. In recent years, the use of ultrasound in the diagnosis of cellulite has grown substantially, making reproducible and validated ultrasound-based grading systems for stage III cellulite increasingly necessary to support their accurate application in both clinical practice and research. The Intagliata Echo-Cellulite (IEC) staging system identifies three morphological sub-types using high-frequency ultrasound. Objective. The study aims to evaluate the inter-rater reliability and test&amp;amp;ndash;retest reliability of the IEC staging system. Methods. This prospective, image-based reliability study included 150 women with stage III cellulite at a single center. Standardized ultrasound images acquired by an expert were independently rated by two non-expert raters in two sessions four weeks apart and compared with the expert&amp;amp;rsquo;s ratings; the expert is also the developer of the IEC system. Results. For the primary outcome, IEC stage, both raters achieved almost perfect inter-rater agreement with the gold standard (Rater 1: &amp;amp;kappa; = 0.926, 93.3%; Rater 2: &amp;amp;kappa; = 0.985, 98.7%) and almost perfect test&amp;amp;ndash;retest consistency (Rater 1: &amp;amp;kappa; = 0.840; Rater 2: &amp;amp;kappa; = 0.817). Agreement on secondary ultrasound-based variables was more heterogeneous and consistently lower than for the composite IEC stage. Limitations. The image-based design provides an upper bound reliability estimate; additionally, the gold standard rater is the developer of the IEC system, which constrains the independence of the reference standard. Conclusions. Even when applied by untrained raters, the IEC staging system shows high inter-rater reliability and test&amp;amp;ndash;retest consistency. These findings further independent validation as a standardized grading tool in cellulite research and precision aesthetic medicine.</description>
	<pubDate>2026-08-26</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 218: Reliability and Consistency of the IEC Ultrasound Staging System for Stage III Cellulite: An Image-Based Validation Study</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/218">doi: 10.3390/cosmetics13050218</a></p>
	<p>Authors:
		Dora Intagliata
		Raffaella Benvenuto
		Cristiana Saporosi
		Maria Luisa Garo
		</p>
	<p>Background. In recent years, the use of ultrasound in the diagnosis of cellulite has grown substantially, making reproducible and validated ultrasound-based grading systems for stage III cellulite increasingly necessary to support their accurate application in both clinical practice and research. The Intagliata Echo-Cellulite (IEC) staging system identifies three morphological sub-types using high-frequency ultrasound. Objective. The study aims to evaluate the inter-rater reliability and test&amp;amp;ndash;retest reliability of the IEC staging system. Methods. This prospective, image-based reliability study included 150 women with stage III cellulite at a single center. Standardized ultrasound images acquired by an expert were independently rated by two non-expert raters in two sessions four weeks apart and compared with the expert&amp;amp;rsquo;s ratings; the expert is also the developer of the IEC system. Results. For the primary outcome, IEC stage, both raters achieved almost perfect inter-rater agreement with the gold standard (Rater 1: &amp;amp;kappa; = 0.926, 93.3%; Rater 2: &amp;amp;kappa; = 0.985, 98.7%) and almost perfect test&amp;amp;ndash;retest consistency (Rater 1: &amp;amp;kappa; = 0.840; Rater 2: &amp;amp;kappa; = 0.817). Agreement on secondary ultrasound-based variables was more heterogeneous and consistently lower than for the composite IEC stage. Limitations. The image-based design provides an upper bound reliability estimate; additionally, the gold standard rater is the developer of the IEC system, which constrains the independence of the reference standard. Conclusions. Even when applied by untrained raters, the IEC staging system shows high inter-rater reliability and test&amp;amp;ndash;retest consistency. These findings further independent validation as a standardized grading tool in cellulite research and precision aesthetic medicine.</p>
	]]></content:encoded>

	<dc:title>Reliability and Consistency of the IEC Ultrasound Staging System for Stage III Cellulite: An Image-Based Validation Study</dc:title>
			<dc:creator>Dora Intagliata</dc:creator>
			<dc:creator>Raffaella Benvenuto</dc:creator>
			<dc:creator>Cristiana Saporosi</dc:creator>
			<dc:creator>Maria Luisa Garo</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050218</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-08-26</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-08-26</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>218</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050218</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/218</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/217">

	<title>Cosmetics, Vol. 13, Pages 217: Rapid-Onset Unilateral Papular Granuloma Annulare-like Granulomatous Reaction After a Mesotherapy-like Cosmetic Procedure</title>
	<link>https://www.mdpi.com/2079-9284/13/5/217</link>
	<description>Mesotherapy and related cosmetic microinjection or microneedling procedures are increasingly used for aesthetic indications. However, their safety profile is difficult to define because injectates, devices, injection depths, and treatment protocols vary widely. We report a case of rapid-onset papular granuloma annulare (GA)-like granulomatous reaction after a mesotherapy-like cosmetic procedure. An Asian woman in her forties developed multiple 2&amp;amp;ndash;3 mm erythematous papules in a regular grid-like distribution corresponding to facial injection sites. Papules were limited to the left hemiface despite bilateral treatment with the same sodium hyaluronate-containing skincare serum delivered using a suction-assisted 9-pin multi-needle mesogun. Histology showed necrobiotic granulomas with palisading epithelioid histiocytes and increased dermal mucin. After nine sessions of intralesional triamcinolone acetonide, near-complete clinical resolution was documented 14 months after the first intralesional triamcinolone session. This case highlights an unusual rapid-onset, papular, grid-patterned GA-like granulomatous reaction after a mesotherapy-like cosmetic procedure. The temporal and anatomical relationship to injection supports a procedure-associated reaction. Potential contributors include injected materials, use of products not intended for injection, suction-assisted multi-needle delivery, altered injection pressure or depth, repeated passes, mechanical trauma or Koebnerisation, delayed-type hypersensitivity, foreign-body response, contamination, and host susceptibility. This case does not establish a causative agent or reproducible procedure-specific adverse reaction, but documents a distinctive rapid-onset, grid-like papular GA-like reaction after poorly characterized cosmetic interventions.</description>
	<pubDate>2026-08-26</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 217: Rapid-Onset Unilateral Papular Granuloma Annulare-like Granulomatous Reaction After a Mesotherapy-like Cosmetic Procedure</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/217">doi: 10.3390/cosmetics13050217</a></p>
	<p>Authors:
		Woo Chiao Tay
		Rebecca Tian Mei Au
		Joyce Siong See Lee
		Chee Leok Goh
		Suzanne Wei Na Cheng
		</p>
	<p>Mesotherapy and related cosmetic microinjection or microneedling procedures are increasingly used for aesthetic indications. However, their safety profile is difficult to define because injectates, devices, injection depths, and treatment protocols vary widely. We report a case of rapid-onset papular granuloma annulare (GA)-like granulomatous reaction after a mesotherapy-like cosmetic procedure. An Asian woman in her forties developed multiple 2&amp;amp;ndash;3 mm erythematous papules in a regular grid-like distribution corresponding to facial injection sites. Papules were limited to the left hemiface despite bilateral treatment with the same sodium hyaluronate-containing skincare serum delivered using a suction-assisted 9-pin multi-needle mesogun. Histology showed necrobiotic granulomas with palisading epithelioid histiocytes and increased dermal mucin. After nine sessions of intralesional triamcinolone acetonide, near-complete clinical resolution was documented 14 months after the first intralesional triamcinolone session. This case highlights an unusual rapid-onset, papular, grid-patterned GA-like granulomatous reaction after a mesotherapy-like cosmetic procedure. The temporal and anatomical relationship to injection supports a procedure-associated reaction. Potential contributors include injected materials, use of products not intended for injection, suction-assisted multi-needle delivery, altered injection pressure or depth, repeated passes, mechanical trauma or Koebnerisation, delayed-type hypersensitivity, foreign-body response, contamination, and host susceptibility. This case does not establish a causative agent or reproducible procedure-specific adverse reaction, but documents a distinctive rapid-onset, grid-like papular GA-like reaction after poorly characterized cosmetic interventions.</p>
	]]></content:encoded>

	<dc:title>Rapid-Onset Unilateral Papular Granuloma Annulare-like Granulomatous Reaction After a Mesotherapy-like Cosmetic Procedure</dc:title>
			<dc:creator>Woo Chiao Tay</dc:creator>
			<dc:creator>Rebecca Tian Mei Au</dc:creator>
			<dc:creator>Joyce Siong See Lee</dc:creator>
			<dc:creator>Chee Leok Goh</dc:creator>
			<dc:creator>Suzanne Wei Na Cheng</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050217</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-08-26</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-08-26</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Case Report</prism:section>
	<prism:startingPage>217</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050217</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/217</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2079-9284/13/5/216">

	<title>Cosmetics, Vol. 13, Pages 216: Poly-L-Lactic Acid (Sculptra&amp;reg;) for Perioral Rejuvenation: A Case Series</title>
	<link>https://www.mdpi.com/2079-9284/13/5/216</link>
	<description>Rejuvenation of the perioral region using minimally invasive aesthetic techniques is frequently used to address age-related changes. While hyaluronic acid-based dermal fillers are a frequently used treatment, limited data are available on the injectable biostimulator poly-L-lactic acid (PLLA-SCA; Sculptra&amp;amp;reg;). This study described the aesthetic outcomes of PLLA-SCA injectable treatment for perioral rejuvenation using a series of patient cases collected up to 8&amp;amp;ndash;13 months post-first injection. This retrospective, single-center case series involved adults (age &amp;amp;ge; 18 years) who presented with concerns related to age-associated changes in the perioral region and were treated with PLLA-SCA as part of a full-face rejuvenation regimen. Reconstituted PLLA-SCA was injected subdermally, as superficially as technically feasible, using a 25-gauge blunt-tip cannula equally across both sides of the full face, adjusted to individual findings, at Baseline (Day 0) and at Weeks 8 and 16, with a follow-up at Week 28. This series of patient cases demonstrated positive aesthetic outcomes with PLLA-SCA that included visible softening of the vertical lip lines at rest and restoration of a more horizontal commissural axis, preserved dynamic expression, improved definition of the Cupid&amp;amp;rsquo;s bow and the vermilion border, reduced prominence of the mentolabial crease, improved midfacial support, and improvement of peri-commissural skin texture. For all cases, the investigator-rated Global Aesthetic Improvement Scale score at Week 28 was either &amp;amp;ldquo;very much improved&amp;amp;rdquo; or &amp;amp;ldquo;much improved&amp;amp;rdquo;, and the patient-reported satisfaction was rated at 5/5. Adverse events were limited to mild, transient injection-site bruising that quickly resolved without intervention, and short-lived edema; no nodules, vascular events, or delayed-onset reactions were observed. While these preliminary clinical observations at Week 28 suggest that PLLA-SCA can be used in a safe and effective manner for rejuvenation of the perioral region, future, larger, and longer-duration studies are warranted.</description>
	<pubDate>2026-08-25</pubDate>

	<content:encoded><![CDATA[
	<p><b>Cosmetics, Vol. 13, Pages 216: Poly-L-Lactic Acid (Sculptra&amp;reg;) for Perioral Rejuvenation: A Case Series</b></p>
	<p>Cosmetics <a href="https://www.mdpi.com/2079-9284/13/5/216">doi: 10.3390/cosmetics13050216</a></p>
	<p>Authors:
		Adrian Palma
		</p>
	<p>Rejuvenation of the perioral region using minimally invasive aesthetic techniques is frequently used to address age-related changes. While hyaluronic acid-based dermal fillers are a frequently used treatment, limited data are available on the injectable biostimulator poly-L-lactic acid (PLLA-SCA; Sculptra&amp;amp;reg;). This study described the aesthetic outcomes of PLLA-SCA injectable treatment for perioral rejuvenation using a series of patient cases collected up to 8&amp;amp;ndash;13 months post-first injection. This retrospective, single-center case series involved adults (age &amp;amp;ge; 18 years) who presented with concerns related to age-associated changes in the perioral region and were treated with PLLA-SCA as part of a full-face rejuvenation regimen. Reconstituted PLLA-SCA was injected subdermally, as superficially as technically feasible, using a 25-gauge blunt-tip cannula equally across both sides of the full face, adjusted to individual findings, at Baseline (Day 0) and at Weeks 8 and 16, with a follow-up at Week 28. This series of patient cases demonstrated positive aesthetic outcomes with PLLA-SCA that included visible softening of the vertical lip lines at rest and restoration of a more horizontal commissural axis, preserved dynamic expression, improved definition of the Cupid&amp;amp;rsquo;s bow and the vermilion border, reduced prominence of the mentolabial crease, improved midfacial support, and improvement of peri-commissural skin texture. For all cases, the investigator-rated Global Aesthetic Improvement Scale score at Week 28 was either &amp;amp;ldquo;very much improved&amp;amp;rdquo; or &amp;amp;ldquo;much improved&amp;amp;rdquo;, and the patient-reported satisfaction was rated at 5/5. Adverse events were limited to mild, transient injection-site bruising that quickly resolved without intervention, and short-lived edema; no nodules, vascular events, or delayed-onset reactions were observed. While these preliminary clinical observations at Week 28 suggest that PLLA-SCA can be used in a safe and effective manner for rejuvenation of the perioral region, future, larger, and longer-duration studies are warranted.</p>
	]]></content:encoded>

	<dc:title>Poly-L-Lactic Acid (Sculptra&amp;amp;reg;) for Perioral Rejuvenation: A Case Series</dc:title>
			<dc:creator>Adrian Palma</dc:creator>
		<dc:identifier>doi: 10.3390/cosmetics13050216</dc:identifier>
	<dc:source>Cosmetics</dc:source>
	<dc:date>2026-08-25</dc:date>

	<prism:publicationName>Cosmetics</prism:publicationName>
	<prism:publicationDate>2026-08-25</prism:publicationDate>
	<prism:volume>13</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>216</prism:startingPage>
		<prism:doi>10.3390/cosmetics13050216</prism:doi>
	<prism:url>https://www.mdpi.com/2079-9284/13/5/216</prism:url>

	<cc:license rdf:resource="CC BY 4.0"/>
</item>
    
<cc:License rdf:about="https://creativecommons.org/licenses/by/4.0/">
	<cc:permits rdf:resource="https://creativecommons.org/ns#Reproduction" />
	<cc:permits rdf:resource="https://creativecommons.org/ns#Distribution" />
	<cc:permits rdf:resource="https://creativecommons.org/ns#DerivativeWorks" />
</cc:License>

</rdf:RDF>
